{
    "data": [
        {
            "active": true,
            "alternatives": [
                {
                    "answer_percentage": 9,
                    "answers": 293,
                    "body": "I e II.",
                    "correct": false,
                    "created_at": "2021-07-05 20:55:33.016838 +0000 UTC",
                    "id": "0e96563e-108d-4aef-a7ae-ef4d3df44f55",
                    "position": "0",
                    "sanitized_body": "I e II.",
                    "solution": {
                        "alternative_id": "0e96563e-108d-4aef-a7ae-ef4d3df44f55",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-07-07 12:07:16.136725 +0000 UTC",
                        "id": "cfc05803-261b-452f-9b8e-bd16c46dc103",
                        "sanitized_brief": "",
                        "sanitized_complete": "",
                        "updated_at": "2021-07-07 12:07:19.956951 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-07-05 20:55:42.377157 +0000 UTC"
                },
                {
                    "answer_percentage": 11,
                    "answers": 378,
                    "body": "I e II.",
                    "correct": false,
                    "created_at": "2021-07-05 20:55:33.016838 +0000 UTC",
                    "id": "7b201258-055b-4f33-a9b5-d2ba5c5e5407",
                    "position": "1",
                    "sanitized_body": "I e II.",
                    "solution": {
                        "alternative_id": "7b201258-055b-4f33-a9b5-d2ba5c5e5407",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-07-07 12:07:16.046822 +0000 UTC",
                        "id": "0e54f59a-0619-48a2-b1ef-99d504791bcf",
                        "sanitized_brief": "",
                        "sanitized_complete": "",
                        "updated_at": "2021-07-07 12:07:20.347738 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-07-05 20:55:42.544462 +0000 UTC"
                },
                {
                    "answer_percentage": 46,
                    "answers": 1561,
                    "body": "I e III.",
                    "correct": true,
                    "created_at": "2021-07-05 20:55:33.016838 +0000 UTC",
                    "id": "ca7a2eaa-4b8f-4aa1-a5e6-b4f37ed4d2d6",
                    "position": "2",
                    "sanitized_body": "I e III.",
                    "solution": {
                        "alternative_id": "ca7a2eaa-4b8f-4aa1-a5e6-b4f37ed4d2d6",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-07-07 12:07:16.857185 +0000 UTC",
                        "id": "e594626f-17d8-4634-94db-65eb8c7500e9",
                        "sanitized_brief": "",
                        "sanitized_complete": "",
                        "updated_at": "2021-07-07 12:07:19.848609 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-07-05 20:55:42.736083 +0000 UTC"
                },
                {
                    "answer_percentage": 18,
                    "answers": 594,
                    "body": "Apenas III.",
                    "correct": false,
                    "created_at": "2021-07-05 20:55:33.016838 +0000 UTC",
                    "id": "10c58010-8638-4965-a8f9-c5d42f5e4ffd",
                    "position": "3",
                    "sanitized_body": "Apenas III.",
                    "solution": {
                        "alternative_id": "10c58010-8638-4965-a8f9-c5d42f5e4ffd",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-07-07 12:07:16.047453 +0000 UTC",
                        "id": "5283d06a-0f50-4bff-9932-f48403710e97",
                        "sanitized_brief": "",
                        "sanitized_complete": "",
                        "updated_at": "2021-07-07 12:07:20.3475 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-07-05 20:55:42.929935 +0000 UTC"
                },
                {
                    "answer_percentage": 16,
                    "answers": 545,
                    "body": "I, II e III.",
                    "correct": false,
                    "created_at": "2021-07-05 20:55:33.016838 +0000 UTC",
                    "id": "e6415960-cc5f-4339-b659-c0f7348245a2",
                    "position": "4",
                    "sanitized_body": "I, II e III.",
                    "solution": {
                        "alternative_id": "e6415960-cc5f-4339-b659-c0f7348245a2",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-07-07 12:07:16.857226 +0000 UTC",
                        "id": "372a3bdc-8326-4d65-8183-606aa32cda48",
                        "sanitized_brief": "",
                        "sanitized_complete": "",
                        "updated_at": "2021-07-07 12:07:19.957157 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-07-05 20:55:43.120366 +0000 UTC"
                }
            ],
            "answer_type": "MULTIPLE_CHOICE",
            "author_id": "bruno-cesar110@hotmail.com",
            "correct_answer_percentage": 46,
            "created_at": "2021-07-05 20:55:33.016838 +0000 UTC",
            "difficulty_level": "MEDIUM",
            "exams": [
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "cad77a08-2520-453c-bb37-b023d5161d6d",
                        "goal_id": "509858a1-11ed-4c96-a194-33b16db1300e",
                        "institution_id": "1d2d3153-8023-4908-8121-dd46fdaa4462",
                        "jury_id": "48ff920d-c16a-439d-8d9b-01971c94c5da"
                    },
                    "created_at": "2021-07-05T20:24:22Z",
                    "degree_proof": false,
                    "id": "4000004686",
                    "location": {
                        "id": "1"
                    },
                    "number": 2,
                    "open_spaces": 0,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "F69CF06D-F4DC-0269-AB0C-8275520A1BC2"
                        }
                    ],
                    "questions_number": 50,
                    "scholarity": "placeholder",
                    "year": 2021
                }
            ],
            "forum_id": "f91ba3d8-d6ad-45f8-815c-f605d40b5560",
            "has_student_answer": false,
            "has_user_solution": false,
            "has_video_solution": false,
            "id": "4000151924",
            "labels": [
                "FINAL_ANSWER_SHEET"
            ],
            "public": true,
            "slug": "Considere-seguintes159be5a77df",
            "solution": {
                "alternative_solutions": null,
                "author_email": "camila.moma@estrategiamed.com.br",
                "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                "brief": "",
                "brief_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "complete": "<b>GABARITO: ALTERNATIVA C</b><div><b><br></b></div><div>O diabetes mellitus tipo 2 Ã© uma doenÃ§a crÃ´nica, cuja principal caracterÃ­stica Ã© a resistÃªncia Ã  insulina associada Ã  falÃªncia progressiva das  cÃ©lulas beta pancreÃ¡ticas. Assim, com o passar do tempo, hÃ¡ necessidade de introduÃ§Ã£o de nova droga para controle da hiperglicemia. A escolha  medicamentosa deve ser individualizada, a fim de reduzir efeitos colaterais e, atÃ© mesmo, trazer benefÃ­cios para o paciente</div><div><br></div><div><!-- BEGIN:IMAGE_TO_REPLACE --><img src=\"https://estrategia-prod-questoes.s3.amazonaws.com/images/129A30AC-ADC3-FF42-5492-C1CE52EC6346/129A30AC-ADC3-FF42-5492-C1CE52EC6346-400.png\"><!-- END:IMAGE_TO_REPLACE --><br></div><div><br></div><div>A manutenÃ§Ã£o de nÃ­veis glicÃªmicos adequados permite a reduÃ§Ã£o do risco de complicaÃ§Ãµes crÃ´nicas, principalmente microvasculares  (nefro, retino e neuropatias). Para isso, hÃ¡ metas definidas de controle glicÃªmico, considerando adultos nÃ£o fragilizados:</div><div><br></div><div>â¢ Glicemia em jejum: &lt; 130 mg/dL;</div><div>â¢ Glicemia 2 horas apÃ³s a refeiÃ§Ã£o: &lt; 180 mg/dL;</div><div>â¢ Hemoglobina glicada fraÃ§Ã£o A1c (HbA1c) &lt; 7%.</div><div><br></div><div>Dessa maneira, uma vez que o paciente nÃ£o se encontra dentro das metas estabelecidas, Ã© necessÃ¡rio o ajuste medicamentoso e a verificaÃ§Ã£o  dos hÃ¡bitos de vida e alimentares. Aqui, nessa questÃ£o, temos que escolher qual Ã© o paciente que se beneficiaria com o uso de inibidores de  SGLT-2, que sÃ£o drogas que inibem a reabsorÃ§Ã£o renal de glicose, promovendo glicosÃºria. Tais medicaÃ§Ãµes nÃ£o causam hipoglicemia, promovem  perda ponderal (pois criam um balanÃ§o energÃ©tico negativo) e apresentam efeitos extra glicÃªmicos, como diminuiÃ§Ã£o de risco cardiovascular  e de mortalidade em indivÃ­duos com doenÃ§a cardiovascular estabelecida (como infarto e AVC), reduÃ§Ã£o de hospitalizaÃ§Ãµes (pacientes com  insuficiÃªncia cardÃ­aca, com fraÃ§Ã£o de ejeÃ§Ã£o reduzida) e menor progressÃ£o da doenÃ§a renal crÃ´nica (indivÃ­duos com taxa de filtraÃ§Ã£o glomerular  &gt; 30 mL/minuto e albuminÃºria &gt; 300 mg/g de creatinina).</div><div><br></div><div>Tendo em vista o explicitado acima, vamos analisar cada paciente:</div><div><br></div><div>I. JoÃ£o: Ã© um paciente sem doenÃ§a cardiovascular estabelecida, mas que apresenta obesidade grau 1 e se encontra fora da meta de controle  glicÃªmico, necessitando de uma segunda droga. Por apresentar obesidade, os inibidores de SGLT-2 seriam Ã³timas opÃ§Ãµes para promover  melhora metabÃ³lica e perda ponderal, o que colabora com a reduÃ§Ã£o da resistÃªncia Ã  insulina.</div><div><br></div><div>II. Maria: apesar de ser uma paciente com sobrepeso, os inibidores de SGLT-2 nÃ£o seriam uma boa escolha, visto que hÃ¡ histÃ³rico de  amputaÃ§Ã£o. No estudo da canagliflozina, observou-se um aumento de, aproximadamente, 2 vezes no risco de amputaÃ§Ãµes em pacientes  que utilizaram a droga. Assim, indivÃ­duos com pÃ© diabÃ©tico, Ãºlceras e amputaÃ§Ãµes prÃ©vias nÃ£o sÃ£o candidatos ao uso de inibidores de SGLT\u00022. Outras contraindicaÃ§Ãµes incluem o diabetes mellitus tipo 1, histÃ³rico de cetoacidose diabÃ©tica, taxa de filtraÃ§Ã£o glomerular &lt; 30 mL/ minuto e infecÃ§Ãµes de trato genitourinÃ¡rio de repetiÃ§Ã£o.</div><div><br></div><div>III. JosÃ©: paciente com diabetes mellitus em uso de metformina e linagliptina (um inibidor de DPP-4, que aumenta a secreÃ§Ã£o de insulina  de forma dependente dos nÃ­veis glicÃªmicos) e que se encontra com HbA1c discretamente fora da meta. O que chama a atenÃ§Ã£o aqui Ã© a  albuminÃºria significativa, portanto, hÃ¡ benefÃ­cio no uso de inibidores de SGLT-2, a fim de reduzir a progressÃ£o da doenÃ§a renal e auxiliar  no controle glicÃªmico.</div><div><br></div><div>Portanto, os pacientes que teriam benefÃ­cio com o uso de inibidores de SGLT-2 sÃ£o o I e o III.</div><div><br></div><div><b>Correta a alternativa C.</b></div>",
                "complete_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "created_at": "2021-07-07 12:07:17.937335 +0000 UTC",
                "id": "5eb73b98-2f92-409a-a028-6905f3879a34",
                "is_default": false,
                "sanitized_brief": "",
                "sanitized_complete": "GABARITO: ALTERNATIVA CO diabetes mellitus tipo 2 Ã© uma doenÃ§a crÃ´nica, cuja principal caracterÃ­stica Ã© a resistÃªncia Ã  insulina associada Ã  falÃªncia progressiva das  cÃ©lulas beta pancreÃ¡ticas. Assim, com o passar do tempo, hÃ¡ necessidade de introduÃ§Ã£o de nova droga para controle da hiperglicemia. A escolha  medicamentosa deve ser individualizada, a fim de reduzir efeitos colaterais e, atÃ© mesmo, trazer benefÃ­cios para o pacienteA manutenÃ§Ã£o de nÃ­veis glicÃªmicos adequados permite a reduÃ§Ã£o do risco de complicaÃ§Ãµes crÃ´nicas, principalmente microvasculares  (nefro, retino e neuropatias). Para isso, hÃ¡ metas definidas de controle glicÃªmico, considerando adultos nÃ£o fragilizados:â¢ Glicemia em jejum: &lt; 130 mg/dL;â¢ Glicemia 2 horas apÃ³s a refeiÃ§Ã£o: &lt; 180 mg/dL;â¢ Hemoglobina glicada fraÃ§Ã£o A1c (HbA1c) &lt; 7%.Dessa maneira, uma vez que o paciente nÃ£o se encontra dentro das metas estabelecidas, Ã© necessÃ¡rio o ajuste medicamentoso e a verificaÃ§Ã£o  dos hÃ¡bitos de vida e alimentares. Aqui, nessa questÃ£o, temos que escolher qual Ã© o paciente que se beneficiaria com o uso de inibidores de  SGLT-2, que sÃ£o drogas que inibem a reabsorÃ§Ã£o renal de glicose, promovendo glicosÃºria. Tais medicaÃ§Ãµes nÃ£o causam hipoglicemia, promovem  perda ponderal (pois criam um balanÃ§o energÃ©tico negativo) e apresentam efeitos extra glicÃªmicos, como diminuiÃ§Ã£o de risco cardiovascular  e de mortalidade em indivÃ­duos com doenÃ§a cardiovascular estabelecida (como infarto e AVC), reduÃ§Ã£o de hospitalizaÃ§Ãµes (pacientes com  insuficiÃªncia cardÃ­aca, com fraÃ§Ã£o de ejeÃ§Ã£o reduzida) e menor progressÃ£o da doenÃ§a renal crÃ´nica (indivÃ­duos com taxa de filtraÃ§Ã£o glomerular  &gt; 30 mL/minuto e albuminÃºria &gt; 300 mg/g de creatinina).Tendo em vista o explicitado acima, vamos analisar cada paciente:I. JoÃ£o: Ã© um paciente sem doenÃ§a cardiovascular estabelecida, mas que apresenta obesidade grau 1 e se encontra fora da meta de controle  glicÃªmico, necessitando de uma segunda droga. Por apresentar obesidade, os inibidores de SGLT-2 seriam Ã³timas opÃ§Ãµes para promover  melhora metabÃ³lica e perda ponderal, o que colabora com a reduÃ§Ã£o da resistÃªncia Ã  insulina.II. Maria: apesar de ser uma paciente com sobrepeso, os inibidores de SGLT-2 nÃ£o seriam uma boa escolha, visto que hÃ¡ histÃ³rico de  amputaÃ§Ã£o. No estudo da canagliflozina, observou-se um aumento de, aproximadamente, 2 vezes no risco de amputaÃ§Ãµes em pacientes  que utilizaram a droga. Assim, indivÃ­duos com pÃ© diabÃ©tico, Ãºlceras e amputaÃ§Ãµes prÃ©vias nÃ£o sÃ£o candidatos ao uso de inibidores de SGLT\u00022. Outras contraindicaÃ§Ãµes incluem o diabetes mellitus tipo 1, histÃ³rico de cetoacidose diabÃ©tica, taxa de filtraÃ§Ã£o glomerular &lt; 30 mL/ minuto e infecÃ§Ãµes de trato genitourinÃ¡rio de repetiÃ§Ã£o.III. JosÃ©: paciente com diabetes mellitus em uso de metformina e linagliptina (um inibidor de DPP-4, que aumenta a secreÃ§Ã£o de insulina  de forma dependente dos nÃ­veis glicÃªmicos) e que se encontra com HbA1c discretamente fora da meta. O que chama a atenÃ§Ã£o aqui Ã© a  albuminÃºria significativa, portanto, hÃ¡ benefÃ­cio no uso de inibidores de SGLT-2, a fim de reduzir a progressÃ£o da doenÃ§a renal e auxiliar  no controle glicÃªmico.Portanto, os pacientes que teriam benefÃ­cio com o uso de inibidores de SGLT-2 sÃ£o o I e o III.Correta a alternativa C.",
                "updated_at": "2021-07-07 12:07:22.236696 +0000 UTC"
            },
            "statement": "Considere os seguintes pacientes:<div><br></div><div>I. JoÃ£o, 59 anos, IMC= 31 kg/m2 , hipertenso, diabetes mellitus tipo 2 hÃ¡ 10 anos, em uso de metformina 1 g 12/12 h, com glicemia em jejum 134  mg/dL, HbA1c 7,5%, creatinina 1 mg/dL e albuminÃºria 20 mg/g de creatinina;</div><div><br></div><div>II. Maria, 70 anos, IMC= 26,4 kg/m2 , diabetes mellitus tipo 2 hÃ¡ 20 anos, amputaÃ§Ã£o prÃ©via de hÃ¡lux direito por Ãºlcera complicada, em uso de  metformina 1 g/dia, insulina NPH 10 UI cedo e 10 UI ao deitar-se e gliclazida MR 60 mg/dia, com glicemia em jejum 122 mg/dL, HbA1c 8,3%,  creatinina 1,2 mg/dL e albuminÃºria 25 mg/g de creatinina;</div><div><br></div><div>III. JosÃ©, 61 anos, IMC = 25 kg/m2 , diabetes mellitus tipo 2 hÃ¡ 8 anos, em uso de metformina 1 g 12/12h, linagliptina 5 mg/dia, com glicemia em  jejum 131 mg/dL, HbA1c= 7,2%, creatinina 1,1 mg/dL e albuminÃºria 310 mg/g de creatinina</div><div><br></div><div>Que pacientes seriam candidatos ao uso de inibidores de SGLT-2?</div>",
            "statement_text": "Considere os seguintes pacientes:I. JoÃ£o, 59 anos, IMC= 31 kg/m2 , hipertenso, diabetes mellitus tipo 2 hÃ¡ 10 anos, em uso de metformina 1 g 12/12 h, com glicemia em jejum 134  mg/dL, HbA1c 7,5%, creatinina 1 mg/dL e albuminÃºria 20 mg/g de creatinina;II. Maria, 70 anos, IMC= 26,4 kg/m2 , diabetes mellitus tipo 2 hÃ¡ 20 anos, amputaÃ§Ã£o prÃ©via de hÃ¡lux direito por Ãºlcera complicada, em uso de  metformina 1 g/dia, insulina NPH 10 UI cedo e 10 UI ao deitar-se e gliclazida MR 60 mg/dia, com glicemia em jejum 122 mg/dL, HbA1c 8,3%,  creatinina 1,2 mg/dL e albuminÃºria 25 mg/g de creatinina;III. JosÃ©, 61 anos, IMC = 25 kg/m2 , diabetes mellitus tipo 2 hÃ¡ 8 anos, em uso de metformina 1 g 12/12h, linagliptina 5 mg/dia, com glicemia em  jejum 131 mg/dL, HbA1c= 7,2%, creatinina 1,1 mg/dL e albuminÃºria 310 mg/g de creatininaQue pacientes seriam candidatos ao uso de inibidores de SGLT-2?",
            "status": {
                "change_actor": "valencar@admin.admin",
                "created_at": "2021-07-07 18:37:07.57542 +0000 UTC",
                "owner": "camila.moma@estrategiamed.com.br",
                "value": "APPROVED"
            },
            "topics": [
                {
                    "has_children": false,
                    "id": "0cad8ea0fa0e47efa8d56f8a97b383e5",
                    "master_id": "3b9e1e9de9ba4ff3959ae83d455880f9",
                    "name": "MedicaÃ§Ãµes que provocam glicosÃºria (inibidores de SGLT-2)",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Tratamento[$$]Tratamento medicamentoso[$$]Drogas antidiabÃ©ticas nÃ£o insulina[$$]MedicaÃ§Ãµes que provocam glicosÃºria (inibidores de SGLT-2)"
                }
            ],
            "unlisted": false,
            "video_solution": {
                "available_resolutions": null,
                "id": "",
                "identifier": "",
                "question_id": ""
            }
        },
        {
            "active": true,
            "alternatives": [
                {
                    "answer_percentage": 9,
                    "answers": 186,
                    "body": "Apenas as afirmativas II e IV estÃ£o corretas.",
                    "correct": false,
                    "created_at": "2021-04-16 02:30:34.824946 +0000 UTC",
                    "id": "125a9177-6df1-466a-9c87-808113614dd3",
                    "position": "0",
                    "sanitized_body": "Apenas as afirmativas II e IV estÃ£o corretas.",
                    "solution": {
                        "alternative_id": "125a9177-6df1-466a-9c87-808113614dd3",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<div><b>Alternativa (A) Ã© incorreta. </b>As afirmativas corretas sÃ£o I, II e IV.<br></div><div><br></div>",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-24 01:58:47.771983 +0000 UTC",
                        "id": "982be38b-323a-4604-8af5-334f86adf0c5",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (A) Ã© incorreta. As afirmativas corretas sÃ£o I, II e IV.",
                        "updated_at": "2021-05-24 03:20:20.266463 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-24 01:59:50.027277 +0000 UTC"
                },
                {
                    "answer_percentage": 74,
                    "answers": 1579,
                    "body": "Apenas as afirmativas I, II e IV estÃ£o corretas.",
                    "correct": true,
                    "created_at": "2021-04-16 02:30:34.824946 +0000 UTC",
                    "id": "2d5d54b1-5c92-44ce-b36f-c47ffe2e4623",
                    "position": "1",
                    "sanitized_body": "Apenas as afirmativas I, II e IV estÃ£o corretas.",
                    "solution": {
                        "alternative_id": "2d5d54b1-5c92-44ce-b36f-c47ffe2e4623",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (B) Ã© correta. </b>Vide comentÃ¡rio inicial.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-24 01:58:47.804107 +0000 UTC",
                        "id": "18480878-7cac-4a2d-94b3-4f7df297be13",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (B) Ã© correta. Vide comentÃ¡rio inicial.",
                        "updated_at": "2021-05-24 03:20:20.297704 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-24 01:59:50.146616 +0000 UTC"
                },
                {
                    "answer_percentage": 14,
                    "answers": 288,
                    "body": "As afirmativas I, II, III e IV estÃ£o corretas.",
                    "correct": false,
                    "created_at": "2021-04-16 02:30:34.824946 +0000 UTC",
                    "id": "ee2d16f7-c440-4b2f-8fd9-abaaf9331ed8",
                    "position": "2",
                    "sanitized_body": "As afirmativas I, II, III e IV estÃ£o corretas.",
                    "solution": {
                        "alternative_id": "ee2d16f7-c440-4b2f-8fd9-abaaf9331ed8",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (C) Ã© incorreta. </b>As afirmativas corretas sÃ£o I, II e IV.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-24 01:58:47.754026 +0000 UTC",
                        "id": "f430232e-6f9e-4bdc-a142-31c73df8dd6b",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (C) Ã© incorreta. As afirmativas corretas sÃ£o I, II e IV.",
                        "updated_at": "2021-05-24 03:20:20.306975 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-24 01:59:50.242695 +0000 UTC"
                },
                {
                    "answer_percentage": 4,
                    "answers": 78,
                    "body": "Apenas as afirmativas II e III estÃ£o corretas.",
                    "correct": false,
                    "created_at": "2021-04-16 02:30:34.824946 +0000 UTC",
                    "id": "9bcd25e8-e73b-4a7f-a749-cb5febe77cbf",
                    "position": "3",
                    "sanitized_body": "Apenas as afirmativas II e III estÃ£o corretas.",
                    "solution": {
                        "alternative_id": "9bcd25e8-e73b-4a7f-a749-cb5febe77cbf",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (D) Ã© incorreta. </b>As afirmativas corretas sÃ£o I, II e IV.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-24 01:58:47.726171 +0000 UTC",
                        "id": "a26ecc32-a7b3-4e15-a505-6294a715d366",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (D) Ã© incorreta. As afirmativas corretas sÃ£o I, II e IV.",
                        "updated_at": "2021-05-24 03:20:20.290602 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-24 01:59:50.358644 +0000 UTC"
                }
            ],
            "answer_type": "MULTIPLE_CHOICE",
            "author_id": "bruno-cesar110@hotmail.com",
            "correct_answer_percentage": 74,
            "created_at": "2021-04-16 02:30:34.824946 +0000 UTC",
            "difficulty_level": "MEDIUM",
            "exams": [
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5df92204-9354-4676-994d-573306d752c8",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "046f0505-90c9-4862-b318-388c0d1e8026",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-15T21:31:29Z",
                    "degree_proof": false,
                    "id": "4000003762",
                    "location": {
                        "id": "2"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "0DEB44B4-8340-9747-5FA5-18571D181FC2"
                        }
                    ],
                    "questions_number": 0,
                    "scholarity": "placeholder",
                    "subscription_fee": 350,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5df92204-9354-4676-994d-573306d752c8",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "32bef8bd-8aac-4ede-aede-06b9458b026b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-15T21:31:50Z",
                    "degree_proof": false,
                    "id": "4000003763",
                    "location": {
                        "id": "2"
                    },
                    "number": 1,
                    "open_spaces": 4,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "0DEB44B4-8340-9747-5FA5-18571D181FC2"
                        }
                    ],
                    "questions_number": 0,
                    "scholarity": "placeholder",
                    "subscription_fee": 350,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5df92204-9354-4676-994d-573306d752c8",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "dfa90599-1ee1-4de3-8605-a75ecd3799bd",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-15T21:32:06Z",
                    "degree_proof": false,
                    "id": "4000003764",
                    "location": {
                        "id": "2"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "0DEB44B4-8340-9747-5FA5-18571D181FC2"
                        }
                    ],
                    "questions_number": 0,
                    "scholarity": "placeholder",
                    "subscription_fee": 350,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5df92204-9354-4676-994d-573306d752c8",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "9b34a94d-754d-4510-8bad-60f649fa825b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-15T21:32:26Z",
                    "degree_proof": false,
                    "id": "4000003765",
                    "location": {
                        "id": "2"
                    },
                    "number": 1,
                    "open_spaces": 6,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "0DEB44B4-8340-9747-5FA5-18571D181FC2"
                        }
                    ],
                    "questions_number": 0,
                    "scholarity": "placeholder",
                    "subscription_fee": 350,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5df92204-9354-4676-994d-573306d752c8",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "2ca62942-4eab-49e5-acaf-e395254eee99",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-15T21:32:39Z",
                    "degree_proof": false,
                    "id": "4000003766",
                    "location": {
                        "id": "2"
                    },
                    "number": 1,
                    "open_spaces": 3,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "0DEB44B4-8340-9747-5FA5-18571D181FC2"
                        }
                    ],
                    "questions_number": 0,
                    "scholarity": "placeholder",
                    "subscription_fee": 350,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5df92204-9354-4676-994d-573306d752c8",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "dcb47678-bdba-4669-aa0e-01f71e32541b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-15T21:32:54Z",
                    "degree_proof": false,
                    "id": "4000003767",
                    "location": {
                        "id": "2"
                    },
                    "number": 1,
                    "open_spaces": 20,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "0DEB44B4-8340-9747-5FA5-18571D181FC2"
                        }
                    ],
                    "questions_number": 0,
                    "scholarity": "placeholder",
                    "subscription_fee": 350,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5df92204-9354-4676-994d-573306d752c8",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "0609ccdb-db5c-4c47-a306-31a0a655e95c",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-15T21:33:12Z",
                    "degree_proof": false,
                    "id": "4000003768",
                    "location": {
                        "id": "2"
                    },
                    "number": 1,
                    "open_spaces": 5,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "0DEB44B4-8340-9747-5FA5-18571D181FC2"
                        }
                    ],
                    "questions_number": 0,
                    "scholarity": "placeholder",
                    "subscription_fee": 350,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5df92204-9354-4676-994d-573306d752c8",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "f2f2f3c5-9759-4201-bca7-2487751bd626",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-15T21:33:23Z",
                    "degree_proof": false,
                    "id": "4000003769",
                    "location": {
                        "id": "2"
                    },
                    "number": 1,
                    "open_spaces": 3,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "0DEB44B4-8340-9747-5FA5-18571D181FC2"
                        }
                    ],
                    "questions_number": 0,
                    "scholarity": "placeholder",
                    "subscription_fee": 350,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5df92204-9354-4676-994d-573306d752c8",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "710b6098-b1cc-40fb-a6e9-1978c156b947",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-15T21:33:38Z",
                    "degree_proof": false,
                    "id": "4000003770",
                    "location": {
                        "id": "2"
                    },
                    "number": 1,
                    "open_spaces": 7,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "0DEB44B4-8340-9747-5FA5-18571D181FC2"
                        }
                    ],
                    "questions_number": 0,
                    "scholarity": "placeholder",
                    "subscription_fee": 350,
                    "year": 2021
                }
            ],
            "forum_id": "240beb7a-6c57-4435-88eb-826e8e205dac",
            "has_student_answer": false,
            "has_user_solution": false,
            "has_video_solution": true,
            "id": "4000144427",
            "labels": [
                "FINAL_ANSWER_SHEET"
            ],
            "public": true,
            "slug": "metformina-e11715a77017",
            "solution": {
                "alternative_solutions": null,
                "author_email": "camila.moma@estrategiamed.com.br",
                "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                "brief": "",
                "brief_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "complete": "<b>Gabarito: alternativa (B).</b><div><b>ComentÃ¡rios:</b></div><div><br></div><div>Vamos analisar cada afirmativa:</div><div><b>A afirmativa I </b>âO uso prolongado de metformina pode estar associado Ã  deficiÃªncia bioquÃ­mica de vitamina B12â <b>Ã© correta. </b>A metformina pode diminuir a absorÃ§Ã£o da vitamina B12, portanto, Ã© importante monitorar seus nÃ­veis, uma vez que sua deficiÃªncia gera sintomas neurolÃ³gicos que podem se confundir com a neuropatia perifÃ©rica diabÃ©tica (como perda de forÃ§a, parestesias).</div><div><b>A afirmativa II </b>âA metformina Ã© o agente farmacolÃ³gico inicial preferencial para o tratamento do diabetes tipo 2â <b>Ã© correta. </b>A metformina Ã© a primeira escolha de tratamento para pacientes com diabetes mellitus tipo 2 devido a sua eficÃ¡cia, tolerabilidade, seguranÃ§a e baixo custo. Promove melhora da resistÃªncia Ã  insulina no fÃ­gado, reduzindo a produÃ§Ã£o hepÃ¡tica de glicose. TambÃ©m aumenta a utilizaÃ§Ã£o de glicose pelo intestino, colaborando para o controle glicÃªmico. NÃ£o causa hipoglicemia nem ganho ponderal e hÃ¡ dados mostrando benefÃ­cio cardiovascular quando comparada Ã s sulfonilureias e insulina.</div><div><b>A afirmativa III</b> âUma vez iniciada, a metformina deve ser continuada desde que seja tolerada e nÃ£o contraindicada; outros agentes, exceto a insulina, podem ser adicionados Ã  metforminaâ <b>Ã© incorreta.</b> Uma vez que o paciente nÃ£o atinja as metas de controle glicÃªmico (para adultos nÃ£o fragilizados, a meta Ã© hemoglobina glicada &lt; 7%), devemos associar outras drogas para diminuir o risco de complicaÃ§Ãµes relacionadas Ã  hiperglicemia crÃ´nica.</div><div><b>A afirmativa IV </b>âA terapÃªutica com metformina para prevenÃ§Ã£o da diabetes tipo 2 deve ser considerada em indivÃ­duos com prÃ©-diabetes, especialmente para aqueles com IMC â¥ 35 kg/m2, aqueles com idade &lt; 60 anos, e mulheres com diabetes mellitus gestacional prÃ©vioâ <b>Ã© correta.</b> O principal tratamento em indivÃ­duos com prÃ©-diabetes sÃ£o as modificaÃ§Ãµes de estilo de vida (readequaÃ§Ã£o dietÃ©tica e prÃ¡tica de atividade fÃ­sica) associadas Ã  perda ponderal significativa (pelo menos, 7% do peso inicial). Entretanto, em determinados pacientes, o uso da metformina pode auxiliar na prevenÃ§Ã£o do diabetes mellitus, sendo candidatos ao uso da medicaÃ§Ã£o, segundo as diretrizes da <i>American Diabetes Association</i>:</div><div>â¢\tPacientes com IMC â¥ 35 kg/m2;</div><div>â¢\tAntecedente pessoal de diabetes gestacional;</div><div>â¢\tIdade &lt; 60 anos.</div><div><br></div>",
                "complete_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "created_at": "2021-05-24 01:58:48.026396 +0000 UTC",
                "id": "4b20a9a0-c84f-4768-8dcc-718424fd34a0",
                "is_default": false,
                "sanitized_brief": "",
                "sanitized_complete": "Gabarito: alternativa (B).ComentÃ¡rios:Vamos analisar cada afirmativa:A afirmativa I âO uso prolongado de metformina pode estar associado Ã  deficiÃªncia bioquÃ­mica de vitamina B12â Ã© correta. A metformina pode diminuir a absorÃ§Ã£o da vitamina B12, portanto, Ã© importante monitorar seus nÃ­veis, uma vez que sua deficiÃªncia gera sintomas neurolÃ³gicos que podem se confundir com a neuropatia perifÃ©rica diabÃ©tica (como perda de forÃ§a, parestesias).A afirmativa II âA metformina Ã© o agente farmacolÃ³gico inicial preferencial para o tratamento do diabetes tipo 2â Ã© correta. A metformina Ã© a primeira escolha de tratamento para pacientes com diabetes mellitus tipo 2 devido a sua eficÃ¡cia, tolerabilidade, seguranÃ§a e baixo custo. Promove melhora da resistÃªncia Ã  insulina no fÃ­gado, reduzindo a produÃ§Ã£o hepÃ¡tica de glicose. TambÃ©m aumenta a utilizaÃ§Ã£o de glicose pelo intestino, colaborando para o controle glicÃªmico. NÃ£o causa hipoglicemia nem ganho ponderal e hÃ¡ dados mostrando benefÃ­cio cardiovascular quando comparada Ã s sulfonilureias e insulina.A afirmativa III âUma vez iniciada, a metformina deve ser continuada desde que seja tolerada e nÃ£o contraindicada; outros agentes, exceto a insulina, podem ser adicionados Ã  metforminaâ Ã© incorreta. Uma vez que o paciente nÃ£o atinja as metas de controle glicÃªmico (para adultos nÃ£o fragilizados, a meta Ã© hemoglobina glicada &lt; 7%), devemos associar outras drogas para diminuir o risco de complicaÃ§Ãµes relacionadas Ã  hiperglicemia crÃ´nica.A afirmativa IV âA terapÃªutica com metformina para prevenÃ§Ã£o da diabetes tipo 2 deve ser considerada em indivÃ­duos com prÃ©-diabetes, especialmente para aqueles com IMC â¥ 35 kg/m2, aqueles com idade &lt; 60 anos, e mulheres com diabetes mellitus gestacional prÃ©vioâ Ã© correta. O principal tratamento em indivÃ­duos com prÃ©-diabetes sÃ£o as modificaÃ§Ãµes de estilo de vida (readequaÃ§Ã£o dietÃ©tica e prÃ¡tica de atividade fÃ­sica) associadas Ã  perda ponderal significativa (pelo menos, 7% do peso inicial). Entretanto, em determinados pacientes, o uso da metformina pode auxiliar na prevenÃ§Ã£o do diabetes mellitus, sendo candidatos ao uso da medicaÃ§Ã£o, segundo as diretrizes da American Diabetes Association:â¢\tPacientes com IMC â¥ 35 kg/m2;â¢\tAntecedente pessoal de diabetes gestacional;â¢\tIdade &lt; 60 anos.",
                "updated_at": "2021-05-24 03:20:20.381933 +0000 UTC",
                "video_solution_id": "5f2e9808-d85e-4ec2-8fc6-10f7dc58b943"
            },
            "statement": "A metformina Ã© um hipoglicemiante oral amplamente utilizado no tratamento farmacolÃ³gico do diabetes mellitus tipo 2. Analise as afirmativas abaixo e assinale a alternativa correta.&nbsp;<div>I. O uso prolongado de metformina pode estar associado Ã  deficiÃªncia bioquÃ­mica de vitamina B12.&nbsp;</div><div>II. A metformina Ã© o agente farmacolÃ³gico inicial preferencial para o tratamento do diabetes tipo 2.&nbsp;</div><div>III. Uma vez iniciada, a metformina deve ser continuada desde que seja tolerada e nÃ£o contraindicada; outros agentes, exceto a insulina, podem ser adicionados Ã  metformina.&nbsp;</div><div>IV. A terapÃªutica com metformina para prevenÃ§Ã£o da diabetes tipo 2 deve ser considerada em indivÃ­duos com prÃ©-diabetes, especialmente para aqueles com IMC â¥ 35 kg/m2, aqueles com idade &lt; 60 anos, e mulheres com diabetes mellitus gestacional prÃ©vio.</div>",
            "statement_text": "A metformina Ã© um hipoglicemiante oral amplamente utilizado no tratamento farmacolÃ³gico do diabetes mellitus tipo 2. Analise as afirmativas abaixo e assinale a alternativa correta.Â I. O uso prolongado de metformina pode estar associado Ã  deficiÃªncia bioquÃ­mica de vitamina B12.Â II. A metformina Ã© o agente farmacolÃ³gico inicial preferencial para o tratamento do diabetes tipo 2.Â III. Uma vez iniciada, a metformina deve ser continuada desde que seja tolerada e nÃ£o contraindicada; outros agentes, exceto a insulina, podem ser adicionados Ã  metformina.Â IV. A terapÃªutica com metformina para prevenÃ§Ã£o da diabetes tipo 2 deve ser considerada em indivÃ­duos com prÃ©-diabetes, especialmente para aqueles com IMC â¥ 35 kg/m2, aqueles com idade &lt; 60 anos, e mulheres com diabetes mellitus gestacional prÃ©vio.",
            "status": {
                "change_actor": "cnishiama@admin.admin",
                "created_at": "2021-05-24 22:57:10.493266 +0000 UTC",
                "owner": "camila.moma@estrategiamed.com.br",
                "value": "APPROVED"
            },
            "topics": [
                {
                    "has_children": false,
                    "id": "51912f5f3d3249d9bf9ce18407f82cf0",
                    "master_id": "e7750157ebd549b78392eee4b4b3154d",
                    "name": "PrevenÃ§Ã£o",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]PrevenÃ§Ã£o"
                },
                {
                    "has_children": false,
                    "id": "ab6c6a1fb6604cf98243ac486f80dac8",
                    "master_id": "0a6abdce2fbc45aa8ba8f0e75875ec84",
                    "name": "Endocrinologia ",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia "
                },
                {
                    "has_children": false,
                    "id": "d53b61e527fa4a61b5a22bb715b8d0f8",
                    "master_id": "8bdc1fbeb2e54046a2c3ba4ac4e63ead",
                    "name": "Biguanida (metformina)",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Tratamento[$$]Tratamento medicamentoso[$$]Drogas antidiabÃ©ticas nÃ£o insulina[$$]MedicaÃ§Ãµes com efeito sensibilizador de insulina[$$]Biguanida (metformina)"
                }
            ],
            "unlisted": false,
            "video_solution": {
                "available_resolutions": [
                    {
                        "resolution": "720",
                        "url": "https://api.estrategia.com/questoes/sign/medicina/processadas/4000144427-720.mp4"
                    }
                ],
                "id": "5f2e9808-d85e-4ec2-8fc6-10f7dc58b943",
                "identifier": "",
                "question_id": "4000144427"
            },
            "video_solution_id": "5f2e9808-d85e-4ec2-8fc6-10f7dc58b943"
        },
        {
            "active": true,
            "alternatives": [
                {
                    "answer_percentage": 61,
                    "answers": 3929,
                    "body": "Acrescentar anlodipino Ã  prescriÃ§Ã£o \n",
                    "correct": true,
                    "created_at": "2022-01-03 23:13:04.959374 +0000 UTC",
                    "id": "b1ba9af5-f5fb-4d1c-9c97-235976e0d5ac",
                    "position": "0",
                    "sanitized_body": "Acrescentar anlodipino Ã  prescriÃ§Ã£o \n",
                    "solution": {
                        "alternative_id": "b1ba9af5-f5fb-4d1c-9c97-235976e0d5ac",
                        "author_email": "tereza.guerra@estrategiamed.com.br",
                        "author_id": "52736c7a-b73f-429e-a5c2-678cb9bd4640",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Correta a alternativa âaâ: </b>A Sociedade Brasileira de Diabetes (SBD) recomenda que pessoas com diabetes sem doenÃ§a coronariana mantenham pressÃ£o arterial sistÃ³lica (PAS) < 130 mmHg e pressÃ£o arterial diastÃ³lica (PAD) < 80 mmHg. Ou seja, a pressÃ£o arterial estÃ¡ dentro da meta terapÃªutica, portanto, Ã© desnecessÃ¡rio acrescentar um segundo anti-hipertensivo.Â ",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2022-03-22 06:52:13.948306 +0000 UTC",
                        "id": "4b169387-8aed-436b-8949-d8cfda9b6abc",
                        "sanitized_brief": "",
                        "sanitized_complete": "Correta a alternativa âaâ: A Sociedade Brasileira de Diabetes (SBD) recomenda que pessoas com diabetes sem doenÃ§a coronariana mantenham pressÃ£o arterial sistÃ³lica (PAS) &lt; 130 mmHg e pressÃ£o arterial diastÃ³lica (PAD) &lt; 80 mmHg. Ou seja, a pressÃ£o arterial estÃ¡ dentro da meta terapÃªutica, portanto, Ã© desnecessÃ¡rio acrescentar um segundo anti-hipertensivo.",
                        "updated_at": "2022-03-22 06:54:31.993354 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2022-03-22 06:49:37.15298 +0000 UTC"
                },
                {
                    "answer_percentage": 16,
                    "answers": 1018,
                    "body": "Reduzir a dosagem de gliclazida \n",
                    "correct": false,
                    "created_at": "2022-01-03 23:13:04.959374 +0000 UTC",
                    "id": "074b64b3-1f65-4051-a520-b275ef1fd807",
                    "position": "1",
                    "sanitized_body": "Reduzir a dosagem de gliclazida \n",
                    "solution": {
                        "alternative_id": "074b64b3-1f65-4051-a520-b275ef1fd807",
                        "author_email": "tereza.guerra@estrategiamed.com.br",
                        "author_id": "52736c7a-b73f-429e-a5c2-678cb9bd4640",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Incorreta a alternativa âbâ: </b>A gliclazida Ã© um antidiabÃ©tico secretagogo (estimula a secreÃ§Ã£o pancreÃ¡tica de insulina), portanto, devemos ponderar uma reduÃ§Ã£o de dose para minimizar o risco de hipoglicemia.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2022-03-22 06:52:13.99431 +0000 UTC",
                        "id": "c264e56d-4f0a-45a6-8529-c62b82ba2e6c",
                        "sanitized_brief": "",
                        "sanitized_complete": "Incorreta a alternativa âbâ: A gliclazida Ã© um antidiabÃ©tico secretagogo (estimula a secreÃ§Ã£o pancreÃ¡tica de insulina), portanto, devemos ponderar uma reduÃ§Ã£o de dose para minimizar o risco de hipoglicemia.",
                        "updated_at": "2022-03-22 06:54:31.999844 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2022-03-22 06:49:37.441078 +0000 UTC"
                },
                {
                    "answer_percentage": 8,
                    "answers": 534,
                    "body": "Solicitar dosagem de vitamina B12 \n",
                    "correct": false,
                    "created_at": "2022-01-03 23:13:04.959374 +0000 UTC",
                    "id": "20f40e55-d511-44b1-84e9-56d01cea4466",
                    "position": "2",
                    "sanitized_body": "Solicitar dosagem de vitamina B12 \n",
                    "solution": {
                        "alternative_id": "20f40e55-d511-44b1-84e9-56d01cea4466",
                        "author_email": "tereza.guerra@estrategiamed.com.br",
                        "author_id": "52736c7a-b73f-429e-a5c2-678cb9bd4640",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Incorreta a alternativa âcâ:</b> A metformina prejudica a absorÃ§Ã£o intestinal de vitamina B12, portanto, pode associar-se ao desenvolvimento de deficiÃªncia de vitamina B12 e atÃ© de neuropatia perifÃ©rica. A diretriz da SBD traz o seguinte trecho:<div><br></div><div><i>âOs nÃ­veis de vitamina B12 deverÃ£o ser avaliados anualmente apÃ³s 4 anos de inÃ­cio da metformina em funÃ§Ã£o do risco de deficiÃªncia, e repostos, se necessÃ¡rio.â</i></div><div><br></div><div>Como a paciente sÃ³ utiliza metformina hÃ¡ 2 anos, nÃ£o somos obrigados a tomar essa conduta, mas trata-se de uma sugestÃ£o com mais plausibilidade que a alternativa âaâ.Â </div><div><br></div><div>Ou seja, a alternativa âcâ traz uma sugestÃ£o ADIANTADA, porÃ©m, menos INADEQUADA que a alternativa âaâ.</div>",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2022-03-22 06:52:13.942124 +0000 UTC",
                        "id": "7e0271c4-198c-42d0-b021-8524a9cc8004",
                        "sanitized_brief": "",
                        "sanitized_complete": "Incorreta a alternativa âcâ: A metformina prejudica a absorÃ§Ã£o intestinal de vitamina B12, portanto, pode associar-se ao desenvolvimento de deficiÃªncia de vitamina B12 e atÃ© de neuropatia perifÃ©rica. A diretriz da SBD traz o seguinte trecho:âOs nÃ­veis de vitamina B12 deverÃ£o ser avaliados anualmente apÃ³s 4 anos de inÃ­cio da metformina em funÃ§Ã£o do risco de deficiÃªncia, e repostos, se necessÃ¡rio.âComo a paciente sÃ³ utiliza metformina hÃ¡ 2 anos, nÃ£o somos obrigados a tomar essa conduta, mas trata-se de uma sugestÃ£o com mais plausibilidade que a alternativa âaâ.Â Ou seja, a alternativa âcâ traz uma sugestÃ£o ADIANTADA, porÃ©m, menos INADEQUADA que a alternativa âaâ.",
                        "updated_at": "2022-03-22 06:54:31.971288 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2022-03-22 06:49:37.73414 +0000 UTC"
                },
                {
                    "answer_percentage": 15,
                    "answers": 931,
                    "body": "Solicitar aferiÃ§Ãµes de glicemia capilar durante a madrugada\n",
                    "correct": false,
                    "created_at": "2022-01-03 23:13:04.959374 +0000 UTC",
                    "id": "4a353b78-f1fc-40ad-b5ba-4a0dd243f68c",
                    "position": "3",
                    "sanitized_body": "Solicitar aferiÃ§Ãµes de glicemia capilar durante a madrugada\n",
                    "solution": {
                        "alternative_id": "4a353b78-f1fc-40ad-b5ba-4a0dd243f68c",
                        "author_email": "tereza.guerra@estrategiamed.com.br",
                        "author_id": "52736c7a-b73f-429e-a5c2-678cb9bd4640",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Incorreta a alternativa âdâ: </b>Como os sinais e sintomas de hipoglicemia sÃ£o inespecÃ­ficos, o ideal Ã© que o diagnÃ³stico seja feito com base na clÃ¡ssica trÃ­ade de Whipple:<div>â Sinais e sintomas compatÃ­veis com a suspeita clÃ­nica de hipoglicemia.</div><div>â DocumentaÃ§Ã£o de que a glicemia estÃ¡ baixa na vigÃªncia dos sinais e dos sintomas apresentados.</div><div>â DemonstraÃ§Ã£o de que os sinais e sintomas regrediram apÃ³s a correÃ§Ã£o da hipoglicemia (com glicose ou glucagon).</div><div><br></div><div><!-- BEGIN:IMAGE_TO_REPLACE --><img src=\"https://estrategia-prod-questoes.s3.amazonaws.com/images/23F8965F-C67F-F7AE-5B30-D9467E4BFF29/23F8965F-C67F-F7AE-5B30-D9467E4BFF29-400.jpeg\"><!-- END:IMAGE_TO_REPLACE --><br></div>",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2022-03-22 06:52:13.97713 +0000 UTC",
                        "id": "a739e886-307f-4b0b-9434-ace47976d39a",
                        "sanitized_brief": "",
                        "sanitized_complete": "Incorreta a alternativa âdâ: Como os sinais e sintomas de hipoglicemia sÃ£o inespecÃ­ficos, o ideal Ã© que o diagnÃ³stico seja feito com base na clÃ¡ssica trÃ­ade de Whipple:â Sinais e sintomas compatÃ­veis com a suspeita clÃ­nica de hipoglicemia.â DocumentaÃ§Ã£o de que a glicemia estÃ¡ baixa na vigÃªncia dos sinais e dos sintomas apresentados.â DemonstraÃ§Ã£o de que os sinais e sintomas regrediram apÃ³s a correÃ§Ã£o da hipoglicemia (com glicose ou glucagon).",
                        "updated_at": "2022-03-22 06:54:31.9909 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2022-03-22 06:49:38.023669 +0000 UTC"
                }
            ],
            "answer_type": "MULTIPLE_CHOICE",
            "author_id": "socorrosantos2408@gmail.com",
            "correct_answer_percentage": 61,
            "created_at": "2022-01-03 23:13:04.959374 +0000 UTC",
            "difficulty_level": "MEDIUM",
            "exams": [
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "cad77a08-2520-453c-bb37-b023d5161d6d",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "0a315fc2-21c5-4185-806d-a9a6ab041b19",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "55402575-a6ef-41f1-a190-9ecdce1af36b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2022-01-03T19:28:11Z",
                    "degree_proof": false,
                    "id": "4000005916",
                    "location": {
                        "id": "12"
                    },
                    "number": 1,
                    "open_spaces": 0,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "810AB805-4D87-F4AF-EDB7-80874A272252"
                        },
                        {
                            "type": "EXAM",
                            "url": "A7D7E762-6A40-6E9B-2751-F62D133262AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "0E3E5578-D122-27D5-ABF5-E867B95022C1"
                        },
                        {
                            "type": "ANSWER",
                            "url": "58A96A54-4A65-831F-CFC9-8AA4A1B333D0"
                        }
                    ],
                    "questions_number": 75,
                    "scholarity": "placeholder",
                    "year": 2022
                }
            ],
            "forum_id": "006469ff-de6a-49aa-a462-816eb0fd8cc6",
            "has_student_answer": false,
            "has_user_solution": false,
            "has_video_solution": true,
            "id": "4000168775",
            "labels": [
                "FINAL_ANSWER_SHEET"
            ],
            "public": true,
            "slug": "Mulher-58-anos-vai117110d3b6e",
            "solution": {
                "alternative_solutions": null,
                "author_email": "tereza.guerra@estrategiamed.com.br",
                "author_id": "52736c7a-b73f-429e-a5c2-678cb9bd4640",
                "brief": "",
                "brief_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "complete": "<b>Gabarito: alternativa A.</b><div><b><br></b><div>A HbA1c de 6,3% e as queixas de taquicardia e sudorese durante a madrugada sugestionam que a paciente vem apresentando episÃ³dios de hipoglicemia.Â </div><div><br></div><div>A hipoglicemia pode causar sintomas neurogÃªnicos (autonÃ´micos) e neuroglicopÃªnicos. Os sintomas neurogÃªnicos podem ser mediados pelas catecolaminas (tremores, palpitaÃ§Ãµes, ansiedade e excitaÃ§Ã£o) ou pela acetilcolina (sudorese, fome e parestesia). JÃ¡ os sintomas neuroglicopÃªnicos decorrem do efeito da escassez de glicose na homeostase das funÃ§Ãµes neurolÃ³gicas: cefaleia, tontura, fraqueza, sonolÃªncia, delÃ­rio, confusÃ£o, convulsÃ£o e coma.</div></div>",
                "complete_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "created_at": "2022-03-22 06:52:14.275984 +0000 UTC",
                "id": "ef2c2a07-f225-4a09-9aa1-2dc9b8465903",
                "is_default": false,
                "sanitized_brief": "",
                "sanitized_complete": "Gabarito: alternativa A.A HbA1c de 6,3% e as queixas de taquicardia e sudorese durante a madrugada sugestionam que a paciente vem apresentando episÃ³dios de hipoglicemia.Â A hipoglicemia pode causar sintomas neurogÃªnicos (autonÃ´micos) e neuroglicopÃªnicos. Os sintomas neurogÃªnicos podem ser mediados pelas catecolaminas (tremores, palpitaÃ§Ãµes, ansiedade e excitaÃ§Ã£o) ou pela acetilcolina (sudorese, fome e parestesia). JÃ¡ os sintomas neuroglicopÃªnicos decorrem do efeito da escassez de glicose na homeostase das funÃ§Ãµes neurolÃ³gicas: cefaleia, tontura, fraqueza, sonolÃªncia, delÃ­rio, confusÃ£o, convulsÃ£o e coma.",
                "updated_at": "2022-03-22 06:54:32.246253 +0000 UTC",
                "video_solution_id": "d58f5213-6528-481c-9245-1ff71fd1b2f3"
            },
            "statement": "Mulher de 58 anos vai ao Centro de SaÃºde para consulta de acompanhamento mÃ©dico. Queixa-se deÂ <span>acordar frequentemente durante a madrugada com taquicardia e sudorese. Possui diabetes melito tipo 2Â </span><span>e hipertensÃ£o arterial sistÃªmica. Faz uso domiciliar regular, hÃ¡ dois anos, de metformina 850mg duasÂ </span><span>vezes ao dia, gliclazida 60mg pela manhÃ£, enalapril 20mg duas vezes ao dia. Relata menopausa hÃ¡ trÃªsÂ </span><span>anos, Ã© viÃºva hÃ¡ seis anos e nÃ£o possui parceiro sexual desde entÃ£o. Ao exame, PA 156/84mmHg, FCÂ </span><span>98bpm, FR 19ipm; sem outras anormalidades. Diz que a PA aferida pela filha enfermeira, em casa,Â </span><span>geralmente estÃ¡ em torno de 120/80mmHg. Exames de laboratÃ³rio atuais: hemoglobina glicada A1c 6,3%;Â </span><span>creatinina 0,7mg/dL, potÃ¡ssio 4,3mg/dL. Assinale a alternativa que apresenta uma conduta INADEQUADAÂ </span><span>apÃ³s essa consulta</span>",
            "statement_text": "Mulher de 58 anos vai ao Centro de SaÃºde para consulta de acompanhamento mÃ©dico. Queixa-se deÂ acordar frequentemente durante a madrugada com taquicardia e sudorese. Possui diabetes melito tipo 2Â e hipertensÃ£o arterial sistÃªmica. Faz uso domiciliar regular, hÃ¡ dois anos, de metformina 850mg duasÂ vezes ao dia, gliclazida 60mg pela manhÃ£, enalapril 20mg duas vezes ao dia. Relata menopausa hÃ¡ trÃªsÂ anos, Ã© viÃºva hÃ¡ seis anos e nÃ£o possui parceiro sexual desde entÃ£o. Ao exame, PA 156/84mmHg, FCÂ 98bpm, FR 19ipm; sem outras anormalidades. Diz que a PA aferida pela filha enfermeira, em casa,Â geralmente estÃ¡ em torno de 120/80mmHg. Exames de laboratÃ³rio atuais: hemoglobina glicada A1c 6,3%;Â creatinina 0,7mg/dL, potÃ¡ssio 4,3mg/dL. Assinale a alternativa que apresenta uma conduta INADEQUADAÂ apÃ³s essa consulta",
            "status": {
                "change_actor": "frank.martins@estrategiamed.com.br",
                "created_at": "2022-03-22 12:35:33.561181 +0000 UTC",
                "owner": "tereza.guerra@estrategiamed.com.br",
                "value": "APPROVED"
            },
            "topics": [
                {
                    "has_children": false,
                    "id": "71083845e1444d54bc5e5a1418f9f5a4",
                    "master_id": "8f3ef55103104dd8af5a7797a4c33f8b",
                    "name": "Metas de controle pressÃ³rico",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]IntroduÃ§Ã£o ao Diabetes Mellitus[$$]Acompanhamento ambulatorial[$$]Metas de controle[$$]Metas de controle pressÃ³rico"
                },
                {
                    "has_children": false,
                    "id": "8bdc1fbeb2e54046a2c3ba4ac4e63ead",
                    "master_id": "3b9e1e9de9ba4ff3959ae83d455880f9",
                    "name": "MedicaÃ§Ãµes com efeito sensibilizador de insulina",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Tratamento[$$]Tratamento medicamentoso[$$]Drogas antidiabÃ©ticas nÃ£o insulina[$$]MedicaÃ§Ãµes com efeito sensibilizador de insulina"
                },
                {
                    "has_children": false,
                    "id": "a82e2807902548e6a9d573dd463fdff8",
                    "master_id": "3b9e1e9de9ba4ff3959ae83d455880f9",
                    "name": "MedicaÃ§Ãµes que aumentam a secreÃ§Ã£o de insulina",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Tratamento[$$]Tratamento medicamentoso[$$]Drogas antidiabÃ©ticas nÃ£o insulina[$$]MedicaÃ§Ãµes que aumentam a secreÃ§Ã£o de insulina"
                },
                {
                    "has_children": false,
                    "id": "ff472c5ae85044b18f39d2c2a3ecbdcf",
                    "master_id": "b9f204715e5443f494a070cb1814daab",
                    "name": "Hipoglicemia ",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]ComplicaÃ§Ãµes agudas[$$]Hipoglicemia "
                }
            ],
            "unlisted": false,
            "video_solution": {
                "available_resolutions": [
                    {
                        "resolution": "720",
                        "url": "https://api.estrategia.com/questoes/sign/medicina/processadas/4000168775-720.mp4"
                    },
                    {
                        "resolution": "360",
                        "url": "https://api.estrategia.com/questoes/sign/medicina/processadas/4000168775-360.mp4"
                    },
                    {
                        "resolution": "480",
                        "url": "https://api.estrategia.com/questoes/sign/medicina/processadas/4000168775-480.mp4"
                    }
                ],
                "id": "d58f5213-6528-481c-9245-1ff71fd1b2f3",
                "identifier": "",
                "question_id": "4000168775"
            },
            "video_solution_id": "d58f5213-6528-481c-9245-1ff71fd1b2f3"
        },
        {
            "active": true,
            "alternatives": [
                {
                    "answer_percentage": 4,
                    "answers": 105,
                    "body": "Canaglifozina/insuficiÃªncia cardÃ­aca.",
                    "correct": false,
                    "created_at": "2021-04-26 21:55:22.82861 +0000 UTC",
                    "id": "14842116-9a39-44fc-b5db-e7299db59607",
                    "position": "0",
                    "sanitized_body": "Canaglifozina/insuficiÃªncia cardÃ­aca.",
                    "solution": {
                        "alternative_id": "14842116-9a39-44fc-b5db-e7299db59607",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (A) Ã© incorreta. </b>A canagliflozina Ã© um inibidor do transportador de sÃ³dio e glicose tipo 2 (SGLT-2) presente, principalmente, no tÃºbulo proximal renal; assim, ao inibi-lo, a canagliflozina promove glicosÃºria, auxiliando no controle glicÃªmico.&nbsp;<div>Os inibidores de SGLT-2 sÃ£o drogas seguras do ponto de vista de hipoglicemias, ocasionam perda ponderal e possui benefÃ­cios extra-glicÃªmicos:</div><div>â¢\tReduÃ§Ã£o de mortalidade e risco cardiovascular: em pacientes com doenÃ§a cardiovascular estabelecida (como infarto e AVC) ou com insuficiÃªncia cardÃ­aca com fraÃ§Ã£o de ejeÃ§Ã£o reduzida;</div><div>â¢\tMenor progressÃ£o da doenÃ§a renal crÃ´nica: em pacientes com taxa de filtraÃ§Ã£o glomerular &gt; 30 mL/minuto e albuminÃºria &gt; 300 mg/g de creatinina.</div><div>Quanto aos efeitos adversos, temos maior risco de infecÃ§Ãµes genitourinÃ¡rias (mais frequentes em mulheres), amputaÃ§Ãµes (principalmente em pacientes com histÃ³rico de amputaÃ§Ã£o ou Ãºlcera em membros inferiores) e cetoacidose euglicÃªmica (em pacientes insulinopÃªnicos, como aqueles com diabetes de longa data).</div><div><br></div>",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-06-01 02:28:33.326332 +0000 UTC",
                        "id": "c4226558-2109-434f-8063-5d0457fbc647",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (A) Ã© incorreta. A canagliflozina Ã© um inibidor do transportador de sÃ³dio e glicose tipo 2 (SGLT-2) presente, principalmente, no tÃºbulo proximal renal; assim, ao inibi-lo, a canagliflozina promove glicosÃºria, auxiliando no controle glicÃªmico.Â Os inibidores de SGLT-2 sÃ£o drogas seguras do ponto de vista de hipoglicemias, ocasionam perda ponderal e possui benefÃ­cios extra-glicÃªmicos:â¢\tReduÃ§Ã£o de mortalidade e risco cardiovascular: em pacientes com doenÃ§a cardiovascular estabelecida (como infarto e AVC) ou com insuficiÃªncia cardÃ­aca com fraÃ§Ã£o de ejeÃ§Ã£o reduzida;â¢\tMenor progressÃ£o da doenÃ§a renal crÃ´nica: em pacientes com taxa de filtraÃ§Ã£o glomerular &gt; 30 mL/minuto e albuminÃºria &gt; 300 mg/g de creatinina.Quanto aos efeitos adversos, temos maior risco de infecÃ§Ãµes genitourinÃ¡rias (mais frequentes em mulheres), amputaÃ§Ãµes (principalmente em pacientes com histÃ³rico de amputaÃ§Ã£o ou Ãºlcera em membros inferiores) e cetoacidose euglicÃªmica (em pacientes insulinopÃªnicos, como aqueles com diabetes de longa data).",
                        "updated_at": "2021-06-01 02:28:34.745387 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-06-01 02:27:13.746601 +0000 UTC"
                },
                {
                    "answer_percentage": 25,
                    "answers": 705,
                    "body": "Metformina/insuficiÃªncia renal.",
                    "correct": false,
                    "created_at": "2021-04-26 21:55:22.82861 +0000 UTC",
                    "id": "34c8020c-2afd-4e81-9a38-1331c5b125cf",
                    "position": "1",
                    "sanitized_body": "Metformina/insuficiÃªncia renal.",
                    "solution": {
                        "alternative_id": "34c8020c-2afd-4e81-9a38-1331c5b125cf",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (B) Ã© incorreta.</b> A metformina reduz a produÃ§Ã£o hepÃ¡tica de glicose, com consequente aumento nos nÃ­veis circulantes de lactato. Em pacientes sem alteraÃ§Ãµes renais ou sujeitos Ã  hipÃ³xia, esse aumento nÃ£o Ã© significativo. Entretanto, se hÃ¡ perda da filtraÃ§Ã£o renal ou aumento do metabolismo anaerÃ³bico (como em sepse e na insuficiÃªncia cardÃ­aca descompensada), hÃ¡ maior retenÃ§Ã£o do lactato, aumentando a chance de acidose lÃ¡ctica.<div>Quanto aos efeitos adversos mais frequentes, observamos os de trato gastrointestinal (flatulÃªncia, distensÃ£o, diarreia), que sÃ£o muitas vezes contornados com o uso de apresentaÃ§Ãµes de liberaÃ§Ã£o estendida (metformina XR).</div><div><br></div>",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-06-01 02:28:33.358727 +0000 UTC",
                        "id": "76abea23-dc8d-4d5e-9af5-e676c4e2b887",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (B) Ã© incorreta. A metformina reduz a produÃ§Ã£o hepÃ¡tica de glicose, com consequente aumento nos nÃ­veis circulantes de lactato. Em pacientes sem alteraÃ§Ãµes renais ou sujeitos Ã  hipÃ³xia, esse aumento nÃ£o Ã© significativo. Entretanto, se hÃ¡ perda da filtraÃ§Ã£o renal ou aumento do metabolismo anaerÃ³bico (como em sepse e na insuficiÃªncia cardÃ­aca descompensada), hÃ¡ maior retenÃ§Ã£o do lactato, aumentando a chance de acidose lÃ¡ctica.Quanto aos efeitos adversos mais frequentes, observamos os de trato gastrointestinal (flatulÃªncia, distensÃ£o, diarreia), que sÃ£o muitas vezes contornados com o uso de apresentaÃ§Ãµes de liberaÃ§Ã£o estendida (metformina XR).",
                        "updated_at": "2021-06-01 02:28:34.77609 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-06-01 02:27:13.830636 +0000 UTC"
                },
                {
                    "answer_percentage": 14,
                    "answers": 382,
                    "body": "Pioglitazona/insuficiÃªncia renal.",
                    "correct": false,
                    "created_at": "2021-04-26 21:55:22.82861 +0000 UTC",
                    "id": "5b231e72-b29f-4ec8-ab64-d5bb1f869a6c",
                    "position": "2",
                    "sanitized_body": "Pioglitazona/insuficiÃªncia renal.",
                    "solution": {
                        "alternative_id": "5b231e72-b29f-4ec8-ab64-d5bb1f869a6c",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (C) Ã© incorreta. </b>A pioglitazona pertence Ã  classe das tiazolidinedionas, que sÃ£o agonistas do receptor de ativaÃ§Ã£o da proliferaÃ§Ã£o de peroxissomos gama (PPAR-áµ), portanto, atua nesses receptores intranucleares, levando a modificaÃ§Ãµes que culminam com melhora da resistÃªncia perifÃ©rica Ã  insulina, com consequente aumento da captaÃ§Ã£o de glicose pelos tecidos. TambÃ©m estimula receptores PPAR-áµ nos rins, promovendo maior reabsorÃ§Ã£o de sÃ³dio e Ã¡gua, o que pode incrementar a volemia e descompensar quadros de insuficiÃªncia cardÃ­aca. Por este motivo, Ã© contraindicada em pacientes com IC classes funcionais NYHA III e IV (indivÃ­duos com dispneia a pequenos/moderados esforÃ§os ou em repouso).<div>Pode causar ganho ponderal por atuar em centros hipotalÃ¢micos, aumentando o apetite, e estÃ¡ relacionada a aumento de fraturas. Portanto, nÃ£o deve ser utilizada em pacientes com risco aumentado de fraturas (como, por exemplo, fratura de fÃªmur prÃ©via, osteopenia/osteoporose, artrite reumatoide, tabagistas e etilistas).</div>",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-06-01 02:28:33.358275 +0000 UTC",
                        "id": "14e5e8cf-f878-41c5-8541-287ece2cde37",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (C) Ã© incorreta. A pioglitazona pertence Ã  classe das tiazolidinedionas, que sÃ£o agonistas do receptor de ativaÃ§Ã£o da proliferaÃ§Ã£o de peroxissomos gama (PPAR-áµ), portanto, atua nesses receptores intranucleares, levando a modificaÃ§Ãµes que culminam com melhora da resistÃªncia perifÃ©rica Ã  insulina, com consequente aumento da captaÃ§Ã£o de glicose pelos tecidos. TambÃ©m estimula receptores PPAR-áµ nos rins, promovendo maior reabsorÃ§Ã£o de sÃ³dio e Ã¡gua, o que pode incrementar a volemia e descompensar quadros de insuficiÃªncia cardÃ­aca. Por este motivo, Ã© contraindicada em pacientes com IC classes funcionais NYHA III e IV (indivÃ­duos com dispneia a pequenos/moderados esforÃ§os ou em repouso).Pode causar ganho ponderal por atuar em centros hipotalÃ¢micos, aumentando o apetite, e estÃ¡ relacionada a aumento de fraturas. Portanto, nÃ£o deve ser utilizada em pacientes com risco aumentado de fraturas (como, por exemplo, fratura de fÃªmur prÃ©via, osteopenia/osteoporose, artrite reumatoide, tabagistas e etilistas).",
                        "updated_at": "2021-06-01 02:28:34.749454 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-06-01 02:27:13.909919 +0000 UTC"
                },
                {
                    "answer_percentage": 3,
                    "answers": 81,
                    "body": "Metformina/insuficiÃªncia cardÃ­aca.",
                    "correct": false,
                    "created_at": "2021-04-26 21:55:22.82861 +0000 UTC",
                    "id": "908ef0d9-ba9e-4ba6-a34a-3e58e1540dde",
                    "position": "3",
                    "sanitized_body": "Metformina/insuficiÃªncia cardÃ­aca.",
                    "solution": {
                        "alternative_id": "908ef0d9-ba9e-4ba6-a34a-3e58e1540dde",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (D) Ã© incorreta. </b>Vide comentÃ¡rio da alternativa (B).",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-06-01 02:28:33.363488 +0000 UTC",
                        "id": "521610d9-4eb3-4bba-8c00-45e987daf6ff",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (D) Ã© incorreta. Vide comentÃ¡rio da alternativa (B).",
                        "updated_at": "2021-06-01 02:28:34.799101 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-06-01 02:27:14.002589 +0000 UTC"
                },
                {
                    "answer_percentage": 55,
                    "answers": 1554,
                    "body": "Pioglitazona/insuficiÃªncia cardÃ­aca.",
                    "correct": true,
                    "created_at": "2021-04-26 21:55:22.82861 +0000 UTC",
                    "id": "0b9557fe-2b35-4fcc-8c9f-4aea5d376b91",
                    "position": "4",
                    "sanitized_body": "Pioglitazona/insuficiÃªncia cardÃ­aca.",
                    "solution": {
                        "alternative_id": "0b9557fe-2b35-4fcc-8c9f-4aea5d376b91",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (E) Ã© correta.</b> Vide comentÃ¡rio da alternativa (C).",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-06-01 02:28:33.345011 +0000 UTC",
                        "id": "cd093525-1cdb-4c41-a5fd-cc4bf3a006be",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (E) Ã© correta. Vide comentÃ¡rio da alternativa (C).",
                        "updated_at": "2021-06-01 02:28:34.768161 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-06-01 02:27:14.071599 +0000 UTC"
                }
            ],
            "answer_type": "MULTIPLE_CHOICE",
            "author_id": "bruno-cesar110@hotmail.com",
            "correct_answer_percentage": 55,
            "created_at": "2021-04-26 21:55:22.82861 +0000 UTC",
            "difficulty_level": "MEDIUM",
            "exams": [
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "ccabed1b-1941-4f6d-ad9e-b73055330db9",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "9607e88b-5be4-450a-b638-4a5cfdb7d584",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-26T17:22:58Z",
                    "degree_proof": false,
                    "id": "4000004060",
                    "location": {
                        "id": "20"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "07D52C94-8919-0CA0-AD84-333A04EF55E1"
                        },
                        {
                            "type": "ANSWER",
                            "url": "559E8D24-E59B-3758-8153-E77E6ECB7CD7"
                        }
                    ],
                    "questions_number": 50,
                    "remuneration": 333043,
                    "scholarity": "placeholder",
                    "subscription_fee": 290,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "ccabed1b-1941-4f6d-ad9e-b73055330db9",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "710b6098-b1cc-40fb-a6e9-1978c156b947",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-26T17:23:18Z",
                    "degree_proof": false,
                    "id": "4000004061",
                    "location": {
                        "id": "20"
                    },
                    "number": 1,
                    "open_spaces": 12,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "07D52C94-8919-0CA0-AD84-333A04EF55E1"
                        },
                        {
                            "type": "ANSWER",
                            "url": "559E8D24-E59B-3758-8153-E77E6ECB7CD7"
                        }
                    ],
                    "questions_number": 50,
                    "remuneration": 333043,
                    "scholarity": "placeholder",
                    "subscription_fee": 290,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "ccabed1b-1941-4f6d-ad9e-b73055330db9",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "0609ccdb-db5c-4c47-a306-31a0a655e95c",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-26T17:23:30Z",
                    "degree_proof": false,
                    "id": "4000004062",
                    "location": {
                        "id": "20"
                    },
                    "number": 1,
                    "open_spaces": 8,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "07D52C94-8919-0CA0-AD84-333A04EF55E1"
                        },
                        {
                            "type": "ANSWER",
                            "url": "559E8D24-E59B-3758-8153-E77E6ECB7CD7"
                        }
                    ],
                    "questions_number": 50,
                    "remuneration": 333043,
                    "scholarity": "placeholder",
                    "subscription_fee": 290,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "ccabed1b-1941-4f6d-ad9e-b73055330db9",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "2ca62942-4eab-49e5-acaf-e395254eee99",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-26T17:23:48Z",
                    "degree_proof": false,
                    "id": "4000004063",
                    "location": {
                        "id": "20"
                    },
                    "number": 1,
                    "open_spaces": 5,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "07D52C94-8919-0CA0-AD84-333A04EF55E1"
                        },
                        {
                            "type": "ANSWER",
                            "url": "559E8D24-E59B-3758-8153-E77E6ECB7CD7"
                        }
                    ],
                    "questions_number": 50,
                    "remuneration": 333043,
                    "scholarity": "placeholder",
                    "subscription_fee": 290,
                    "year": 2021
                }
            ],
            "forum_id": "1dc3a947-3edf-43e5-bae3-83d6c2c83340",
            "has_student_answer": false,
            "has_user_solution": false,
            "has_video_solution": true,
            "id": "4000146739",
            "labels": [
                "FINAL_ANSWER_SHEET"
            ],
            "public": true,
            "slug": "Atualmente-dispomos3851b7ca74",
            "solution": {
                "alternative_solutions": null,
                "author_email": "camila.moma@estrategiamed.com.br",
                "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                "brief": "",
                "brief_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "complete": "<b>Gabarito: alternativa (E).</b><div><b>ComentÃ¡rios:</b></div><div>A primeira escolha terapÃªutica em pacientes com diabetes mellitus tipo 2 Ã© a metformina, droga pertencente ao grupo das biguanidas, que atua reduzindo a produÃ§Ã£o hepÃ¡tica de glicose e promovendo maior captaÃ§Ã£o de glicose pelo prÃ³prio intestino. NÃ£o causa hipoglicemia nem ganho ponderal e, em comparaÃ§Ã£o Ã s sulfonilureias e Ã  insulina, possui benefÃ­cios em reduÃ§Ã£o de risco cardiovascular.</div><div>Como o diabetes mellitus tipo 2 Ã© uma doenÃ§a progressiva, uma vez que hÃ¡ falÃªncia das cÃ©lulas beta pancreÃ¡ticas, sÃ£o necessÃ¡rias adiÃ§Ãµes medicamentosas ao longo do acompanhamento, a fim de manter o controle glicÃªmico adequado, evitando, assim, complicaÃ§Ãµes crÃ´nicas.</div><div>Para a maioria dos pacientes, as metas de controle glicÃªmico sÃ£o glicemia em jejum &lt; 130 mg/dL, glicemia 2 horas apÃ³s a refeiÃ§Ã£o &lt; 180 mg/dL e hemoglobina glicada fraÃ§Ã£o A1c &lt; 7%.</div><div>A escolha do segundo ou terceiro agente, associado Ã  metformina, depende das caracterÃ­sticas individuais:</div><div>â¢\tPresenÃ§a de obesidade: preferÃªncia pelos inibidores de SGLT-2 e pelos anÃ¡logos de GLP-1, pois promovem perda de peso;</div><div>â¢\tPresenÃ§a de doenÃ§a cardiovascular estabelecida: inibidores de SGLT-2 ou anÃ¡logos de GLP-1;</div><div>â¢\tPresenÃ§a de doenÃ§a renal crÃ´nica com taxa de filtraÃ§Ã£o glomerular &gt; 30 mL/min e albuminÃºria &gt; 300 mg/g de creatinina: inibidores de SGLT-2;</div><div>â¢\tPresenÃ§a de insuficiÃªncia cardÃ­aca com fraÃ§Ã£o de ejeÃ§Ã£o reduzida: inibidores de SGLT-2;</div><div>â¢\tPresenÃ§a de doenÃ§a renal crÃ´nica dialÃ­tica: nesta situaÃ§Ã£o, a metformina Ã© contraindicada e podem ser utilizados os inibidores de DPP-4 e a insulina.</div><div><br></div>",
                "complete_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "created_at": "2021-06-01 02:28:33.430576 +0000 UTC",
                "id": "de82df5a-9b0e-4600-a537-409593fa7229",
                "is_default": false,
                "sanitized_brief": "",
                "sanitized_complete": "Gabarito: alternativa (E).ComentÃ¡rios:A primeira escolha terapÃªutica em pacientes com diabetes mellitus tipo 2 Ã© a metformina, droga pertencente ao grupo das biguanidas, que atua reduzindo a produÃ§Ã£o hepÃ¡tica de glicose e promovendo maior captaÃ§Ã£o de glicose pelo prÃ³prio intestino. NÃ£o causa hipoglicemia nem ganho ponderal e, em comparaÃ§Ã£o Ã s sulfonilureias e Ã  insulina, possui benefÃ­cios em reduÃ§Ã£o de risco cardiovascular.Como o diabetes mellitus tipo 2 Ã© uma doenÃ§a progressiva, uma vez que hÃ¡ falÃªncia das cÃ©lulas beta pancreÃ¡ticas, sÃ£o necessÃ¡rias adiÃ§Ãµes medicamentosas ao longo do acompanhamento, a fim de manter o controle glicÃªmico adequado, evitando, assim, complicaÃ§Ãµes crÃ´nicas.Para a maioria dos pacientes, as metas de controle glicÃªmico sÃ£o glicemia em jejum &lt; 130 mg/dL, glicemia 2 horas apÃ³s a refeiÃ§Ã£o &lt; 180 mg/dL e hemoglobina glicada fraÃ§Ã£o A1c &lt; 7%.A escolha do segundo ou terceiro agente, associado Ã  metformina, depende das caracterÃ­sticas individuais:â¢\tPresenÃ§a de obesidade: preferÃªncia pelos inibidores de SGLT-2 e pelos anÃ¡logos de GLP-1, pois promovem perda de peso;â¢\tPresenÃ§a de doenÃ§a cardiovascular estabelecida: inibidores de SGLT-2 ou anÃ¡logos de GLP-1;â¢\tPresenÃ§a de doenÃ§a renal crÃ´nica com taxa de filtraÃ§Ã£o glomerular &gt; 30 mL/min e albuminÃºria &gt; 300 mg/g de creatinina: inibidores de SGLT-2;â¢\tPresenÃ§a de insuficiÃªncia cardÃ­aca com fraÃ§Ã£o de ejeÃ§Ã£o reduzida: inibidores de SGLT-2;â¢\tPresenÃ§a de doenÃ§a renal crÃ´nica dialÃ­tica: nesta situaÃ§Ã£o, a metformina Ã© contraindicada e podem ser utilizados os inibidores de DPP-4 e a insulina.",
                "updated_at": "2021-06-01 02:28:34.882411 +0000 UTC",
                "video_solution_id": "99e4d222-b6aa-4690-9574-a5a9c4307b52"
            },
            "statement": "Atualmente dispomos de vÃ¡rias alternativas farmacolÃ³gicas para o manejo do diabete melito tipo 2. Entretanto, algumas drogas podem se acompanhar de efeitos adversos significativos. Assinale a alternativa CORRETA em relaÃ§Ã£o ao medicamento hipoglicemiante e seu respectivo efeito colateral.",
            "statement_text": "Atualmente dispomos de vÃ¡rias alternativas farmacolÃ³gicas para o manejo do diabete melito tipo 2. Entretanto, algumas drogas podem se acompanhar de efeitos adversos significativos. Assinale a alternativa CORRETA em relaÃ§Ã£o ao medicamento hipoglicemiante e seu respectivo efeito colateral.",
            "status": {
                "change_actor": "frank.martins@estrategiamed.com.br",
                "created_at": "2021-06-02 01:05:47.36613 +0000 UTC",
                "owner": "camila.moma@estrategiamed.com.br",
                "value": "APPROVED"
            },
            "topics": [
                {
                    "has_children": false,
                    "id": "0cad8ea0fa0e47efa8d56f8a97b383e5",
                    "master_id": "3b9e1e9de9ba4ff3959ae83d455880f9",
                    "name": "MedicaÃ§Ãµes que provocam glicosÃºria (inibidores de SGLT-2)",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Tratamento[$$]Tratamento medicamentoso[$$]Drogas antidiabÃ©ticas nÃ£o insulina[$$]MedicaÃ§Ãµes que provocam glicosÃºria (inibidores de SGLT-2)"
                },
                {
                    "has_children": false,
                    "id": "778ea293dac8426ab5447d56646b3e72",
                    "master_id": "e39487f7326345f982716782efb6d872",
                    "name": "Tratamento medicamentoso",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Tratamento[$$]Tratamento medicamentoso"
                },
                {
                    "has_children": false,
                    "id": "ab6c6a1fb6604cf98243ac486f80dac8",
                    "master_id": "0a6abdce2fbc45aa8ba8f0e75875ec84",
                    "name": "Endocrinologia ",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia "
                },
                {
                    "has_children": false,
                    "id": "d53b61e527fa4a61b5a22bb715b8d0f8",
                    "master_id": "8bdc1fbeb2e54046a2c3ba4ac4e63ead",
                    "name": "Biguanida (metformina)",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Tratamento[$$]Tratamento medicamentoso[$$]Drogas antidiabÃ©ticas nÃ£o insulina[$$]MedicaÃ§Ãµes com efeito sensibilizador de insulina[$$]Biguanida (metformina)"
                },
                {
                    "has_children": false,
                    "id": "ff17842ceb1d4396a7ea1a21c9e2c9f1",
                    "master_id": "8bdc1fbeb2e54046a2c3ba4ac4e63ead",
                    "name": "Tiazolidinedionas (pioglitazona)",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Tratamento[$$]Tratamento medicamentoso[$$]Drogas antidiabÃ©ticas nÃ£o insulina[$$]MedicaÃ§Ãµes com efeito sensibilizador de insulina[$$]Tiazolidinedionas (pioglitazona)"
                }
            ],
            "unlisted": false,
            "video_solution": {
                "available_resolutions": [
                    {
                        "resolution": "720",
                        "url": "https://api.estrategia.com/questoes/sign/medicina/processadas/4000146739-720.mp4"
                    }
                ],
                "id": "99e4d222-b6aa-4690-9574-a5a9c4307b52",
                "identifier": "",
                "question_id": "4000146739"
            },
            "video_solution_id": "99e4d222-b6aa-4690-9574-a5a9c4307b52"
        },
        {
            "active": true,
            "alternatives": [
                {
                    "answer_percentage": 4,
                    "answers": 108,
                    "body": "a acarbose tem aÃ§Ã£o intestinal e reduz, em nÃ­veis absolutos, atÃ© 3 pontos percentuais a hemoglobina glicada.",
                    "correct": false,
                    "created_at": "2021-04-25 23:20:49.301927 +0000 UTC",
                    "id": "d5271e10-6c11-47d0-89d7-756c4dcff35d",
                    "position": "0",
                    "sanitized_body": "a acarbose tem aÃ§Ã£o intestinal e reduz, em nÃ­veis absolutos, atÃ© 3 pontos percentuais a hemoglobina glicada.",
                    "solution": {
                        "alternative_id": "d5271e10-6c11-47d0-89d7-756c4dcff35d",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (A) Ã© incorreta.</b> A acarbose Ã© um inibidor da Î±-glicosidase, enzima intestinal responsÃ¡vel pela quebra de dissacarÃ­deos em monossacarÃ­deos, retardando, assim, a absorÃ§Ã£o da glicose e atenuando a excursÃ£o glicÃªmica pÃ³s-prandial. Tem potÃªncia em reduzir hemoglobina glicada da ordem de 0,5%; as drogas mais potentes sÃ£o a metformina, as glinidas e as sulfonilureias.<div wfd-id=\"50470\"><!-- BEGIN:IMAGE_TO_REPLACE --><img src=\"https://estrategia-prod-questoes.s3.amazonaws.com/images/3BF3FFAC-C809-BBF3-0868-C6570D99C958/3BF3FFAC-C809-BBF3-0868-C6570D99C958-400.png\"><!-- END:IMAGE_TO_REPLACE --><br></div>",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-31 18:12:31.017378 +0000 UTC",
                        "id": "aed9bf71-609f-414e-9cc0-34f3a29c661e",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (A) Ã© incorreta. A acarbose Ã© um inibidor da Î±-glicosidase, enzima intestinal responsÃ¡vel pela quebra de dissacarÃ­deos em monossacarÃ­deos, retardando, assim, a absorÃ§Ã£o da glicose e atenuando a excursÃ£o glicÃªmica pÃ³s-prandial. Tem potÃªncia em reduzir hemoglobina glicada da ordem de 0,5%; as drogas mais potentes sÃ£o a metformina, as glinidas e as sulfonilureias.",
                        "updated_at": "2021-05-31 18:12:32.494518 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-04-29 21:27:11.940762 +0000 UTC"
                },
                {
                    "answer_percentage": 76,
                    "answers": 2142,
                    "body": "a metformina tem aÃ§Ã£o no fÃ­gado diminuindo a gliconeogÃªnese.",
                    "correct": true,
                    "created_at": "2021-04-25 23:20:49.301927 +0000 UTC",
                    "id": "2f2e93f0-c650-471f-892a-d9b345d60ff4",
                    "position": "1",
                    "sanitized_body": "a metformina tem aÃ§Ã£o no fÃ­gado diminuindo a gliconeogÃªnese.",
                    "solution": {
                        "alternative_id": "2f2e93f0-c650-471f-892a-d9b345d60ff4",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (B) Ã© correta. </b>A metformina diminui a produÃ§Ã£o hepÃ¡tica de glicose e promove maior captaÃ§Ã£o de glicose pelo intestino (para uso prÃ³prio como fonte de energia). Ã a droga de primeira escolha, pois nÃ£o causa ganho ponderal nem hipoglicemia, tem boa tolerabilidade e baixo custo.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-31 18:12:31.017512 +0000 UTC",
                        "id": "d225133a-1564-41d0-b056-8f603c2fe2fe",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (B) Ã© correta. A metformina diminui a produÃ§Ã£o hepÃ¡tica de glicose e promove maior captaÃ§Ã£o de glicose pelo intestino (para uso prÃ³prio como fonte de energia). Ã a droga de primeira escolha, pois nÃ£o causa ganho ponderal nem hipoglicemia, tem boa tolerabilidade e baixo custo.",
                        "updated_at": "2021-05-31 18:12:32.508441 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-04-29 21:27:12.015296 +0000 UTC"
                },
                {
                    "answer_percentage": 4,
                    "answers": 110,
                    "body": "os inibidores da dipeptidil peptidase 4 inibem a reabsorÃ§Ã£o renal de glicose e podem causar distÃºrbios eletrolÃ­ticos.",
                    "correct": false,
                    "created_at": "2021-04-25 23:20:49.301927 +0000 UTC",
                    "id": "d74d858c-f31b-421b-9007-dd33c36f3ccf",
                    "position": "2",
                    "sanitized_body": "os inibidores da dipeptidil peptidase 4 inibem a reabsorÃ§Ã£o renal de glicose e podem causar distÃºrbios eletrolÃ­ticos.",
                    "solution": {
                        "alternative_id": "d74d858c-f31b-421b-9007-dd33c36f3ccf",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (C) Ã© incorreta.</b> Os inibidores de DPP-4, tambÃ©m chamados de gliptinas, inibem a dipeptidil peptidase-4, enzima responsÃ¡vel pela degradaÃ§Ã£o do GLP-1. Assim, promovem aumento dos nÃ­veis endÃ³genos de GLP-1, com consequente estimulaÃ§Ã£o da secreÃ§Ã£o de insulina (que ocorre de forma dependente dos nÃ­veis glicÃªmicos, nÃ£o causando hipoglicemia) e reduÃ§Ã£o da secreÃ§Ã£o de glucagon.&nbsp;",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-31 18:12:31.041997 +0000 UTC",
                        "id": "f7938bf0-77e0-4ee1-85e9-ebfe0c999cde",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (C) Ã© incorreta. Os inibidores de DPP-4, tambÃ©m chamados de gliptinas, inibem a dipeptidil peptidase-4, enzima responsÃ¡vel pela degradaÃ§Ã£o do GLP-1. Assim, promovem aumento dos nÃ­veis endÃ³genos de GLP-1, com consequente estimulaÃ§Ã£o da secreÃ§Ã£o de insulina (que ocorre de forma dependente dos nÃ­veis glicÃªmicos, nÃ£o causando hipoglicemia) e reduÃ§Ã£o da secreÃ§Ã£o de glucagon.Â ",
                        "updated_at": "2021-05-31 18:12:32.507907 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-04-29 21:27:12.138572 +0000 UTC"
                },
                {
                    "answer_percentage": 5,
                    "answers": 135,
                    "body": "as meglitinidas atuam em receptores nucleares aumentando a sÃ­ntese de transportadores de glicose.",
                    "correct": false,
                    "created_at": "2021-04-25 23:20:49.301927 +0000 UTC",
                    "id": "a0bc6418-5a52-4e4f-b990-c4fb564c20bc",
                    "position": "3",
                    "sanitized_body": "as meglitinidas atuam em receptores nucleares aumentando a sÃ­ntese de transportadores de glicose.",
                    "solution": {
                        "alternative_id": "a0bc6418-5a52-4e4f-b990-c4fb564c20bc",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (D) Ã© incorreta.</b> As glinidas atuam em receptores especÃ­ficos na membrana celular da cÃ©lula beta pancreÃ¡tica, levando Ã  sua despolarizaÃ§Ã£o, com consequente influxo de cÃ¡lcio e secreÃ§Ã£o dos grÃ¢nulos de insulina. Como tal processo ocorre de forma independente dos nÃ­veis glicÃªmicos, hÃ¡ maior risco de hipoglicemia e de ganho ponderal.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-31 18:12:31.015943 +0000 UTC",
                        "id": "f2c350c1-02df-4699-8776-8993243ce998",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (D) Ã© incorreta. As glinidas atuam em receptores especÃ­ficos na membrana celular da cÃ©lula beta pancreÃ¡tica, levando Ã  sua despolarizaÃ§Ã£o, com consequente influxo de cÃ¡lcio e secreÃ§Ã£o dos grÃ¢nulos de insulina. Como tal processo ocorre de forma independente dos nÃ­veis glicÃªmicos, hÃ¡ maior risco de hipoglicemia e de ganho ponderal.",
                        "updated_at": "2021-05-31 18:12:32.506253 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-04-29 21:27:12.270072 +0000 UTC"
                },
                {
                    "answer_percentage": 12,
                    "answers": 340,
                    "body": "os anÃ¡logos das glitazonas sÃ£o especialmente Ãºteis no paciente obeso, uma vez que se associam Ã  reduÃ§Ã£o de peso.",
                    "correct": false,
                    "created_at": "2021-04-25 23:20:49.301927 +0000 UTC",
                    "id": "25e9ac14-ea7b-4852-9f5e-ab2413d500a7",
                    "position": "4",
                    "sanitized_body": "os anÃ¡logos das glitazonas sÃ£o especialmente Ãºteis no paciente obeso, uma vez que se associam Ã  reduÃ§Ã£o de peso.",
                    "solution": {
                        "alternative_id": "25e9ac14-ea7b-4852-9f5e-ab2413d500a7",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (E) Ã© incorreta. </b>NÃ£o hÃ¡ anÃ¡logos de glitazona! HÃ¡ anÃ¡logos de GLP-1 e glitazonas, que sÃ£o duas classes medicamentosas diferentes!<div>Os anÃ¡logos de GLP-1, como o prÃ³prio nome diz, assemelham-se ao prÃ³prio GLP-1, porÃ©m, sÃ£o resistentes Ã  degradaÃ§Ã£o pela dipeptidil peptidase-4. Estimulam a secreÃ§Ã£o de insulina (de forma dependente dos nÃ­veis glicÃªmicos) e reduzem o glucagon, alÃ©m de promoverem retardo do esvaziamento gÃ¡strico (o que diminui a velocidade de absorÃ§Ã£o dos carboidratos) e estÃ£o associados Ã  perda ponderal (por aÃ§Ã£o hipotalÃ¢mica, levando Ã  diminuiÃ§Ã£o do apetite). Dentro da classe, a liraglutida e a semaglutida diminuem risco cardiovascular em pacientes com doenÃ§a cardiovascular estabelecida (infarto, AVC, por exemplo).</div><div>JÃ¡ as glitazonas, tambÃ©m denominadas tiazolidinedionas ou agonistas do PPAR-áµ, sÃ£o drogas que atuam em receptores intranucleares, levando a uma sÃ©rie de reaÃ§Ãµes que culminam com a maior expressÃ£o de transportadores de glicose na membrana celular, aumentando a captaÃ§Ã£o de glicose pelos tecidos perifÃ©ricos (mÃºsculo, tecido adiposo e fÃ­gado). NÃ£o causam hipoglicemia, mas estÃ£o associadas ao ganho ponderal (por aumento de apetite via hipotÃ¡lamo). Como tambÃ©m atuam nos rins, aumentando a reabsorÃ§Ã£o de sÃ³dio e Ã¡gua, sÃ£o contraindicadas na insuficiÃªncia cardÃ­aca classes funcionais NYHA III e IV, uma vez que podem ocorrer descompensaÃ§Ãµes devido ao incremento da volemia.</div><div><br></div>",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-31 18:12:30.996563 +0000 UTC",
                        "id": "9a6139fe-9ce3-4383-9409-9c2fe0fb2e04",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (E) Ã© incorreta. NÃ£o hÃ¡ anÃ¡logos de glitazona! HÃ¡ anÃ¡logos de GLP-1 e glitazonas, que sÃ£o duas classes medicamentosas diferentes!Os anÃ¡logos de GLP-1, como o prÃ³prio nome diz, assemelham-se ao prÃ³prio GLP-1, porÃ©m, sÃ£o resistentes Ã  degradaÃ§Ã£o pela dipeptidil peptidase-4. Estimulam a secreÃ§Ã£o de insulina (de forma dependente dos nÃ­veis glicÃªmicos) e reduzem o glucagon, alÃ©m de promoverem retardo do esvaziamento gÃ¡strico (o que diminui a velocidade de absorÃ§Ã£o dos carboidratos) e estÃ£o associados Ã  perda ponderal (por aÃ§Ã£o hipotalÃ¢mica, levando Ã  diminuiÃ§Ã£o do apetite). Dentro da classe, a liraglutida e a semaglutida diminuem risco cardiovascular em pacientes com doenÃ§a cardiovascular estabelecida (infarto, AVC, por exemplo).JÃ¡ as glitazonas, tambÃ©m denominadas tiazolidinedionas ou agonistas do PPAR-áµ, sÃ£o drogas que atuam em receptores intranucleares, levando a uma sÃ©rie de reaÃ§Ãµes que culminam com a maior expressÃ£o de transportadores de glicose na membrana celular, aumentando a captaÃ§Ã£o de glicose pelos tecidos perifÃ©ricos (mÃºsculo, tecido adiposo e fÃ­gado). NÃ£o causam hipoglicemia, mas estÃ£o associadas ao ganho ponderal (por aumento de apetite via hipotÃ¡lamo). Como tambÃ©m atuam nos rins, aumentando a reabsorÃ§Ã£o de sÃ³dio e Ã¡gua, sÃ£o contraindicadas na insuficiÃªncia cardÃ­aca classes funcionais NYHA III e IV, uma vez que podem ocorrer descompensaÃ§Ãµes devido ao incremento da volemia.",
                        "updated_at": "2021-05-31 18:12:32.519668 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-04-29 21:27:12.367088 +0000 UTC"
                }
            ],
            "answer_type": "MULTIPLE_CHOICE",
            "author_id": "bruno-cesar110@hotmail.com",
            "correct_answer_percentage": 76,
            "created_at": "2021-04-25 23:20:49.301927 +0000 UTC",
            "difficulty_level": "MEDIUM",
            "exams": [
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5d212410-93d4-4d82-bb58-3c20232ece32",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "417a198f-03b2-417e-8505-8acf83f3059d",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-25T01:41:33Z",
                    "degree_proof": false,
                    "id": "4000004039",
                    "location": {
                        "id": "27"
                    },
                    "number": 1,
                    "open_spaces": 8,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "B67F72AD-30B8-333A-49FC-6B0D8AFEF51A"
                        },
                        {
                            "type": "EXAM",
                            "url": "F44E4929-555E-1D66-592D-53117FB08C40"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 550,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5d212410-93d4-4d82-bb58-3c20232ece32",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "4d4116be-190d-4321-94c8-66da6d1acb11",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-25T01:42:15Z",
                    "degree_proof": false,
                    "id": "4000004040",
                    "location": {
                        "id": "27"
                    },
                    "number": 1,
                    "open_spaces": 3,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "B67F72AD-30B8-333A-49FC-6B0D8AFEF51A"
                        },
                        {
                            "type": "EXAM",
                            "url": "F44E4929-555E-1D66-592D-53117FB08C40"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 550,
                    "year": 2021
                }
            ],
            "has_student_answer": false,
            "has_user_solution": false,
            "has_video_solution": true,
            "id": "4000146323",
            "labels": [
                "FINAL_ANSWER_SHEET"
            ],
            "public": true,
            "slug": "tratamento-paciente12630361f6",
            "solution": {
                "alternative_solutions": null,
                "author_email": "camila.moma@estrategiamed.com.br",
                "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                "brief": "",
                "brief_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "complete": "<b>Gabarito: alternativa (B).</b><div><b>ComentÃ¡rios:</b></div><div>A primeira escolha terapÃªutica em pacientes com diabetes mellitus tipo 2 Ã© a metformina, droga pertencente ao grupo das biguanidas, que atua reduzindo a produÃ§Ã£o hepÃ¡tica de glicose e promovendo maior captaÃ§Ã£o de glicose pelo prÃ³prio intestino. NÃ£o causa hipoglicemia nem ganho ponderal e, em comparaÃ§Ã£o Ã s sulfonilureias e Ã  insulina, possui benefÃ­cios em reduÃ§Ã£o de risco cardiovascular.</div><div>Como o diabetes mellitus tipo 2 Ã© uma doenÃ§a progressiva, uma vez que hÃ¡ falÃªncia das cÃ©lulas beta pancreÃ¡ticas, sÃ£o necessÃ¡rias adiÃ§Ãµes medicamentosas ao longo do acompanhamento, a fim de manter o controle glicÃªmico adequado, evitando, assim, complicaÃ§Ãµes crÃ´nicas.</div><div>A escolha do segundo ou terceiro agentes depende das caracterÃ­sticas individuais:</div><div>â¢\tPresenÃ§a de obesidade: preferÃªncia pelos inibidores de SGLT-2 e pelos anÃ¡logos de GLP-1, pois promovem perda de peso;</div><div>â¢\tPresenÃ§a de doenÃ§a cardiovascular estabelecida: inibidores de SGLT-2 ou anÃ¡logos de GLP-1;</div><div>â¢\tPresenÃ§a de doenÃ§a renal crÃ´nica com taxa de filtraÃ§Ã£o glomerular &gt; 30 mL/min e albuminÃºria &gt; 300 mg/g de creatinina: inibidores de SGLT-2;</div><div>â¢\tPresenÃ§a de insuficiÃªncia cardÃ­aca com fraÃ§Ã£o de ejeÃ§Ã£o reduzida: inibidores de SGLT-2;</div><div>â¢\tPresenÃ§a de doenÃ§a renal crÃ´nica dialÃ­tica: nesta situaÃ§Ã£o, a metformina Ã© contraindicada e podem ser utilizados os inibidores de DPP-4 e a insulina.</div><div><br></div>",
                "complete_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "created_at": "2021-05-31 18:12:31.153324 +0000 UTC",
                "id": "46e76b43-9a52-4529-abb9-aa67d0d5e4d7",
                "is_default": false,
                "sanitized_brief": "",
                "sanitized_complete": "Gabarito: alternativa (B).ComentÃ¡rios:A primeira escolha terapÃªutica em pacientes com diabetes mellitus tipo 2 Ã© a metformina, droga pertencente ao grupo das biguanidas, que atua reduzindo a produÃ§Ã£o hepÃ¡tica de glicose e promovendo maior captaÃ§Ã£o de glicose pelo prÃ³prio intestino. NÃ£o causa hipoglicemia nem ganho ponderal e, em comparaÃ§Ã£o Ã s sulfonilureias e Ã  insulina, possui benefÃ­cios em reduÃ§Ã£o de risco cardiovascular.Como o diabetes mellitus tipo 2 Ã© uma doenÃ§a progressiva, uma vez que hÃ¡ falÃªncia das cÃ©lulas beta pancreÃ¡ticas, sÃ£o necessÃ¡rias adiÃ§Ãµes medicamentosas ao longo do acompanhamento, a fim de manter o controle glicÃªmico adequado, evitando, assim, complicaÃ§Ãµes crÃ´nicas.A escolha do segundo ou terceiro agentes depende das caracterÃ­sticas individuais:â¢\tPresenÃ§a de obesidade: preferÃªncia pelos inibidores de SGLT-2 e pelos anÃ¡logos de GLP-1, pois promovem perda de peso;â¢\tPresenÃ§a de doenÃ§a cardiovascular estabelecida: inibidores de SGLT-2 ou anÃ¡logos de GLP-1;â¢\tPresenÃ§a de doenÃ§a renal crÃ´nica com taxa de filtraÃ§Ã£o glomerular &gt; 30 mL/min e albuminÃºria &gt; 300 mg/g de creatinina: inibidores de SGLT-2;â¢\tPresenÃ§a de insuficiÃªncia cardÃ­aca com fraÃ§Ã£o de ejeÃ§Ã£o reduzida: inibidores de SGLT-2;â¢\tPresenÃ§a de doenÃ§a renal crÃ´nica dialÃ­tica: nesta situaÃ§Ã£o, a metformina Ã© contraindicada e podem ser utilizados os inibidores de DPP-4 e a insulina.",
                "updated_at": "2021-05-31 18:12:32.574048 +0000 UTC",
                "video_solution_id": "aa0a3d69-2327-466a-8b4b-48eec10970cb"
            },
            "statement": "Em relaÃ§Ã£o ao tratamento do paciente com diabetes mellitus, Ã© correto afirmar:",
            "statement_text": "Em relaÃ§Ã£o ao tratamento do paciente com diabetes mellitus, Ã© correto afirmar:",
            "status": {
                "change_actor": "frank.martins@estrategiamed.com.br",
                "created_at": "2021-05-31 19:49:09.99129 +0000 UTC",
                "owner": "camila.moma@estrategiamed.com.br",
                "value": "APPROVED"
            },
            "topics": [
                {
                    "has_children": false,
                    "id": "ab6c6a1fb6604cf98243ac486f80dac8",
                    "master_id": "0a6abdce2fbc45aa8ba8f0e75875ec84",
                    "name": "Endocrinologia ",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia "
                },
                {
                    "has_children": false,
                    "id": "d53b61e527fa4a61b5a22bb715b8d0f8",
                    "master_id": "8bdc1fbeb2e54046a2c3ba4ac4e63ead",
                    "name": "Biguanida (metformina)",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Tratamento[$$]Tratamento medicamentoso[$$]Drogas antidiabÃ©ticas nÃ£o insulina[$$]MedicaÃ§Ãµes com efeito sensibilizador de insulina[$$]Biguanida (metformina)"
                }
            ],
            "unlisted": false,
            "video_solution": {
                "available_resolutions": [
                    {
                        "resolution": "720",
                        "url": "https://api.estrategia.com/questoes/sign/medicina/processadas/4000146323-720.mp4"
                    }
                ],
                "id": "aa0a3d69-2327-466a-8b4b-48eec10970cb",
                "identifier": "",
                "question_id": "4000146323"
            },
            "video_solution_id": "aa0a3d69-2327-466a-8b4b-48eec10970cb"
        },
        {
            "active": true,
            "alternatives": [
                {
                    "answer_percentage": 11,
                    "answers": 201,
                    "body": "Metformina, uma biguanida, alÃ©m da aÃ§Ã£o benÃ©fica sobre o metabolismo da glicose, proporciona diminuiÃ§Ã£o de eventos cardiovasculares e reduÃ§Ã£o de peso corpÃ³reo.",
                    "correct": false,
                    "created_at": "2021-01-05 02:30:09.439349 +0000 UTC",
                    "id": "937344f2-f9ab-464a-b079-88039fc68392",
                    "position": "0",
                    "sanitized_body": "Metformina, uma biguanida, alÃ©m da aÃ§Ã£o benÃ©fica sobre o metabolismo da glicose, proporciona diminuiÃ§Ã£o de eventos cardiovasculares e reduÃ§Ã£o de peso corpÃ³reo.",
                    "solution": {
                        "alternative_id": "937344f2-f9ab-464a-b079-88039fc68392",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (A) Ã© incorreta. </b>A metformina Ã© uma biguanida que melhora a resistÃªncia hepÃ¡tica Ã  insulina, diminuindo a gliconeogÃªnese. AlÃ©m disso, promove maior utilizaÃ§Ã£o de glicose pelo intestino. Em geral, Ã© neutra em relaÃ§Ã£o ao peso e nÃ£o causa hipoglicemias. Em determinados subgrupos, como nos obesos, pode promover perda ponderal discreta. HÃ¡ dados em que se comparou a metformina com sulfonilureia e insulina, mostrando benefÃ­cio cardiovascular com a metformina.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-19 02:15:03.16652 +0000 UTC",
                        "id": "b0670e53-49db-4e3c-86a4-d35d074bf3e2",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (A) Ã© incorreta. A metformina Ã© uma biguanida que melhora a resistÃªncia hepÃ¡tica Ã  insulina, diminuindo a gliconeogÃªnese. AlÃ©m disso, promove maior utilizaÃ§Ã£o de glicose pelo intestino. Em geral, Ã© neutra em relaÃ§Ã£o ao peso e nÃ£o causa hipoglicemias. Em determinados subgrupos, como nos obesos, pode promover perda ponderal discreta. HÃ¡ dados em que se comparou a metformina com sulfonilureia e insulina, mostrando benefÃ­cio cardiovascular com a metformina.",
                        "updated_at": "2021-05-19 02:15:05.778196 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-19 02:12:21.305532 +0000 UTC"
                },
                {
                    "answer_percentage": 9,
                    "answers": 157,
                    "body": "A gliclazida Ã© uma sulfonilureia que atua no aumento da secreÃ§Ã£o de insulina, favorece o ganho de peso corporal, mas protege contra a nefropatia diabÃ©tica.",
                    "correct": false,
                    "created_at": "2021-01-05 02:30:09.439349 +0000 UTC",
                    "id": "f9034ddf-6d14-495e-8c1b-b8a6553a9d5f",
                    "position": "1",
                    "sanitized_body": "A gliclazida Ã© uma sulfonilureia que atua no aumento da secreÃ§Ã£o de insulina, favorece o ganho de peso corporal, mas protege contra a nefropatia diabÃ©tica.",
                    "solution": {
                        "alternative_id": "f9034ddf-6d14-495e-8c1b-b8a6553a9d5f",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (B) Ã© incorreta.</b> A gliclazida Ã© uma sulfonilureia que estimula a secreÃ§Ã£o de insulina de forma independente dos nÃ­veis glicÃªmicos, o que aumenta o risco de hipoglicemias e de ganho ponderal. Reduz a nefropatia diabÃ©tica por promover melhor controle glicÃªmico. Devemos evita-las em indivÃ­duos com excesso ponderal e/ou risco de hipoglicemias.<div><b>ReferÃªncia:</b> <i>ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008 Jun 12;358(24):2560-72.</i></div><div><br></div>",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-19 02:15:03.206766 +0000 UTC",
                        "id": "0590558a-c32c-4d15-ac82-986cf136c96b",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (B) Ã© incorreta. A gliclazida Ã© uma sulfonilureia que estimula a secreÃ§Ã£o de insulina de forma independente dos nÃ­veis glicÃªmicos, o que aumenta o risco de hipoglicemias e de ganho ponderal. Reduz a nefropatia diabÃ©tica por promover melhor controle glicÃªmico. Devemos evita-las em indivÃ­duos com excesso ponderal e/ou risco de hipoglicemias.ReferÃªncia: ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008 Jun 12;358(24):2560-72.",
                        "updated_at": "2021-05-19 02:15:05.883374 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-19 02:12:21.438518 +0000 UTC"
                },
                {
                    "answer_percentage": 4,
                    "answers": 78,
                    "body": "As tiazolidinedionas, (Pioglitazona) proporcionam aumento da sensibilidade Ã  insulina em mÃºsculo, adipÃ³cito e hepatÃ³cito, mas pode apresentar efeitos colaterais como o ganho ponderal e piora da insuficiÃªncia cardÃ­aca.",
                    "correct": false,
                    "created_at": "2021-01-05 02:30:09.439349 +0000 UTC",
                    "id": "ab6e4f51-b657-4fb3-9cfa-50e94144b3ac",
                    "position": "2",
                    "sanitized_body": "As tiazolidinedionas, (Pioglitazona) proporcionam aumento da sensibilidade Ã  insulina em mÃºsculo, adipÃ³cito e hepatÃ³cito, mas pode apresentar efeitos colaterais como o ganho ponderal e piora da insuficiÃªncia cardÃ­aca.",
                    "solution": {
                        "alternative_id": "ab6e4f51-b657-4fb3-9cfa-50e94144b3ac",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (C) Ã© incorreta.</b> As tiazolidinedionas sÃ£o agonistas do receptor de ativaÃ§Ã£o da proliferaÃ§Ã£o de peroxissomos gama (PPAR-áµ), portanto, atuam nesses receptores intranucleares, levando a modificaÃ§Ãµes que culminam com melhora da resistÃªncia perifÃ©rica Ã  insulina, com consequente aumento da captaÃ§Ã£o de glicose pelos tecidos. TambÃ©m atua em receptores PPAR-áµ nos rins, promovendo maior reabsorÃ§Ã£o de sÃ³dio e Ã¡gua, o que pode incrementar a volemia e descompensar quadros de insuficiÃªncia cardÃ­aca. Por este motivo, Ã© contraindicada em pacientes com IC classes funcionais NYHA III e IV (indivÃ­duos com dispneia a pequenos/moderados esforÃ§os ou em repouso).<div>TambÃ©m causa ganho ponderal por atuar em centros hipotalÃ¢micos, aumentando o apetite, e estÃ¡ relacionada a aumento de fraturas. Portanto, nÃ£o deve ser utilizada em pacientes com risco aumentado de fraturas (como, por exemplo, fratura de fÃªmur prÃ©via, osteopenia/osteoporose, artrite reumatoide, tabagistas e etilistas).</div><div><br></div>",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-19 02:15:03.182476 +0000 UTC",
                        "id": "2ad4eabc-3072-4057-baec-72b5a596a8f7",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (C) Ã© incorreta. As tiazolidinedionas sÃ£o agonistas do receptor de ativaÃ§Ã£o da proliferaÃ§Ã£o de peroxissomos gama (PPAR-áµ), portanto, atuam nesses receptores intranucleares, levando a modificaÃ§Ãµes que culminam com melhora da resistÃªncia perifÃ©rica Ã  insulina, com consequente aumento da captaÃ§Ã£o de glicose pelos tecidos. TambÃ©m atua em receptores PPAR-áµ nos rins, promovendo maior reabsorÃ§Ã£o de sÃ³dio e Ã¡gua, o que pode incrementar a volemia e descompensar quadros de insuficiÃªncia cardÃ­aca. Por este motivo, Ã© contraindicada em pacientes com IC classes funcionais NYHA III e IV (indivÃ­duos com dispneia a pequenos/moderados esforÃ§os ou em repouso).TambÃ©m causa ganho ponderal por atuar em centros hipotalÃ¢micos, aumentando o apetite, e estÃ¡ relacionada a aumento de fraturas. Portanto, nÃ£o deve ser utilizada em pacientes com risco aumentado de fraturas (como, por exemplo, fratura de fÃªmur prÃ©via, osteopenia/osteoporose, artrite reumatoide, tabagistas e etilistas).",
                        "updated_at": "2021-05-19 02:15:05.882308 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-19 02:12:21.545414 +0000 UTC"
                },
                {
                    "answer_percentage": 7,
                    "answers": 119,
                    "body": "A sitagliptina, droga inibidora da DPP-4, aumenta os nÃ­veis de GLP-1 (peptÃ­deo anÃ¡logo ao glucagon), potencializando a secreÃ§Ã£o de insulina pelas cÃ©lulas beta das ilhotas pancreÃ¡ticas em resposta Ã  glicose absorvida no intestino.",
                    "correct": false,
                    "created_at": "2021-01-05 02:30:09.439349 +0000 UTC",
                    "id": "1428a93f-8453-4dc2-b8db-4501386dd456",
                    "position": "3",
                    "sanitized_body": "A sitagliptina, droga inibidora da DPP-4, aumenta os nÃ­veis de GLP-1 (peptÃ­deo anÃ¡logo ao glucagon), potencializando a secreÃ§Ã£o de insulina pelas cÃ©lulas beta das ilhotas pancreÃ¡ticas em resposta Ã  glicose absorvida no intestino.",
                    "solution": {
                        "alternative_id": "1428a93f-8453-4dc2-b8db-4501386dd456",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (D) Ã© incorreta. </b>A sitagliptina Ã© uma droga que inibe a enzima dipeptidil peptidase-4 (DPP-4), responsÃ¡vel pela degradaÃ§Ã£o do GLP-1. Deste modo, promove aumento do GLP-1 endÃ³geno, o que estimula a secreÃ§Ã£o de insulina, porÃ©m, de forma dependente dos nÃ­veis glicÃªmicos, portanto, nÃ£o causa hipoglicemias. Ã neutra em relaÃ§Ã£o ao peso e pode ser utilizada atÃ© na doenÃ§a renal crÃ´nica dialÃ­tica (entretanto, seu ajuste Ã© necessÃ¡rio para a taxa de filtraÃ§Ã£o glomerular).",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-19 02:15:03.157044 +0000 UTC",
                        "id": "83a4a076-061e-4403-9791-146d7fd7b6d4",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (D) Ã© incorreta. A sitagliptina Ã© uma droga que inibe a enzima dipeptidil peptidase-4 (DPP-4), responsÃ¡vel pela degradaÃ§Ã£o do GLP-1. Deste modo, promove aumento do GLP-1 endÃ³geno, o que estimula a secreÃ§Ã£o de insulina, porÃ©m, de forma dependente dos nÃ­veis glicÃªmicos, portanto, nÃ£o causa hipoglicemias. Ã neutra em relaÃ§Ã£o ao peso e pode ser utilizada atÃ© na doenÃ§a renal crÃ´nica dialÃ­tica (entretanto, seu ajuste Ã© necessÃ¡rio para a taxa de filtraÃ§Ã£o glomerular).",
                        "updated_at": "2021-05-19 02:15:05.9042 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-19 02:12:21.670115 +0000 UTC"
                },
                {
                    "answer_percentage": 69,
                    "answers": 1264,
                    "body": "A dapagliflozina Ã© um inibidor do co-transportador de sÃ³dio e glucose 2 (SGLT2), o que leva Ã  excreÃ§Ã£o urinÃ¡ria da glicose. Ela proporciona efeitos de perda ponderal, mas sem diminuiÃ§Ã£o de eventos cardiovasculares.",
                    "correct": true,
                    "created_at": "2021-01-05 02:30:09.439349 +0000 UTC",
                    "id": "824ccd44-f757-4476-8fea-5b574327e55b",
                    "position": "4",
                    "sanitized_body": "A dapagliflozina Ã© um inibidor do co-transportador de sÃ³dio e glucose 2 (SGLT2), o que leva Ã  excreÃ§Ã£o urinÃ¡ria da glicose. Ela proporciona efeitos de perda ponderal, mas sem diminuiÃ§Ã£o de eventos cardiovasculares.",
                    "solution": {
                        "alternative_id": "824ccd44-f757-4476-8fea-5b574327e55b",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (E) Ã© correta. </b>A dapagliflozina Ã© um inibidor do transportador de sÃ³dio e glicose tipo 2 (SGLT-2) presente principalmente no tÃºbulo proximal renal. Assim, impede a reabsorÃ§Ã£o renal de glicose, promovendo glicosÃºria; essa perda de glicose leva ao balanÃ§o energÃ©tico negativo, com consequente reduÃ§Ã£o ponderal.<div>Os inibidores de SGLT-2 tÃªm mostrado benefÃ­cios extra glicÃªmicos em pacientes com doenÃ§a cardiovascular estabelecida e diabetes mellitus tipo 2, com reduÃ§Ã£o de mortalidade. A dapagliflozina tambÃ©m mostrou benefÃ­cio cardiovascular nos pacientes com insuficiÃªncia cardÃ­aca com fraÃ§Ã£o de ejeÃ§Ã£o reduzida, mesmo nÃ£o sendo diabÃ©ticos, com menor descompensaÃ§Ã£o do quadro, reduÃ§Ã£o de hospitalizaÃ§Ãµes e de mortalidade.</div><div><br></div>",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-19 02:15:03.176517 +0000 UTC",
                        "id": "281fb4e0-e4be-4b6e-8c53-53ab3beab281",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (E) Ã© correta. A dapagliflozina Ã© um inibidor do transportador de sÃ³dio e glicose tipo 2 (SGLT-2) presente principalmente no tÃºbulo proximal renal. Assim, impede a reabsorÃ§Ã£o renal de glicose, promovendo glicosÃºria; essa perda de glicose leva ao balanÃ§o energÃ©tico negativo, com consequente reduÃ§Ã£o ponderal.Os inibidores de SGLT-2 tÃªm mostrado benefÃ­cios extra glicÃªmicos em pacientes com doenÃ§a cardiovascular estabelecida e diabetes mellitus tipo 2, com reduÃ§Ã£o de mortalidade. A dapagliflozina tambÃ©m mostrou benefÃ­cio cardiovascular nos pacientes com insuficiÃªncia cardÃ­aca com fraÃ§Ã£o de ejeÃ§Ã£o reduzida, mesmo nÃ£o sendo diabÃ©ticos, com menor descompensaÃ§Ã£o do quadro, reduÃ§Ã£o de hospitalizaÃ§Ãµes e de mortalidade.",
                        "updated_at": "2021-05-19 02:15:05.878007 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-19 02:12:21.823022 +0000 UTC"
                }
            ],
            "answer_type": "MULTIPLE_CHOICE",
            "author_id": "bruno-cesar110@hotmail.com",
            "correct_answer_percentage": 69,
            "created_at": "2021-01-05 02:30:09.439349 +0000 UTC",
            "difficulty_level": "MEDIUM",
            "exams": [
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5a1e5909-2f5a-477c-924a-ec32151bdf80",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "046f0505-90c9-4862-b318-388c0d1e8026",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-04T23:27:03Z",
                    "degree_proof": false,
                    "id": "4000002763",
                    "location": {
                        "id": "19"
                    },
                    "number": 1,
                    "open_spaces": 4,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "426ED979-7A5E-C3C8-7B68-28C484FBF158"
                        },
                        {
                            "type": "EXAM",
                            "url": "1AF73EA9-3F75-E29D-12B0-ACFC4A9FECE4"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 400,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5a1e5909-2f5a-477c-924a-ec32151bdf80",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "9b34a94d-754d-4510-8bad-60f649fa825b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-04T23:27:45Z",
                    "degree_proof": false,
                    "id": "4000002764",
                    "location": {
                        "id": "19"
                    },
                    "number": 1,
                    "open_spaces": 5,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "426ED979-7A5E-C3C8-7B68-28C484FBF158"
                        },
                        {
                            "type": "EXAM",
                            "url": "1AF73EA9-3F75-E29D-12B0-ACFC4A9FECE4"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 400,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "f30d24a0-2f2d-43be-9812-73746e91a61a",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5a1e5909-2f5a-477c-924a-ec32151bdf80",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "66678bdd-d9e1-4267-a4cf-f3beebfd7d0e",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-04T23:28:13Z",
                    "degree_proof": false,
                    "id": "4000002765",
                    "location": {
                        "id": "19"
                    },
                    "number": 1,
                    "open_spaces": 1,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "426ED979-7A5E-C3C8-7B68-28C484FBF158"
                        },
                        {
                            "type": "EXAM",
                            "url": "1AF73EA9-3F75-E29D-12B0-ACFC4A9FECE4"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 400,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5a1e5909-2f5a-477c-924a-ec32151bdf80",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "8d4e50ad-d41e-40c9-9f4d-842251c2d2d9",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-04T23:28:49Z",
                    "degree_proof": false,
                    "id": "4000002766",
                    "location": {
                        "id": "19"
                    },
                    "number": 1,
                    "open_spaces": 1,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "426ED979-7A5E-C3C8-7B68-28C484FBF158"
                        },
                        {
                            "type": "EXAM",
                            "url": "1AF73EA9-3F75-E29D-12B0-ACFC4A9FECE4"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 400,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5a1e5909-2f5a-477c-924a-ec32151bdf80",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "0609ccdb-db5c-4c47-a306-31a0a655e95c",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-04T23:29:20Z",
                    "degree_proof": false,
                    "id": "4000002767",
                    "location": {
                        "id": "19"
                    },
                    "number": 1,
                    "open_spaces": 4,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "426ED979-7A5E-C3C8-7B68-28C484FBF158"
                        },
                        {
                            "type": "EXAM",
                            "url": "1AF73EA9-3F75-E29D-12B0-ACFC4A9FECE4"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 400,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5a1e5909-2f5a-477c-924a-ec32151bdf80",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "417a198f-03b2-417e-8505-8acf83f3059d",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-04T23:29:58Z",
                    "degree_proof": false,
                    "id": "4000002768",
                    "location": {
                        "id": "19"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "426ED979-7A5E-C3C8-7B68-28C484FBF158"
                        },
                        {
                            "type": "EXAM",
                            "url": "1AF73EA9-3F75-E29D-12B0-ACFC4A9FECE4"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 400,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5a1e5909-2f5a-477c-924a-ec32151bdf80",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "f2f2f3c5-9759-4201-bca7-2487751bd626",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-04T23:30:24Z",
                    "degree_proof": false,
                    "id": "4000002769",
                    "location": {
                        "id": "19"
                    },
                    "number": 1,
                    "open_spaces": 3,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "426ED979-7A5E-C3C8-7B68-28C484FBF158"
                        },
                        {
                            "type": "EXAM",
                            "url": "1AF73EA9-3F75-E29D-12B0-ACFC4A9FECE4"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 400,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5a1e5909-2f5a-477c-924a-ec32151bdf80",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "4d4116be-190d-4321-94c8-66da6d1acb11",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-04T23:30:53Z",
                    "degree_proof": false,
                    "id": "4000002770",
                    "location": {
                        "id": "19"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "426ED979-7A5E-C3C8-7B68-28C484FBF158"
                        },
                        {
                            "type": "EXAM",
                            "url": "1AF73EA9-3F75-E29D-12B0-ACFC4A9FECE4"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 400,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5a1e5909-2f5a-477c-924a-ec32151bdf80",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "710b6098-b1cc-40fb-a6e9-1978c156b947",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-04T23:31:11Z",
                    "degree_proof": false,
                    "id": "4000002771",
                    "location": {
                        "id": "19"
                    },
                    "number": 1,
                    "open_spaces": 4,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "426ED979-7A5E-C3C8-7B68-28C484FBF158"
                        },
                        {
                            "type": "EXAM",
                            "url": "1AF73EA9-3F75-E29D-12B0-ACFC4A9FECE4"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 400,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5a1e5909-2f5a-477c-924a-ec32151bdf80",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "dfa90599-1ee1-4de3-8605-a75ecd3799bd",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-04T23:31:34Z",
                    "degree_proof": false,
                    "id": "4000002772",
                    "location": {
                        "id": "19"
                    },
                    "number": 1,
                    "open_spaces": 5,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "426ED979-7A5E-C3C8-7B68-28C484FBF158"
                        },
                        {
                            "type": "EXAM",
                            "url": "1AF73EA9-3F75-E29D-12B0-ACFC4A9FECE4"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 400,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "23112f36-223f-447c-a1b6-08bf6dad1276",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5a1e5909-2f5a-477c-924a-ec32151bdf80",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "b39a29ec-d8c7-4592-b019-d0c7ee728856",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-04T23:31:58Z",
                    "degree_proof": false,
                    "id": "4000002773",
                    "location": {
                        "id": "19"
                    },
                    "number": 1,
                    "open_spaces": 1,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "426ED979-7A5E-C3C8-7B68-28C484FBF158"
                        },
                        {
                            "type": "EXAM",
                            "url": "1AF73EA9-3F75-E29D-12B0-ACFC4A9FECE4"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 400,
                    "year": 2021
                }
            ],
            "forum_id": "fa99fd30-d9df-49c4-b1f7-129e576a25e1",
            "has_student_answer": false,
            "has_user_solution": false,
            "has_video_solution": true,
            "id": "4000138372",
            "labels": [
                "TEMPORARY_ANSWER_SHEET"
            ],
            "public": true,
            "slug": "medicamentos-orais16dc579ef5",
            "solution": {
                "alternative_solutions": null,
                "author_email": "camila.moma@estrategiamed.com.br",
                "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                "brief": "",
                "brief_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "complete": "<b>Gabarito: alternativa (E).</b><div wfd-id=\"29557\"><b>ComentÃ¡rios:</b></div><div wfd-id=\"29556\">O tratamento inicial do paciente com diabetes mellitus tipo 2 depende da presenÃ§a de sintomas e do controle glicÃªmico. Nos indivÃ­duos com perda ponderal e polis (poliÃºria, polidipsia e polifagia), associados a nÃ­veis glicÃªmicos &gt; 300 mg/dL e hemoglobina glicada &gt; 9%, a terapia inicial deve ser insulinoterapia para compensaÃ§Ã£o.&nbsp;</div><div wfd-id=\"29555\">JÃ¡ nos demais pacientes, a droga de primeira escolha Ã© a metformina. Nos pacientes com nÃ­veis glicÃªmicos entre 200-300 mg/dL e hemoglobina glicada entre 7,5-9%, devemos associar um segundo agente antidiabÃ©tico Ã  metformina. A escolha da segunda droga deve ser baseada nas caracterÃ­sticas do paciente, como, por exemplo, se apresenta doenÃ§a cardiovascular estabelecida (como infarto do miocÃ¡rdio ou AVC), os anÃ¡logos de GLP-1 e os inibidores de SGLT-2 sÃ£o excelentes opÃ§Ãµes, pois, alÃ©m do controle glicÃªmico, promovem reduÃ§Ã£o do risco cardiovascular nesses indivÃ­duos.</div><div wfd-id=\"29554\"><!-- BEGIN:IMAGE_TO_REPLACE --><img src=\"https://estrategia-prod-questoes.s3.amazonaws.com/images/3027F52F-6A52-C401-355E-2301B0FA69C4/3027F52F-6A52-C401-355E-2301B0FA69C4-400.png\"><!-- END:IMAGE_TO_REPLACE --><br></div><div wfd-id=\"29553\"><br></div><div wfd-id=\"29553\"><br></div><div wfd-id=\"29553\"><b>AtenÃ§Ã£o! A alternativa correta Ã© a que contÃ©m uma afirmaÃ§Ã£o errada!</b></div><div wfd-id=\"29553\"><br></div>",
                "complete_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "created_at": "2021-05-19 02:15:03.371451 +0000 UTC",
                "id": "9521d15f-35f5-48db-b505-35458e27c72f",
                "is_default": false,
                "sanitized_brief": "",
                "sanitized_complete": "Gabarito: alternativa (E).ComentÃ¡rios:O tratamento inicial do paciente com diabetes mellitus tipo 2 depende da presenÃ§a de sintomas e do controle glicÃªmico. Nos indivÃ­duos com perda ponderal e polis (poliÃºria, polidipsia e polifagia), associados a nÃ­veis glicÃªmicos &gt; 300 mg/dL e hemoglobina glicada &gt; 9%, a terapia inicial deve ser insulinoterapia para compensaÃ§Ã£o.Â JÃ¡ nos demais pacientes, a droga de primeira escolha Ã© a metformina. Nos pacientes com nÃ­veis glicÃªmicos entre 200-300 mg/dL e hemoglobina glicada entre 7,5-9%, devemos associar um segundo agente antidiabÃ©tico Ã  metformina. A escolha da segunda droga deve ser baseada nas caracterÃ­sticas do paciente, como, por exemplo, se apresenta doenÃ§a cardiovascular estabelecida (como infarto do miocÃ¡rdio ou AVC), os anÃ¡logos de GLP-1 e os inibidores de SGLT-2 sÃ£o excelentes opÃ§Ãµes, pois, alÃ©m do controle glicÃªmico, promovem reduÃ§Ã£o do risco cardiovascular nesses indivÃ­duos.AtenÃ§Ã£o! A alternativa correta Ã© a que contÃ©m uma afirmaÃ§Ã£o errada!",
                "updated_at": "2021-05-19 02:15:06.010784 +0000 UTC",
                "video_solution_id": "b61475c6-7acd-4187-b425-ce67654bb076"
            },
            "statement": "Sobre os medicamentos orais utilizados no manejo do diabetes mellitus tipo 2, assinale a alternativa ERRADA:",
            "statement_text": "Sobre os medicamentos orais utilizados no manejo do diabetes mellitus tipo 2, assinale a alternativa ERRADA:",
            "status": {
                "change_actor": "cnishiama@admin.admin",
                "created_at": "2021-05-19 14:33:45.410455 +0000 UTC",
                "owner": "camila.moma@estrategiamed.com.br",
                "value": "APPROVED"
            },
            "topics": [
                {
                    "has_children": false,
                    "id": "3b9e1e9de9ba4ff3959ae83d455880f9",
                    "master_id": "778ea293dac8426ab5447d56646b3e72",
                    "name": "Drogas antidiabÃ©ticas nÃ£o insulina",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Tratamento[$$]Tratamento medicamentoso[$$]Drogas antidiabÃ©ticas nÃ£o insulina"
                },
                {
                    "has_children": false,
                    "id": "ab6c6a1fb6604cf98243ac486f80dac8",
                    "master_id": "0a6abdce2fbc45aa8ba8f0e75875ec84",
                    "name": "Endocrinologia ",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia "
                }
            ],
            "unlisted": false,
            "video_solution": {
                "available_resolutions": [
                    {
                        "resolution": "720",
                        "url": "https://api.estrategia.com/questoes/sign/medicina/processadas/4000138372-720.mp4"
                    }
                ],
                "id": "b61475c6-7acd-4187-b425-ce67654bb076",
                "identifier": "",
                "question_id": "4000138372"
            },
            "video_solution_id": "b61475c6-7acd-4187-b425-ce67654bb076"
        },
        {
            "active": true,
            "alternatives": [
                {
                    "answer_percentage": 78,
                    "answers": 2822,
                    "body": "Os anÃ¡logos de GLP-1 estÃ£o indicados por serem potentes em reduzir a hemoglobina glicada e promoverem perda ponderal.",
                    "correct": true,
                    "created_at": "2021-01-05 15:48:26.812972 +0000 UTC",
                    "id": "1d7b053a-244e-4497-9d97-b7de7df0f7bc",
                    "position": "0",
                    "sanitized_body": "Os anÃ¡logos de GLP-1 estÃ£o indicados por serem potentes em reduzir a hemoglobina glicada e promoverem perda ponderal.",
                    "solution": {
                        "alternative_id": "1d7b053a-244e-4497-9d97-b7de7df0f7bc",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Correta a alternativa A. </b>Os anÃ¡logos de GLP-1 tÃªm uma potÃªncia adequada de reduÃ§Ã£o de hemoglobina glicada (atingindo atÃ© 1,4% de diminuiÃ§Ã£o) e promovem perda ponderal, o que Ã© excelente para indivÃ­duos com excesso de peso.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-08-04 14:59:28.652422 +0000 UTC",
                        "id": "4523cd62-e107-4350-a267-70696ef298a2",
                        "sanitized_brief": "",
                        "sanitized_complete": "Correta a alternativa A. Os anÃ¡logos de GLP-1 tÃªm uma potÃªncia adequada de reduÃ§Ã£o de hemoglobina glicada (atingindo atÃ© 1,4% de diminuiÃ§Ã£o) e promovem perda ponderal, o que Ã© excelente para indivÃ­duos com excesso de peso.",
                        "updated_at": "2021-08-04 14:59:31.049475 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-08-04 13:40:57.533381 +0000 UTC"
                },
                {
                    "answer_percentage": 10,
                    "answers": 378,
                    "body": "A medicaÃ§Ã£o em uso deve ser mantida e o paciente deve ser orientado a respeito de mudanÃ§as de estilo de vida.",
                    "correct": false,
                    "created_at": "2021-01-05 15:48:26.812972 +0000 UTC",
                    "id": "673be315-4047-4840-bbe9-c0b40e16010a",
                    "position": "1",
                    "sanitized_body": "A medicaÃ§Ã£o em uso deve ser mantida e o paciente deve ser orientado a respeito de mudanÃ§as de estilo de vida.",
                    "solution": {
                        "alternative_id": "673be315-4047-4840-bbe9-c0b40e16010a",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Incorreta a alternativa B.</b> NÃ£o devemos ter inÃ©rcia terapÃªutica! Lembre-se que a hiperglicemia mantida aumenta o risco de complicaÃ§Ãµes crÃ´nicas!",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-08-04 14:59:28.679055 +0000 UTC",
                        "id": "036372c8-249e-4d5b-9147-230f983c29af",
                        "sanitized_brief": "",
                        "sanitized_complete": "Incorreta a alternativa B. NÃ£o devemos ter inÃ©rcia terapÃªutica! Lembre-se que a hiperglicemia mantida aumenta o risco de complicaÃ§Ãµes crÃ´nicas!",
                        "updated_at": "2021-08-04 14:59:31.03515 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-08-04 13:40:57.66629 +0000 UTC"
                },
                {
                    "answer_percentage": 2,
                    "answers": 72,
                    "body": "Os inibidores da SGLT-2 (cotransportador sÃ³dio-glicose 2) sÃ£o neutros em relaÃ§Ã£o Ã  proteÃ§Ã£o renal e cardiovascular.",
                    "correct": false,
                    "created_at": "2021-01-05 15:48:26.812972 +0000 UTC",
                    "id": "5cc08e94-36bb-470b-85ff-150f10a3ad7c",
                    "position": "2",
                    "sanitized_body": "Os inibidores da SGLT-2 (cotransportador sÃ³dio-glicose 2) sÃ£o neutros em relaÃ§Ã£o Ã  proteÃ§Ã£o renal e cardiovascular.",
                    "solution": {
                        "alternative_id": "5cc08e94-36bb-470b-85ff-150f10a3ad7c",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Incorreta a alternativa C. </b>Os inibidores de SGLT-2 sÃ£o benÃ©ficos na proteÃ§Ã£o cardiovascular e renal e promovem perda ponderal.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-08-04 14:59:28.649849 +0000 UTC",
                        "id": "3fef9a26-db0d-4653-839b-6a983b975dac",
                        "sanitized_brief": "",
                        "sanitized_complete": "Incorreta a alternativa C. Os inibidores de SGLT-2 sÃ£o benÃ©ficos na proteÃ§Ã£o cardiovascular e renal e promovem perda ponderal.",
                        "updated_at": "2021-08-04 14:59:31.040542 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-08-04 13:40:57.793608 +0000 UTC"
                },
                {
                    "answer_percentage": 3,
                    "answers": 102,
                    "body": "Os anÃ¡logos de GLP-1 diminuem o risco de internaÃ§Ã£o por insuficiÃªncia cardÃ­aca, pois promovem glicosÃºria.",
                    "correct": false,
                    "created_at": "2021-01-05 15:48:26.812972 +0000 UTC",
                    "id": "2ba3e034-8a5e-40ca-ae06-b26b299bcaf4",
                    "position": "3",
                    "sanitized_body": "Os anÃ¡logos de GLP-1 diminuem o risco de internaÃ§Ã£o por insuficiÃªncia cardÃ­aca, pois promovem glicosÃºria.",
                    "solution": {
                        "alternative_id": "2ba3e034-8a5e-40ca-ae06-b26b299bcaf4",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Incorreta a alternativa D.</b> Os anÃ¡logos de GLP-1 nÃ£o promovem glicosÃºria, mas sim, efeitos semelhantes ao prÃ³prio GLP-1 (aumento de insulina e reduÃ§Ã£o de glucagon).",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-08-04 14:59:28.6584 +0000 UTC",
                        "id": "cbf3e6f3-8d1f-424a-afc8-375345047346",
                        "sanitized_brief": "",
                        "sanitized_complete": "Incorreta a alternativa D. Os anÃ¡logos de GLP-1 nÃ£o promovem glicosÃºria, mas sim, efeitos semelhantes ao prÃ³prio GLP-1 (aumento de insulina e reduÃ§Ã£o de glucagon).",
                        "updated_at": "2021-08-04 14:59:31.083654 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-08-04 13:40:57.914724 +0000 UTC"
                },
                {
                    "answer_percentage": 6,
                    "answers": 227,
                    "body": "Deve ser iniciada insulinoterapia intensiva.",
                    "correct": false,
                    "created_at": "2021-01-05 15:48:26.812972 +0000 UTC",
                    "id": "03255ae4-7f75-4870-8ee9-5abcab156336",
                    "position": "4",
                    "sanitized_body": "Deve ser iniciada insulinoterapia intensiva.",
                    "solution": {
                        "alternative_id": "03255ae4-7f75-4870-8ee9-5abcab156336",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Incorreta a alternativa E.</b> Devido ao aumento do portifÃ³lio de drogas anti-hiperglicemiantes nas Ãºltimas dÃ©cadas, podemos tentar a tripla e, atÃ© mesmo, quÃ¡drupla terapia antes da insulinizaÃ§Ã£o, que se inicia com insulina basal. Conforme hÃ¡ perda da secreÃ§Ã£o de insulina, passamos para insulinizaÃ§Ã£o plena (intensiva), com insulinas basal e prandial.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-08-04 14:59:28.656546 +0000 UTC",
                        "id": "00a8a698-1071-4363-9933-0cb302d65985",
                        "sanitized_brief": "",
                        "sanitized_complete": "Incorreta a alternativa E. Devido ao aumento do portifÃ³lio de drogas anti-hiperglicemiantes nas Ãºltimas dÃ©cadas, podemos tentar a tripla e, atÃ© mesmo, quÃ¡drupla terapia antes da insulinizaÃ§Ã£o, que se inicia com insulina basal. Conforme hÃ¡ perda da secreÃ§Ã£o de insulina, passamos para insulinizaÃ§Ã£o plena (intensiva), com insulinas basal e prandial.",
                        "updated_at": "2021-08-04 14:59:31.078197 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-08-04 13:40:58.033548 +0000 UTC"
                }
            ],
            "answer_type": "MULTIPLE_CHOICE",
            "author_id": "bruno-cesar110@hotmail.com",
            "correct_answer_percentage": 78,
            "created_at": "2021-01-05 15:48:26.812972 +0000 UTC",
            "difficulty_level": "MEDIUM",
            "exams": [
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "e065f3c7-f50f-48e1-9c96-f66871d20a65",
                        "institution_id": "ea32d90b-d0d8-45f9-b0fe-7c1df3cac842",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "722913ff-abeb-4035-9b4d-f40b2ea2bb4a",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "9b34a94d-754d-4510-8bad-60f649fa825b",
                        "subspecialty_id": "34301849-3bd6-44bc-8bd0-1e412d95d58c"
                    },
                    "created_at": "2021-01-05T03:53:15Z",
                    "degree_proof": false,
                    "id": "4000002804",
                    "location": {
                        "id": "27"
                    },
                    "number": 1,
                    "open_spaces": 1,
                    "pdfs": [
                        {
                            "type": "ANSWER",
                            "url": "D473F504-B487-041A-440A-7BED52139502"
                        },
                        {
                            "type": "NOTICE",
                            "url": "E514BAC4-27AC-79B0-0F5D-5F65A03E12C3"
                        },
                        {
                            "type": "EXAM",
                            "url": "1D8D344D-D111-052B-0414-1C0079A07A7A"
                        }
                    ],
                    "questions_number": 80,
                    "scholarity": "placeholder",
                    "subscription_fee": 294,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "e065f3c7-f50f-48e1-9c96-f66871d20a65",
                        "institution_id": "ea32d90b-d0d8-45f9-b0fe-7c1df3cac842",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "722913ff-abeb-4035-9b4d-f40b2ea2bb4a",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "9b34a94d-754d-4510-8bad-60f649fa825b",
                        "subspecialty_id": "e3ddf019-57ce-4141-99b4-cd1a9d8b4285"
                    },
                    "created_at": "2021-01-05T03:53:52Z",
                    "degree_proof": false,
                    "id": "4000002805",
                    "location": {
                        "id": "27"
                    },
                    "number": 1,
                    "open_spaces": 3,
                    "pdfs": [
                        {
                            "type": "ANSWER",
                            "url": "D473F504-B487-041A-440A-7BED52139502"
                        },
                        {
                            "type": "NOTICE",
                            "url": "E514BAC4-27AC-79B0-0F5D-5F65A03E12C3"
                        },
                        {
                            "type": "EXAM",
                            "url": "1D8D344D-D111-052B-0414-1C0079A07A7A"
                        }
                    ],
                    "questions_number": 80,
                    "scholarity": "placeholder",
                    "subscription_fee": 294,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "e065f3c7-f50f-48e1-9c96-f66871d20a65",
                        "institution_id": "ea32d90b-d0d8-45f9-b0fe-7c1df3cac842",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "722913ff-abeb-4035-9b4d-f40b2ea2bb4a",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "9b34a94d-754d-4510-8bad-60f649fa825b",
                        "subspecialty_id": "c042a8dc-0b42-476b-a09a-96e9c3ad56cf"
                    },
                    "created_at": "2021-01-05T03:54:09Z",
                    "degree_proof": false,
                    "id": "4000002806",
                    "location": {
                        "id": "27"
                    },
                    "number": 1,
                    "open_spaces": 5,
                    "pdfs": [
                        {
                            "type": "ANSWER",
                            "url": "D473F504-B487-041A-440A-7BED52139502"
                        },
                        {
                            "type": "NOTICE",
                            "url": "E514BAC4-27AC-79B0-0F5D-5F65A03E12C3"
                        },
                        {
                            "type": "EXAM",
                            "url": "1D8D344D-D111-052B-0414-1C0079A07A7A"
                        }
                    ],
                    "questions_number": 80,
                    "scholarity": "placeholder",
                    "subscription_fee": 294,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "e065f3c7-f50f-48e1-9c96-f66871d20a65",
                        "institution_id": "ea32d90b-d0d8-45f9-b0fe-7c1df3cac842",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "722913ff-abeb-4035-9b4d-f40b2ea2bb4a",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "9b34a94d-754d-4510-8bad-60f649fa825b",
                        "subspecialty_id": "57c93b05-4de1-4794-8438-d8a8db6f33ac"
                    },
                    "created_at": "2021-01-05T03:54:36Z",
                    "degree_proof": false,
                    "id": "4000002807",
                    "location": {
                        "id": "27"
                    },
                    "number": 1,
                    "open_spaces": 5,
                    "pdfs": [
                        {
                            "type": "ANSWER",
                            "url": "D473F504-B487-041A-440A-7BED52139502"
                        },
                        {
                            "type": "NOTICE",
                            "url": "E514BAC4-27AC-79B0-0F5D-5F65A03E12C3"
                        },
                        {
                            "type": "EXAM",
                            "url": "1D8D344D-D111-052B-0414-1C0079A07A7A"
                        }
                    ],
                    "questions_number": 80,
                    "scholarity": "placeholder",
                    "subscription_fee": 294,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "e065f3c7-f50f-48e1-9c96-f66871d20a65",
                        "institution_id": "ea32d90b-d0d8-45f9-b0fe-7c1df3cac842",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "722913ff-abeb-4035-9b4d-f40b2ea2bb4a",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "9b34a94d-754d-4510-8bad-60f649fa825b",
                        "subspecialty_id": "9a2b71d4-fec7-4588-808a-6ace4abf137b"
                    },
                    "created_at": "2021-01-05T03:55:04Z",
                    "degree_proof": false,
                    "id": "4000002808",
                    "location": {
                        "id": "27"
                    },
                    "number": 1,
                    "open_spaces": 10,
                    "pdfs": [
                        {
                            "type": "ANSWER",
                            "url": "D473F504-B487-041A-440A-7BED52139502"
                        },
                        {
                            "type": "NOTICE",
                            "url": "E514BAC4-27AC-79B0-0F5D-5F65A03E12C3"
                        },
                        {
                            "type": "EXAM",
                            "url": "1D8D344D-D111-052B-0414-1C0079A07A7A"
                        }
                    ],
                    "questions_number": 80,
                    "scholarity": "placeholder",
                    "subscription_fee": 294,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "e065f3c7-f50f-48e1-9c96-f66871d20a65",
                        "institution_id": "ea32d90b-d0d8-45f9-b0fe-7c1df3cac842",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "722913ff-abeb-4035-9b4d-f40b2ea2bb4a",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "9b34a94d-754d-4510-8bad-60f649fa825b",
                        "subspecialty_id": "7048c599-6e96-42af-8bcc-46f7ed303286"
                    },
                    "created_at": "2021-01-05T03:55:31Z",
                    "degree_proof": false,
                    "id": "4000002809",
                    "location": {
                        "id": "27"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "ANSWER",
                            "url": "D473F504-B487-041A-440A-7BED52139502"
                        },
                        {
                            "type": "NOTICE",
                            "url": "E514BAC4-27AC-79B0-0F5D-5F65A03E12C3"
                        },
                        {
                            "type": "EXAM",
                            "url": "1D8D344D-D111-052B-0414-1C0079A07A7A"
                        }
                    ],
                    "questions_number": 80,
                    "scholarity": "placeholder",
                    "subscription_fee": 294,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "e065f3c7-f50f-48e1-9c96-f66871d20a65",
                        "institution_id": "ea32d90b-d0d8-45f9-b0fe-7c1df3cac842",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "722913ff-abeb-4035-9b4d-f40b2ea2bb4a",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "9b34a94d-754d-4510-8bad-60f649fa825b",
                        "subspecialty_id": "69a560a4-0210-4e5a-a106-f6b0e6a34a9c"
                    },
                    "created_at": "2021-01-05T03:56:11Z",
                    "degree_proof": false,
                    "id": "4000002810",
                    "location": {
                        "id": "27"
                    },
                    "number": 1,
                    "open_spaces": 8,
                    "pdfs": [
                        {
                            "type": "ANSWER",
                            "url": "D473F504-B487-041A-440A-7BED52139502"
                        },
                        {
                            "type": "NOTICE",
                            "url": "E514BAC4-27AC-79B0-0F5D-5F65A03E12C3"
                        },
                        {
                            "type": "EXAM",
                            "url": "1D8D344D-D111-052B-0414-1C0079A07A7A"
                        }
                    ],
                    "questions_number": 80,
                    "scholarity": "placeholder",
                    "subscription_fee": 294,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "e065f3c7-f50f-48e1-9c96-f66871d20a65",
                        "institution_id": "ea32d90b-d0d8-45f9-b0fe-7c1df3cac842",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "722913ff-abeb-4035-9b4d-f40b2ea2bb4a",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "9b34a94d-754d-4510-8bad-60f649fa825b",
                        "subspecialty_id": "6328c38a-eca4-4440-ba91-55aaee2af075"
                    },
                    "created_at": "2021-01-05T03:56:40Z",
                    "degree_proof": false,
                    "id": "4000002811",
                    "location": {
                        "id": "27"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "ANSWER",
                            "url": "D473F504-B487-041A-440A-7BED52139502"
                        },
                        {
                            "type": "NOTICE",
                            "url": "E514BAC4-27AC-79B0-0F5D-5F65A03E12C3"
                        },
                        {
                            "type": "EXAM",
                            "url": "1D8D344D-D111-052B-0414-1C0079A07A7A"
                        }
                    ],
                    "questions_number": 80,
                    "scholarity": "placeholder",
                    "subscription_fee": 294,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "e065f3c7-f50f-48e1-9c96-f66871d20a65",
                        "institution_id": "ea32d90b-d0d8-45f9-b0fe-7c1df3cac842",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "722913ff-abeb-4035-9b4d-f40b2ea2bb4a",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "9b34a94d-754d-4510-8bad-60f649fa825b",
                        "subspecialty_id": "1bc9ae03-95d7-4522-b9f6-efea8623dc20"
                    },
                    "created_at": "2021-01-05T03:57:02Z",
                    "degree_proof": false,
                    "id": "4000002812",
                    "location": {
                        "id": "27"
                    },
                    "number": 1,
                    "open_spaces": 5,
                    "pdfs": [
                        {
                            "type": "ANSWER",
                            "url": "D473F504-B487-041A-440A-7BED52139502"
                        },
                        {
                            "type": "NOTICE",
                            "url": "E514BAC4-27AC-79B0-0F5D-5F65A03E12C3"
                        },
                        {
                            "type": "EXAM",
                            "url": "1D8D344D-D111-052B-0414-1C0079A07A7A"
                        }
                    ],
                    "questions_number": 80,
                    "scholarity": "placeholder",
                    "subscription_fee": 294,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "e065f3c7-f50f-48e1-9c96-f66871d20a65",
                        "institution_id": "ea32d90b-d0d8-45f9-b0fe-7c1df3cac842",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "722913ff-abeb-4035-9b4d-f40b2ea2bb4a",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "9b34a94d-754d-4510-8bad-60f649fa825b",
                        "subspecialty_id": "b67ba54b-e7fa-427c-bf5d-3e1c72036c29"
                    },
                    "created_at": "2021-01-05T03:57:36Z",
                    "degree_proof": false,
                    "id": "4000002813",
                    "location": {
                        "id": "27"
                    },
                    "number": 1,
                    "open_spaces": 4,
                    "pdfs": [
                        {
                            "type": "ANSWER",
                            "url": "D473F504-B487-041A-440A-7BED52139502"
                        },
                        {
                            "type": "NOTICE",
                            "url": "E514BAC4-27AC-79B0-0F5D-5F65A03E12C3"
                        },
                        {
                            "type": "EXAM",
                            "url": "1D8D344D-D111-052B-0414-1C0079A07A7A"
                        }
                    ],
                    "questions_number": 80,
                    "scholarity": "placeholder",
                    "subscription_fee": 294,
                    "year": 2021
                }
            ],
            "forum_id": "124de6b9-2a18-4c62-9dc1-b9d28bc5e29b",
            "has_student_answer": false,
            "has_user_solution": false,
            "has_video_solution": false,
            "id": "4000138579",
            "labels": [
                "TEMPORARY_ANSWER_SHEET"
            ],
            "public": true,
            "slug": "paciente-55-anos-idade60e0f30202",
            "solution": {
                "alternative_solutions": null,
                "author_email": "camila.moma@estrategiamed.com.br",
                "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                "brief": "",
                "brief_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "complete": "<b>Gabarito: alternativa A.</b><div><b>ComentÃ¡rios:</b></div><div>Estamos diante de um paciente com diabetes mellitus tipo 2, em uso de dupla terapia (metformina e gliclazida), que se encontra fora das metas glicÃªmicas (glicemia em jejum < 130 mg/dL e hemoglobina glicada < 7%). Manter o paciente dentro das metas propostas reduz o desenvolvimento de complicaÃ§Ãµes crÃ´nicas, principalmente microvasculares (nefro, retino e neuropatias), portanto, nÃ£o devemos ter inÃ©rcia terapÃªutica!</div><div>A presenÃ§a de obesidade associada ao diabetes mellitus tipo 2 piora a resistÃªncia Ã  insulina; assim, a perda ponderal diminui as complicaÃ§Ãµes associadas Ã  prÃ³pria obesidade e melhora o controle glicÃªmico. Tendo em vista este conceito, seria ideal a prescriÃ§Ã£o de drogas que sÃ£o neutras ou auxiliem na reduÃ§Ã£o do peso, como os inibidores de SGLT-2 e os anÃ¡logos de GLP-1.</div><div>Os inibidores de SGLT-2 inibem o transportador de sÃ³dio e glicose tipo 2, promovendo glicosÃºria (que melhora o controle glicÃªmico sem ocasionar hipoglicemias e reduz o peso por induzir balanÃ§o energÃ©tico negativo). TambÃ©m sÃ£o drogas excelentes quando o paciente apresenta doenÃ§a cardiovascular estabelecida (IAM ou AVC), doenÃ§a renal crÃ´nica com albuminÃºria > 300 mg/g de creatinina e insuficiÃªncia cardÃ­aca com fraÃ§Ã£o de ejeÃ§Ã£o reduzida, uma vez que reduz mortalidade, risco cardiovascular e progressÃ£o da doenÃ§a renal nesses pacientes. Fazem parte desta classe a empagliflozina, a canagliflozina e a dapagliflozina.</div><div>JÃ¡ os anÃ¡logos de GLP-1 sÃ£o drogas que se assemelham ao prÃ³prio GLP-1, promovendo aumento da secreÃ§Ã£o de insulina (que ocorre de forma dependente dos nÃ­veis glicÃªmicos, nÃ£o causando hipoglicemias) e reduzindo o glucagon (principal hormÃ´nio contrarregulador de insulina). Retardam o esvaziamento gÃ¡strico (o que induz maior sensaÃ§Ã£o de saciedade) e atuam no sistema nervoso central diminuindo o apetite, com consequente perda ponderal. TambÃ©m se mostraram benÃ©ficas na reduÃ§Ã£o de mortalidade e risco cardiovascular em pacientes com doenÃ§a cardiovascular estabelecida. As duas principais representantes sÃ£o a liraglutida e a semaglutida (ambas de uso subcutÃ¢neo, sendo a liraglutida diÃ¡ria e a semaglutida, semanal).</div><div><br></div>",
                "complete_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "created_at": "2021-08-04 14:59:28.751271 +0000 UTC",
                "id": "cd14214d-95a4-451e-9969-2d343132d482",
                "is_default": false,
                "sanitized_brief": "",
                "sanitized_complete": "Gabarito: alternativa A.ComentÃ¡rios:Estamos diante de um paciente com diabetes mellitus tipo 2, em uso de dupla terapia (metformina e gliclazida), que se encontra fora das metas glicÃªmicas (glicemia em jejum &lt; 130 mg/dL e hemoglobina glicada &lt; 7%). Manter o paciente dentro das metas propostas reduz o desenvolvimento de complicaÃ§Ãµes crÃ´nicas, principalmente microvasculares (nefro, retino e neuropatias), portanto, nÃ£o devemos ter inÃ©rcia terapÃªutica!A presenÃ§a de obesidade associada ao diabetes mellitus tipo 2 piora a resistÃªncia Ã  insulina; assim, a perda ponderal diminui as complicaÃ§Ãµes associadas Ã  prÃ³pria obesidade e melhora o controle glicÃªmico. Tendo em vista este conceito, seria ideal a prescriÃ§Ã£o de drogas que sÃ£o neutras ou auxiliem na reduÃ§Ã£o do peso, como os inibidores de SGLT-2 e os anÃ¡logos de GLP-1.Os inibidores de SGLT-2 inibem o transportador de sÃ³dio e glicose tipo 2, promovendo glicosÃºria (que melhora o controle glicÃªmico sem ocasionar hipoglicemias e reduz o peso por induzir balanÃ§o energÃ©tico negativo). TambÃ©m sÃ£o drogas excelentes quando o paciente apresenta doenÃ§a cardiovascular estabelecida (IAM ou AVC), doenÃ§a renal crÃ´nica com albuminÃºria &gt; 300 mg/g de creatinina e insuficiÃªncia cardÃ­aca com fraÃ§Ã£o de ejeÃ§Ã£o reduzida, uma vez que reduz mortalidade, risco cardiovascular e progressÃ£o da doenÃ§a renal nesses pacientes. Fazem parte desta classe a empagliflozina, a canagliflozina e a dapagliflozina.JÃ¡ os anÃ¡logos de GLP-1 sÃ£o drogas que se assemelham ao prÃ³prio GLP-1, promovendo aumento da secreÃ§Ã£o de insulina (que ocorre de forma dependente dos nÃ­veis glicÃªmicos, nÃ£o causando hipoglicemias) e reduzindo o glucagon (principal hormÃ´nio contrarregulador de insulina). Retardam o esvaziamento gÃ¡strico (o que induz maior sensaÃ§Ã£o de saciedade) e atuam no sistema nervoso central diminuindo o apetite, com consequente perda ponderal. TambÃ©m se mostraram benÃ©ficas na reduÃ§Ã£o de mortalidade e risco cardiovascular em pacientes com doenÃ§a cardiovascular estabelecida. As duas principais representantes sÃ£o a liraglutida e a semaglutida (ambas de uso subcutÃ¢neo, sendo a liraglutida diÃ¡ria e a semaglutida, semanal).",
                "updated_at": "2021-08-04 14:59:31.163861 +0000 UTC"
            },
            "statement": "Um paciente de 55 anos de idade, com obesidade grau 2 e diabetes <i>mellitus </i>tipo 2 desde os cinquenta anos, faz uso de metformina 500 mg (duas vezes por dia) e gliclazida 60 mg por dia. Apresenta glicemia de jejum de 190 mg/dL e hemoglobina glicada de 8,5%.<div><br></div><div>Com base nessa situaÃ§Ã£o hipotÃ©tica, assinale a alternativa correta quanto ao tratamento farmacolÃ³gico.</div>",
            "statement_text": "Um paciente de 55 anos de idade, com obesidade grau 2 e diabetes mellitus tipo 2 desde os cinquenta anos, faz uso de metformina 500 mg (duas vezes por dia) e gliclazida 60 mg por dia. Apresenta glicemia de jejum de 190 mg/dL e hemoglobina glicada de 8,5%.Com base nessa situaÃ§Ã£o hipotÃ©tica, assinale a alternativa correta quanto ao tratamento farmacolÃ³gico.",
            "status": {
                "change_actor": "valencar@admin.admin",
                "created_at": "2021-08-04 18:29:43.557164 +0000 UTC",
                "owner": "camila.moma@estrategiamed.com.br",
                "value": "APPROVED"
            },
            "topics": [
                {
                    "has_children": false,
                    "id": "0cad8ea0fa0e47efa8d56f8a97b383e5",
                    "master_id": "3b9e1e9de9ba4ff3959ae83d455880f9",
                    "name": "MedicaÃ§Ãµes que provocam glicosÃºria (inibidores de SGLT-2)",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Tratamento[$$]Tratamento medicamentoso[$$]Drogas antidiabÃ©ticas nÃ£o insulina[$$]MedicaÃ§Ãµes que provocam glicosÃºria (inibidores de SGLT-2)"
                },
                {
                    "has_children": false,
                    "id": "778ea293dac8426ab5447d56646b3e72",
                    "master_id": "e39487f7326345f982716782efb6d872",
                    "name": "Tratamento medicamentoso",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Tratamento[$$]Tratamento medicamentoso"
                },
                {
                    "has_children": false,
                    "id": "ab6c6a1fb6604cf98243ac486f80dac8",
                    "master_id": "0a6abdce2fbc45aa8ba8f0e75875ec84",
                    "name": "Endocrinologia ",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia "
                },
                {
                    "has_children": false,
                    "id": "ddd782e7c9ed45df9d8cd798b1a02591",
                    "master_id": "ec2322658fbd4068a22aac5474f41abc",
                    "name": "Agonistas de receptor de GLP-1",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Tratamento[$$]Tratamento medicamentoso[$$]Drogas antidiabÃ©ticas nÃ£o insulina[$$]MedicaÃ§Ãµes com efeito incretÃ­nico[$$]Agonistas de receptor de GLP-1"
                }
            ],
            "unlisted": false,
            "video_solution": {
                "available_resolutions": null,
                "id": "",
                "identifier": "",
                "question_id": ""
            }
        },
        {
            "active": true,
            "alternatives": [
                {
                    "answer_percentage": 11,
                    "answers": 324,
                    "body": "Gliclazida.",
                    "correct": false,
                    "created_at": "2021-04-26 00:27:09.132447 +0000 UTC",
                    "id": "d5b5d160-ebbb-4517-aca2-c858941abdd1",
                    "position": "0",
                    "sanitized_body": "Gliclazida.",
                    "solution": {
                        "alternative_id": "d5b5d160-ebbb-4517-aca2-c858941abdd1",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (A) Ã© incorreta.</b> A gliclazida Ã© uma sulfonilureia, cuja funÃ§Ã£o Ã© se ligar a receptores especÃ­ficos nas cÃ©lulas beta pancreÃ¡ticas, levando Ã  despolarizaÃ§Ã£o da membrana celular, o que culmina com a entrada de cÃ¡lcio no citoplasma e consequente secreÃ§Ã£o dos grÃ¢nulos de insulina. Tal aÃ§Ã£o ocorre de forma independente dos nÃ­veis glicÃªmicos, o que aumenta o risco de hipoglicemias. NÃ£o hÃ¡ benefÃ­cios em relaÃ§Ã£o ao risco cardiovascular.<div><div><br></div></div>",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-31 21:43:17.798591 +0000 UTC",
                        "id": "cf02f0ab-fd94-4aab-a7c4-0964331f29fd",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (A) Ã© incorreta. A gliclazida Ã© uma sulfonilureia, cuja funÃ§Ã£o Ã© se ligar a receptores especÃ­ficos nas cÃ©lulas beta pancreÃ¡ticas, levando Ã  despolarizaÃ§Ã£o da membrana celular, o que culmina com a entrada de cÃ¡lcio no citoplasma e consequente secreÃ§Ã£o dos grÃ¢nulos de insulina. Tal aÃ§Ã£o ocorre de forma independente dos nÃ­veis glicÃªmicos, o que aumenta o risco de hipoglicemias. NÃ£o hÃ¡ benefÃ­cios em relaÃ§Ã£o ao risco cardiovascular.",
                        "updated_at": "2021-05-31 21:43:19.393618 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-04-29 21:27:15.889507 +0000 UTC"
                },
                {
                    "answer_percentage": 79,
                    "answers": 2426,
                    "body": "Empagliflozina.",
                    "correct": true,
                    "created_at": "2021-04-26 00:27:09.132447 +0000 UTC",
                    "id": "4dc54086-3879-4c2f-af92-005442f3628c",
                    "position": "1",
                    "sanitized_body": "Empagliflozina.",
                    "solution": {
                        "alternative_id": "4dc54086-3879-4c2f-af92-005442f3628c",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (B) Ã© correta.</b> Os inibidores de SGLT-2 inibem o transportador de sÃ³dio e glicose tipo 2, presente principalmente no tÃºbulo renal proximal, impedindo a reabsorÃ§Ã£o de glicose e sÃ³dio. Assim, promovem glicosÃºria e, por nÃ£o aumentarem a insulina circulante, nÃ£o causam hipoglicemia. Adicionalmente, a perda calÃ³rica resultante da glicosÃºria se reflete em diminuiÃ§Ã£o ponderal.&nbsp;<div>Em pacientes com doenÃ§a cardiovascular estabelecida (como infarto do miocÃ¡rdio e AVC), insuficiÃªncia cardÃ­aca com fraÃ§Ã£o de ejeÃ§Ã£o reduzida e doenÃ§a renal crÃ´nica (com taxa de filtraÃ§Ã£o glomerular &gt; 30 mL/minuto e albuminÃºria &gt; 300 mg/g de creatinina), tais drogas se mostraram benÃ©ficas, pois diminuÃ­ram mortalidade e risco cardiovascular, sendo os medicamentos de escolha na associaÃ§Ã£o com a metformina nestes indivÃ­duos.</div>",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-31 21:43:17.771452 +0000 UTC",
                        "id": "ca64ab05-c777-41d9-a75f-62a486f32535",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (B) Ã© correta. Os inibidores de SGLT-2 inibem o transportador de sÃ³dio e glicose tipo 2, presente principalmente no tÃºbulo renal proximal, impedindo a reabsorÃ§Ã£o de glicose e sÃ³dio. Assim, promovem glicosÃºria e, por nÃ£o aumentarem a insulina circulante, nÃ£o causam hipoglicemia. Adicionalmente, a perda calÃ³rica resultante da glicosÃºria se reflete em diminuiÃ§Ã£o ponderal.Â Em pacientes com doenÃ§a cardiovascular estabelecida (como infarto do miocÃ¡rdio e AVC), insuficiÃªncia cardÃ­aca com fraÃ§Ã£o de ejeÃ§Ã£o reduzida e doenÃ§a renal crÃ´nica (com taxa de filtraÃ§Ã£o glomerular &gt; 30 mL/minuto e albuminÃºria &gt; 300 mg/g de creatinina), tais drogas se mostraram benÃ©ficas, pois diminuÃ­ram mortalidade e risco cardiovascular, sendo os medicamentos de escolha na associaÃ§Ã£o com a metformina nestes indivÃ­duos.",
                        "updated_at": "2021-05-31 21:43:19.404907 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-04-29 21:27:15.967203 +0000 UTC"
                },
                {
                    "answer_percentage": 4,
                    "answers": 109,
                    "body": "Pioglitazona.",
                    "correct": false,
                    "created_at": "2021-04-26 00:27:09.132447 +0000 UTC",
                    "id": "a28e4864-1768-438f-9dd1-0657cf3062eb",
                    "position": "2",
                    "sanitized_body": "Pioglitazona.",
                    "solution": {
                        "alternative_id": "a28e4864-1768-438f-9dd1-0657cf3062eb",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (C) Ã© incorreta. </b>As glitazonas, tambÃ©m denominadas tiazolidinedionas ou agonistas do PPAR-áµ, sÃ£o drogas que atuam em receptores intranucleares, levando a uma sÃ©rie de reaÃ§Ãµes que culminam com a maior expressÃ£o de transportadores de glicose na membrana celular, aumentando a captaÃ§Ã£o de glicose pelos tecidos perifÃ©ricos (mÃºsculo, tecido adiposo e fÃ­gado). NÃ£o causam hipoglicemia, mas estÃ£o associadas ao ganho ponderal (por aumento de apetite via hipotÃ¡lamo). Como tambÃ©m atuam nos rins, aumentando a reabsorÃ§Ã£o de sÃ³dio e Ã¡gua, sÃ£o contraindicadas na insuficiÃªncia cardÃ­aca classes funcionais NYHA III e IV, uma vez que podem ocorrer descompensaÃ§Ãµes devido ao incremento da volemia.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-31 21:43:17.800203 +0000 UTC",
                        "id": "444e41f8-b954-4f1a-9157-b377f907b6f8",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (C) Ã© incorreta. As glitazonas, tambÃ©m denominadas tiazolidinedionas ou agonistas do PPAR-áµ, sÃ£o drogas que atuam em receptores intranucleares, levando a uma sÃ©rie de reaÃ§Ãµes que culminam com a maior expressÃ£o de transportadores de glicose na membrana celular, aumentando a captaÃ§Ã£o de glicose pelos tecidos perifÃ©ricos (mÃºsculo, tecido adiposo e fÃ­gado). NÃ£o causam hipoglicemia, mas estÃ£o associadas ao ganho ponderal (por aumento de apetite via hipotÃ¡lamo). Como tambÃ©m atuam nos rins, aumentando a reabsorÃ§Ã£o de sÃ³dio e Ã¡gua, sÃ£o contraindicadas na insuficiÃªncia cardÃ­aca classes funcionais NYHA III e IV, uma vez que podem ocorrer descompensaÃ§Ãµes devido ao incremento da volemia.",
                        "updated_at": "2021-05-31 21:43:19.441306 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-04-29 21:27:16.054818 +0000 UTC"
                },
                {
                    "answer_percentage": 6,
                    "answers": 179,
                    "body": "Insulina NPH antes de deitar.",
                    "correct": false,
                    "created_at": "2021-04-26 00:27:09.132447 +0000 UTC",
                    "id": "9f45fd1b-e104-44cd-a798-12d49fef3f60",
                    "position": "3",
                    "sanitized_body": "Insulina NPH antes de deitar.",
                    "solution": {
                        "alternative_id": "9f45fd1b-e104-44cd-a798-12d49fef3f60",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (D) Ã© incorreta. </b>Como o paciente estÃ¡ em uso de apenas uma droga nÃ£o insulina, podemos associar outras medicaÃ§Ãµes antes da insulinoterapia. Apenas optarÃ­amos por insulinizaÃ§Ã£o caso o paciente jÃ¡ estivesse em uso de, pelo menos, duas drogas. Veja a sequÃªncia recomendada pela Sociedade Brasileira de Diabetes:<div wfd-id=\"62765\"><!-- BEGIN:IMAGE_TO_REPLACE --><img src=\"https://estrategia-prod-questoes.s3.amazonaws.com/images/4FEA1CC3-E10D-DA26-7E4E-48B2DF4CA9DD/4FEA1CC3-E10D-DA26-7E4E-48B2DF4CA9DD-400.png\"><!-- END:IMAGE_TO_REPLACE --><br></div><div wfd-id=\"62764\">Na fase de insulinizaÃ§Ã£o plena (insulina basal + insulina prandial), podemos manter drogas cujo mecanismo nÃ£o seja a estimulaÃ§Ã£o da secreÃ§Ã£o de insulina (pois, nesta fase, hÃ¡ falÃªncia das cÃ©lulas betas e tais medicaÃ§Ãµes seriam de pouca valia), tais como metformina, inibidores de SGLT-2, pioglitazona e acarbose.</div><div wfd-id=\"62763\"><br></div>",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-31 21:43:17.791113 +0000 UTC",
                        "id": "9a34bb60-555b-415d-aa41-c598f2f0b816",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (D) Ã© incorreta. Como o paciente estÃ¡ em uso de apenas uma droga nÃ£o insulina, podemos associar outras medicaÃ§Ãµes antes da insulinoterapia. Apenas optarÃ­amos por insulinizaÃ§Ã£o caso o paciente jÃ¡ estivesse em uso de, pelo menos, duas drogas. Veja a sequÃªncia recomendada pela Sociedade Brasileira de Diabetes:Na fase de insulinizaÃ§Ã£o plena (insulina basal + insulina prandial), podemos manter drogas cujo mecanismo nÃ£o seja a estimulaÃ§Ã£o da secreÃ§Ã£o de insulina (pois, nesta fase, hÃ¡ falÃªncia das cÃ©lulas betas e tais medicaÃ§Ãµes seriam de pouca valia), tais como metformina, inibidores de SGLT-2, pioglitazona e acarbose.",
                        "updated_at": "2021-05-31 21:43:19.518533 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-04-29 21:27:16.152434 +0000 UTC"
                },
                {
                    "answer_percentage": 1,
                    "answers": 19,
                    "body": "Insulina ultra-rÃ¡pida antes das refeiÃ§Ãµes.",
                    "correct": false,
                    "created_at": "2021-04-26 00:27:09.132447 +0000 UTC",
                    "id": "b74d8ec1-28d8-4723-b7d8-07b6f613b865",
                    "position": "4",
                    "sanitized_body": "Insulina ultra-rÃ¡pida antes das refeiÃ§Ãµes.",
                    "solution": {
                        "alternative_id": "b74d8ec1-28d8-4723-b7d8-07b6f613b865",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (E) Ã© incorreta. </b>A insulina ultra-rÃ¡pida antes das refeiÃ§Ãµes Ã© utilizada durante a fase de insulinizaÃ§Ã£o plena. Vide comentÃ¡rio da alternativa (D).",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-31 21:43:17.830438 +0000 UTC",
                        "id": "5891d5b2-1d3e-4f28-a297-a69d80bc1a8d",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (E) Ã© incorreta. A insulina ultra-rÃ¡pida antes das refeiÃ§Ãµes Ã© utilizada durante a fase de insulinizaÃ§Ã£o plena. Vide comentÃ¡rio da alternativa (D).",
                        "updated_at": "2021-05-31 21:43:19.444034 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-04-29 21:27:16.344196 +0000 UTC"
                }
            ],
            "answer_type": "MULTIPLE_CHOICE",
            "author_id": "bruno-cesar110@hotmail.com",
            "correct_answer_percentage": 79,
            "created_at": "2021-04-26 00:27:09.132447 +0000 UTC",
            "difficulty_level": "MEDIUM",
            "exams": [
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "3b2d4b6f-dc8b-47d5-b3e6-566a48355f32",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "046f0505-90c9-4862-b318-388c0d1e8026",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-25T02:30:29Z",
                    "degree_proof": false,
                    "id": "4000004041",
                    "location": {
                        "id": "5223"
                    },
                    "number": 1,
                    "open_spaces": 6,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "6BB64D98-EA08-3C1B-50BF-B52FD14F64BC"
                        },
                        {
                            "type": "EXAM",
                            "url": "C3637DBF-3D77-33BC-BF73-F1EA557D827B"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 600,
                    "updated_at": "2023-08-08T20:39:41Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "3b2d4b6f-dc8b-47d5-b3e6-566a48355f32",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "32bef8bd-8aac-4ede-aede-06b9458b026b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-25T02:30:57Z",
                    "degree_proof": false,
                    "id": "4000004042",
                    "location": {
                        "id": "5223"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "6BB64D98-EA08-3C1B-50BF-B52FD14F64BC"
                        },
                        {
                            "type": "EXAM",
                            "url": "C3637DBF-3D77-33BC-BF73-F1EA557D827B"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 600,
                    "updated_at": "2023-08-08T20:40:18Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "3b2d4b6f-dc8b-47d5-b3e6-566a48355f32",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "9b34a94d-754d-4510-8bad-60f649fa825b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-25T02:31:16Z",
                    "degree_proof": false,
                    "id": "4000004043",
                    "location": {
                        "id": "5223"
                    },
                    "number": 1,
                    "open_spaces": 15,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "6BB64D98-EA08-3C1B-50BF-B52FD14F64BC"
                        },
                        {
                            "type": "EXAM",
                            "url": "C3637DBF-3D77-33BC-BF73-F1EA557D827B"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 600,
                    "updated_at": "2023-08-08T20:40:52Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "f30d24a0-2f2d-43be-9812-73746e91a61a",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "3b2d4b6f-dc8b-47d5-b3e6-566a48355f32",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "66678bdd-d9e1-4267-a4cf-f3beebfd7d0e",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-25T02:32:07Z",
                    "degree_proof": false,
                    "id": "4000004044",
                    "location": {
                        "id": "5223"
                    },
                    "number": 1,
                    "open_spaces": 1,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "6BB64D98-EA08-3C1B-50BF-B52FD14F64BC"
                        },
                        {
                            "type": "EXAM",
                            "url": "C3637DBF-3D77-33BC-BF73-F1EA557D827B"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 600,
                    "updated_at": "2023-08-08T20:41:25Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "3b2d4b6f-dc8b-47d5-b3e6-566a48355f32",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "0609ccdb-db5c-4c47-a306-31a0a655e95c",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-25T02:32:24Z",
                    "degree_proof": false,
                    "id": "4000004045",
                    "location": {
                        "id": "5223"
                    },
                    "number": 1,
                    "open_spaces": 5,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "6BB64D98-EA08-3C1B-50BF-B52FD14F64BC"
                        },
                        {
                            "type": "EXAM",
                            "url": "C3637DBF-3D77-33BC-BF73-F1EA557D827B"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 600,
                    "updated_at": "2023-08-08T20:41:57Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "3b2d4b6f-dc8b-47d5-b3e6-566a48355f32",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "417a198f-03b2-417e-8505-8acf83f3059d",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-25T02:32:47Z",
                    "degree_proof": false,
                    "id": "4000004046",
                    "location": {
                        "id": "5223"
                    },
                    "number": 1,
                    "open_spaces": 4,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "6BB64D98-EA08-3C1B-50BF-B52FD14F64BC"
                        },
                        {
                            "type": "EXAM",
                            "url": "C3637DBF-3D77-33BC-BF73-F1EA557D827B"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 600,
                    "updated_at": "2023-08-08T20:42:22Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "3b2d4b6f-dc8b-47d5-b3e6-566a48355f32",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "710b6098-b1cc-40fb-a6e9-1978c156b947",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-25T02:33:00Z",
                    "degree_proof": false,
                    "id": "4000004047",
                    "location": {
                        "id": "5223"
                    },
                    "number": 1,
                    "open_spaces": 4,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "6BB64D98-EA08-3C1B-50BF-B52FD14F64BC"
                        },
                        {
                            "type": "EXAM",
                            "url": "C3637DBF-3D77-33BC-BF73-F1EA557D827B"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 600,
                    "updated_at": "2023-08-08T20:43:03Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "3b2d4b6f-dc8b-47d5-b3e6-566a48355f32",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "dfa90599-1ee1-4de3-8605-a75ecd3799bd",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-25T02:33:34Z",
                    "degree_proof": false,
                    "id": "4000004048",
                    "location": {
                        "id": "5223"
                    },
                    "number": 1,
                    "open_spaces": 6,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "6BB64D98-EA08-3C1B-50BF-B52FD14F64BC"
                        },
                        {
                            "type": "EXAM",
                            "url": "C3637DBF-3D77-33BC-BF73-F1EA557D827B"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 600,
                    "updated_at": "2023-08-08T20:43:32Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "3b2d4b6f-dc8b-47d5-b3e6-566a48355f32",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "f2f2f3c5-9759-4201-bca7-2487751bd626",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-25T02:33:50Z",
                    "degree_proof": false,
                    "id": "4000004049",
                    "location": {
                        "id": "5223"
                    },
                    "number": 1,
                    "open_spaces": 6,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "6BB64D98-EA08-3C1B-50BF-B52FD14F64BC"
                        },
                        {
                            "type": "EXAM",
                            "url": "C3637DBF-3D77-33BC-BF73-F1EA557D827B"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 600,
                    "updated_at": "2023-08-08T20:43:56Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "3b2d4b6f-dc8b-47d5-b3e6-566a48355f32",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "4d4116be-190d-4321-94c8-66da6d1acb11",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-25T02:34:24Z",
                    "degree_proof": false,
                    "id": "4000004050",
                    "location": {
                        "id": "5223"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "6BB64D98-EA08-3C1B-50BF-B52FD14F64BC"
                        },
                        {
                            "type": "EXAM",
                            "url": "C3637DBF-3D77-33BC-BF73-F1EA557D827B"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 600,
                    "updated_at": "2023-08-08T20:44:18Z",
                    "year": 2021
                }
            ],
            "forum_id": "f2c77790-dd1a-4d4b-a9e2-77325dc1e77f",
            "has_student_answer": false,
            "has_user_solution": false,
            "has_video_solution": true,
            "id": "4000146421",
            "labels": [
                "FINAL_ANSWER_SHEET"
            ],
            "public": true,
            "slug": "Considere-caso84716ff6f7",
            "solution": {
                "alternative_solutions": null,
                "author_email": "camila.moma@estrategiamed.com.br",
                "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                "brief": "",
                "brief_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "complete": "<b>Gabarito: alternativa (B).</b><div><b>ComentÃ¡rios:</b></div><div>A primeira escolha terapÃªutica em pacientes com diabetes mellitus tipo 2 Ã© a metformina, droga pertencente ao grupo das biguanidas, que atua reduzindo a produÃ§Ã£o hepÃ¡tica de glicose e promovendo maior captaÃ§Ã£o de glicose pelo prÃ³prio intestino. NÃ£o causa hipoglicemia nem ganho ponderal e, em comparaÃ§Ã£o Ã s sulfonilureias e Ã  insulina, possui benefÃ­cios em reduÃ§Ã£o de risco cardiovascular.</div><div>Como o diabetes mellitus tipo 2 Ã© uma doenÃ§a progressiva, uma vez que hÃ¡ falÃªncia das cÃ©lulas beta pancreÃ¡ticas, sÃ£o necessÃ¡rias adiÃ§Ãµes medicamentosas ao longo do acompanhamento, a fim de manter o controle glicÃªmico adequado, evitando, assim, complicaÃ§Ãµes crÃ´nicas.</div><div>Para a maioria dos pacientes, as metas de controle glicÃªmico sÃ£o glicemia em jejum &lt; 130 mg/dL, glicemia 2 horas apÃ³s a refeiÃ§Ã£o &lt; 180 mg/dL e hemoglobina glicada fraÃ§Ã£o A1c &lt; 7%. Observe que o paciente em questÃ£o estÃ¡ fora das metas propostas e, portanto, deve ter seu tratamento ajustado.</div><div>A escolha do segundo ou terceiro agente, associado Ã  metformina, depende das caracterÃ­sticas individuais:</div><div>â¢\tPresenÃ§a de obesidade: preferÃªncia pelos inibidores de SGLT-2 e pelos anÃ¡logos de GLP-1, pois promovem perda de peso;</div><div>â¢\tPresenÃ§a de doenÃ§a cardiovascular estabelecida: inibidores de SGLT-2 ou anÃ¡logos de GLP-1;</div><div>â¢\tPresenÃ§a de doenÃ§a renal crÃ´nica com taxa de filtraÃ§Ã£o glomerular &gt; 30 mL/min e albuminÃºria &gt; 300 mg/g de creatinina: inibidores de SGLT-2;</div><div>â¢\tPresenÃ§a de insuficiÃªncia cardÃ­aca com fraÃ§Ã£o de ejeÃ§Ã£o reduzida: inibidores de SGLT-2;</div><div>â¢\tPresenÃ§a de doenÃ§a renal crÃ´nica dialÃ­tica: nesta situaÃ§Ã£o, a metformina Ã© contraindicada e podem ser utilizados os inibidores de DPP-4 e a insulina.</div><div><br></div>",
                "complete_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "created_at": "2021-05-31 21:43:17.928695 +0000 UTC",
                "id": "dcebe97f-0baf-4cab-ac0e-0e73b2aeb60e",
                "is_default": false,
                "sanitized_brief": "",
                "sanitized_complete": "Gabarito: alternativa (B).ComentÃ¡rios:A primeira escolha terapÃªutica em pacientes com diabetes mellitus tipo 2 Ã© a metformina, droga pertencente ao grupo das biguanidas, que atua reduzindo a produÃ§Ã£o hepÃ¡tica de glicose e promovendo maior captaÃ§Ã£o de glicose pelo prÃ³prio intestino. NÃ£o causa hipoglicemia nem ganho ponderal e, em comparaÃ§Ã£o Ã s sulfonilureias e Ã  insulina, possui benefÃ­cios em reduÃ§Ã£o de risco cardiovascular.Como o diabetes mellitus tipo 2 Ã© uma doenÃ§a progressiva, uma vez que hÃ¡ falÃªncia das cÃ©lulas beta pancreÃ¡ticas, sÃ£o necessÃ¡rias adiÃ§Ãµes medicamentosas ao longo do acompanhamento, a fim de manter o controle glicÃªmico adequado, evitando, assim, complicaÃ§Ãµes crÃ´nicas.Para a maioria dos pacientes, as metas de controle glicÃªmico sÃ£o glicemia em jejum &lt; 130 mg/dL, glicemia 2 horas apÃ³s a refeiÃ§Ã£o &lt; 180 mg/dL e hemoglobina glicada fraÃ§Ã£o A1c &lt; 7%. Observe que o paciente em questÃ£o estÃ¡ fora das metas propostas e, portanto, deve ter seu tratamento ajustado.A escolha do segundo ou terceiro agente, associado Ã  metformina, depende das caracterÃ­sticas individuais:â¢\tPresenÃ§a de obesidade: preferÃªncia pelos inibidores de SGLT-2 e pelos anÃ¡logos de GLP-1, pois promovem perda de peso;â¢\tPresenÃ§a de doenÃ§a cardiovascular estabelecida: inibidores de SGLT-2 ou anÃ¡logos de GLP-1;â¢\tPresenÃ§a de doenÃ§a renal crÃ´nica com taxa de filtraÃ§Ã£o glomerular &gt; 30 mL/min e albuminÃºria &gt; 300 mg/g de creatinina: inibidores de SGLT-2;â¢\tPresenÃ§a de insuficiÃªncia cardÃ­aca com fraÃ§Ã£o de ejeÃ§Ã£o reduzida: inibidores de SGLT-2;â¢\tPresenÃ§a de doenÃ§a renal crÃ´nica dialÃ­tica: nesta situaÃ§Ã£o, a metformina Ã© contraindicada e podem ser utilizados os inibidores de DPP-4 e a insulina.",
                "updated_at": "2021-05-31 21:43:19.535493 +0000 UTC",
                "video_solution_id": "745d8a67-d7cd-41e6-8afe-c77c208789a4"
            },
            "statement": "Considere o caso de uma paciente do sexo feminino, portadora de diabetes mellitus tipo 2 hÃ¡ alguns anos. Tem ainda antecedentes de hipertensÃ£o arterial e insuficiÃªncia cardÃ­aca, em decorrÃªncia de miocardiopatia hipertensiva. MedicaÃ§Ã£o em uso para diabetes: metformina XR 2.000 mg/dia. Exames laboratoriais: glicemia de jejum = 162 mg/dL, HbA1c = 7,9% e funÃ§Ã£o renal dentro da normalidade. Exame fÃ­sico: IMC: 26,1 kg/mÂ² , auscultas cardÃ­aca e pulmonar normais. Assinale a alternativa que apresenta a medicaÃ§Ã£o melhor indicada para o controle glicÃªmico dessa paciente.",
            "statement_text": "Considere o caso de uma paciente do sexo feminino, portadora de diabetes mellitus tipo 2 hÃ¡ alguns anos. Tem ainda antecedentes de hipertensÃ£o arterial e insuficiÃªncia cardÃ­aca, em decorrÃªncia de miocardiopatia hipertensiva. MedicaÃ§Ã£o em uso para diabetes: metformina XR 2.000 mg/dia. Exames laboratoriais: glicemia de jejum = 162 mg/dL, HbA1c = 7,9% e funÃ§Ã£o renal dentro da normalidade. Exame fÃ­sico: IMC: 26,1 kg/mÂ² , auscultas cardÃ­aca e pulmonar normais. Assinale a alternativa que apresenta a medicaÃ§Ã£o melhor indicada para o controle glicÃªmico dessa paciente.",
            "status": {
                "change_actor": "frank.martins@estrategiamed.com.br",
                "created_at": "2021-05-31 21:45:20.65823 +0000 UTC",
                "owner": "camila.moma@estrategiamed.com.br",
                "value": "APPROVED"
            },
            "topics": [
                {
                    "has_children": false,
                    "id": "0cad8ea0fa0e47efa8d56f8a97b383e5",
                    "master_id": "3b9e1e9de9ba4ff3959ae83d455880f9",
                    "name": "MedicaÃ§Ãµes que provocam glicosÃºria (inibidores de SGLT-2)",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Tratamento[$$]Tratamento medicamentoso[$$]Drogas antidiabÃ©ticas nÃ£o insulina[$$]MedicaÃ§Ãµes que provocam glicosÃºria (inibidores de SGLT-2)"
                },
                {
                    "has_children": false,
                    "id": "ab6c6a1fb6604cf98243ac486f80dac8",
                    "master_id": "0a6abdce2fbc45aa8ba8f0e75875ec84",
                    "name": "Endocrinologia ",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia "
                }
            ],
            "unlisted": false,
            "video_solution": {
                "available_resolutions": [
                    {
                        "resolution": "720",
                        "url": "https://api.estrategia.com/questoes/sign/medicina/processadas/4000146421-720.mp4"
                    }
                ],
                "id": "745d8a67-d7cd-41e6-8afe-c77c208789a4",
                "identifier": "",
                "question_id": "4000146421"
            },
            "video_solution_id": "745d8a67-d7cd-41e6-8afe-c77c208789a4"
        },
        {
            "active": true,
            "alternatives": [
                {
                    "answer_percentage": 89,
                    "answers": 1151,
                    "body": "Certo.",
                    "correct": true,
                    "created_at": "2020-12-08 18:38:17.603338 +0000 UTC",
                    "id": "cc4f8662-1215-44b1-93a9-2084c1af75ab",
                    "position": "0",
                    "sanitized_body": "Certo.",
                    "solution": {
                        "alternative_id": "cc4f8662-1215-44b1-93a9-2084c1af75ab",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Correta a alternativa A.</b> A metformina deve ser suspensa em pacientes com TFG < 30 mL/minuto.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2022-03-01 23:29:33.555112 +0000 UTC",
                        "id": "5a6224c8-6a7c-4a0b-beeb-a9d7a79173e1",
                        "sanitized_brief": "",
                        "sanitized_complete": "Correta a alternativa A. A metformina deve ser suspensa em pacientes com TFG &lt; 30 mL/minuto.",
                        "updated_at": "2022-03-01 23:29:35.565828 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-11-25 17:50:05.193578 +0000 UTC"
                },
                {
                    "answer_percentage": 11,
                    "answers": 141,
                    "body": "Errado.",
                    "correct": false,
                    "created_at": "2020-12-08 18:38:17.603338 +0000 UTC",
                    "id": "58d18537-aaa0-4779-a033-8f70bbd21271",
                    "position": "1",
                    "sanitized_body": "Errado.",
                    "solution": {
                        "alternative_id": "58d18537-aaa0-4779-a033-8f70bbd21271",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Incorreta a alternativa B.</b> Vide comentÃ¡rio inicial.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2022-03-01 23:29:33.556831 +0000 UTC",
                        "id": "69af753d-3e98-4b3a-8fef-b2c5015593b9",
                        "sanitized_brief": "",
                        "sanitized_complete": "Incorreta a alternativa B. Vide comentÃ¡rio inicial.",
                        "updated_at": "2022-03-01 23:29:35.570376 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-11-25 17:50:05.837827 +0000 UTC"
                }
            ],
            "answer_type": "TRUE_OR_FALSE",
            "author_id": "bruno-cesar110@hotmail.com",
            "correct_answer_percentage": 89,
            "created_at": "2020-12-08 18:38:17.603338 +0000 UTC",
            "difficulty_level": "MEDIUM",
            "exams": [
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "Certo/Errado",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "0ed3e5bf-ad01-47b3-baf6-99da715764f0",
                        "jury_id": "d0957ba3-b5a4-4d0a-8fd0-f2bb2041301f",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "ebf58361-1728-4144-93bb-7f962e8b9fd6",
                        "specialty_id": "9fbb6169-ce34-45e3-ac72-71bd7e965496",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-12-08T16:08:15Z",
                    "degree_proof": false,
                    "id": "4000002182",
                    "location": {
                        "id": "8"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "733F8FAD-41A9-21F1-FC79-78D083F1CF69"
                        },
                        {
                            "type": "NOTICE",
                            "url": "28A00EFB-0C1A-6724-A646-45C0CF18691E"
                        },
                        {
                            "type": "ANSWER",
                            "url": "96482E6E-AEC1-6C8A-4ED8-863D915A8BF3"
                        }
                    ],
                    "questions_number": 120,
                    "scholarity": "placeholder",
                    "subscription_fee": 246,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "Certo/Errado",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "0ed3e5bf-ad01-47b3-baf6-99da715764f0",
                        "jury_id": "d0957ba3-b5a4-4d0a-8fd0-f2bb2041301f",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "ebf58361-1728-4144-93bb-7f962e8b9fd6",
                        "specialty_id": "046f0505-90c9-4862-b318-388c0d1e8026",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-12-08T16:08:44Z",
                    "degree_proof": false,
                    "id": "4000002183",
                    "location": {
                        "id": "8"
                    },
                    "number": 1,
                    "open_spaces": 17,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "733F8FAD-41A9-21F1-FC79-78D083F1CF69"
                        },
                        {
                            "type": "NOTICE",
                            "url": "28A00EFB-0C1A-6724-A646-45C0CF18691E"
                        },
                        {
                            "type": "ANSWER",
                            "url": "96482E6E-AEC1-6C8A-4ED8-863D915A8BF3"
                        }
                    ],
                    "questions_number": 120,
                    "scholarity": "placeholder",
                    "subscription_fee": 246,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "Certo/Errado",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "0ed3e5bf-ad01-47b3-baf6-99da715764f0",
                        "jury_id": "d0957ba3-b5a4-4d0a-8fd0-f2bb2041301f",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "ebf58361-1728-4144-93bb-7f962e8b9fd6",
                        "specialty_id": "dfa90599-1ee1-4de3-8605-a75ecd3799bd",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-12-08T16:09:13Z",
                    "degree_proof": false,
                    "id": "4000002184",
                    "location": {
                        "id": "8"
                    },
                    "number": 1,
                    "open_spaces": 22,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "733F8FAD-41A9-21F1-FC79-78D083F1CF69"
                        },
                        {
                            "type": "NOTICE",
                            "url": "28A00EFB-0C1A-6724-A646-45C0CF18691E"
                        },
                        {
                            "type": "ANSWER",
                            "url": "96482E6E-AEC1-6C8A-4ED8-863D915A8BF3"
                        }
                    ],
                    "questions_number": 120,
                    "scholarity": "placeholder",
                    "subscription_fee": 246,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "Certo/Errado",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "0ed3e5bf-ad01-47b3-baf6-99da715764f0",
                        "jury_id": "d0957ba3-b5a4-4d0a-8fd0-f2bb2041301f",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "ebf58361-1728-4144-93bb-7f962e8b9fd6",
                        "specialty_id": "32bef8bd-8aac-4ede-aede-06b9458b026b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-12-08T16:09:35Z",
                    "degree_proof": false,
                    "id": "4000002185",
                    "location": {
                        "id": "8"
                    },
                    "number": 1,
                    "open_spaces": 11,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "733F8FAD-41A9-21F1-FC79-78D083F1CF69"
                        },
                        {
                            "type": "NOTICE",
                            "url": "28A00EFB-0C1A-6724-A646-45C0CF18691E"
                        },
                        {
                            "type": "ANSWER",
                            "url": "96482E6E-AEC1-6C8A-4ED8-863D915A8BF3"
                        }
                    ],
                    "questions_number": 120,
                    "scholarity": "placeholder",
                    "subscription_fee": 246,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "Certo/Errado",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "0ed3e5bf-ad01-47b3-baf6-99da715764f0",
                        "jury_id": "d0957ba3-b5a4-4d0a-8fd0-f2bb2041301f",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "ebf58361-1728-4144-93bb-7f962e8b9fd6",
                        "specialty_id": "9b34a94d-754d-4510-8bad-60f649fa825b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-12-08T16:10:01Z",
                    "degree_proof": false,
                    "id": "4000002186",
                    "location": {
                        "id": "8"
                    },
                    "number": 1,
                    "open_spaces": 62,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "733F8FAD-41A9-21F1-FC79-78D083F1CF69"
                        },
                        {
                            "type": "NOTICE",
                            "url": "28A00EFB-0C1A-6724-A646-45C0CF18691E"
                        },
                        {
                            "type": "ANSWER",
                            "url": "96482E6E-AEC1-6C8A-4ED8-863D915A8BF3"
                        }
                    ],
                    "questions_number": 120,
                    "scholarity": "placeholder",
                    "subscription_fee": 246,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "Certo/Errado",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "0ed3e5bf-ad01-47b3-baf6-99da715764f0",
                        "jury_id": "d0957ba3-b5a4-4d0a-8fd0-f2bb2041301f",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "ebf58361-1728-4144-93bb-7f962e8b9fd6",
                        "specialty_id": "2ca62942-4eab-49e5-acaf-e395254eee99",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-12-08T16:11:13Z",
                    "degree_proof": false,
                    "id": "4000002187",
                    "location": {
                        "id": "8"
                    },
                    "number": 1,
                    "open_spaces": 4,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "733F8FAD-41A9-21F1-FC79-78D083F1CF69"
                        },
                        {
                            "type": "NOTICE",
                            "url": "28A00EFB-0C1A-6724-A646-45C0CF18691E"
                        },
                        {
                            "type": "ANSWER",
                            "url": "96482E6E-AEC1-6C8A-4ED8-863D915A8BF3"
                        }
                    ],
                    "questions_number": 120,
                    "scholarity": "placeholder",
                    "subscription_fee": 246,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "Certo/Errado",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "0ed3e5bf-ad01-47b3-baf6-99da715764f0",
                        "jury_id": "d0957ba3-b5a4-4d0a-8fd0-f2bb2041301f",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "ebf58361-1728-4144-93bb-7f962e8b9fd6",
                        "specialty_id": "09229d65-4632-456a-829b-e97c2ff93f9a",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-12-08T16:11:40Z",
                    "degree_proof": false,
                    "id": "4000002188",
                    "location": {
                        "id": "8"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "733F8FAD-41A9-21F1-FC79-78D083F1CF69"
                        },
                        {
                            "type": "NOTICE",
                            "url": "28A00EFB-0C1A-6724-A646-45C0CF18691E"
                        },
                        {
                            "type": "ANSWER",
                            "url": "96482E6E-AEC1-6C8A-4ED8-863D915A8BF3"
                        }
                    ],
                    "questions_number": 120,
                    "scholarity": "placeholder",
                    "subscription_fee": 246,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "Certo/Errado",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "f30d24a0-2f2d-43be-9812-73746e91a61a",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "0ed3e5bf-ad01-47b3-baf6-99da715764f0",
                        "jury_id": "d0957ba3-b5a4-4d0a-8fd0-f2bb2041301f",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "ebf58361-1728-4144-93bb-7f962e8b9fd6",
                        "specialty_id": "66678bdd-d9e1-4267-a4cf-f3beebfd7d0e",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-12-08T16:12:08Z",
                    "degree_proof": false,
                    "id": "4000002189",
                    "location": {
                        "id": "8"
                    },
                    "number": 1,
                    "open_spaces": 1,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "733F8FAD-41A9-21F1-FC79-78D083F1CF69"
                        },
                        {
                            "type": "NOTICE",
                            "url": "28A00EFB-0C1A-6724-A646-45C0CF18691E"
                        },
                        {
                            "type": "ANSWER",
                            "url": "96482E6E-AEC1-6C8A-4ED8-863D915A8BF3"
                        }
                    ],
                    "questions_number": 120,
                    "scholarity": "placeholder",
                    "subscription_fee": 246,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "Certo/Errado",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "0ed3e5bf-ad01-47b3-baf6-99da715764f0",
                        "jury_id": "d0957ba3-b5a4-4d0a-8fd0-f2bb2041301f",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "ebf58361-1728-4144-93bb-7f962e8b9fd6",
                        "specialty_id": "8d4e50ad-d41e-40c9-9f4d-842251c2d2d9",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-12-08T16:12:45Z",
                    "degree_proof": false,
                    "id": "4000002190",
                    "location": {
                        "id": "8"
                    },
                    "number": 1,
                    "open_spaces": 6,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "733F8FAD-41A9-21F1-FC79-78D083F1CF69"
                        },
                        {
                            "type": "NOTICE",
                            "url": "28A00EFB-0C1A-6724-A646-45C0CF18691E"
                        },
                        {
                            "type": "ANSWER",
                            "url": "96482E6E-AEC1-6C8A-4ED8-863D915A8BF3"
                        }
                    ],
                    "questions_number": 120,
                    "scholarity": "placeholder",
                    "subscription_fee": 246,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "Certo/Errado",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "0ed3e5bf-ad01-47b3-baf6-99da715764f0",
                        "jury_id": "d0957ba3-b5a4-4d0a-8fd0-f2bb2041301f",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "ebf58361-1728-4144-93bb-7f962e8b9fd6",
                        "specialty_id": "0609ccdb-db5c-4c47-a306-31a0a655e95c",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-12-08T16:13:14Z",
                    "degree_proof": false,
                    "id": "4000002191",
                    "location": {
                        "id": "8"
                    },
                    "number": 1,
                    "open_spaces": 35,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "733F8FAD-41A9-21F1-FC79-78D083F1CF69"
                        },
                        {
                            "type": "NOTICE",
                            "url": "28A00EFB-0C1A-6724-A646-45C0CF18691E"
                        },
                        {
                            "type": "ANSWER",
                            "url": "96482E6E-AEC1-6C8A-4ED8-863D915A8BF3"
                        }
                    ],
                    "questions_number": 120,
                    "scholarity": "placeholder",
                    "subscription_fee": 246,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "Certo/Errado",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "0ed3e5bf-ad01-47b3-baf6-99da715764f0",
                        "jury_id": "d0957ba3-b5a4-4d0a-8fd0-f2bb2041301f",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "ebf58361-1728-4144-93bb-7f962e8b9fd6",
                        "specialty_id": "417a198f-03b2-417e-8505-8acf83f3059d",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-12-08T16:13:52Z",
                    "degree_proof": false,
                    "id": "4000002192",
                    "location": {
                        "id": "8"
                    },
                    "number": 1,
                    "open_spaces": 6,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "733F8FAD-41A9-21F1-FC79-78D083F1CF69"
                        },
                        {
                            "type": "NOTICE",
                            "url": "28A00EFB-0C1A-6724-A646-45C0CF18691E"
                        },
                        {
                            "type": "ANSWER",
                            "url": "96482E6E-AEC1-6C8A-4ED8-863D915A8BF3"
                        }
                    ],
                    "questions_number": 120,
                    "scholarity": "placeholder",
                    "subscription_fee": 246,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "Certo/Errado",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "0ed3e5bf-ad01-47b3-baf6-99da715764f0",
                        "jury_id": "d0957ba3-b5a4-4d0a-8fd0-f2bb2041301f",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "ebf58361-1728-4144-93bb-7f962e8b9fd6",
                        "specialty_id": "f2f2f3c5-9759-4201-bca7-2487751bd626",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-12-08T16:14:14Z",
                    "degree_proof": false,
                    "id": "4000002193",
                    "location": {
                        "id": "8"
                    },
                    "number": 1,
                    "open_spaces": 28,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "733F8FAD-41A9-21F1-FC79-78D083F1CF69"
                        },
                        {
                            "type": "NOTICE",
                            "url": "28A00EFB-0C1A-6724-A646-45C0CF18691E"
                        },
                        {
                            "type": "ANSWER",
                            "url": "96482E6E-AEC1-6C8A-4ED8-863D915A8BF3"
                        }
                    ],
                    "questions_number": 120,
                    "scholarity": "placeholder",
                    "subscription_fee": 246,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "Certo/Errado",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "0ed3e5bf-ad01-47b3-baf6-99da715764f0",
                        "jury_id": "d0957ba3-b5a4-4d0a-8fd0-f2bb2041301f",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "ebf58361-1728-4144-93bb-7f962e8b9fd6",
                        "specialty_id": "25b55daa-bd57-453d-9099-8c9dfe6d622a",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-12-08T16:14:33Z",
                    "degree_proof": false,
                    "id": "4000002194",
                    "location": {
                        "id": "8"
                    },
                    "number": 1,
                    "open_spaces": 3,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "733F8FAD-41A9-21F1-FC79-78D083F1CF69"
                        },
                        {
                            "type": "NOTICE",
                            "url": "28A00EFB-0C1A-6724-A646-45C0CF18691E"
                        },
                        {
                            "type": "ANSWER",
                            "url": "96482E6E-AEC1-6C8A-4ED8-863D915A8BF3"
                        }
                    ],
                    "questions_number": 120,
                    "scholarity": "placeholder",
                    "subscription_fee": 246,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "Certo/Errado",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "0ed3e5bf-ad01-47b3-baf6-99da715764f0",
                        "jury_id": "d0957ba3-b5a4-4d0a-8fd0-f2bb2041301f",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "ebf58361-1728-4144-93bb-7f962e8b9fd6",
                        "specialty_id": "710b6098-b1cc-40fb-a6e9-1978c156b947",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-12-08T16:14:55Z",
                    "degree_proof": false,
                    "id": "4000002195",
                    "location": {
                        "id": "8"
                    },
                    "number": 1,
                    "open_spaces": 41,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "733F8FAD-41A9-21F1-FC79-78D083F1CF69"
                        },
                        {
                            "type": "NOTICE",
                            "url": "28A00EFB-0C1A-6724-A646-45C0CF18691E"
                        },
                        {
                            "type": "ANSWER",
                            "url": "96482E6E-AEC1-6C8A-4ED8-863D915A8BF3"
                        }
                    ],
                    "questions_number": 120,
                    "scholarity": "placeholder",
                    "subscription_fee": 246,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "Certo/Errado",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "0ed3e5bf-ad01-47b3-baf6-99da715764f0",
                        "jury_id": "d0957ba3-b5a4-4d0a-8fd0-f2bb2041301f",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "ebf58361-1728-4144-93bb-7f962e8b9fd6",
                        "specialty_id": "cccffc77-8a54-477d-b101-01edbb244b74",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-12-08T16:15:19Z",
                    "degree_proof": false,
                    "id": "4000002196",
                    "location": {
                        "id": "8"
                    },
                    "number": 1,
                    "open_spaces": 7,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "733F8FAD-41A9-21F1-FC79-78D083F1CF69"
                        },
                        {
                            "type": "NOTICE",
                            "url": "28A00EFB-0C1A-6724-A646-45C0CF18691E"
                        },
                        {
                            "type": "ANSWER",
                            "url": "96482E6E-AEC1-6C8A-4ED8-863D915A8BF3"
                        },
                        {
                            "type": "EXAM",
                            "url": "3AD41BB9-6384-6C04-B4A5-BB87A7908840"
                        }
                    ],
                    "questions_number": 120,
                    "scholarity": "placeholder",
                    "subscription_fee": 246,
                    "updated_at": "2023-12-12T17:09:51Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "Certo/Errado",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "0ed3e5bf-ad01-47b3-baf6-99da715764f0",
                        "jury_id": "d0957ba3-b5a4-4d0a-8fd0-f2bb2041301f",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "ebf58361-1728-4144-93bb-7f962e8b9fd6",
                        "specialty_id": "776b092f-eb41-4150-a252-b23a0f7914b3",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-12-08T16:15:45Z",
                    "degree_proof": false,
                    "id": "4000002197",
                    "location": {
                        "id": "8"
                    },
                    "number": 1,
                    "open_spaces": 6,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "733F8FAD-41A9-21F1-FC79-78D083F1CF69"
                        },
                        {
                            "type": "NOTICE",
                            "url": "28A00EFB-0C1A-6724-A646-45C0CF18691E"
                        },
                        {
                            "type": "ANSWER",
                            "url": "96482E6E-AEC1-6C8A-4ED8-863D915A8BF3"
                        }
                    ],
                    "questions_number": 120,
                    "scholarity": "placeholder",
                    "subscription_fee": 246,
                    "year": 2021
                }
            ],
            "has_student_answer": false,
            "has_user_solution": false,
            "has_video_solution": false,
            "id": "4000131209",
            "labels": [
                "FINAL_ANSWER_SHEET"
            ],
            "public": true,
            "slug": "Determinado-paciente108ed8976ce",
            "solution": {
                "alternative_solutions": null,
                "author_email": "camila.moma@estrategiamed.com.br",
                "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                "brief": "",
                "brief_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "complete": "<b>Gabarito: alternativa A.</b><div><b>ComentÃ¡rio:</b></div><div>A metformina  Ã© uma droga anti-hiperglicemiante pertencente Ã  classe das biguanidas, cuja aÃ§Ã£o principal Ã© reduzir a gliconeogÃªnese hepÃ¡tica. TambÃ©m contribui para a reduÃ§Ã£o da hiperglicemia ao promover maior captaÃ§Ã£o de glicose pelas cÃ©lulas intestinais para utilizaÃ§Ã£o prÃ³pria.Â </div><div>Como nÃ£o aumenta os nÃ­veis circulantes de insulina, a metformina nÃ£o causa hipoglicemia e Ã© neutra em relaÃ§Ã£o ao peso. Entretanto, como sua depuraÃ§Ã£o Ã© renal, seu uso Ã© contraindicado nos indivÃ­duos com taxa de filtraÃ§Ã£o glomerular (TFG) < 30 mL/minuto, devido ao risco de acidose lÃ¡ctica. Isso ocorre, pois, ao inibir a produÃ§Ã£o hepÃ¡tica de glicose, hÃ¡ aumento do lactato circulante, que pode ser clinicamente significativo nas seguintes situaÃ§Ãµes:</div><div>â¢\tReduÃ§Ã£o do clearance renal  (insuficiÃªncia renal), levando a maior retenÃ§Ã£o do lactato;</div><div>â¢\tAumento da produÃ§Ã£o de lactato, como na sepse e na insuficiÃªncia cardÃ­aca descompensada (devido Ã  hipÃ³xia, hÃ¡ maior metabolismo anaerÃ³bico para formaÃ§Ã£o de ATP, com consequente elevaÃ§Ã£o nos nÃ­veis de lactato);</div><div>â¢\tDoenÃ§a hepÃ¡tica ativa: reduz a utilizaÃ§Ã£o do lactato, possibilitando seu acÃºmulo;</div><div>â¢\tAbuso de Ã¡lcool: a oxidaÃ§Ã£o do etanol leva Ã  formaÃ§Ã£o de NADH, que faz com que o piruvato seja transformado em lactato, acumulando-o.</div><div>A orientaÃ§Ã£o posolÃ³gica da metformina na insuficiÃªncia renal, conforme a KDIGO (Kidney Disease Improving Global Outcomes), Ã©:</div><div>â¢\tTFG > 45 mL/minuto: 2 g/dia;</div><div>â¢\tTFG entre 30-45 mL/minuto: 1 g/dia;</div><div>â¢\tTFG < 30 mL/minuto: contraindicada.</div><div><br></div>",
                "complete_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "created_at": "2022-03-01 23:29:33.66461 +0000 UTC",
                "id": "79c21b4d-3a5d-4e8b-95b9-e5cf91f01d97",
                "is_default": false,
                "sanitized_brief": "",
                "sanitized_complete": "Gabarito: alternativa A.ComentÃ¡rio:A metformina  Ã© uma droga anti-hiperglicemiante pertencente Ã  classe das biguanidas, cuja aÃ§Ã£o principal Ã© reduzir a gliconeogÃªnese hepÃ¡tica. TambÃ©m contribui para a reduÃ§Ã£o da hiperglicemia ao promover maior captaÃ§Ã£o de glicose pelas cÃ©lulas intestinais para utilizaÃ§Ã£o prÃ³pria.Â Como nÃ£o aumenta os nÃ­veis circulantes de insulina, a metformina nÃ£o causa hipoglicemia e Ã© neutra em relaÃ§Ã£o ao peso. Entretanto, como sua depuraÃ§Ã£o Ã© renal, seu uso Ã© contraindicado nos indivÃ­duos com taxa de filtraÃ§Ã£o glomerular (TFG) &lt; 30 mL/minuto, devido ao risco de acidose lÃ¡ctica. Isso ocorre, pois, ao inibir a produÃ§Ã£o hepÃ¡tica de glicose, hÃ¡ aumento do lactato circulante, que pode ser clinicamente significativo nas seguintes situaÃ§Ãµes:â¢\tReduÃ§Ã£o do clearance renal  (insuficiÃªncia renal), levando a maior retenÃ§Ã£o do lactato;â¢\tAumento da produÃ§Ã£o de lactato, como na sepse e na insuficiÃªncia cardÃ­aca descompensada (devido Ã  hipÃ³xia, hÃ¡ maior metabolismo anaerÃ³bico para formaÃ§Ã£o de ATP, com consequente elevaÃ§Ã£o nos nÃ­veis de lactato);â¢\tDoenÃ§a hepÃ¡tica ativa: reduz a utilizaÃ§Ã£o do lactato, possibilitando seu acÃºmulo;â¢\tAbuso de Ã¡lcool: a oxidaÃ§Ã£o do etanol leva Ã  formaÃ§Ã£o de NADH, que faz com que o piruvato seja transformado em lactato, acumulando-o.A orientaÃ§Ã£o posolÃ³gica da metformina na insuficiÃªncia renal, conforme a KDIGO (Kidney Disease Improving Global Outcomes), Ã©:â¢\tTFG &gt; 45 mL/minuto: 2 g/dia;â¢\tTFG entre 30-45 mL/minuto: 1 g/dia;â¢\tTFG &lt; 30 mL/minuto: contraindicada.",
                "updated_at": "2022-03-01 23:29:35.617391 +0000 UTC"
            },
            "statement": "Determinado paciente de 58 anos de idade, tabagista, com histÃ³rico de IAM hÃ¡ cinco anos e DM2, em uso de metformina, comparece Ã  consulta com os seguintes exames laboratoriais: glicemia = 136 mg/dL; colesterol HDL = 32 mg/dL; colesterol LDL = 192,3 mg/dL; e creatinina sÃ©rica = 1,32 mg/dL. Apresenta medida de PA = 165 mmHg x 102 mmHg, FC = 80 bpm, SatO2 = 92% com nÃ­veis tensionais confirmados em duas consultas com mais de quatro semanas entre elas.<div><br></div><div>Considerando esse caso clÃ­nico e os conhecimentos mÃ©dicos correlatos, julgue os itens a seguir.</div><div><br></div><div>O uso de metformina Ã© contraindicado em pacientes com depuraÃ§Ã£o de creatinina inferior a 30 mL/min.</div>",
            "statement_text": "Determinado paciente de 58 anos de idade, tabagista, com histÃ³rico de IAM hÃ¡ cinco anos e DM2, em uso de metformina, comparece Ã  consulta com os seguintes exames laboratoriais: glicemia = 136 mg/dL; colesterol HDL = 32 mg/dL; colesterol LDL = 192,3 mg/dL; e creatinina sÃ©rica = 1,32 mg/dL. Apresenta medida de PA = 165 mmHg x 102 mmHg, FC = 80 bpm, SatO2 = 92% com nÃ­veis tensionais confirmados em duas consultas com mais de quatro semanas entre elas.Considerando esse caso clÃ­nico e os conhecimentos mÃ©dicos correlatos, julgue os itens a seguir.O uso de metformina Ã© contraindicado em pacientes com depuraÃ§Ã£o de creatinina inferior a 30 mL/min.",
            "status": {
                "change_actor": "frank.martins@estrategiamed.com.br",
                "created_at": "2022-03-02 01:13:35.210579 +0000 UTC",
                "owner": "camila.moma@estrategiamed.com.br",
                "value": "APPROVED"
            },
            "topics": [
                {
                    "has_children": false,
                    "id": "ab6c6a1fb6604cf98243ac486f80dac8",
                    "master_id": "0a6abdce2fbc45aa8ba8f0e75875ec84",
                    "name": "Endocrinologia ",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia "
                },
                {
                    "has_children": false,
                    "id": "d53b61e527fa4a61b5a22bb715b8d0f8",
                    "master_id": "8bdc1fbeb2e54046a2c3ba4ac4e63ead",
                    "name": "Biguanida (metformina)",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Tratamento[$$]Tratamento medicamentoso[$$]Drogas antidiabÃ©ticas nÃ£o insulina[$$]MedicaÃ§Ãµes com efeito sensibilizador de insulina[$$]Biguanida (metformina)"
                }
            ],
            "unlisted": false,
            "video_solution": {
                "available_resolutions": null,
                "id": "",
                "identifier": "",
                "question_id": ""
            }
        },
        {
            "active": true,
            "alternatives": [
                {
                    "answer_percentage": 4,
                    "answers": 235,
                    "body": "antecendente familiar, alimentaÃ§Ã£o com excesso de carboidratos e ansiedade.",
                    "correct": false,
                    "created_at": "2021-01-25 12:38:11.483647 +0000 UTC",
                    "id": "54b3dd83-b0be-48b9-abb8-1395368f3e65",
                    "position": "0",
                    "sanitized_body": "antecendente familiar, alimentaÃ§Ã£o com excesso de carboidratos e ansiedade.",
                    "solution": {
                        "alternative_id": "54b3dd83-b0be-48b9-abb8-1395368f3e65",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "Incorreta a alternativa A. Apenas o antecedente familiar para DM tipo 2 Ã© um dos fatores de risco a serem considerados para o rastreamento",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-02-05 00:32:01.428245 +0000 UTC",
                        "id": "2b415ab0-72ce-489f-8eda-628ebb485b46",
                        "sanitized_brief": "",
                        "sanitized_complete": "Incorreta a alternativa A. Apenas o antecedente familiar para DM tipo 2 Ã© um dos fatores de risco a serem considerados para o rastreamento",
                        "updated_at": "2021-02-05 01:44:53.629144 +0000 UTC"
                    },
                    "topics": []
                },
                {
                    "answer_percentage": 90,
                    "answers": 5158,
                    "body": "obesidade central, hipertensÃ£o arterial e sobrepeso.",
                    "correct": true,
                    "created_at": "2021-01-25 12:38:11.483647 +0000 UTC",
                    "id": "a550ac6c-0325-4690-aeec-10c2425f6715",
                    "position": "1",
                    "sanitized_body": "obesidade central, hipertensÃ£o arterial e sobrepeso.",
                    "solution": {
                        "alternative_id": "a550ac6c-0325-4690-aeec-10c2425f6715",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "Correta a alternativa B A adiposidade central relaciona-se Ã  resistÃªncia Ã  aÃ§Ã£o da insulina, portanto, Ã© um fator de risco para diabetes mellitus tipo 2, assim como a hipertensÃ£o arterial. IndivÃ­duos com sobrepeso ou obesidade devem ser rastreados na presenÃ§a de algum fator de risco adicional, independentemente da idade.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-02-05 00:32:01.416974 +0000 UTC",
                        "id": "4e5fd5d1-3eb5-4a8b-9c79-9dd243df203f",
                        "sanitized_brief": "",
                        "sanitized_complete": "Correta a alternativa B A adiposidade central relaciona-se Ã  resistÃªncia Ã  aÃ§Ã£o da insulina, portanto, Ã© um fator de risco para diabetes mellitus tipo 2, assim como a hipertensÃ£o arterial. IndivÃ­duos com sobrepeso ou obesidade devem ser rastreados na presenÃ§a de algum fator de risco adicional, independentemente da idade.",
                        "updated_at": "2021-02-05 01:44:53.624242 +0000 UTC"
                    },
                    "topics": []
                },
                {
                    "answer_percentage": 0,
                    "answers": 15,
                    "body": "ansiedade, insÃ´nia e sobrepeso.",
                    "correct": false,
                    "created_at": "2021-01-25 12:38:11.483647 +0000 UTC",
                    "id": "98143e5c-5a7a-459d-94dc-de3897fa7017",
                    "position": "2",
                    "sanitized_body": "ansiedade, insÃ´nia e sobrepeso.",
                    "solution": {
                        "alternative_id": "98143e5c-5a7a-459d-94dc-de3897fa7017",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "Incorreta a alternativa C. Ansiedade e insÃ´nia nÃ£o sÃ£o indicadores de rastreamento para diabetes mellitus tipo 2.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-02-05 00:32:01.416126 +0000 UTC",
                        "id": "f37eefe1-e744-436d-9efe-eb95c62d3648",
                        "sanitized_brief": "",
                        "sanitized_complete": "Incorreta a alternativa C. Ansiedade e insÃ´nia nÃ£o sÃ£o indicadores de rastreamento para diabetes mellitus tipo 2.",
                        "updated_at": "2021-02-05 01:44:53.628957 +0000 UTC"
                    },
                    "topics": []
                },
                {
                    "answer_percentage": 5,
                    "answers": 263,
                    "body": "alteraÃ§Ã£o do sono, antecedente familiar e sedentarismo.",
                    "correct": false,
                    "created_at": "2021-01-25 12:38:11.483647 +0000 UTC",
                    "id": "f7b05297-0652-488b-bd81-daa670e99478",
                    "position": "3",
                    "sanitized_body": "alteraÃ§Ã£o do sono, antecedente familiar e sedentarismo.",
                    "solution": {
                        "alternative_id": "f7b05297-0652-488b-bd81-daa670e99478",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "Incorreta a alternativa D. Antecedente familiar e sedentarismo sÃ£o fatores de risco a serem considerados no rastreamento, entretanto, alteraÃ§Ã£o de sono nÃ£o",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-02-05 00:32:01.427909 +0000 UTC",
                        "id": "afb4db91-a92e-4b4e-a1c6-63565b870af1",
                        "sanitized_brief": "",
                        "sanitized_complete": "Incorreta a alternativa D. Antecedente familiar e sedentarismo sÃ£o fatores de risco a serem considerados no rastreamento, entretanto, alteraÃ§Ã£o de sono nÃ£o",
                        "updated_at": "2021-02-05 01:44:53.621146 +0000 UTC"
                    },
                    "topics": []
                },
                {
                    "answer_percentage": 1,
                    "answers": 39,
                    "body": "hipotireoidismo, insÃ´nia e obesidade central.",
                    "correct": false,
                    "created_at": "2021-01-25 12:38:11.483647 +0000 UTC",
                    "id": "9abec234-4212-4c92-8f40-770e8a9b2b6c",
                    "position": "4",
                    "sanitized_body": "hipotireoidismo, insÃ´nia e obesidade central.",
                    "solution": {
                        "alternative_id": "9abec234-4212-4c92-8f40-770e8a9b2b6c",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "Incorreta a alternativa E. A disfunÃ§Ã£o tireoidiana que se relaciona Ã  hiperglicemia Ã© o hipertireoidismo, uma vez que o excesso de hormÃ´nios tireoidianos leva ao aumento da resistÃªncia Ã  aÃ§Ã£o da insulina.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-02-05 00:32:01.425256 +0000 UTC",
                        "id": "43f6057e-6506-4acf-8267-aee8ef1f31a3",
                        "sanitized_brief": "",
                        "sanitized_complete": "Incorreta a alternativa E. A disfunÃ§Ã£o tireoidiana que se relaciona Ã  hiperglicemia Ã© o hipertireoidismo, uma vez que o excesso de hormÃ´nios tireoidianos leva ao aumento da resistÃªncia Ã  aÃ§Ã£o da insulina.",
                        "updated_at": "2021-02-05 01:44:53.61544 +0000 UTC"
                    },
                    "topics": []
                }
            ],
            "answer_type": "MULTIPLE_CHOICE",
            "author_id": "bruno-cesar110@hotmail.com",
            "correct_answer_percentage": 90,
            "created_at": "2021-01-25 12:38:11.483647 +0000 UTC",
            "difficulty_level": "MEDIUM",
            "exams": [
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "9b34a94d-754d-4510-8bad-60f649fa825b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:03:06Z",
                    "degree_proof": false,
                    "id": "4000003036",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 98,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "dfa90599-1ee1-4de3-8605-a75ecd3799bd",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:03:45Z",
                    "degree_proof": false,
                    "id": "4000003037",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 77,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "32bef8bd-8aac-4ede-aede-06b9458b026b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:08:01Z",
                    "degree_proof": false,
                    "id": "4000003038",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 8,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "710b6098-b1cc-40fb-a6e9-1978c156b947",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:08:28Z",
                    "degree_proof": false,
                    "id": "4000003039",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 44,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "0609ccdb-db5c-4c47-a306-31a0a655e95c",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:08:57Z",
                    "degree_proof": false,
                    "id": "4000003040",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 66,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "dcb47678-bdba-4669-aa0e-01f71e32541b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:10:05Z",
                    "degree_proof": false,
                    "id": "4000003041",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 3,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "25b55daa-bd57-453d-9099-8c9dfe6d622a",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:10:32Z",
                    "degree_proof": false,
                    "id": "4000003042",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 3,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "2ca62942-4eab-49e5-acaf-e395254eee99",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:10:50Z",
                    "degree_proof": false,
                    "id": "4000003043",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 27,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "776b092f-eb41-4150-a252-b23a0f7914b3",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:11:22Z",
                    "degree_proof": false,
                    "id": "4000003044",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 22,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "046f0505-90c9-4862-b318-388c0d1e8026",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:11:38Z",
                    "degree_proof": false,
                    "id": "4000003045",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 53,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "f2f2f3c5-9759-4201-bca7-2487751bd626",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:11:55Z",
                    "degree_proof": false,
                    "id": "4000003046",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 40,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "f30d24a0-2f2d-43be-9812-73746e91a61a",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "66678bdd-d9e1-4267-a4cf-f3beebfd7d0e",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:12:56Z",
                    "degree_proof": false,
                    "id": "4000003047",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 5,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "417a198f-03b2-417e-8505-8acf83f3059d",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:13:27Z",
                    "degree_proof": false,
                    "id": "4000003048",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 14,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "4d4116be-190d-4321-94c8-66da6d1acb11",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:13:50Z",
                    "degree_proof": false,
                    "id": "4000003049",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 7,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "cccffc77-8a54-477d-b101-01edbb244b74",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:14:09Z",
                    "degree_proof": false,
                    "id": "4000003050",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 31,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "b39a29ec-d8c7-4592-b019-d0c7ee728856",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:14:31Z",
                    "degree_proof": false,
                    "id": "4000003051",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 4,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "eca7ae7c-654b-407e-9b37-ad41ad2834b1",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:14:52Z",
                    "degree_proof": false,
                    "id": "4000003052",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 12,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 3,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "8d4e50ad-d41e-40c9-9f4d-842251c2d2d9",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:15:20Z",
                    "degree_proof": false,
                    "id": "4000003053",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 3,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "updated_at": "2021-01-25T12:16:17Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 3,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "727c6216-9122-4b12-88d1-7f8462a8cce7",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:16:00Z",
                    "degree_proof": false,
                    "id": "4000003054",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 1,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 3,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "c51ec097-d9c1-43e8-9cc7-af320ab894a1",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:17:22Z",
                    "degree_proof": false,
                    "id": "4000003055",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 4,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 3,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "171045d3-6935-423f-bdaf-b95ac441fd8e",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:17:51Z",
                    "degree_proof": false,
                    "id": "4000003056",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 3,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "f30d24a0-2f2d-43be-9812-73746e91a61a",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "ffd79a37-01ce-4d4e-8bda-950d51a56fe4",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:18:44Z",
                    "degree_proof": false,
                    "id": "4000003057",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 7,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                }
            ],
            "forum_id": "e05cfa7d-2676-46f8-a399-78655119fce8",
            "has_student_answer": false,
            "has_user_solution": false,
            "has_video_solution": false,
            "id": "4000140982",
            "labels": [
                "FINAL_ANSWER_SHEET"
            ],
            "public": true,
            "slug": "Sa-considerados-para8f24fd801",
            "solution": {
                "alternative_solutions": null,
                "author_email": "camila.moma@estrategiamed.com.br",
                "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                "brief": "",
                "brief_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "complete": "<div><b>GABARITO: ALTERNATIVA B</b></div><div><br></div>As indicaÃ§Ãµes de rastreamento para diabetes mellitus tipo 2, conforme a American Diabetes Association e a Sociedade Brasileira de Diabetes, sÃ£o:<div><br></div><div><!-- BEGIN:IMAGE_TO_REPLACE --><img src=\"https://estrategia-prod-questoes.s3.amazonaws.com/images/A7F9D3E4-0DE5-BBC9-E827-E76A37E0C0D6/A7F9D3E4-0DE5-BBC9-E827-E76A37E0C0D6-400.png\"><!-- END:IMAGE_TO_REPLACE --><br></div>",
                "complete_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "created_at": "2021-02-05 00:32:01.625551 +0000 UTC",
                "id": "b6e4571e-6c27-4571-99bd-b16f101735f8",
                "is_default": false,
                "sanitized_brief": "",
                "sanitized_complete": "GABARITO: ALTERNATIVA BAs indicaÃ§Ãµes de rastreamento para diabetes mellitus tipo 2, conforme a American Diabetes Association e a Sociedade Brasileira de Diabetes, sÃ£o:",
                "updated_at": "2021-02-05 01:44:53.872618 +0000 UTC"
            },
            "statement": "SÃ£o considerados para rastreamento do diabetes tipo 2:",
            "statement_text": "SÃ£o considerados para rastreamento do diabetes tipo 2:",
            "status": {
                "change_actor": "cnishiama@admin.admin",
                "created_at": "2021-02-05 16:31:15.863347 +0000 UTC",
                "owner": "camila.moma@estrategiamed.com.br",
                "value": "APPROVED"
            },
            "topics": [
                {
                    "has_children": false,
                    "id": "022fbdd6ba4a409ab0e705d1cb4f13ae",
                    "master_id": "e7750157ebd549b78392eee4b4b3154d",
                    "name": "Rastreamento",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Rastreamento"
                },
                {
                    "has_children": false,
                    "id": "ab6c6a1fb6604cf98243ac486f80dac8",
                    "master_id": "0a6abdce2fbc45aa8ba8f0e75875ec84",
                    "name": "Endocrinologia ",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia "
                }
            ],
            "unlisted": false,
            "video_solution": {
                "available_resolutions": null,
                "id": "",
                "identifier": "",
                "question_id": ""
            }
        },
        {
            "active": true,
            "alternatives": [
                {
                    "answer_percentage": 9,
                    "answers": 186,
                    "body": "Apenas as afirmativas II e IV estÃ£o corretas.",
                    "correct": false,
                    "created_at": "2021-04-16 02:30:34.824946 +0000 UTC",
                    "id": "125a9177-6df1-466a-9c87-808113614dd3",
                    "position": "0",
                    "sanitized_body": "Apenas as afirmativas II e IV estÃ£o corretas.",
                    "solution": {
                        "alternative_id": "125a9177-6df1-466a-9c87-808113614dd3",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<div><b>Alternativa (A) Ã© incorreta. </b>As afirmativas corretas sÃ£o I, II e IV.<br></div><div><br></div>",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-24 01:58:47.771983 +0000 UTC",
                        "id": "982be38b-323a-4604-8af5-334f86adf0c5",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (A) Ã© incorreta. As afirmativas corretas sÃ£o I, II e IV.",
                        "updated_at": "2021-05-24 03:20:20.266463 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-24 01:59:50.027277 +0000 UTC"
                },
                {
                    "answer_percentage": 74,
                    "answers": 1579,
                    "body": "Apenas as afirmativas I, II e IV estÃ£o corretas.",
                    "correct": true,
                    "created_at": "2021-04-16 02:30:34.824946 +0000 UTC",
                    "id": "2d5d54b1-5c92-44ce-b36f-c47ffe2e4623",
                    "position": "1",
                    "sanitized_body": "Apenas as afirmativas I, II e IV estÃ£o corretas.",
                    "solution": {
                        "alternative_id": "2d5d54b1-5c92-44ce-b36f-c47ffe2e4623",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (B) Ã© correta. </b>Vide comentÃ¡rio inicial.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-24 01:58:47.804107 +0000 UTC",
                        "id": "18480878-7cac-4a2d-94b3-4f7df297be13",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (B) Ã© correta. Vide comentÃ¡rio inicial.",
                        "updated_at": "2021-05-24 03:20:20.297704 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-24 01:59:50.146616 +0000 UTC"
                },
                {
                    "answer_percentage": 14,
                    "answers": 288,
                    "body": "As afirmativas I, II, III e IV estÃ£o corretas.",
                    "correct": false,
                    "created_at": "2021-04-16 02:30:34.824946 +0000 UTC",
                    "id": "ee2d16f7-c440-4b2f-8fd9-abaaf9331ed8",
                    "position": "2",
                    "sanitized_body": "As afirmativas I, II, III e IV estÃ£o corretas.",
                    "solution": {
                        "alternative_id": "ee2d16f7-c440-4b2f-8fd9-abaaf9331ed8",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (C) Ã© incorreta. </b>As afirmativas corretas sÃ£o I, II e IV.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-24 01:58:47.754026 +0000 UTC",
                        "id": "f430232e-6f9e-4bdc-a142-31c73df8dd6b",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (C) Ã© incorreta. As afirmativas corretas sÃ£o I, II e IV.",
                        "updated_at": "2021-05-24 03:20:20.306975 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-24 01:59:50.242695 +0000 UTC"
                },
                {
                    "answer_percentage": 4,
                    "answers": 78,
                    "body": "Apenas as afirmativas II e III estÃ£o corretas.",
                    "correct": false,
                    "created_at": "2021-04-16 02:30:34.824946 +0000 UTC",
                    "id": "9bcd25e8-e73b-4a7f-a749-cb5febe77cbf",
                    "position": "3",
                    "sanitized_body": "Apenas as afirmativas II e III estÃ£o corretas.",
                    "solution": {
                        "alternative_id": "9bcd25e8-e73b-4a7f-a749-cb5febe77cbf",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (D) Ã© incorreta. </b>As afirmativas corretas sÃ£o I, II e IV.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-24 01:58:47.726171 +0000 UTC",
                        "id": "a26ecc32-a7b3-4e15-a505-6294a715d366",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (D) Ã© incorreta. As afirmativas corretas sÃ£o I, II e IV.",
                        "updated_at": "2021-05-24 03:20:20.290602 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-24 01:59:50.358644 +0000 UTC"
                }
            ],
            "answer_type": "MULTIPLE_CHOICE",
            "author_id": "bruno-cesar110@hotmail.com",
            "correct_answer_percentage": 74,
            "created_at": "2021-04-16 02:30:34.824946 +0000 UTC",
            "difficulty_level": "MEDIUM",
            "exams": [
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5df92204-9354-4676-994d-573306d752c8",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "046f0505-90c9-4862-b318-388c0d1e8026",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-15T21:31:29Z",
                    "degree_proof": false,
                    "id": "4000003762",
                    "location": {
                        "id": "2"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "0DEB44B4-8340-9747-5FA5-18571D181FC2"
                        }
                    ],
                    "questions_number": 0,
                    "scholarity": "placeholder",
                    "subscription_fee": 350,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5df92204-9354-4676-994d-573306d752c8",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "32bef8bd-8aac-4ede-aede-06b9458b026b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-15T21:31:50Z",
                    "degree_proof": false,
                    "id": "4000003763",
                    "location": {
                        "id": "2"
                    },
                    "number": 1,
                    "open_spaces": 4,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "0DEB44B4-8340-9747-5FA5-18571D181FC2"
                        }
                    ],
                    "questions_number": 0,
                    "scholarity": "placeholder",
                    "subscription_fee": 350,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5df92204-9354-4676-994d-573306d752c8",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "dfa90599-1ee1-4de3-8605-a75ecd3799bd",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-15T21:32:06Z",
                    "degree_proof": false,
                    "id": "4000003764",
                    "location": {
                        "id": "2"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "0DEB44B4-8340-9747-5FA5-18571D181FC2"
                        }
                    ],
                    "questions_number": 0,
                    "scholarity": "placeholder",
                    "subscription_fee": 350,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5df92204-9354-4676-994d-573306d752c8",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "9b34a94d-754d-4510-8bad-60f649fa825b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-15T21:32:26Z",
                    "degree_proof": false,
                    "id": "4000003765",
                    "location": {
                        "id": "2"
                    },
                    "number": 1,
                    "open_spaces": 6,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "0DEB44B4-8340-9747-5FA5-18571D181FC2"
                        }
                    ],
                    "questions_number": 0,
                    "scholarity": "placeholder",
                    "subscription_fee": 350,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5df92204-9354-4676-994d-573306d752c8",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "2ca62942-4eab-49e5-acaf-e395254eee99",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-15T21:32:39Z",
                    "degree_proof": false,
                    "id": "4000003766",
                    "location": {
                        "id": "2"
                    },
                    "number": 1,
                    "open_spaces": 3,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "0DEB44B4-8340-9747-5FA5-18571D181FC2"
                        }
                    ],
                    "questions_number": 0,
                    "scholarity": "placeholder",
                    "subscription_fee": 350,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5df92204-9354-4676-994d-573306d752c8",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "dcb47678-bdba-4669-aa0e-01f71e32541b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-15T21:32:54Z",
                    "degree_proof": false,
                    "id": "4000003767",
                    "location": {
                        "id": "2"
                    },
                    "number": 1,
                    "open_spaces": 20,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "0DEB44B4-8340-9747-5FA5-18571D181FC2"
                        }
                    ],
                    "questions_number": 0,
                    "scholarity": "placeholder",
                    "subscription_fee": 350,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5df92204-9354-4676-994d-573306d752c8",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "0609ccdb-db5c-4c47-a306-31a0a655e95c",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-15T21:33:12Z",
                    "degree_proof": false,
                    "id": "4000003768",
                    "location": {
                        "id": "2"
                    },
                    "number": 1,
                    "open_spaces": 5,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "0DEB44B4-8340-9747-5FA5-18571D181FC2"
                        }
                    ],
                    "questions_number": 0,
                    "scholarity": "placeholder",
                    "subscription_fee": 350,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5df92204-9354-4676-994d-573306d752c8",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "f2f2f3c5-9759-4201-bca7-2487751bd626",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-15T21:33:23Z",
                    "degree_proof": false,
                    "id": "4000003769",
                    "location": {
                        "id": "2"
                    },
                    "number": 1,
                    "open_spaces": 3,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "0DEB44B4-8340-9747-5FA5-18571D181FC2"
                        }
                    ],
                    "questions_number": 0,
                    "scholarity": "placeholder",
                    "subscription_fee": 350,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "5df92204-9354-4676-994d-573306d752c8",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "710b6098-b1cc-40fb-a6e9-1978c156b947",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-15T21:33:38Z",
                    "degree_proof": false,
                    "id": "4000003770",
                    "location": {
                        "id": "2"
                    },
                    "number": 1,
                    "open_spaces": 7,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "0DEB44B4-8340-9747-5FA5-18571D181FC2"
                        }
                    ],
                    "questions_number": 0,
                    "scholarity": "placeholder",
                    "subscription_fee": 350,
                    "year": 2021
                }
            ],
            "forum_id": "240beb7a-6c57-4435-88eb-826e8e205dac",
            "has_student_answer": false,
            "has_user_solution": false,
            "has_video_solution": true,
            "id": "4000144427",
            "labels": [
                "FINAL_ANSWER_SHEET"
            ],
            "public": true,
            "slug": "metformina-e11715a77017",
            "solution": {
                "alternative_solutions": null,
                "author_email": "camila.moma@estrategiamed.com.br",
                "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                "brief": "",
                "brief_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "complete": "<b>Gabarito: alternativa (B).</b><div><b>ComentÃ¡rios:</b></div><div><br></div><div>Vamos analisar cada afirmativa:</div><div><b>A afirmativa I </b>âO uso prolongado de metformina pode estar associado Ã  deficiÃªncia bioquÃ­mica de vitamina B12â <b>Ã© correta. </b>A metformina pode diminuir a absorÃ§Ã£o da vitamina B12, portanto, Ã© importante monitorar seus nÃ­veis, uma vez que sua deficiÃªncia gera sintomas neurolÃ³gicos que podem se confundir com a neuropatia perifÃ©rica diabÃ©tica (como perda de forÃ§a, parestesias).</div><div><b>A afirmativa II </b>âA metformina Ã© o agente farmacolÃ³gico inicial preferencial para o tratamento do diabetes tipo 2â <b>Ã© correta. </b>A metformina Ã© a primeira escolha de tratamento para pacientes com diabetes mellitus tipo 2 devido a sua eficÃ¡cia, tolerabilidade, seguranÃ§a e baixo custo. Promove melhora da resistÃªncia Ã  insulina no fÃ­gado, reduzindo a produÃ§Ã£o hepÃ¡tica de glicose. TambÃ©m aumenta a utilizaÃ§Ã£o de glicose pelo intestino, colaborando para o controle glicÃªmico. NÃ£o causa hipoglicemia nem ganho ponderal e hÃ¡ dados mostrando benefÃ­cio cardiovascular quando comparada Ã s sulfonilureias e insulina.</div><div><b>A afirmativa III</b> âUma vez iniciada, a metformina deve ser continuada desde que seja tolerada e nÃ£o contraindicada; outros agentes, exceto a insulina, podem ser adicionados Ã  metforminaâ <b>Ã© incorreta.</b> Uma vez que o paciente nÃ£o atinja as metas de controle glicÃªmico (para adultos nÃ£o fragilizados, a meta Ã© hemoglobina glicada &lt; 7%), devemos associar outras drogas para diminuir o risco de complicaÃ§Ãµes relacionadas Ã  hiperglicemia crÃ´nica.</div><div><b>A afirmativa IV </b>âA terapÃªutica com metformina para prevenÃ§Ã£o da diabetes tipo 2 deve ser considerada em indivÃ­duos com prÃ©-diabetes, especialmente para aqueles com IMC â¥ 35 kg/m2, aqueles com idade &lt; 60 anos, e mulheres com diabetes mellitus gestacional prÃ©vioâ <b>Ã© correta.</b> O principal tratamento em indivÃ­duos com prÃ©-diabetes sÃ£o as modificaÃ§Ãµes de estilo de vida (readequaÃ§Ã£o dietÃ©tica e prÃ¡tica de atividade fÃ­sica) associadas Ã  perda ponderal significativa (pelo menos, 7% do peso inicial). Entretanto, em determinados pacientes, o uso da metformina pode auxiliar na prevenÃ§Ã£o do diabetes mellitus, sendo candidatos ao uso da medicaÃ§Ã£o, segundo as diretrizes da <i>American Diabetes Association</i>:</div><div>â¢\tPacientes com IMC â¥ 35 kg/m2;</div><div>â¢\tAntecedente pessoal de diabetes gestacional;</div><div>â¢\tIdade &lt; 60 anos.</div><div><br></div>",
                "complete_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "created_at": "2021-05-24 01:58:48.026396 +0000 UTC",
                "id": "4b20a9a0-c84f-4768-8dcc-718424fd34a0",
                "is_default": false,
                "sanitized_brief": "",
                "sanitized_complete": "Gabarito: alternativa (B).ComentÃ¡rios:Vamos analisar cada afirmativa:A afirmativa I âO uso prolongado de metformina pode estar associado Ã  deficiÃªncia bioquÃ­mica de vitamina B12â Ã© correta. A metformina pode diminuir a absorÃ§Ã£o da vitamina B12, portanto, Ã© importante monitorar seus nÃ­veis, uma vez que sua deficiÃªncia gera sintomas neurolÃ³gicos que podem se confundir com a neuropatia perifÃ©rica diabÃ©tica (como perda de forÃ§a, parestesias).A afirmativa II âA metformina Ã© o agente farmacolÃ³gico inicial preferencial para o tratamento do diabetes tipo 2â Ã© correta. A metformina Ã© a primeira escolha de tratamento para pacientes com diabetes mellitus tipo 2 devido a sua eficÃ¡cia, tolerabilidade, seguranÃ§a e baixo custo. Promove melhora da resistÃªncia Ã  insulina no fÃ­gado, reduzindo a produÃ§Ã£o hepÃ¡tica de glicose. TambÃ©m aumenta a utilizaÃ§Ã£o de glicose pelo intestino, colaborando para o controle glicÃªmico. NÃ£o causa hipoglicemia nem ganho ponderal e hÃ¡ dados mostrando benefÃ­cio cardiovascular quando comparada Ã s sulfonilureias e insulina.A afirmativa III âUma vez iniciada, a metformina deve ser continuada desde que seja tolerada e nÃ£o contraindicada; outros agentes, exceto a insulina, podem ser adicionados Ã  metforminaâ Ã© incorreta. Uma vez que o paciente nÃ£o atinja as metas de controle glicÃªmico (para adultos nÃ£o fragilizados, a meta Ã© hemoglobina glicada &lt; 7%), devemos associar outras drogas para diminuir o risco de complicaÃ§Ãµes relacionadas Ã  hiperglicemia crÃ´nica.A afirmativa IV âA terapÃªutica com metformina para prevenÃ§Ã£o da diabetes tipo 2 deve ser considerada em indivÃ­duos com prÃ©-diabetes, especialmente para aqueles com IMC â¥ 35 kg/m2, aqueles com idade &lt; 60 anos, e mulheres com diabetes mellitus gestacional prÃ©vioâ Ã© correta. O principal tratamento em indivÃ­duos com prÃ©-diabetes sÃ£o as modificaÃ§Ãµes de estilo de vida (readequaÃ§Ã£o dietÃ©tica e prÃ¡tica de atividade fÃ­sica) associadas Ã  perda ponderal significativa (pelo menos, 7% do peso inicial). Entretanto, em determinados pacientes, o uso da metformina pode auxiliar na prevenÃ§Ã£o do diabetes mellitus, sendo candidatos ao uso da medicaÃ§Ã£o, segundo as diretrizes da American Diabetes Association:â¢\tPacientes com IMC â¥ 35 kg/m2;â¢\tAntecedente pessoal de diabetes gestacional;â¢\tIdade &lt; 60 anos.",
                "updated_at": "2021-05-24 03:20:20.381933 +0000 UTC",
                "video_solution_id": "5f2e9808-d85e-4ec2-8fc6-10f7dc58b943"
            },
            "statement": "A metformina Ã© um hipoglicemiante oral amplamente utilizado no tratamento farmacolÃ³gico do diabetes mellitus tipo 2. Analise as afirmativas abaixo e assinale a alternativa correta.&nbsp;<div>I. O uso prolongado de metformina pode estar associado Ã  deficiÃªncia bioquÃ­mica de vitamina B12.&nbsp;</div><div>II. A metformina Ã© o agente farmacolÃ³gico inicial preferencial para o tratamento do diabetes tipo 2.&nbsp;</div><div>III. Uma vez iniciada, a metformina deve ser continuada desde que seja tolerada e nÃ£o contraindicada; outros agentes, exceto a insulina, podem ser adicionados Ã  metformina.&nbsp;</div><div>IV. A terapÃªutica com metformina para prevenÃ§Ã£o da diabetes tipo 2 deve ser considerada em indivÃ­duos com prÃ©-diabetes, especialmente para aqueles com IMC â¥ 35 kg/m2, aqueles com idade &lt; 60 anos, e mulheres com diabetes mellitus gestacional prÃ©vio.</div>",
            "statement_text": "A metformina Ã© um hipoglicemiante oral amplamente utilizado no tratamento farmacolÃ³gico do diabetes mellitus tipo 2. Analise as afirmativas abaixo e assinale a alternativa correta.Â I. O uso prolongado de metformina pode estar associado Ã  deficiÃªncia bioquÃ­mica de vitamina B12.Â II. A metformina Ã© o agente farmacolÃ³gico inicial preferencial para o tratamento do diabetes tipo 2.Â III. Uma vez iniciada, a metformina deve ser continuada desde que seja tolerada e nÃ£o contraindicada; outros agentes, exceto a insulina, podem ser adicionados Ã  metformina.Â IV. A terapÃªutica com metformina para prevenÃ§Ã£o da diabetes tipo 2 deve ser considerada em indivÃ­duos com prÃ©-diabetes, especialmente para aqueles com IMC â¥ 35 kg/m2, aqueles com idade &lt; 60 anos, e mulheres com diabetes mellitus gestacional prÃ©vio.",
            "status": {
                "change_actor": "cnishiama@admin.admin",
                "created_at": "2021-05-24 22:57:10.493266 +0000 UTC",
                "owner": "camila.moma@estrategiamed.com.br",
                "value": "APPROVED"
            },
            "topics": [
                {
                    "has_children": false,
                    "id": "51912f5f3d3249d9bf9ce18407f82cf0",
                    "master_id": "e7750157ebd549b78392eee4b4b3154d",
                    "name": "PrevenÃ§Ã£o",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]PrevenÃ§Ã£o"
                },
                {
                    "has_children": false,
                    "id": "ab6c6a1fb6604cf98243ac486f80dac8",
                    "master_id": "0a6abdce2fbc45aa8ba8f0e75875ec84",
                    "name": "Endocrinologia ",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia "
                },
                {
                    "has_children": false,
                    "id": "d53b61e527fa4a61b5a22bb715b8d0f8",
                    "master_id": "8bdc1fbeb2e54046a2c3ba4ac4e63ead",
                    "name": "Biguanida (metformina)",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Tratamento[$$]Tratamento medicamentoso[$$]Drogas antidiabÃ©ticas nÃ£o insulina[$$]MedicaÃ§Ãµes com efeito sensibilizador de insulina[$$]Biguanida (metformina)"
                }
            ],
            "unlisted": false,
            "video_solution": {
                "available_resolutions": [
                    {
                        "resolution": "720",
                        "url": "https://api.estrategia.com/questoes/sign/medicina/processadas/4000144427-720.mp4"
                    }
                ],
                "id": "5f2e9808-d85e-4ec2-8fc6-10f7dc58b943",
                "identifier": "",
                "question_id": "4000144427"
            },
            "video_solution_id": "5f2e9808-d85e-4ec2-8fc6-10f7dc58b943"
        },
        {
            "active": true,
            "alternatives": [
                {
                    "answer_percentage": 3,
                    "answers": 166,
                    "body": "alimentos sem gordura.",
                    "correct": false,
                    "created_at": "2021-01-25 12:38:58.372767 +0000 UTC",
                    "id": "1166b728-d880-4ddc-a5c2-eb831a5a4272",
                    "position": "0",
                    "sanitized_body": "alimentos sem gordura.",
                    "solution": {
                        "alternative_id": "1166b728-d880-4ddc-a5c2-eb831a5a4272",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "Incorreta a alternativa A. NÃ£o hÃ¡ dados que mostrem que a restriÃ§Ã£o de gorduras se correlaciona com melhora no controle glicÃªmico. A orientaÃ§Ã£o a ser mantida Ã© a restriÃ§Ã£o das gorduras saturadas (no mÃ¡ximo, atÃ© 10% do VET), visto que se correlacionam com piores desfechos cardiovasculares.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-02-05 00:36:07.924326 +0000 UTC",
                        "id": "52dfbc65-8d1c-4099-ba8f-62e59aeb9167",
                        "sanitized_brief": "",
                        "sanitized_complete": "Incorreta a alternativa A. NÃ£o hÃ¡ dados que mostrem que a restriÃ§Ã£o de gorduras se correlaciona com melhora no controle glicÃªmico. A orientaÃ§Ã£o a ser mantida Ã© a restriÃ§Ã£o das gorduras saturadas (no mÃ¡ximo, atÃ© 10% do VET), visto que se correlacionam com piores desfechos cardiovasculares.",
                        "updated_at": "2021-02-05 01:45:27.537064 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2024-03-21 12:51:57.803168 +0000 UTC"
                },
                {
                    "answer_percentage": 88,
                    "answers": 4602,
                    "body": "alimentos ricos em fibras.",
                    "correct": true,
                    "created_at": "2021-01-25 12:38:58.372767 +0000 UTC",
                    "id": "298963df-9e85-444a-bb2b-524e06c4b109",
                    "position": "1",
                    "sanitized_body": "alimentos ricos em fibras.",
                    "solution": {
                        "alternative_id": "298963df-9e85-444a-bb2b-524e06c4b109",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "Correta a alternativa B A maior quantidade de fibras na dieta para indivÃ­duos diabÃ©ticos advÃ©m do fato de que elas retardam a absorÃ§Ã£o intestinal de carboidratos, diminuindo o pico hiperglicÃªmico pÃ³s prandial. AlÃ©m disso, as fibras aumentam a saciedade, o que Ã© importante para auxiliar no controle do peso",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-02-05 00:36:07.924442 +0000 UTC",
                        "id": "17ee9ddf-060f-4673-97d8-e42b034398c1",
                        "sanitized_brief": "",
                        "sanitized_complete": "Correta a alternativa B A maior quantidade de fibras na dieta para indivÃ­duos diabÃ©ticos advÃ©m do fato de que elas retardam a absorÃ§Ã£o intestinal de carboidratos, diminuindo o pico hiperglicÃªmico pÃ³s prandial. AlÃ©m disso, as fibras aumentam a saciedade, o que Ã© importante para auxiliar no controle do peso",
                        "updated_at": "2021-02-05 01:45:27.542699 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2024-03-21 12:51:58.178365 +0000 UTC"
                },
                {
                    "answer_percentage": 6,
                    "answers": 290,
                    "body": "corte total de Ã¡lcool.",
                    "correct": false,
                    "created_at": "2021-01-25 12:38:58.372767 +0000 UTC",
                    "id": "5e2fed9b-c19e-4476-835e-7854e04dc7dc",
                    "position": "2",
                    "sanitized_body": "corte total de Ã¡lcool.",
                    "solution": {
                        "alternative_id": "5e2fed9b-c19e-4476-835e-7854e04dc7dc",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "Incorreta a alternativa C. A ingesta moderada de Ã¡lcool nÃ£o causa maiores prejuÃ­zos no controle glicÃªmico. PorÃ©m, cabe lembrar que hÃ¡ maior risco de hipoglicemia com seu uso, principalmente em pacientes que utilizam insulina ou secretagogos de insulina, como as sulfonilureias e as glinidas. Nos pacientes com ingesta muito aumentada de Ã¡lcool, ocorre ganho de peso e hiperglicemia.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-02-05 00:36:07.92448 +0000 UTC",
                        "id": "9d48399f-b0de-4083-abf6-c5566ef4d1af",
                        "sanitized_brief": "",
                        "sanitized_complete": "Incorreta a alternativa C. A ingesta moderada de Ã¡lcool nÃ£o causa maiores prejuÃ­zos no controle glicÃªmico. PorÃ©m, cabe lembrar que hÃ¡ maior risco de hipoglicemia com seu uso, principalmente em pacientes que utilizam insulina ou secretagogos de insulina, como as sulfonilureias e as glinidas. Nos pacientes com ingesta muito aumentada de Ã¡lcool, ocorre ganho de peso e hiperglicemia.",
                        "updated_at": "2021-02-05 01:45:27.542869 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2024-03-21 12:51:58.609654 +0000 UTC"
                },
                {
                    "answer_percentage": 2,
                    "answers": 81,
                    "body": "corte total de carboidratos.",
                    "correct": false,
                    "created_at": "2021-01-25 12:38:58.372767 +0000 UTC",
                    "id": "35c952ab-5f0c-4f00-8cfe-e053c895eca4",
                    "position": "3",
                    "sanitized_body": "corte total de carboidratos.",
                    "solution": {
                        "alternative_id": "35c952ab-5f0c-4f00-8cfe-e053c895eca4",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "Incorreta a alternativa D. Apesar de as dietas <i>low carb</i> serem correlacionadas Ã  melhora do controle glicÃªmico, a adesÃ£o a longo prazo Ã© baixa, pois nÃ£o respeita individualidades dietÃ©ticas. HÃ¡ diversos tipos de dietas<i> low carb</i>, cujo conceito Ã© que se tenha &lt; 55% do VET em carboidratos, sendo mais restritivas as dietas cetogÃªnicas, com &lt; 10% VET.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-02-05 00:36:07.933065 +0000 UTC",
                        "id": "4d0a1574-c362-43e0-8aed-fa47e81e41ae",
                        "sanitized_brief": "",
                        "sanitized_complete": "Incorreta a alternativa D. Apesar de as dietas low carb serem correlacionadas Ã  melhora do controle glicÃªmico, a adesÃ£o a longo prazo Ã© baixa, pois nÃ£o respeita individualidades dietÃ©ticas. HÃ¡ diversos tipos de dietas low carb, cujo conceito Ã© que se tenha &lt; 55% do VET em carboidratos, sendo mais restritivas as dietas cetogÃªnicas, com &lt; 10% VET.",
                        "updated_at": "2021-02-05 01:45:27.569789 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2024-03-21 12:51:59.051592 +0000 UTC"
                },
                {
                    "answer_percentage": 1,
                    "answers": 78,
                    "body": "ingestÃ£o de alimentos 3 vezes por dia, no mÃ¡ximo.",
                    "correct": false,
                    "created_at": "2021-01-25 12:38:58.372767 +0000 UTC",
                    "id": "c6155b3e-9f06-488c-85ff-bdf8c57518f0",
                    "position": "4",
                    "sanitized_body": "ingestÃ£o de alimentos 3 vezes por dia, no mÃ¡ximo.",
                    "solution": {
                        "alternative_id": "c6155b3e-9f06-488c-85ff-bdf8c57518f0",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "Incorreta a alternativa E. NÃ£o hÃ¡ dados que suportem o nÃºmero de refeiÃ§Ãµes relacionado a melhores desfechos glicÃªmicos a longo prazo. Essa ideia vem do fato de que os pacientes com diabetes mellitus deveriam se alimentar mais frequentemente pelo risco de hipoglicemias. Entretanto, com as drogas antidiabÃ©ticas atuais e os anÃ¡logos de insulina, hÃ¡ menor risco de hipoglicemias, enfraquecendo tal conceito em relaÃ§Ã£o Ã  dieta.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-02-05 00:36:07.933877 +0000 UTC",
                        "id": "a152af98-bb17-4450-8ba8-bb5c63dadf13",
                        "sanitized_brief": "",
                        "sanitized_complete": "Incorreta a alternativa E. NÃ£o hÃ¡ dados que suportem o nÃºmero de refeiÃ§Ãµes relacionado a melhores desfechos glicÃªmicos a longo prazo. Essa ideia vem do fato de que os pacientes com diabetes mellitus deveriam se alimentar mais frequentemente pelo risco de hipoglicemias. Entretanto, com as drogas antidiabÃ©ticas atuais e os anÃ¡logos de insulina, hÃ¡ menor risco de hipoglicemias, enfraquecendo tal conceito em relaÃ§Ã£o Ã  dieta.",
                        "updated_at": "2021-02-05 01:45:27.557294 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2024-03-21 12:51:59.409495 +0000 UTC"
                }
            ],
            "answer_type": "MULTIPLE_CHOICE",
            "author_id": "bruno-cesar110@hotmail.com",
            "correct_answer_percentage": 88,
            "created_at": "2021-01-25 12:38:58.372767 +0000 UTC",
            "difficulty_level": "MEDIUM",
            "exams": [
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "9b34a94d-754d-4510-8bad-60f649fa825b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:03:06Z",
                    "degree_proof": false,
                    "id": "4000003036",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 98,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "dfa90599-1ee1-4de3-8605-a75ecd3799bd",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:03:45Z",
                    "degree_proof": false,
                    "id": "4000003037",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 77,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "32bef8bd-8aac-4ede-aede-06b9458b026b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:08:01Z",
                    "degree_proof": false,
                    "id": "4000003038",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 8,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "710b6098-b1cc-40fb-a6e9-1978c156b947",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:08:28Z",
                    "degree_proof": false,
                    "id": "4000003039",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 44,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "0609ccdb-db5c-4c47-a306-31a0a655e95c",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:08:57Z",
                    "degree_proof": false,
                    "id": "4000003040",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 66,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "dcb47678-bdba-4669-aa0e-01f71e32541b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:10:05Z",
                    "degree_proof": false,
                    "id": "4000003041",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 3,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "25b55daa-bd57-453d-9099-8c9dfe6d622a",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:10:32Z",
                    "degree_proof": false,
                    "id": "4000003042",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 3,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "2ca62942-4eab-49e5-acaf-e395254eee99",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:10:50Z",
                    "degree_proof": false,
                    "id": "4000003043",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 27,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "776b092f-eb41-4150-a252-b23a0f7914b3",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:11:22Z",
                    "degree_proof": false,
                    "id": "4000003044",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 22,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "046f0505-90c9-4862-b318-388c0d1e8026",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:11:38Z",
                    "degree_proof": false,
                    "id": "4000003045",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 53,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "f2f2f3c5-9759-4201-bca7-2487751bd626",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:11:55Z",
                    "degree_proof": false,
                    "id": "4000003046",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 40,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "f30d24a0-2f2d-43be-9812-73746e91a61a",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "66678bdd-d9e1-4267-a4cf-f3beebfd7d0e",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:12:56Z",
                    "degree_proof": false,
                    "id": "4000003047",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 5,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "417a198f-03b2-417e-8505-8acf83f3059d",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:13:27Z",
                    "degree_proof": false,
                    "id": "4000003048",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 14,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "4d4116be-190d-4321-94c8-66da6d1acb11",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:13:50Z",
                    "degree_proof": false,
                    "id": "4000003049",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 7,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "cccffc77-8a54-477d-b101-01edbb244b74",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:14:09Z",
                    "degree_proof": false,
                    "id": "4000003050",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 31,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "b39a29ec-d8c7-4592-b019-d0c7ee728856",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:14:31Z",
                    "degree_proof": false,
                    "id": "4000003051",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 4,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "eca7ae7c-654b-407e-9b37-ad41ad2834b1",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:14:52Z",
                    "degree_proof": false,
                    "id": "4000003052",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 12,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 3,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "8d4e50ad-d41e-40c9-9f4d-842251c2d2d9",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:15:20Z",
                    "degree_proof": false,
                    "id": "4000003053",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 3,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "updated_at": "2021-01-25T12:16:17Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 3,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "727c6216-9122-4b12-88d1-7f8462a8cce7",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:16:00Z",
                    "degree_proof": false,
                    "id": "4000003054",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 1,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 3,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "c51ec097-d9c1-43e8-9cc7-af320ab894a1",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:17:22Z",
                    "degree_proof": false,
                    "id": "4000003055",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 4,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 3,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "171045d3-6935-423f-bdaf-b95ac441fd8e",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:17:51Z",
                    "degree_proof": false,
                    "id": "4000003056",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 3,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "f30d24a0-2f2d-43be-9812-73746e91a61a",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "ffd79a37-01ce-4d4e-8bda-950d51a56fe4",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:18:44Z",
                    "degree_proof": false,
                    "id": "4000003057",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 7,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                }
            ],
            "forum_id": "d8b09525-9233-42f7-89fa-7398addc615a",
            "has_student_answer": false,
            "has_user_solution": false,
            "has_video_solution": false,
            "id": "4000140983",
            "labels": [
                "FINAL_ANSWER_SHEET"
            ],
            "public": true,
            "slug": "terapia-nutricional11a5606ce5",
            "solution": {
                "alternative_solutions": null,
                "author_email": "camila.moma@estrategiamed.com.br",
                "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                "brief": "",
                "brief_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "complete": "<b>GABARITO: ALTERNATIVA B</b><div><b><br></b></div><div>A terapia nutricional em indivÃ­duos diabÃ©ticos deve ser individualizada, a fim de que as orientaÃ§Ãµes sejam seguidas e mantidas ao longo do tempo. Em geral, a dieta deve manter o equilÃ­brio entre os macronutrientes, sendo semelhante Ã  da populaÃ§Ã£o em geral: 45-60% de carboidratos, 15-20% de proteÃ­nas e 20-30% de gorduras. As principais diferenÃ§as sÃ£o:</div><div><br></div><div>â¢ ComposiÃ§Ã£o dos carboidratos, com preferÃªncia para aqueles de baixo Ã­ndice glicÃªmico, alÃ©m da restriÃ§Ã£o de sacarose a 5% -10% do valor energÃ©tico total (VET). TambÃ©m nÃ£o se recomenda adiÃ§Ã£o de frutose aos alimentos;</div><div><br></div><div>â¢ LimitaÃ§Ã£o da quantidade de gorduras saturadas a 10% do VET;</div><div><br></div><div>â¢ Quantidade maior de fibras (20g para cada 1000kcal). As fibras retardam a velocidade de absorÃ§Ã£o intestinal dos carboidratos, diminuindo o pico hiperglicÃªmico pÃ³s prandial. AlÃ©m disso, promovem maior saciaÃ§Ã£o, contribuindo para a manutenÃ§Ã£o ou, atÃ© mesmo, perda de peso.</div>",
                "complete_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "created_at": "2021-02-05 00:36:08.137723 +0000 UTC",
                "id": "65ae0ace-55c9-4877-a1ec-964a298be3f5",
                "is_default": false,
                "sanitized_brief": "",
                "sanitized_complete": "GABARITO: ALTERNATIVA BA terapia nutricional em indivÃ­duos diabÃ©ticos deve ser individualizada, a fim de que as orientaÃ§Ãµes sejam seguidas e mantidas ao longo do tempo. Em geral, a dieta deve manter o equilÃ­brio entre os macronutrientes, sendo semelhante Ã  da populaÃ§Ã£o em geral: 45-60% de carboidratos, 15-20% de proteÃ­nas e 20-30% de gorduras. As principais diferenÃ§as sÃ£o:â¢ ComposiÃ§Ã£o dos carboidratos, com preferÃªncia para aqueles de baixo Ã­ndice glicÃªmico, alÃ©m da restriÃ§Ã£o de sacarose a 5% -10% do valor energÃ©tico total (VET). TambÃ©m nÃ£o se recomenda adiÃ§Ã£o de frutose aos alimentos;â¢ LimitaÃ§Ã£o da quantidade de gorduras saturadas a 10% do VET;â¢ Quantidade maior de fibras (20g para cada 1000kcal). As fibras retardam a velocidade de absorÃ§Ã£o intestinal dos carboidratos, diminuindo o pico hiperglicÃªmico pÃ³s prandial. AlÃ©m disso, promovem maior saciaÃ§Ã£o, contribuindo para a manutenÃ§Ã£o ou, atÃ© mesmo, perda de peso.",
                "updated_at": "2021-02-05 01:45:27.747128 +0000 UTC"
            },
            "statement": "A terapia nutricional de uma pessoa com diabetes tipo 2 inclui:",
            "statement_text": "A terapia nutricional de uma pessoa com diabetes tipo 2 inclui:",
            "status": {
                "change_actor": "cnishiama@admin.admin",
                "created_at": "2021-02-05 16:31:12.176077 +0000 UTC",
                "owner": "camila.moma@estrategiamed.com.br",
                "value": "APPROVED"
            },
            "topics": [
                {
                    "has_children": false,
                    "id": "9b23b048c1e34392b641792b33bf2a9a",
                    "master_id": "f8ca00708dc64fb2a95e840b4337a434",
                    "name": "OrientaÃ§Ãµes nutricionais no diabetes mellitus tipo 2",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Tratamento[$$]Tratamento nÃ£o medicamentoso[$$]OrientaÃ§Ãµes nutricionais no diabetes mellitus tipo 2"
                }
            ],
            "unlisted": false,
            "video_solution": {
                "available_resolutions": null,
                "id": "",
                "identifier": "",
                "question_id": ""
            }
        },
        {
            "active": true,
            "alternatives": [
                {
                    "answer_percentage": 1,
                    "answers": 55,
                    "body": "glinidas.",
                    "correct": false,
                    "created_at": "2021-04-20 17:48:02.011425 +0000 UTC",
                    "id": "b7e1a799-43b8-417e-adec-a2c05f5f4a05",
                    "position": "0",
                    "sanitized_body": "glinidas.",
                    "solution": {
                        "alternative_id": "b7e1a799-43b8-417e-adec-a2c05f5f4a05",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (A) Ã© incorreta</b>. As glinidas sÃ£o secretagogos de insulina, isto Ã©, promovem a secreÃ§Ã£o de insulina, porÃ©m de forma independente dos nÃ­veis glicÃªmicos, o que aumenta o risco de hipoglicemias. NÃ£o hÃ¡ benefÃ­cios extraglicÃªmicos em relaÃ§Ã£o ao risco cardiovascular.<div>- Glinidas: repaglinida, nateglinida.</div>",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-31 03:19:05.60802 +0000 UTC",
                        "id": "e9802f6f-0f2d-4825-beb3-d4f49dd1204a",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (A) Ã© incorreta. As glinidas sÃ£o secretagogos de insulina, isto Ã©, promovem a secreÃ§Ã£o de insulina, porÃ©m de forma independente dos nÃ­veis glicÃªmicos, o que aumenta o risco de hipoglicemias. NÃ£o hÃ¡ benefÃ­cios extraglicÃªmicos em relaÃ§Ã£o ao risco cardiovascular.- Glinidas: repaglinida, nateglinida.",
                        "updated_at": "2021-05-31 03:19:08.319445 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-31 02:48:35.90312 +0000 UTC"
                },
                {
                    "answer_percentage": 3,
                    "answers": 156,
                    "body": "sulfonilureias.",
                    "correct": false,
                    "created_at": "2021-04-20 17:48:02.011425 +0000 UTC",
                    "id": "4ca224e7-5ce2-474b-962f-80c3997bc908",
                    "position": "1",
                    "sanitized_body": "sulfonilureias.",
                    "solution": {
                        "alternative_id": "4ca224e7-5ce2-474b-962f-80c3997bc908",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (B) Ã© incorreta. </b>Da mesma maneira que as glinidas, as sulfonilureias se ligam a receptores especÃ­ficos nas cÃ©lulas beta pancreÃ¡ticas, levando Ã  despolarizaÃ§Ã£o da membrana celular, o que culmina com a entrada de cÃ¡lcio no citoplasma e consequente secreÃ§Ã£o dos grÃ¢nulos de insulina. Tal aÃ§Ã£o ocorre de forma independente dos nÃ­veis glicÃªmicos, o que aumenta o risco de hipoglicemias. NÃ£o hÃ¡ benefÃ­cios em relaÃ§Ã£o ao risco cardiovascular.<div><br><div>-Sulfonilureias: glibenclamida, gliclazida, glimepirida, Clorpropamida, glipizida.</div><div><br></div></div>",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-31 03:19:05.599948 +0000 UTC",
                        "id": "0b3c5116-d3b4-4638-a428-bfbe8e0c2950",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (B) Ã© incorreta. Da mesma maneira que as glinidas, as sulfonilureias se ligam a receptores especÃ­ficos nas cÃ©lulas beta pancreÃ¡ticas, levando Ã  despolarizaÃ§Ã£o da membrana celular, o que culmina com a entrada de cÃ¡lcio no citoplasma e consequente secreÃ§Ã£o dos grÃ¢nulos de insulina. Tal aÃ§Ã£o ocorre de forma independente dos nÃ­veis glicÃªmicos, o que aumenta o risco de hipoglicemias. NÃ£o hÃ¡ benefÃ­cios em relaÃ§Ã£o ao risco cardiovascular.-Sulfonilureias: glibenclamida, gliclazida, glimepirida, Clorpropamida, glipizida.",
                        "updated_at": "2021-05-31 03:19:08.337914 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-31 02:48:36.039239 +0000 UTC"
                },
                {
                    "answer_percentage": 91,
                    "answers": 4217,
                    "body": "inibidores de SGLT-2.",
                    "correct": true,
                    "created_at": "2021-04-20 17:48:02.011425 +0000 UTC",
                    "id": "6b322386-2869-4ca4-8b4a-6d0964beccce",
                    "position": "2",
                    "sanitized_body": "inibidores de SGLT-2.",
                    "solution": {
                        "alternative_id": "6b322386-2869-4ca4-8b4a-6d0964beccce",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (C) Ã© correta.</b> Os inibidores de SGLT-2 inibem o transportador de sÃ³dio e glicose tipo 2, presente principalmente no tÃºbulo renal proximal, impedindo a reabsorÃ§Ã£o de glicose e sÃ³dio. Assim, promovem glicosÃºria e, por nÃ£o aumentarem a insulina circulante, nÃ£o causam hipoglicemia. Adicionalmente, a perda calÃ³rica resultante da glicosÃºria se reflete em diminuiÃ§Ã£o ponderal.&nbsp;<div>Em pacientes com doenÃ§a estabelecida (como infarto do miocÃ¡rdio e AVC), tais drogas se mostraram benÃ©ficas, pois diminuÃ­ram mortalidade e risco cardiovascular, sendo os medicamentos de escolha na associaÃ§Ã£o com a metformina nestes indivÃ­duos.</div><div><br></div><div>- Inibidores de SGLT-2: empagliflozina, canagliflozina, dapagliflozina</div><div><br></div>",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-31 03:19:05.582231 +0000 UTC",
                        "id": "7b9bf5ca-1b33-4d39-a03a-ed97778073ae",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (C) Ã© correta. Os inibidores de SGLT-2 inibem o transportador de sÃ³dio e glicose tipo 2, presente principalmente no tÃºbulo renal proximal, impedindo a reabsorÃ§Ã£o de glicose e sÃ³dio. Assim, promovem glicosÃºria e, por nÃ£o aumentarem a insulina circulante, nÃ£o causam hipoglicemia. Adicionalmente, a perda calÃ³rica resultante da glicosÃºria se reflete em diminuiÃ§Ã£o ponderal.Â Em pacientes com doenÃ§a estabelecida (como infarto do miocÃ¡rdio e AVC), tais drogas se mostraram benÃ©ficas, pois diminuÃ­ram mortalidade e risco cardiovascular, sendo os medicamentos de escolha na associaÃ§Ã£o com a metformina nestes indivÃ­duos.- Inibidores de SGLT-2: empagliflozina, canagliflozina, dapagliflozina",
                        "updated_at": "2021-05-31 03:19:08.317258 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-31 02:48:36.14948 +0000 UTC"
                },
                {
                    "answer_percentage": 0,
                    "answers": 17,
                    "body": "inibidores das alfaglicosidases.",
                    "correct": false,
                    "created_at": "2021-04-20 17:48:02.011425 +0000 UTC",
                    "id": "f04eac4c-b78e-4ec8-8c75-9b548afe74a8",
                    "position": "3",
                    "sanitized_body": "inibidores das alfaglicosidases.",
                    "solution": {
                        "alternative_id": "f04eac4c-b78e-4ec8-8c75-9b548afe74a8",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (D) Ã© incorreta.</b> A acarbose Ã© um inibidor da Î±-glicosidase intestinal, enzima responsÃ¡vel pela quebra de dissacarÃ­deos em monossacarÃ­deos, retardando, assim, a absorÃ§Ã£o intestinal de glicose. Deste modo, promove melhor controle glicÃªmico pÃ³s-prandial. NÃ£o causa hipoglicemia nem ganho ponderal. NÃ£o hÃ¡ dados que mostrem benefÃ­cio do uso de acarbose em pacientes com doenÃ§a cardiovascular estabelecida.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-31 03:19:05.613929 +0000 UTC",
                        "id": "61ff22e7-a5e4-4c97-9528-5b0e1dd3c45b",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (D) Ã© incorreta. A acarbose Ã© um inibidor da Î±-glicosidase intestinal, enzima responsÃ¡vel pela quebra de dissacarÃ­deos em monossacarÃ­deos, retardando, assim, a absorÃ§Ã£o intestinal de glicose. Deste modo, promove melhor controle glicÃªmico pÃ³s-prandial. NÃ£o causa hipoglicemia nem ganho ponderal. NÃ£o hÃ¡ dados que mostrem benefÃ­cio do uso de acarbose em pacientes com doenÃ§a cardiovascular estabelecida.",
                        "updated_at": "2021-05-31 03:19:08.343891 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-31 02:48:36.226537 +0000 UTC"
                },
                {
                    "answer_percentage": 4,
                    "answers": 168,
                    "body": "inibidores de DPP-4.",
                    "correct": false,
                    "created_at": "2021-04-20 17:48:02.011425 +0000 UTC",
                    "id": "948f7952-f949-4833-b4a5-d442b871b578",
                    "position": "4",
                    "sanitized_body": "inibidores de DPP-4.",
                    "solution": {
                        "alternative_id": "948f7952-f949-4833-b4a5-d442b871b578",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (E) Ã© incorreta.</b> Os inibidores de DPP-4 inibem a enzima dipeptidil peptidase-4, responsÃ¡vel pela degradaÃ§Ã£o do GLP-1. Assim, possibilitam o aumento dos nÃ­veis endÃ³genos desse hormÃ´nio, que estimula a secreÃ§Ã£o de insulina pelas cÃ©lulas beta (de forma dependente dos nÃ­veis glicÃªmicos, o que nÃ£o causa hipoglicemia) e reduz a secreÃ§Ã£o de glucagon pelas cÃ©lulas alfa. SÃ£o drogas neutras em relaÃ§Ã£o ao peso e seguras do ponto de vista cardiovascular, porÃ©m, sem benefÃ­cios adicionais para pacientes com doenÃ§a cardiovascular estabelecida.&nbsp;<div>Uma grande vantagem Ã© a possibilidade de uso em qualquer fase da doenÃ§a renal crÃ´nica (com exceÃ§Ã£o da linagliptina, todas as demais drogas necessitam de ajuste posolÃ³gico conforme a taxa de filtraÃ§Ã£o glomerular).</div><div><br></div><div>-Inibidores de DPP-4: vildagliptina, sitagliptina, saxagliptina, alogliptina, linagliptina.</div><div><br></div>",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-31 03:19:05.607442 +0000 UTC",
                        "id": "18748d70-a449-40a7-a0af-b2da1ca36fb3",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (E) Ã© incorreta. Os inibidores de DPP-4 inibem a enzima dipeptidil peptidase-4, responsÃ¡vel pela degradaÃ§Ã£o do GLP-1. Assim, possibilitam o aumento dos nÃ­veis endÃ³genos desse hormÃ´nio, que estimula a secreÃ§Ã£o de insulina pelas cÃ©lulas beta (de forma dependente dos nÃ­veis glicÃªmicos, o que nÃ£o causa hipoglicemia) e reduz a secreÃ§Ã£o de glucagon pelas cÃ©lulas alfa. SÃ£o drogas neutras em relaÃ§Ã£o ao peso e seguras do ponto de vista cardiovascular, porÃ©m, sem benefÃ­cios adicionais para pacientes com doenÃ§a cardiovascular estabelecida.Â Uma grande vantagem Ã© a possibilidade de uso em qualquer fase da doenÃ§a renal crÃ´nica (com exceÃ§Ã£o da linagliptina, todas as demais drogas necessitam de ajuste posolÃ³gico conforme a taxa de filtraÃ§Ã£o glomerular).-Inibidores de DPP-4: vildagliptina, sitagliptina, saxagliptina, alogliptina, linagliptina.",
                        "updated_at": "2021-05-31 03:19:08.350373 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-31 02:48:36.351083 +0000 UTC"
                }
            ],
            "answer_type": "MULTIPLE_CHOICE",
            "author_id": "bruno-cesar110@hotmail.com",
            "correct_answer_percentage": 91,
            "created_at": "2021-04-20 17:48:02.011425 +0000 UTC",
            "difficulty_level": "MEDIUM",
            "exams": [
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "cf8b9c8b-e3ee-4ca1-99fc-401e6f50443d",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "046f0505-90c9-4862-b318-388c0d1e8026",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-20T16:09:12Z",
                    "degree_proof": false,
                    "id": "4000003967",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 17,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "B8395535-4F42-CB45-D885-813E1E715F63"
                        },
                        {
                            "type": "EXAM",
                            "url": "6FD3D73C-1002-BC22-186B-B20778505C18"
                        },
                        {
                            "type": "ANSWER",
                            "url": "A076EBD1-1804-61D2-5AE4-EBF76EC2E406"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 750,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "cf8b9c8b-e3ee-4ca1-99fc-401e6f50443d",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "dfa90599-1ee1-4de3-8605-a75ecd3799bd",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-20T16:09:30Z",
                    "degree_proof": false,
                    "id": "4000003968",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 16,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "B8395535-4F42-CB45-D885-813E1E715F63"
                        },
                        {
                            "type": "EXAM",
                            "url": "6FD3D73C-1002-BC22-186B-B20778505C18"
                        },
                        {
                            "type": "ANSWER",
                            "url": "A076EBD1-1804-61D2-5AE4-EBF76EC2E406"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 750,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "f30d24a0-2f2d-43be-9812-73746e91a61a",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "cf8b9c8b-e3ee-4ca1-99fc-401e6f50443d",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "ffd79a37-01ce-4d4e-8bda-950d51a56fe4",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-20T16:09:45Z",
                    "degree_proof": false,
                    "id": "4000003969",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "B8395535-4F42-CB45-D885-813E1E715F63"
                        },
                        {
                            "type": "EXAM",
                            "url": "6FD3D73C-1002-BC22-186B-B20778505C18"
                        },
                        {
                            "type": "ANSWER",
                            "url": "A076EBD1-1804-61D2-5AE4-EBF76EC2E406"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 750,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "cf8b9c8b-e3ee-4ca1-99fc-401e6f50443d",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "9b34a94d-754d-4510-8bad-60f649fa825b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-20T16:10:00Z",
                    "degree_proof": false,
                    "id": "4000003970",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 46,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "B8395535-4F42-CB45-D885-813E1E715F63"
                        },
                        {
                            "type": "EXAM",
                            "url": "6FD3D73C-1002-BC22-186B-B20778505C18"
                        },
                        {
                            "type": "ANSWER",
                            "url": "A076EBD1-1804-61D2-5AE4-EBF76EC2E406"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 750,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "cf8b9c8b-e3ee-4ca1-99fc-401e6f50443d",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "eca7ae7c-654b-407e-9b37-ad41ad2834b1",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-20T16:10:13Z",
                    "degree_proof": false,
                    "id": "4000003971",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "B8395535-4F42-CB45-D885-813E1E715F63"
                        },
                        {
                            "type": "EXAM",
                            "url": "6FD3D73C-1002-BC22-186B-B20778505C18"
                        },
                        {
                            "type": "ANSWER",
                            "url": "A076EBD1-1804-61D2-5AE4-EBF76EC2E406"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 750,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "cf8b9c8b-e3ee-4ca1-99fc-401e6f50443d",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "2ca62942-4eab-49e5-acaf-e395254eee99",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-20T16:10:26Z",
                    "degree_proof": false,
                    "id": "4000003972",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "B8395535-4F42-CB45-D885-813E1E715F63"
                        },
                        {
                            "type": "EXAM",
                            "url": "6FD3D73C-1002-BC22-186B-B20778505C18"
                        },
                        {
                            "type": "ANSWER",
                            "url": "A076EBD1-1804-61D2-5AE4-EBF76EC2E406"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 750,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "cf8b9c8b-e3ee-4ca1-99fc-401e6f50443d",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "dcb47678-bdba-4669-aa0e-01f71e32541b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-20T16:10:40Z",
                    "degree_proof": false,
                    "id": "4000003973",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "B8395535-4F42-CB45-D885-813E1E715F63"
                        },
                        {
                            "type": "EXAM",
                            "url": "6FD3D73C-1002-BC22-186B-B20778505C18"
                        },
                        {
                            "type": "ANSWER",
                            "url": "A076EBD1-1804-61D2-5AE4-EBF76EC2E406"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 750,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "cf8b9c8b-e3ee-4ca1-99fc-401e6f50443d",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "c51ec097-d9c1-43e8-9cc7-af320ab894a1",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-20T16:10:52Z",
                    "degree_proof": false,
                    "id": "4000003974",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "B8395535-4F42-CB45-D885-813E1E715F63"
                        },
                        {
                            "type": "EXAM",
                            "url": "6FD3D73C-1002-BC22-186B-B20778505C18"
                        },
                        {
                            "type": "ANSWER",
                            "url": "A076EBD1-1804-61D2-5AE4-EBF76EC2E406"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 750,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "cf8b9c8b-e3ee-4ca1-99fc-401e6f50443d",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "171045d3-6935-423f-bdaf-b95ac441fd8e",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-20T16:11:13Z",
                    "degree_proof": false,
                    "id": "4000003975",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 1,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "B8395535-4F42-CB45-D885-813E1E715F63"
                        },
                        {
                            "type": "EXAM",
                            "url": "6FD3D73C-1002-BC22-186B-B20778505C18"
                        },
                        {
                            "type": "ANSWER",
                            "url": "A076EBD1-1804-61D2-5AE4-EBF76EC2E406"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 750,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "cf8b9c8b-e3ee-4ca1-99fc-401e6f50443d",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "72d95e8b-a81e-43d1-aee8-6e9113f0939c",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-20T16:11:29Z",
                    "degree_proof": false,
                    "id": "4000003976",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "B8395535-4F42-CB45-D885-813E1E715F63"
                        },
                        {
                            "type": "EXAM",
                            "url": "6FD3D73C-1002-BC22-186B-B20778505C18"
                        },
                        {
                            "type": "ANSWER",
                            "url": "A076EBD1-1804-61D2-5AE4-EBF76EC2E406"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 750,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "cf8b9c8b-e3ee-4ca1-99fc-401e6f50443d",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "0e9d1d61-fc29-4c31-9a09-18ee25e99c7c",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-20T16:11:49Z",
                    "degree_proof": false,
                    "id": "4000003977",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 1,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "B8395535-4F42-CB45-D885-813E1E715F63"
                        },
                        {
                            "type": "EXAM",
                            "url": "6FD3D73C-1002-BC22-186B-B20778505C18"
                        },
                        {
                            "type": "ANSWER",
                            "url": "A076EBD1-1804-61D2-5AE4-EBF76EC2E406"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 750,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "f30d24a0-2f2d-43be-9812-73746e91a61a",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "cf8b9c8b-e3ee-4ca1-99fc-401e6f50443d",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "66678bdd-d9e1-4267-a4cf-f3beebfd7d0e",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-20T16:12:05Z",
                    "degree_proof": false,
                    "id": "4000003978",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 3,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "B8395535-4F42-CB45-D885-813E1E715F63"
                        },
                        {
                            "type": "EXAM",
                            "url": "6FD3D73C-1002-BC22-186B-B20778505C18"
                        },
                        {
                            "type": "ANSWER",
                            "url": "A076EBD1-1804-61D2-5AE4-EBF76EC2E406"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 750,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "cf8b9c8b-e3ee-4ca1-99fc-401e6f50443d",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "8d4e50ad-d41e-40c9-9f4d-842251c2d2d9",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-20T16:12:27Z",
                    "degree_proof": false,
                    "id": "4000003979",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 4,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "B8395535-4F42-CB45-D885-813E1E715F63"
                        },
                        {
                            "type": "EXAM",
                            "url": "6FD3D73C-1002-BC22-186B-B20778505C18"
                        },
                        {
                            "type": "ANSWER",
                            "url": "A076EBD1-1804-61D2-5AE4-EBF76EC2E406"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 750,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "cf8b9c8b-e3ee-4ca1-99fc-401e6f50443d",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "0609ccdb-db5c-4c47-a306-31a0a655e95c",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-20T16:12:43Z",
                    "degree_proof": false,
                    "id": "4000003980",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 15,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "B8395535-4F42-CB45-D885-813E1E715F63"
                        },
                        {
                            "type": "EXAM",
                            "url": "6FD3D73C-1002-BC22-186B-B20778505C18"
                        },
                        {
                            "type": "ANSWER",
                            "url": "A076EBD1-1804-61D2-5AE4-EBF76EC2E406"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 750,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "cf8b9c8b-e3ee-4ca1-99fc-401e6f50443d",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "417a198f-03b2-417e-8505-8acf83f3059d",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-20T16:12:54Z",
                    "degree_proof": false,
                    "id": "4000003981",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 4,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "B8395535-4F42-CB45-D885-813E1E715F63"
                        },
                        {
                            "type": "EXAM",
                            "url": "6FD3D73C-1002-BC22-186B-B20778505C18"
                        },
                        {
                            "type": "ANSWER",
                            "url": "A076EBD1-1804-61D2-5AE4-EBF76EC2E406"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 750,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "cf8b9c8b-e3ee-4ca1-99fc-401e6f50443d",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "f2f2f3c5-9759-4201-bca7-2487751bd626",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-20T16:13:09Z",
                    "degree_proof": false,
                    "id": "4000003982",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 19,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "B8395535-4F42-CB45-D885-813E1E715F63"
                        },
                        {
                            "type": "EXAM",
                            "url": "6FD3D73C-1002-BC22-186B-B20778505C18"
                        },
                        {
                            "type": "ANSWER",
                            "url": "A076EBD1-1804-61D2-5AE4-EBF76EC2E406"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 750,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "cf8b9c8b-e3ee-4ca1-99fc-401e6f50443d",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "4d4116be-190d-4321-94c8-66da6d1acb11",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-20T16:13:25Z",
                    "degree_proof": false,
                    "id": "4000003983",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "B8395535-4F42-CB45-D885-813E1E715F63"
                        },
                        {
                            "type": "EXAM",
                            "url": "6FD3D73C-1002-BC22-186B-B20778505C18"
                        },
                        {
                            "type": "ANSWER",
                            "url": "A076EBD1-1804-61D2-5AE4-EBF76EC2E406"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 750,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "cf8b9c8b-e3ee-4ca1-99fc-401e6f50443d",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "25b55daa-bd57-453d-9099-8c9dfe6d622a",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-20T16:13:41Z",
                    "degree_proof": false,
                    "id": "4000003984",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 1,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "B8395535-4F42-CB45-D885-813E1E715F63"
                        },
                        {
                            "type": "EXAM",
                            "url": "6FD3D73C-1002-BC22-186B-B20778505C18"
                        },
                        {
                            "type": "ANSWER",
                            "url": "A076EBD1-1804-61D2-5AE4-EBF76EC2E406"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 750,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "cf8b9c8b-e3ee-4ca1-99fc-401e6f50443d",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "710b6098-b1cc-40fb-a6e9-1978c156b947",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-20T16:14:00Z",
                    "degree_proof": false,
                    "id": "4000003985",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 24,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "B8395535-4F42-CB45-D885-813E1E715F63"
                        },
                        {
                            "type": "EXAM",
                            "url": "6FD3D73C-1002-BC22-186B-B20778505C18"
                        },
                        {
                            "type": "ANSWER",
                            "url": "A076EBD1-1804-61D2-5AE4-EBF76EC2E406"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 750,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "cf8b9c8b-e3ee-4ca1-99fc-401e6f50443d",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "cccffc77-8a54-477d-b101-01edbb244b74",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-20T16:14:15Z",
                    "degree_proof": false,
                    "id": "4000003986",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 12,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "B8395535-4F42-CB45-D885-813E1E715F63"
                        },
                        {
                            "type": "EXAM",
                            "url": "6FD3D73C-1002-BC22-186B-B20778505C18"
                        },
                        {
                            "type": "ANSWER",
                            "url": "A076EBD1-1804-61D2-5AE4-EBF76EC2E406"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 750,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "cf8b9c8b-e3ee-4ca1-99fc-401e6f50443d",
                        "jury_id": "139c0a0b-9494-4065-808f-ef53aa1ce524",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "776b092f-eb41-4150-a252-b23a0f7914b3",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-04-20T16:14:41Z",
                    "degree_proof": false,
                    "id": "4000003987",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 11,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "B8395535-4F42-CB45-D885-813E1E715F63"
                        },
                        {
                            "type": "EXAM",
                            "url": "6FD3D73C-1002-BC22-186B-B20778505C18"
                        },
                        {
                            "type": "ANSWER",
                            "url": "A076EBD1-1804-61D2-5AE4-EBF76EC2E406"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 750,
                    "year": 2021
                }
            ],
            "has_student_answer": false,
            "has_user_solution": false,
            "has_video_solution": true,
            "id": "4000145859",
            "labels": [
                "FINAL_ANSWER_SHEET"
            ],
            "public": true,
            "slug": "homem-54-anos-idade84b1486782",
            "solution": {
                "alternative_solutions": null,
                "author_email": "camila.moma@estrategiamed.com.br",
                "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                "brief": "",
                "brief_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "complete": "<b>Gabarito: alternativa (C).</b><div><b>ComentÃ¡rios:</b></div><div>A primeira escolha terapÃªutica em pacientes com diabetes mellitus tipo 2 Ã© a metformina, droga pertencente ao grupo das biguanidas, que atua reduzindo a produÃ§Ã£o hepÃ¡tica de glicose e promovendo maior captaÃ§Ã£o de glicose pelo prÃ³prio intestino. NÃ£o causa hipoglicemia nem ganho ponderal e, em comparaÃ§Ã£o Ã s sulfonilureias e Ã  insulina, possui benefÃ­cios em reduÃ§Ã£o de risco cardiovascular.</div><div>Como o diabetes mellitus tipo 2 Ã© uma doenÃ§a progressiva, uma vez que hÃ¡ falÃªncia das cÃ©lulas beta pancreÃ¡ticas, sÃ£o necessÃ¡rias adiÃ§Ãµes medicamentosas ao longo do acompanhamento, a fim de manter o controle glicÃªmico adequado, evitando, assim, complicaÃ§Ãµes crÃ´nicas.</div><div>A escolha do segundo ou terceiro agentes depende das caracterÃ­sticas individuais:</div><div>â¢\tPresenÃ§a de obesidade: preferÃªncia pelos inibidores de SGLT-2 e pelos anÃ¡logos de GLP-1, pois promovem perda de peso;</div><div>â¢\tPresenÃ§a de doenÃ§a cardiovascular estabelecida: inibidores de SGLT-2 ou anÃ¡logos de GLP-1;</div><div>â¢\tPresenÃ§a de doenÃ§a renal crÃ´nica com taxa de filtraÃ§Ã£o glomerular &gt; 30 mL/min e albuminÃºria &gt; 300 mg/g de creatinina: inibidores de SGLT-2;</div><div>â¢\tPresenÃ§a de insuficiÃªncia cardÃ­aca com fraÃ§Ã£o de ejeÃ§Ã£o reduzida: inibidores de SGLT-2;</div><div>â¢\tPresenÃ§a de doenÃ§a renal crÃ´nica dialÃ­tica: nesta situaÃ§Ã£o, a metformina Ã© contraindicada e podem ser utilizados os inibidores de DPP-4 e a insulina.</div>",
                "complete_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "created_at": "2021-05-31 03:19:05.753432 +0000 UTC",
                "id": "1b536b4f-87d6-4924-86c2-371c2febcdad",
                "is_default": false,
                "sanitized_brief": "",
                "sanitized_complete": "Gabarito: alternativa (C).ComentÃ¡rios:A primeira escolha terapÃªutica em pacientes com diabetes mellitus tipo 2 Ã© a metformina, droga pertencente ao grupo das biguanidas, que atua reduzindo a produÃ§Ã£o hepÃ¡tica de glicose e promovendo maior captaÃ§Ã£o de glicose pelo prÃ³prio intestino. NÃ£o causa hipoglicemia nem ganho ponderal e, em comparaÃ§Ã£o Ã s sulfonilureias e Ã  insulina, possui benefÃ­cios em reduÃ§Ã£o de risco cardiovascular.Como o diabetes mellitus tipo 2 Ã© uma doenÃ§a progressiva, uma vez que hÃ¡ falÃªncia das cÃ©lulas beta pancreÃ¡ticas, sÃ£o necessÃ¡rias adiÃ§Ãµes medicamentosas ao longo do acompanhamento, a fim de manter o controle glicÃªmico adequado, evitando, assim, complicaÃ§Ãµes crÃ´nicas.A escolha do segundo ou terceiro agentes depende das caracterÃ­sticas individuais:â¢\tPresenÃ§a de obesidade: preferÃªncia pelos inibidores de SGLT-2 e pelos anÃ¡logos de GLP-1, pois promovem perda de peso;â¢\tPresenÃ§a de doenÃ§a cardiovascular estabelecida: inibidores de SGLT-2 ou anÃ¡logos de GLP-1;â¢\tPresenÃ§a de doenÃ§a renal crÃ´nica com taxa de filtraÃ§Ã£o glomerular &gt; 30 mL/min e albuminÃºria &gt; 300 mg/g de creatinina: inibidores de SGLT-2;â¢\tPresenÃ§a de insuficiÃªncia cardÃ­aca com fraÃ§Ã£o de ejeÃ§Ã£o reduzida: inibidores de SGLT-2;â¢\tPresenÃ§a de doenÃ§a renal crÃ´nica dialÃ­tica: nesta situaÃ§Ã£o, a metformina Ã© contraindicada e podem ser utilizados os inibidores de DPP-4 e a insulina.",
                "updated_at": "2021-05-31 03:19:08.449764 +0000 UTC",
                "video_solution_id": "53d8cd43-94ce-4008-bbf3-672c5c236ff8"
            },
            "statement": "Um homem de 54 anos de idade, com antecedente de DM2 e IAM hÃ¡ cinco anos, faz uso de AAS, atorvastatina e metformina em doses otimizadas. HÃ¡ duas consultas no ambulatÃ³rio, vem apresentando aumento de HbA1C e glicemia de jejum, porÃ©m ainda sem indicaÃ§Ã£o para o uso de insulina.<div><br></div><div>Considerando-se as comorbidades do paciente nessa situaÃ§Ã£o hipotÃ©tica, os recentes estudos e as recomendaÃ§Ãµes da Sociedade Brasileira de Diabetes, Ã© correto afirmar que a melhor opÃ§Ã£o farmacolÃ³gica para associaÃ§Ã£o Ã  terapÃªutica jÃ¡ realizada Ã© composta por</div>",
            "statement_text": "Um homem de 54 anos de idade, com antecedente de DM2 e IAM hÃ¡ cinco anos, faz uso de AAS, atorvastatina e metformina em doses otimizadas. HÃ¡ duas consultas no ambulatÃ³rio, vem apresentando aumento de HbA1C e glicemia de jejum, porÃ©m ainda sem indicaÃ§Ã£o para o uso de insulina.Considerando-se as comorbidades do paciente nessa situaÃ§Ã£o hipotÃ©tica, os recentes estudos e as recomendaÃ§Ãµes da Sociedade Brasileira de Diabetes, Ã© correto afirmar que a melhor opÃ§Ã£o farmacolÃ³gica para associaÃ§Ã£o Ã  terapÃªutica jÃ¡ realizada Ã© composta por",
            "status": {
                "change_actor": "cnishiama@admin.admin",
                "created_at": "2021-05-31 17:10:54.743642 +0000 UTC",
                "owner": "camila.moma@estrategiamed.com.br",
                "value": "APPROVED"
            },
            "topics": [
                {
                    "has_children": false,
                    "id": "0cad8ea0fa0e47efa8d56f8a97b383e5",
                    "master_id": "3b9e1e9de9ba4ff3959ae83d455880f9",
                    "name": "MedicaÃ§Ãµes que provocam glicosÃºria (inibidores de SGLT-2)",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Tratamento[$$]Tratamento medicamentoso[$$]Drogas antidiabÃ©ticas nÃ£o insulina[$$]MedicaÃ§Ãµes que provocam glicosÃºria (inibidores de SGLT-2)"
                },
                {
                    "has_children": false,
                    "id": "ab6c6a1fb6604cf98243ac486f80dac8",
                    "master_id": "0a6abdce2fbc45aa8ba8f0e75875ec84",
                    "name": "Endocrinologia ",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia "
                }
            ],
            "unlisted": false,
            "video_solution": {
                "available_resolutions": [
                    {
                        "resolution": "720",
                        "url": "https://api.estrategia.com/questoes/sign/medicina/processadas/4000145859-720.mp4"
                    }
                ],
                "id": "53d8cd43-94ce-4008-bbf3-672c5c236ff8",
                "identifier": "",
                "question_id": "4000145859"
            },
            "video_solution_id": "53d8cd43-94ce-4008-bbf3-672c5c236ff8"
        },
        {
            "active": true,
            "alternatives": [
                {
                    "answer_percentage": 4,
                    "answers": 235,
                    "body": "antecendente familiar, alimentaÃ§Ã£o com excesso de carboidratos e ansiedade.",
                    "correct": false,
                    "created_at": "2021-01-25 12:38:11.483647 +0000 UTC",
                    "id": "54b3dd83-b0be-48b9-abb8-1395368f3e65",
                    "position": "0",
                    "sanitized_body": "antecendente familiar, alimentaÃ§Ã£o com excesso de carboidratos e ansiedade.",
                    "solution": {
                        "alternative_id": "54b3dd83-b0be-48b9-abb8-1395368f3e65",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "Incorreta a alternativa A. Apenas o antecedente familiar para DM tipo 2 Ã© um dos fatores de risco a serem considerados para o rastreamento",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-02-05 00:32:01.428245 +0000 UTC",
                        "id": "2b415ab0-72ce-489f-8eda-628ebb485b46",
                        "sanitized_brief": "",
                        "sanitized_complete": "Incorreta a alternativa A. Apenas o antecedente familiar para DM tipo 2 Ã© um dos fatores de risco a serem considerados para o rastreamento",
                        "updated_at": "2021-02-05 01:44:53.629144 +0000 UTC"
                    },
                    "topics": []
                },
                {
                    "answer_percentage": 90,
                    "answers": 5158,
                    "body": "obesidade central, hipertensÃ£o arterial e sobrepeso.",
                    "correct": true,
                    "created_at": "2021-01-25 12:38:11.483647 +0000 UTC",
                    "id": "a550ac6c-0325-4690-aeec-10c2425f6715",
                    "position": "1",
                    "sanitized_body": "obesidade central, hipertensÃ£o arterial e sobrepeso.",
                    "solution": {
                        "alternative_id": "a550ac6c-0325-4690-aeec-10c2425f6715",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "Correta a alternativa B A adiposidade central relaciona-se Ã  resistÃªncia Ã  aÃ§Ã£o da insulina, portanto, Ã© um fator de risco para diabetes mellitus tipo 2, assim como a hipertensÃ£o arterial. IndivÃ­duos com sobrepeso ou obesidade devem ser rastreados na presenÃ§a de algum fator de risco adicional, independentemente da idade.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-02-05 00:32:01.416974 +0000 UTC",
                        "id": "4e5fd5d1-3eb5-4a8b-9c79-9dd243df203f",
                        "sanitized_brief": "",
                        "sanitized_complete": "Correta a alternativa B A adiposidade central relaciona-se Ã  resistÃªncia Ã  aÃ§Ã£o da insulina, portanto, Ã© um fator de risco para diabetes mellitus tipo 2, assim como a hipertensÃ£o arterial. IndivÃ­duos com sobrepeso ou obesidade devem ser rastreados na presenÃ§a de algum fator de risco adicional, independentemente da idade.",
                        "updated_at": "2021-02-05 01:44:53.624242 +0000 UTC"
                    },
                    "topics": []
                },
                {
                    "answer_percentage": 0,
                    "answers": 15,
                    "body": "ansiedade, insÃ´nia e sobrepeso.",
                    "correct": false,
                    "created_at": "2021-01-25 12:38:11.483647 +0000 UTC",
                    "id": "98143e5c-5a7a-459d-94dc-de3897fa7017",
                    "position": "2",
                    "sanitized_body": "ansiedade, insÃ´nia e sobrepeso.",
                    "solution": {
                        "alternative_id": "98143e5c-5a7a-459d-94dc-de3897fa7017",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "Incorreta a alternativa C. Ansiedade e insÃ´nia nÃ£o sÃ£o indicadores de rastreamento para diabetes mellitus tipo 2.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-02-05 00:32:01.416126 +0000 UTC",
                        "id": "f37eefe1-e744-436d-9efe-eb95c62d3648",
                        "sanitized_brief": "",
                        "sanitized_complete": "Incorreta a alternativa C. Ansiedade e insÃ´nia nÃ£o sÃ£o indicadores de rastreamento para diabetes mellitus tipo 2.",
                        "updated_at": "2021-02-05 01:44:53.628957 +0000 UTC"
                    },
                    "topics": []
                },
                {
                    "answer_percentage": 5,
                    "answers": 263,
                    "body": "alteraÃ§Ã£o do sono, antecedente familiar e sedentarismo.",
                    "correct": false,
                    "created_at": "2021-01-25 12:38:11.483647 +0000 UTC",
                    "id": "f7b05297-0652-488b-bd81-daa670e99478",
                    "position": "3",
                    "sanitized_body": "alteraÃ§Ã£o do sono, antecedente familiar e sedentarismo.",
                    "solution": {
                        "alternative_id": "f7b05297-0652-488b-bd81-daa670e99478",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "Incorreta a alternativa D. Antecedente familiar e sedentarismo sÃ£o fatores de risco a serem considerados no rastreamento, entretanto, alteraÃ§Ã£o de sono nÃ£o",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-02-05 00:32:01.427909 +0000 UTC",
                        "id": "afb4db91-a92e-4b4e-a1c6-63565b870af1",
                        "sanitized_brief": "",
                        "sanitized_complete": "Incorreta a alternativa D. Antecedente familiar e sedentarismo sÃ£o fatores de risco a serem considerados no rastreamento, entretanto, alteraÃ§Ã£o de sono nÃ£o",
                        "updated_at": "2021-02-05 01:44:53.621146 +0000 UTC"
                    },
                    "topics": []
                },
                {
                    "answer_percentage": 1,
                    "answers": 39,
                    "body": "hipotireoidismo, insÃ´nia e obesidade central.",
                    "correct": false,
                    "created_at": "2021-01-25 12:38:11.483647 +0000 UTC",
                    "id": "9abec234-4212-4c92-8f40-770e8a9b2b6c",
                    "position": "4",
                    "sanitized_body": "hipotireoidismo, insÃ´nia e obesidade central.",
                    "solution": {
                        "alternative_id": "9abec234-4212-4c92-8f40-770e8a9b2b6c",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "Incorreta a alternativa E. A disfunÃ§Ã£o tireoidiana que se relaciona Ã  hiperglicemia Ã© o hipertireoidismo, uma vez que o excesso de hormÃ´nios tireoidianos leva ao aumento da resistÃªncia Ã  aÃ§Ã£o da insulina.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-02-05 00:32:01.425256 +0000 UTC",
                        "id": "43f6057e-6506-4acf-8267-aee8ef1f31a3",
                        "sanitized_brief": "",
                        "sanitized_complete": "Incorreta a alternativa E. A disfunÃ§Ã£o tireoidiana que se relaciona Ã  hiperglicemia Ã© o hipertireoidismo, uma vez que o excesso de hormÃ´nios tireoidianos leva ao aumento da resistÃªncia Ã  aÃ§Ã£o da insulina.",
                        "updated_at": "2021-02-05 01:44:53.61544 +0000 UTC"
                    },
                    "topics": []
                }
            ],
            "answer_type": "MULTIPLE_CHOICE",
            "author_id": "bruno-cesar110@hotmail.com",
            "correct_answer_percentage": 90,
            "created_at": "2021-01-25 12:38:11.483647 +0000 UTC",
            "difficulty_level": "MEDIUM",
            "exams": [
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "9b34a94d-754d-4510-8bad-60f649fa825b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:03:06Z",
                    "degree_proof": false,
                    "id": "4000003036",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 98,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "dfa90599-1ee1-4de3-8605-a75ecd3799bd",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:03:45Z",
                    "degree_proof": false,
                    "id": "4000003037",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 77,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "32bef8bd-8aac-4ede-aede-06b9458b026b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:08:01Z",
                    "degree_proof": false,
                    "id": "4000003038",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 8,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "710b6098-b1cc-40fb-a6e9-1978c156b947",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:08:28Z",
                    "degree_proof": false,
                    "id": "4000003039",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 44,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "0609ccdb-db5c-4c47-a306-31a0a655e95c",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:08:57Z",
                    "degree_proof": false,
                    "id": "4000003040",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 66,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "dcb47678-bdba-4669-aa0e-01f71e32541b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:10:05Z",
                    "degree_proof": false,
                    "id": "4000003041",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 3,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "25b55daa-bd57-453d-9099-8c9dfe6d622a",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:10:32Z",
                    "degree_proof": false,
                    "id": "4000003042",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 3,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "2ca62942-4eab-49e5-acaf-e395254eee99",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:10:50Z",
                    "degree_proof": false,
                    "id": "4000003043",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 27,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "776b092f-eb41-4150-a252-b23a0f7914b3",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:11:22Z",
                    "degree_proof": false,
                    "id": "4000003044",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 22,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "046f0505-90c9-4862-b318-388c0d1e8026",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:11:38Z",
                    "degree_proof": false,
                    "id": "4000003045",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 53,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "f2f2f3c5-9759-4201-bca7-2487751bd626",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:11:55Z",
                    "degree_proof": false,
                    "id": "4000003046",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 40,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "f30d24a0-2f2d-43be-9812-73746e91a61a",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "66678bdd-d9e1-4267-a4cf-f3beebfd7d0e",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:12:56Z",
                    "degree_proof": false,
                    "id": "4000003047",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 5,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "417a198f-03b2-417e-8505-8acf83f3059d",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:13:27Z",
                    "degree_proof": false,
                    "id": "4000003048",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 14,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "4d4116be-190d-4321-94c8-66da6d1acb11",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:13:50Z",
                    "degree_proof": false,
                    "id": "4000003049",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 7,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "cccffc77-8a54-477d-b101-01edbb244b74",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:14:09Z",
                    "degree_proof": false,
                    "id": "4000003050",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 31,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "b39a29ec-d8c7-4592-b019-d0c7ee728856",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:14:31Z",
                    "degree_proof": false,
                    "id": "4000003051",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 4,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "eca7ae7c-654b-407e-9b37-ad41ad2834b1",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:14:52Z",
                    "degree_proof": false,
                    "id": "4000003052",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 12,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 3,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "8d4e50ad-d41e-40c9-9f4d-842251c2d2d9",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:15:20Z",
                    "degree_proof": false,
                    "id": "4000003053",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 3,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "updated_at": "2021-01-25T12:16:17Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 3,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "727c6216-9122-4b12-88d1-7f8462a8cce7",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:16:00Z",
                    "degree_proof": false,
                    "id": "4000003054",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 1,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 3,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "c51ec097-d9c1-43e8-9cc7-af320ab894a1",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:17:22Z",
                    "degree_proof": false,
                    "id": "4000003055",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 4,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 3,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "171045d3-6935-423f-bdaf-b95ac441fd8e",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:17:51Z",
                    "degree_proof": false,
                    "id": "4000003056",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 3,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "f30d24a0-2f2d-43be-9812-73746e91a61a",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "ffd79a37-01ce-4d4e-8bda-950d51a56fe4",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:18:44Z",
                    "degree_proof": false,
                    "id": "4000003057",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 7,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                }
            ],
            "forum_id": "e05cfa7d-2676-46f8-a399-78655119fce8",
            "has_student_answer": false,
            "has_user_solution": false,
            "has_video_solution": false,
            "id": "4000140982",
            "labels": [
                "FINAL_ANSWER_SHEET"
            ],
            "public": true,
            "slug": "Sa-considerados-para8f24fd801",
            "solution": {
                "alternative_solutions": null,
                "author_email": "camila.moma@estrategiamed.com.br",
                "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                "brief": "",
                "brief_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "complete": "<div><b>GABARITO: ALTERNATIVA B</b></div><div><br></div>As indicaÃ§Ãµes de rastreamento para diabetes mellitus tipo 2, conforme a American Diabetes Association e a Sociedade Brasileira de Diabetes, sÃ£o:<div><br></div><div><!-- BEGIN:IMAGE_TO_REPLACE --><img src=\"https://estrategia-prod-questoes.s3.amazonaws.com/images/A7F9D3E4-0DE5-BBC9-E827-E76A37E0C0D6/A7F9D3E4-0DE5-BBC9-E827-E76A37E0C0D6-400.png\"><!-- END:IMAGE_TO_REPLACE --><br></div>",
                "complete_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "created_at": "2021-02-05 00:32:01.625551 +0000 UTC",
                "id": "b6e4571e-6c27-4571-99bd-b16f101735f8",
                "is_default": false,
                "sanitized_brief": "",
                "sanitized_complete": "GABARITO: ALTERNATIVA BAs indicaÃ§Ãµes de rastreamento para diabetes mellitus tipo 2, conforme a American Diabetes Association e a Sociedade Brasileira de Diabetes, sÃ£o:",
                "updated_at": "2021-02-05 01:44:53.872618 +0000 UTC"
            },
            "statement": "SÃ£o considerados para rastreamento do diabetes tipo 2:",
            "statement_text": "SÃ£o considerados para rastreamento do diabetes tipo 2:",
            "status": {
                "change_actor": "cnishiama@admin.admin",
                "created_at": "2021-02-05 16:31:15.863347 +0000 UTC",
                "owner": "camila.moma@estrategiamed.com.br",
                "value": "APPROVED"
            },
            "topics": [
                {
                    "has_children": false,
                    "id": "022fbdd6ba4a409ab0e705d1cb4f13ae",
                    "master_id": "e7750157ebd549b78392eee4b4b3154d",
                    "name": "Rastreamento",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Rastreamento"
                },
                {
                    "has_children": false,
                    "id": "ab6c6a1fb6604cf98243ac486f80dac8",
                    "master_id": "0a6abdce2fbc45aa8ba8f0e75875ec84",
                    "name": "Endocrinologia ",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia "
                }
            ],
            "unlisted": false,
            "video_solution": {
                "available_resolutions": null,
                "id": "",
                "identifier": "",
                "question_id": ""
            }
        },
        {
            "active": true,
            "alternatives": [
                {
                    "answer_percentage": 10,
                    "answers": 24,
                    "body": "manter a medicaÃ§Ã£o em uso e solicitar exame de dosagemÂ <span>de proteinÃºria em amostra de urina de 24 horas.</span>",
                    "correct": false,
                    "created_at": "2024-08-28 18:08:25.479291 +0000 UTC",
                    "id": "5a36638b-43c3-4555-b098-54bb882f2e90",
                    "position": "0",
                    "sanitized_body": "manter a medicaÃ§Ã£o em uso e solicitar exame de dosagemÂ de proteinÃºria em amostra de urina de 24 horas.",
                    "solution": {
                        "alternative_id": "5a36638b-43c3-4555-b098-54bb882f2e90",
                        "author_email": "enio.macedo@estrategia.com",
                        "author_id": "7aa60ac1-958e-47ec-bd5f-5f1babceed19",
                        "brief": "",
                        "brief_attachments": [],
                        "complete": "Incorreta.Â <div>As diretrizes recomendam que o rastreio da doenÃ§a renal diabÃ©tica seja feito com a dosagem de creatinina e albuminÃºria. A elevaÃ§Ã£o de albuminÃºria Ã© a alteraÃ§Ã£o mais precoce. Apesar de ser uma conduta possÃ­vel, a dosagem de proteinÃºria de 24h nÃ£o Ã© obrigatÃ³ria, pois seu resultado nÃ£o mudaria a conduta em um pacientes com diabetes e albuminÃºria.</div><div>AlÃ©m disso, essa alternativa nÃ£o menciona a principal conduta para o paciente da questÃ£o: a prescriÃ§Ã£o de um inibidor do SGLT2.Â </div>",
                        "complete_attachments": [],
                        "created_at": "2024-09-08 01:47:42.027662 +0000 UTC",
                        "id": "859cbce9-659a-47e6-94a3-8743a3ed579f",
                        "sanitized_brief": "",
                        "sanitized_complete": "Incorreta.Â As diretrizes recomendam que o rastreio da doenÃ§a renal diabÃ©tica seja feito com a dosagem de creatinina e albuminÃºria. A elevaÃ§Ã£o de albuminÃºria Ã© a alteraÃ§Ã£o mais precoce. Apesar de ser uma conduta possÃ­vel, a dosagem de proteinÃºria de 24h nÃ£o Ã© obrigatÃ³ria, pois seu resultado nÃ£o mudaria a conduta em um pacientes com diabetes e albuminÃºria.AlÃ©m disso, essa alternativa nÃ£o menciona a principal conduta para o paciente da questÃ£o: a prescriÃ§Ã£o de um inibidor do SGLT2.",
                        "updated_at": "2024-09-08 01:55:05.667189 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2024-09-08 01:45:44.995125 +0000 UTC"
                },
                {
                    "answer_percentage": 3,
                    "answers": 8,
                    "body": "manter a medicaÃ§Ã£o em uso e agendar consulta deÂ <span>retorno solicitando a realizaÃ§Ã£o dos exames habituais.</span>",
                    "correct": false,
                    "created_at": "2024-08-28 18:08:25.479291 +0000 UTC",
                    "id": "1ba6ac75-4db4-4efd-8664-4f48db0c9800",
                    "position": "1",
                    "sanitized_body": "manter a medicaÃ§Ã£o em uso e agendar consulta deÂ retorno solicitando a realizaÃ§Ã£o dos exames habituais.",
                    "solution": {
                        "alternative_id": "1ba6ac75-4db4-4efd-8664-4f48db0c9800",
                        "author_email": "enio.macedo@estrategia.com",
                        "author_id": "7aa60ac1-958e-47ec-bd5f-5f1babceed19",
                        "brief": "",
                        "brief_attachments": [],
                        "complete": "Incorreta. Apesar de o paciente estar dentro da meta glicÃªmica para a sua idade (veja acima), modernamente, buscamos tambÃ©m obter com o nosso tratamento benefÃ­cios extraglicÃªmicos, como reduÃ§Ã£o do risco de eventos cardiovasculares e de progressÃ£o de doenÃ§a renal diabÃ©tica. Essa alternativa ignora essa importante etapa do tratamento.Â ",
                        "complete_attachments": [],
                        "created_at": "2024-09-08 01:47:42.034759 +0000 UTC",
                        "id": "bbd6e0f0-f888-4aa0-9fd3-e62a347efeaf",
                        "sanitized_brief": "",
                        "sanitized_complete": "Incorreta. Apesar de o paciente estar dentro da meta glicÃªmica para a sua idade (veja acima), modernamente, buscamos tambÃ©m obter com o nosso tratamento benefÃ­cios extraglicÃªmicos, como reduÃ§Ã£o do risco de eventos cardiovasculares e de progressÃ£o de doenÃ§a renal diabÃ©tica. Essa alternativa ignora essa importante etapa do tratamento.",
                        "updated_at": "2024-09-08 01:55:05.671027 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2024-09-08 01:45:45.596687 +0000 UTC"
                },
                {
                    "answer_percentage": 10,
                    "answers": 24,
                    "body": "trocar o tratamento para um esquema Ã  base de insulina eÂ <span>solicitar exame de dosagem de proteinÃºria em amostra deÂ </span><span>urina de 24 horas.</span>",
                    "correct": false,
                    "created_at": "2024-08-28 18:08:25.479291 +0000 UTC",
                    "id": "d6d19b51-d43c-4354-b758-e1ac38a667c2",
                    "position": "2",
                    "sanitized_body": "trocar o tratamento para um esquema Ã  base de insulina eÂ solicitar exame de dosagem de proteinÃºria em amostra deÂ urina de 24 horas.",
                    "solution": {
                        "alternative_id": "d6d19b51-d43c-4354-b758-e1ac38a667c2",
                        "author_email": "enio.macedo@estrategia.com",
                        "author_id": "7aa60ac1-958e-47ec-bd5f-5f1babceed19",
                        "brief": "",
                        "brief_attachments": [],
                        "complete": "Incorreta.Â <div>O tratamento com insulina nÃ£o seria interessante para esse paciente por 2 motivos: (1) o paciente encontra-se dentro da meta glicÃªmica para a sua idade (veja acima), assim nÃ£o necessitando de intensificaÃ§Ã£o do controle glicÃªmico e (2) a insulinoterapia nÃ£o traria benefÃ­cios extraglicÃªmicos que os inibidores de SGLT2 poderiam oferecer.Â Â </div><div>Em relaÃ§Ã£o Ã  proteinÃºria de 24h, apesar de ser uma conduta possÃ­vel, a dosagem de proteinÃºria de 24h nÃ£o Ã© obrigatÃ³ria, pois seu resultado nÃ£o mudaria a conduta em um pacientes com diabetes e albuminÃºria.</div><div>AlÃ©m disso, essa alternativa nÃ£o menciona a principal conduta para o paciente da questÃ£o: a prescriÃ§Ã£o de um inibidor do SGLT2.Â </div>",
                        "complete_attachments": [],
                        "created_at": "2024-09-08 01:47:42.039468 +0000 UTC",
                        "id": "1861cf27-d0ce-4d43-a345-e819b2c38350",
                        "sanitized_brief": "",
                        "sanitized_complete": "Incorreta.Â O tratamento com insulina nÃ£o seria interessante para esse paciente por 2 motivos: (1) o paciente encontra-se dentro da meta glicÃªmica para a sua idade (veja acima), assim nÃ£o necessitando de intensificaÃ§Ã£o do controle glicÃªmico e (2) a insulinoterapia nÃ£o traria benefÃ­cios extraglicÃªmicos que os inibidores de SGLT2 poderiam oferecer.Â Â Em relaÃ§Ã£o Ã  proteinÃºria de 24h, apesar de ser uma conduta possÃ­vel, a dosagem de proteinÃºria de 24h nÃ£o Ã© obrigatÃ³ria, pois seu resultado nÃ£o mudaria a conduta em um pacientes com diabetes e albuminÃºria.AlÃ©m disso, essa alternativa nÃ£o menciona a principal conduta para o paciente da questÃ£o: a prescriÃ§Ã£o de um inibidor do SGLT2.",
                        "updated_at": "2024-09-08 01:55:05.675049 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2024-09-08 01:45:45.99022 +0000 UTC"
                },
                {
                    "answer_percentage": 77,
                    "answers": 185,
                    "body": "associar um medicamento inibidor do receptor SGLT2Â <span>(cotransportador sÃ³dio-glicose 2) e manter acompanha</span><span>mento habitual.</span>",
                    "correct": true,
                    "created_at": "2024-08-28 18:08:25.479291 +0000 UTC",
                    "id": "94107aef-7d0a-41df-a141-27809bdee8d4",
                    "position": "3",
                    "sanitized_body": "associar um medicamento inibidor do receptor SGLT2Â (cotransportador sÃ³dio-glicose 2) e manter acompanhamento habitual.",
                    "solution": {
                        "alternative_id": "94107aef-7d0a-41df-a141-27809bdee8d4",
                        "author_email": "enio.macedo@estrategia.com",
                        "author_id": "7aa60ac1-958e-47ec-bd5f-5f1babceed19",
                        "brief": "",
                        "brief_attachments": [],
                        "complete": "Correta. A associaÃ§Ã£o de um inibidor do SGLT2, independentemente de o paciente estar dentro da meta glicÃªmica, traria benefÃ­cios em reduÃ§Ã£o do risco de eventos cardiovasculares e progressÃ£o da doenÃ§a renal diabÃ©tica.Â ",
                        "complete_attachments": [],
                        "created_at": "2024-09-08 01:47:42.048215 +0000 UTC",
                        "id": "45412af5-d456-4f89-b4f6-7a6dce9ca899",
                        "sanitized_brief": "",
                        "sanitized_complete": "Correta. A associaÃ§Ã£o de um inibidor do SGLT2, independentemente de o paciente estar dentro da meta glicÃªmica, traria benefÃ­cios em reduÃ§Ã£o do risco de eventos cardiovasculares e progressÃ£o da doenÃ§a renal diabÃ©tica.",
                        "updated_at": "2024-09-08 01:55:05.67867 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2024-09-08 01:45:46.596016 +0000 UTC"
                }
            ],
            "answer_type": "MULTIPLE_CHOICE",
            "author_id": "eliets.9@gmail.com",
            "correct_answer_percentage": 77,
            "created_at": "2024-08-28 18:08:25.479291 +0000 UTC",
            "difficulty_level": "MEDIUM",
            "exams": [
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "cad77a08-2520-453c-bb37-b023d5161d6d",
                        "goal_id": "509858a1-11ed-4c96-a194-33b16db1300e",
                        "institution_id": "93c3cca3-ed81-43bf-8d66-35d220299c08",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "ebede3c5-fe91-45f0-b53b-6d5231b1c625",
                        "sector_id": "2db85153-c19d-47ed-ae73-2faaaa65c63b",
                        "specialty_id": "55402575-a6ef-41f1-a190-9ecdce1af36b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2024-08-28T16:19:09Z",
                    "degree_proof": false,
                    "id": "4000008142",
                    "location": {
                        "id": "1"
                    },
                    "number": 2,
                    "open_spaces": 0,
                    "questions_number": 105,
                    "scholarity": "placeholder",
                    "subscription_fee": 330,
                    "year": 2024
                }
            ],
            "has_student_answer": false,
            "has_user_solution": false,
            "has_video_solution": false,
            "id": "4000223911",
            "labels": [
                "FINAL_ANSWER_SHEET"
            ],
            "public": true,
            "slug": "homem-67-anos68e056a4fc",
            "solution": {
                "alternative_solutions": null,
                "author_email": "enio.macedo@estrategia.com",
                "author_id": "7aa60ac1-958e-47ec-bd5f-5f1babceed19",
                "brief": "",
                "brief_attachments": [],
                "complete": "Nesta questÃ£o, temos um homem com diabetes de longa data em uso de metformina. O diabetes estÃ¡ bem controlado - na populaÃ§Ã£o geriÃ¡trica sem a meta de HbA1c Ã© < 7,5 a 8% na maioria dos pacientes. Revise as metas do controle do diabetes na populaÃ§Ã£o geriÃ¡trica no quadro abaixo.<div><!-- BEGIN:IMAGE_TO_REPLACE --><img src=\"https://estrategia-prod-questoes.s3.amazonaws.com/images/75D7421A-9327-450B-305A-02592D70D7C1/75D7421A-9327-450B-305A-02592D70D7C1-400.jpeg\"><!-- END:IMAGE_TO_REPLACE --><br></div><div>Â </div><div>Contudo, chamam atenÃ§Ã£o no enunciado dois aspectos: o paciente apresenta histÃ³rico de doenÃ§a cardiovascular (infarto agudo do miocÃ¡rdio) e tem albuminÃºria elevada. Ambos podem ser interpretados como complicaÃ§Ãµes crÃ´nicas do diabetes. Isso muito nos preocupa, pois as doenÃ§as cardiovasculares sÃ£o a principal causa de morte nas pessoas com diabetes.Â </div><div><br></div><div>Modernamente, o tratamento do diabetes nÃ£o deve visar apenas ao controle dos nÃ­veis de glicemia. Devemos buscar tambÃ©m obter benefÃ­cios extraglicÃªmicos, como reduÃ§Ã£o do risco de eventos cardiovasculares independentemente do nÃ­vel de glicemia ou reduÃ§Ã£o de progressÃ£o de doenÃ§a renal crÃ´nica independentemente do nÃ­vel de glicemia. Felizmente, pesquisas recentes indicam que algumas drogas podem ser Ãºteis para a obtenÃ§Ã£o de benefÃ­cios extraglicÃªmicos. Vamos a elas:</div><div><b>- Inibidores do SGLT2</b> - AlÃ©m do controle glicÃªmico, sÃ£o capazes de: (1) Retardar a progressÃ£o da doenÃ§a renal crÃ´nica (mesmo em pessoas sem diabetes); (2) Diminuir mortalidade e hospitalizaÃ§Ãµes em insuficiÃªncia cardÃ­aca independente da fraÃ§Ã£o de ejeÃ§Ã£o (mesmo em pessoas sem diabetes) e (3) Reduzir o risco de eventos cardiovasculares em pessoas com diabetes.Â </div><div><b>- AnÃ¡logos do GLP-1</b> - AlÃ©m do controle glicÃªmico, sÃ£o capazes de: (1) Tratar eficazmente a obesidade (mesmo em pessoas sem diabetes) e (2) Reduzir o risco de eventos cardiovasculares em pessoas com diabetes. Estudos mais recentes estÃ£o comeÃ§ando a explorar tambÃ©m o uso desses medicamentos para o tratamento de doenÃ§a renal crÃ´nica diabÃ©tica, sÃ­ndrome da apneia e hipopneia do sono e esteatose hepÃ¡tica.Â Â </div><div><br></div><div>Como o paciente da nossa questÃ£o estÃ¡ com o diabetes, do ponto de vista glicÃªmico, dentro da meta, devemos agora nos atentar se conseguimos obter algum benefÃ­cio extraglicÃªmico. Ele jÃ¡ apresentou uma doenÃ§a cardiovascular prÃ©via, logo este paciente Ã© de muito alto risco para novos eventos. AlÃ©m disso, possui albuminÃºria elevada. A presenÃ§a de albuminÃºria elevada por mais de 3 meses Ã© diagnÃ³stica de doenÃ§a renal crÃ´nica e Ã© um marcador mais precoce do que a elevaÃ§Ã£o da creatinina para a nefropatia diabÃ©tica. Portanto, para esse paciente, vale muito a pena a prescriÃ§Ã£o de um inibidor do SGLT2, que atuarÃ¡ reduzindo o risco de novos eventos cardiovasculares e reduzindo a progressÃ£o da doenÃ§a renal diabÃ©tica.Â </div><div><br></div>",
                "complete_attachments": [],
                "created_at": "2024-09-08 01:47:42.0129 +0000 UTC",
                "id": "69f750cc-8956-430b-92bd-89d3eb89b255",
                "is_default": false,
                "sanitized_brief": "",
                "sanitized_complete": "Nesta questÃ£o, temos um homem com diabetes de longa data em uso de metformina. O diabetes estÃ¡ bem controlado - na populaÃ§Ã£o geriÃ¡trica sem a meta de HbA1c Ã© &lt; 7,5 a 8% na maioria dos pacientes. Revise as metas do controle do diabetes na populaÃ§Ã£o geriÃ¡trica no quadro abaixo.Â Contudo, chamam atenÃ§Ã£o no enunciado dois aspectos: o paciente apresenta histÃ³rico de doenÃ§a cardiovascular (infarto agudo do miocÃ¡rdio) e tem albuminÃºria elevada. Ambos podem ser interpretados como complicaÃ§Ãµes crÃ´nicas do diabetes. Isso muito nos preocupa, pois as doenÃ§as cardiovasculares sÃ£o a principal causa de morte nas pessoas com diabetes.Â Modernamente, o tratamento do diabetes nÃ£o deve visar apenas ao controle dos nÃ­veis de glicemia. Devemos buscar tambÃ©m obter benefÃ­cios extraglicÃªmicos, como reduÃ§Ã£o do risco de eventos cardiovasculares independentemente do nÃ­vel de glicemia ou reduÃ§Ã£o de progressÃ£o de doenÃ§a renal crÃ´nica independentemente do nÃ­vel de glicemia. Felizmente, pesquisas recentes indicam que algumas drogas podem ser Ãºteis para a obtenÃ§Ã£o de benefÃ­cios extraglicÃªmicos. Vamos a elas:- Inibidores do SGLT2 - AlÃ©m do controle glicÃªmico, sÃ£o capazes de: (1) Retardar a progressÃ£o da doenÃ§a renal crÃ´nica (mesmo em pessoas sem diabetes); (2) Diminuir mortalidade e hospitalizaÃ§Ãµes em insuficiÃªncia cardÃ­aca independente da fraÃ§Ã£o de ejeÃ§Ã£o (mesmo em pessoas sem diabetes) e (3) Reduzir o risco de eventos cardiovasculares em pessoas com diabetes.Â - AnÃ¡logos do GLP-1 - AlÃ©m do controle glicÃªmico, sÃ£o capazes de: (1) Tratar eficazmente a obesidade (mesmo em pessoas sem diabetes) e (2) Reduzir o risco de eventos cardiovasculares em pessoas com diabetes. Estudos mais recentes estÃ£o comeÃ§ando a explorar tambÃ©m o uso desses medicamentos para o tratamento de doenÃ§a renal crÃ´nica diabÃ©tica, sÃ­ndrome da apneia e hipopneia do sono e esteatose hepÃ¡tica.Â Â Como o paciente da nossa questÃ£o estÃ¡ com o diabetes, do ponto de vista glicÃªmico, dentro da meta, devemos agora nos atentar se conseguimos obter algum benefÃ­cio extraglicÃªmico. Ele jÃ¡ apresentou uma doenÃ§a cardiovascular prÃ©via, logo este paciente Ã© de muito alto risco para novos eventos. AlÃ©m disso, possui albuminÃºria elevada. A presenÃ§a de albuminÃºria elevada por mais de 3 meses Ã© diagnÃ³stica de doenÃ§a renal crÃ´nica e Ã© um marcador mais precoce do que a elevaÃ§Ã£o da creatinina para a nefropatia diabÃ©tica. Portanto, para esse paciente, vale muito a pena a prescriÃ§Ã£o de um inibidor do SGLT2, que atuarÃ¡ reduzindo o risco de novos eventos cardiovasculares e reduzindo a progressÃ£o da doenÃ§a renal diabÃ©tica.",
                "updated_at": "2024-09-08 01:55:05.663537 +0000 UTC"
            },
            "statement": "Um homem de 67 anos comparece Ã  consulta de rotina.Â <span>Diagnosticado com</span><i> diabetes mellitus</i><span> tipo 2 hÃ¡ cerca deÂ </span><span>12 meses, em uso regular de metformina 500 mg de 12 emÂ </span><span>12 horas. Possui histÃ³ria prÃ©via de infarto agudo do miocÃ¡rdioÂ </span><span>hÃ¡ 5 anos. Comparece Ã  consulta de acompanhamento comÂ </span><span>exames laboratoriais de controle recentes, que apresentamÂ </span><span>resultados semelhantes aos exames anteriores, realizados hÃ¡Â </span><span>3 e hÃ¡ 6 meses.</span><div><span><br></span></div><div><!-- BEGIN:IMAGE_TO_REPLACE --><img src=\"https://estrategia-prod-questoes.s3.amazonaws.com/images/BF8B88C4-12BD-EE77-4803-B7AAA058AC31/BF8B88C4-12BD-EE77-4803-B7AAA058AC31-400.png\"><!-- END:IMAGE_TO_REPLACE --><span><br></span></div><div><br></div><div>A conduta recomendada para esse paciente Ã©</div>",
            "statement_text": "Um homem de 67 anos comparece Ã  consulta de rotina.Â Diagnosticado com diabetes mellitus tipo 2 hÃ¡ cerca deÂ 12 meses, em uso regular de metformina 500 mg de 12 emÂ 12 horas. Possui histÃ³ria prÃ©via de infarto agudo do miocÃ¡rdioÂ hÃ¡ 5 anos. Comparece Ã  consulta de acompanhamento comÂ exames laboratoriais de controle recentes, que apresentamÂ resultados semelhantes aos exames anteriores, realizados hÃ¡Â 3 e hÃ¡ 6 meses.A conduta recomendada para esse paciente Ã©",
            "status": {
                "change_actor": "viviane.silva@estrategiamed.com.br",
                "created_at": "2024-09-09 14:23:52.526075 +0000 UTC",
                "owner": "enio.macedo@estrategia.com",
                "value": "APPROVED"
            },
            "topics": [
                {
                    "has_children": false,
                    "id": "0cad8ea0fa0e47efa8d56f8a97b383e5",
                    "master_id": "3b9e1e9de9ba4ff3959ae83d455880f9",
                    "name": "MedicaÃ§Ãµes que provocam glicosÃºria (inibidores de SGLT-2)",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Tratamento[$$]Tratamento medicamentoso[$$]Drogas antidiabÃ©ticas nÃ£o insulina[$$]MedicaÃ§Ãµes que provocam glicosÃºria (inibidores de SGLT-2)"
                },
                {
                    "has_children": false,
                    "id": "3b9e1e9de9ba4ff3959ae83d455880f9",
                    "master_id": "778ea293dac8426ab5447d56646b3e72",
                    "name": "Drogas antidiabÃ©ticas nÃ£o insulina",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Tratamento[$$]Tratamento medicamentoso[$$]Drogas antidiabÃ©ticas nÃ£o insulina"
                },
                {
                    "has_children": false,
                    "id": "5c89a0e5355041ecbf15088427eaa347",
                    "master_id": "e4ec8b5d6a5e491386328c17a67d632a",
                    "name": "Etiologia: Diabetes mellitus (DM)",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Nefrologia [$$]DoenÃ§a Renal CrÃ´nica[$$]Etiologia da DoenÃ§a Renal CrÃ´nica (DRC)[$$]Etiologia: Diabetes mellitus (DM)"
                },
                {
                    "has_children": false,
                    "id": "778ea293dac8426ab5447d56646b3e72",
                    "master_id": "e39487f7326345f982716782efb6d872",
                    "name": "Tratamento medicamentoso",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Tratamento[$$]Tratamento medicamentoso"
                },
                {
                    "has_children": false,
                    "id": "90f3709d56b24fc690721dbb734f465a",
                    "master_id": "37409101061444e79f2f246c65e100ed",
                    "name": "ComplicaÃ§Ãµes crÃ´nicas",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]ComplicaÃ§Ãµes crÃ´nicas"
                },
                {
                    "has_children": false,
                    "id": "e39487f7326345f982716782efb6d872",
                    "master_id": "e7750157ebd549b78392eee4b4b3154d",
                    "name": "Tratamento",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Tratamento"
                }
            ],
            "unlisted": false,
            "video_solution": {
                "available_resolutions": null,
                "id": "",
                "identifier": "",
                "question_id": ""
            }
        },
        {
            "active": true,
            "alternatives": [
                {
                    "answer_percentage": 3,
                    "answers": 166,
                    "body": "alimentos sem gordura.",
                    "correct": false,
                    "created_at": "2021-01-25 12:38:58.372767 +0000 UTC",
                    "id": "1166b728-d880-4ddc-a5c2-eb831a5a4272",
                    "position": "0",
                    "sanitized_body": "alimentos sem gordura.",
                    "solution": {
                        "alternative_id": "1166b728-d880-4ddc-a5c2-eb831a5a4272",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "Incorreta a alternativa A. NÃ£o hÃ¡ dados que mostrem que a restriÃ§Ã£o de gorduras se correlaciona com melhora no controle glicÃªmico. A orientaÃ§Ã£o a ser mantida Ã© a restriÃ§Ã£o das gorduras saturadas (no mÃ¡ximo, atÃ© 10% do VET), visto que se correlacionam com piores desfechos cardiovasculares.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-02-05 00:36:07.924326 +0000 UTC",
                        "id": "52dfbc65-8d1c-4099-ba8f-62e59aeb9167",
                        "sanitized_brief": "",
                        "sanitized_complete": "Incorreta a alternativa A. NÃ£o hÃ¡ dados que mostrem que a restriÃ§Ã£o de gorduras se correlaciona com melhora no controle glicÃªmico. A orientaÃ§Ã£o a ser mantida Ã© a restriÃ§Ã£o das gorduras saturadas (no mÃ¡ximo, atÃ© 10% do VET), visto que se correlacionam com piores desfechos cardiovasculares.",
                        "updated_at": "2021-02-05 01:45:27.537064 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2024-03-21 12:51:57.803168 +0000 UTC"
                },
                {
                    "answer_percentage": 88,
                    "answers": 4602,
                    "body": "alimentos ricos em fibras.",
                    "correct": true,
                    "created_at": "2021-01-25 12:38:58.372767 +0000 UTC",
                    "id": "298963df-9e85-444a-bb2b-524e06c4b109",
                    "position": "1",
                    "sanitized_body": "alimentos ricos em fibras.",
                    "solution": {
                        "alternative_id": "298963df-9e85-444a-bb2b-524e06c4b109",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "Correta a alternativa B A maior quantidade de fibras na dieta para indivÃ­duos diabÃ©ticos advÃ©m do fato de que elas retardam a absorÃ§Ã£o intestinal de carboidratos, diminuindo o pico hiperglicÃªmico pÃ³s prandial. AlÃ©m disso, as fibras aumentam a saciedade, o que Ã© importante para auxiliar no controle do peso",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-02-05 00:36:07.924442 +0000 UTC",
                        "id": "17ee9ddf-060f-4673-97d8-e42b034398c1",
                        "sanitized_brief": "",
                        "sanitized_complete": "Correta a alternativa B A maior quantidade de fibras na dieta para indivÃ­duos diabÃ©ticos advÃ©m do fato de que elas retardam a absorÃ§Ã£o intestinal de carboidratos, diminuindo o pico hiperglicÃªmico pÃ³s prandial. AlÃ©m disso, as fibras aumentam a saciedade, o que Ã© importante para auxiliar no controle do peso",
                        "updated_at": "2021-02-05 01:45:27.542699 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2024-03-21 12:51:58.178365 +0000 UTC"
                },
                {
                    "answer_percentage": 6,
                    "answers": 290,
                    "body": "corte total de Ã¡lcool.",
                    "correct": false,
                    "created_at": "2021-01-25 12:38:58.372767 +0000 UTC",
                    "id": "5e2fed9b-c19e-4476-835e-7854e04dc7dc",
                    "position": "2",
                    "sanitized_body": "corte total de Ã¡lcool.",
                    "solution": {
                        "alternative_id": "5e2fed9b-c19e-4476-835e-7854e04dc7dc",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "Incorreta a alternativa C. A ingesta moderada de Ã¡lcool nÃ£o causa maiores prejuÃ­zos no controle glicÃªmico. PorÃ©m, cabe lembrar que hÃ¡ maior risco de hipoglicemia com seu uso, principalmente em pacientes que utilizam insulina ou secretagogos de insulina, como as sulfonilureias e as glinidas. Nos pacientes com ingesta muito aumentada de Ã¡lcool, ocorre ganho de peso e hiperglicemia.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-02-05 00:36:07.92448 +0000 UTC",
                        "id": "9d48399f-b0de-4083-abf6-c5566ef4d1af",
                        "sanitized_brief": "",
                        "sanitized_complete": "Incorreta a alternativa C. A ingesta moderada de Ã¡lcool nÃ£o causa maiores prejuÃ­zos no controle glicÃªmico. PorÃ©m, cabe lembrar que hÃ¡ maior risco de hipoglicemia com seu uso, principalmente em pacientes que utilizam insulina ou secretagogos de insulina, como as sulfonilureias e as glinidas. Nos pacientes com ingesta muito aumentada de Ã¡lcool, ocorre ganho de peso e hiperglicemia.",
                        "updated_at": "2021-02-05 01:45:27.542869 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2024-03-21 12:51:58.609654 +0000 UTC"
                },
                {
                    "answer_percentage": 2,
                    "answers": 81,
                    "body": "corte total de carboidratos.",
                    "correct": false,
                    "created_at": "2021-01-25 12:38:58.372767 +0000 UTC",
                    "id": "35c952ab-5f0c-4f00-8cfe-e053c895eca4",
                    "position": "3",
                    "sanitized_body": "corte total de carboidratos.",
                    "solution": {
                        "alternative_id": "35c952ab-5f0c-4f00-8cfe-e053c895eca4",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "Incorreta a alternativa D. Apesar de as dietas <i>low carb</i> serem correlacionadas Ã  melhora do controle glicÃªmico, a adesÃ£o a longo prazo Ã© baixa, pois nÃ£o respeita individualidades dietÃ©ticas. HÃ¡ diversos tipos de dietas<i> low carb</i>, cujo conceito Ã© que se tenha &lt; 55% do VET em carboidratos, sendo mais restritivas as dietas cetogÃªnicas, com &lt; 10% VET.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-02-05 00:36:07.933065 +0000 UTC",
                        "id": "4d0a1574-c362-43e0-8aed-fa47e81e41ae",
                        "sanitized_brief": "",
                        "sanitized_complete": "Incorreta a alternativa D. Apesar de as dietas low carb serem correlacionadas Ã  melhora do controle glicÃªmico, a adesÃ£o a longo prazo Ã© baixa, pois nÃ£o respeita individualidades dietÃ©ticas. HÃ¡ diversos tipos de dietas low carb, cujo conceito Ã© que se tenha &lt; 55% do VET em carboidratos, sendo mais restritivas as dietas cetogÃªnicas, com &lt; 10% VET.",
                        "updated_at": "2021-02-05 01:45:27.569789 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2024-03-21 12:51:59.051592 +0000 UTC"
                },
                {
                    "answer_percentage": 1,
                    "answers": 78,
                    "body": "ingestÃ£o de alimentos 3 vezes por dia, no mÃ¡ximo.",
                    "correct": false,
                    "created_at": "2021-01-25 12:38:58.372767 +0000 UTC",
                    "id": "c6155b3e-9f06-488c-85ff-bdf8c57518f0",
                    "position": "4",
                    "sanitized_body": "ingestÃ£o de alimentos 3 vezes por dia, no mÃ¡ximo.",
                    "solution": {
                        "alternative_id": "c6155b3e-9f06-488c-85ff-bdf8c57518f0",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "Incorreta a alternativa E. NÃ£o hÃ¡ dados que suportem o nÃºmero de refeiÃ§Ãµes relacionado a melhores desfechos glicÃªmicos a longo prazo. Essa ideia vem do fato de que os pacientes com diabetes mellitus deveriam se alimentar mais frequentemente pelo risco de hipoglicemias. Entretanto, com as drogas antidiabÃ©ticas atuais e os anÃ¡logos de insulina, hÃ¡ menor risco de hipoglicemias, enfraquecendo tal conceito em relaÃ§Ã£o Ã  dieta.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-02-05 00:36:07.933877 +0000 UTC",
                        "id": "a152af98-bb17-4450-8ba8-bb5c63dadf13",
                        "sanitized_brief": "",
                        "sanitized_complete": "Incorreta a alternativa E. NÃ£o hÃ¡ dados que suportem o nÃºmero de refeiÃ§Ãµes relacionado a melhores desfechos glicÃªmicos a longo prazo. Essa ideia vem do fato de que os pacientes com diabetes mellitus deveriam se alimentar mais frequentemente pelo risco de hipoglicemias. Entretanto, com as drogas antidiabÃ©ticas atuais e os anÃ¡logos de insulina, hÃ¡ menor risco de hipoglicemias, enfraquecendo tal conceito em relaÃ§Ã£o Ã  dieta.",
                        "updated_at": "2021-02-05 01:45:27.557294 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2024-03-21 12:51:59.409495 +0000 UTC"
                }
            ],
            "answer_type": "MULTIPLE_CHOICE",
            "author_id": "bruno-cesar110@hotmail.com",
            "correct_answer_percentage": 88,
            "created_at": "2021-01-25 12:38:58.372767 +0000 UTC",
            "difficulty_level": "MEDIUM",
            "exams": [
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "9b34a94d-754d-4510-8bad-60f649fa825b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:03:06Z",
                    "degree_proof": false,
                    "id": "4000003036",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 98,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "dfa90599-1ee1-4de3-8605-a75ecd3799bd",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:03:45Z",
                    "degree_proof": false,
                    "id": "4000003037",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 77,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "32bef8bd-8aac-4ede-aede-06b9458b026b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:08:01Z",
                    "degree_proof": false,
                    "id": "4000003038",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 8,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "710b6098-b1cc-40fb-a6e9-1978c156b947",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:08:28Z",
                    "degree_proof": false,
                    "id": "4000003039",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 44,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "0609ccdb-db5c-4c47-a306-31a0a655e95c",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:08:57Z",
                    "degree_proof": false,
                    "id": "4000003040",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 66,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "dcb47678-bdba-4669-aa0e-01f71e32541b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:10:05Z",
                    "degree_proof": false,
                    "id": "4000003041",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 3,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "25b55daa-bd57-453d-9099-8c9dfe6d622a",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:10:32Z",
                    "degree_proof": false,
                    "id": "4000003042",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 3,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "2ca62942-4eab-49e5-acaf-e395254eee99",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:10:50Z",
                    "degree_proof": false,
                    "id": "4000003043",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 27,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "776b092f-eb41-4150-a252-b23a0f7914b3",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:11:22Z",
                    "degree_proof": false,
                    "id": "4000003044",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 22,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "046f0505-90c9-4862-b318-388c0d1e8026",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:11:38Z",
                    "degree_proof": false,
                    "id": "4000003045",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 53,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "f2f2f3c5-9759-4201-bca7-2487751bd626",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:11:55Z",
                    "degree_proof": false,
                    "id": "4000003046",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 40,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "f30d24a0-2f2d-43be-9812-73746e91a61a",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "66678bdd-d9e1-4267-a4cf-f3beebfd7d0e",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:12:56Z",
                    "degree_proof": false,
                    "id": "4000003047",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 5,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "417a198f-03b2-417e-8505-8acf83f3059d",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:13:27Z",
                    "degree_proof": false,
                    "id": "4000003048",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 14,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "4d4116be-190d-4321-94c8-66da6d1acb11",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:13:50Z",
                    "degree_proof": false,
                    "id": "4000003049",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 7,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "cccffc77-8a54-477d-b101-01edbb244b74",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:14:09Z",
                    "degree_proof": false,
                    "id": "4000003050",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 31,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "b39a29ec-d8c7-4592-b019-d0c7ee728856",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:14:31Z",
                    "degree_proof": false,
                    "id": "4000003051",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 4,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "eca7ae7c-654b-407e-9b37-ad41ad2834b1",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:14:52Z",
                    "degree_proof": false,
                    "id": "4000003052",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 12,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 3,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "8d4e50ad-d41e-40c9-9f4d-842251c2d2d9",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:15:20Z",
                    "degree_proof": false,
                    "id": "4000003053",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 3,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "updated_at": "2021-01-25T12:16:17Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 3,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "727c6216-9122-4b12-88d1-7f8462a8cce7",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:16:00Z",
                    "degree_proof": false,
                    "id": "4000003054",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 1,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 3,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "c51ec097-d9c1-43e8-9cc7-af320ab894a1",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:17:22Z",
                    "degree_proof": false,
                    "id": "4000003055",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 4,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 3,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "171045d3-6935-423f-bdaf-b95ac441fd8e",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:17:51Z",
                    "degree_proof": false,
                    "id": "4000003056",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 3,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "f30d24a0-2f2d-43be-9812-73746e91a61a",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "82491fbd-d567-4d0e-a259-64c7fb171278",
                        "jury_id": "30c22f9e-d2c5-4f61-b429-33f6c7bb2874",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "07e709e5-56ba-4ae8-8b0b-881fb01eafa4",
                        "specialty_id": "ffd79a37-01ce-4d4e-8bda-950d51a56fe4",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-01-25T12:18:44Z",
                    "degree_proof": false,
                    "id": "4000003057",
                    "location": {
                        "id": "5298"
                    },
                    "number": 1,
                    "open_spaces": 7,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "DE17BEB2-87B3-5AC7-7DD8-7EAB3F841A49"
                        },
                        {
                            "type": "EXAM",
                            "url": "8BC634B7-830C-E01D-4D22-78760F5436AA"
                        },
                        {
                            "type": "ANSWER",
                            "url": "C55260A8-E7F4-874F-1429-FE61EB826203"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 150,
                    "year": 2021
                }
            ],
            "forum_id": "d8b09525-9233-42f7-89fa-7398addc615a",
            "has_student_answer": false,
            "has_user_solution": false,
            "has_video_solution": false,
            "id": "4000140983",
            "labels": [
                "FINAL_ANSWER_SHEET"
            ],
            "public": true,
            "slug": "terapia-nutricional11a5606ce5",
            "solution": {
                "alternative_solutions": null,
                "author_email": "camila.moma@estrategiamed.com.br",
                "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                "brief": "",
                "brief_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "complete": "<b>GABARITO: ALTERNATIVA B</b><div><b><br></b></div><div>A terapia nutricional em indivÃ­duos diabÃ©ticos deve ser individualizada, a fim de que as orientaÃ§Ãµes sejam seguidas e mantidas ao longo do tempo. Em geral, a dieta deve manter o equilÃ­brio entre os macronutrientes, sendo semelhante Ã  da populaÃ§Ã£o em geral: 45-60% de carboidratos, 15-20% de proteÃ­nas e 20-30% de gorduras. As principais diferenÃ§as sÃ£o:</div><div><br></div><div>â¢ ComposiÃ§Ã£o dos carboidratos, com preferÃªncia para aqueles de baixo Ã­ndice glicÃªmico, alÃ©m da restriÃ§Ã£o de sacarose a 5% -10% do valor energÃ©tico total (VET). TambÃ©m nÃ£o se recomenda adiÃ§Ã£o de frutose aos alimentos;</div><div><br></div><div>â¢ LimitaÃ§Ã£o da quantidade de gorduras saturadas a 10% do VET;</div><div><br></div><div>â¢ Quantidade maior de fibras (20g para cada 1000kcal). As fibras retardam a velocidade de absorÃ§Ã£o intestinal dos carboidratos, diminuindo o pico hiperglicÃªmico pÃ³s prandial. AlÃ©m disso, promovem maior saciaÃ§Ã£o, contribuindo para a manutenÃ§Ã£o ou, atÃ© mesmo, perda de peso.</div>",
                "complete_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "created_at": "2021-02-05 00:36:08.137723 +0000 UTC",
                "id": "65ae0ace-55c9-4877-a1ec-964a298be3f5",
                "is_default": false,
                "sanitized_brief": "",
                "sanitized_complete": "GABARITO: ALTERNATIVA BA terapia nutricional em indivÃ­duos diabÃ©ticos deve ser individualizada, a fim de que as orientaÃ§Ãµes sejam seguidas e mantidas ao longo do tempo. Em geral, a dieta deve manter o equilÃ­brio entre os macronutrientes, sendo semelhante Ã  da populaÃ§Ã£o em geral: 45-60% de carboidratos, 15-20% de proteÃ­nas e 20-30% de gorduras. As principais diferenÃ§as sÃ£o:â¢ ComposiÃ§Ã£o dos carboidratos, com preferÃªncia para aqueles de baixo Ã­ndice glicÃªmico, alÃ©m da restriÃ§Ã£o de sacarose a 5% -10% do valor energÃ©tico total (VET). TambÃ©m nÃ£o se recomenda adiÃ§Ã£o de frutose aos alimentos;â¢ LimitaÃ§Ã£o da quantidade de gorduras saturadas a 10% do VET;â¢ Quantidade maior de fibras (20g para cada 1000kcal). As fibras retardam a velocidade de absorÃ§Ã£o intestinal dos carboidratos, diminuindo o pico hiperglicÃªmico pÃ³s prandial. AlÃ©m disso, promovem maior saciaÃ§Ã£o, contribuindo para a manutenÃ§Ã£o ou, atÃ© mesmo, perda de peso.",
                "updated_at": "2021-02-05 01:45:27.747128 +0000 UTC"
            },
            "statement": "A terapia nutricional de uma pessoa com diabetes tipo 2 inclui:",
            "statement_text": "A terapia nutricional de uma pessoa com diabetes tipo 2 inclui:",
            "status": {
                "change_actor": "cnishiama@admin.admin",
                "created_at": "2021-02-05 16:31:12.176077 +0000 UTC",
                "owner": "camila.moma@estrategiamed.com.br",
                "value": "APPROVED"
            },
            "topics": [
                {
                    "has_children": false,
                    "id": "9b23b048c1e34392b641792b33bf2a9a",
                    "master_id": "f8ca00708dc64fb2a95e840b4337a434",
                    "name": "OrientaÃ§Ãµes nutricionais no diabetes mellitus tipo 2",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Tratamento[$$]Tratamento nÃ£o medicamentoso[$$]OrientaÃ§Ãµes nutricionais no diabetes mellitus tipo 2"
                }
            ],
            "unlisted": false,
            "video_solution": {
                "available_resolutions": null,
                "id": "",
                "identifier": "",
                "question_id": ""
            }
        },
        {
            "active": true,
            "alternatives": [
                {
                    "answer_percentage": 2,
                    "answers": 35,
                    "body": "V â¢ F â¢ V â¢ F â¢ V",
                    "correct": false,
                    "created_at": "2020-12-03 14:33:04.822043 +0000 UTC",
                    "id": "944cf84a-3f95-4e59-8622-f6a21b52e512",
                    "position": "0",
                    "sanitized_body": "V â¢ F â¢ V â¢ F â¢ V",
                    "solution": {
                        "alternative_id": "944cf84a-3f95-4e59-8622-f6a21b52e512",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (A) Ã© incorreta. </b>Vide comentÃ¡rio inicial.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-16 22:17:11.561691 +0000 UTC",
                        "id": "8e226e89-5ecf-4292-956e-0967dfc9170e",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (A) Ã© incorreta. Vide comentÃ¡rio inicial.",
                        "updated_at": "2021-05-16 22:17:15.656508 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-16 22:18:59.249576 +0000 UTC"
                },
                {
                    "answer_percentage": 81,
                    "answers": 1164,
                    "body": "F â¢ V â¢ V â¢ V â¢ V",
                    "correct": true,
                    "created_at": "2020-12-03 14:33:04.822043 +0000 UTC",
                    "id": "54ff26ed-8af0-470d-8124-7b63d466fcc7",
                    "position": "1",
                    "sanitized_body": "F â¢ V â¢ V â¢ V â¢ V",
                    "solution": {
                        "alternative_id": "54ff26ed-8af0-470d-8124-7b63d466fcc7",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (B) Ã© correta.</b> Vide comentÃ¡rio inicial.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-16 22:17:11.545868 +0000 UTC",
                        "id": "e2fa71a8-88bd-456c-b01a-0bff57e2b84f",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (B) Ã© correta. Vide comentÃ¡rio inicial.",
                        "updated_at": "2021-05-16 22:17:15.656383 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-16 22:18:59.348283 +0000 UTC"
                },
                {
                    "answer_percentage": 11,
                    "answers": 156,
                    "body": "F â¢ V â¢ F â¢ V â¢ F",
                    "correct": false,
                    "created_at": "2020-12-03 14:33:04.822043 +0000 UTC",
                    "id": "4cfe4ebd-a08b-4ab3-ae1d-a506d73dafb1",
                    "position": "2",
                    "sanitized_body": "F â¢ V â¢ F â¢ V â¢ F",
                    "solution": {
                        "alternative_id": "4cfe4ebd-a08b-4ab3-ae1d-a506d73dafb1",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (C) Ã© incorreta. </b>Vide comentÃ¡rio inicial.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-16 22:17:11.501975 +0000 UTC",
                        "id": "bc1d5a74-3a5f-4954-afb9-b76e6ddcbcc9",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (C) Ã© incorreta. Vide comentÃ¡rio inicial.",
                        "updated_at": "2021-05-16 22:17:15.694369 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-16 22:18:59.457663 +0000 UTC"
                },
                {
                    "answer_percentage": 1,
                    "answers": 11,
                    "body": "F â¢ V â¢ F â¢ F â¢ F",
                    "correct": false,
                    "created_at": "2020-12-03 14:33:04.822043 +0000 UTC",
                    "id": "a625f745-5f00-4122-bccf-37423f9e30e2",
                    "position": "3",
                    "sanitized_body": "F â¢ V â¢ F â¢ F â¢ F",
                    "solution": {
                        "alternative_id": "a625f745-5f00-4122-bccf-37423f9e30e2",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (D) Ã© incorreta.</b> Vide comentÃ¡rio inicial.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-16 22:17:11.551129 +0000 UTC",
                        "id": "f341858b-1f81-41d5-b3e6-661fbc1017cd",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (D) Ã© incorreta. Vide comentÃ¡rio inicial.",
                        "updated_at": "2021-05-16 22:17:15.669233 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-16 22:18:59.558666 +0000 UTC"
                },
                {
                    "answer_percentage": 4,
                    "answers": 63,
                    "body": "F â¢ F â¢ V â¢ V â¢ V",
                    "correct": false,
                    "created_at": "2020-12-03 14:33:04.822043 +0000 UTC",
                    "id": "d4b097fc-8876-42be-ab53-8dbde29462c7",
                    "position": "4",
                    "sanitized_body": "F â¢ F â¢ V â¢ V â¢ V",
                    "solution": {
                        "alternative_id": "d4b097fc-8876-42be-ab53-8dbde29462c7",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (E) Ã© incorreta.</b> Vide comentÃ¡rio inicial.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-16 22:17:11.515586 +0000 UTC",
                        "id": "5f883757-1464-4a3b-8fa0-88ce697c3561",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (E) Ã© incorreta. Vide comentÃ¡rio inicial.",
                        "updated_at": "2021-05-16 22:17:15.692878 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-16 22:18:59.689203 +0000 UTC"
                }
            ],
            "answer_type": "MULTIPLE_CHOICE",
            "author_id": "bruno-cesar110@hotmail.com",
            "correct_answer_percentage": 81,
            "created_at": "2020-12-03 14:33:04.822043 +0000 UTC",
            "difficulty_level": "MEDIUM",
            "exams": [
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "64f91c91-f19b-4469-931e-49312fabcde3",
                        "jury_id": "3c4cb318-37fd-4f1d-99bc-0ea3f7943358",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "2db85153-c19d-47ed-ae73-2faaaa65c63b",
                        "specialty_id": "9fbb6169-ce34-45e3-ac72-71bd7e965496",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-12-03T12:25:38Z",
                    "degree_proof": false,
                    "id": "4000002112",
                    "location": {
                        "id": "4528"
                    },
                    "number": 1,
                    "open_spaces": 1,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "D52446B4-C2AD-336D-4435-495E9E73959D"
                        },
                        {
                            "type": "NOTICE",
                            "url": "98D06DA2-63ED-71C9-5C02-C77A81FFE31F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "F561E8A7-071C-511F-0511-6E1836DA22DF"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 350,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "64f91c91-f19b-4469-931e-49312fabcde3",
                        "jury_id": "3c4cb318-37fd-4f1d-99bc-0ea3f7943358",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "2db85153-c19d-47ed-ae73-2faaaa65c63b",
                        "specialty_id": "046f0505-90c9-4862-b318-388c0d1e8026",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-12-03T12:30:46Z",
                    "degree_proof": false,
                    "id": "4000002113",
                    "location": {
                        "id": "4528"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "D52446B4-C2AD-336D-4435-495E9E73959D"
                        },
                        {
                            "type": "NOTICE",
                            "url": "98D06DA2-63ED-71C9-5C02-C77A81FFE31F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "F561E8A7-071C-511F-0511-6E1836DA22DF"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 350,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "64f91c91-f19b-4469-931e-49312fabcde3",
                        "jury_id": "3c4cb318-37fd-4f1d-99bc-0ea3f7943358",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "2db85153-c19d-47ed-ae73-2faaaa65c63b",
                        "specialty_id": "dfa90599-1ee1-4de3-8605-a75ecd3799bd",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-12-03T12:51:10Z",
                    "degree_proof": false,
                    "id": "4000002114",
                    "location": {
                        "id": "4528"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "D52446B4-C2AD-336D-4435-495E9E73959D"
                        },
                        {
                            "type": "NOTICE",
                            "url": "98D06DA2-63ED-71C9-5C02-C77A81FFE31F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "F561E8A7-071C-511F-0511-6E1836DA22DF"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 350,
                    "updated_at": "2020-12-03T13:00:50Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "64f91c91-f19b-4469-931e-49312fabcde3",
                        "jury_id": "3c4cb318-37fd-4f1d-99bc-0ea3f7943358",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "2db85153-c19d-47ed-ae73-2faaaa65c63b",
                        "specialty_id": "32bef8bd-8aac-4ede-aede-06b9458b026b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-12-03T12:53:55Z",
                    "degree_proof": false,
                    "id": "4000002115",
                    "location": {
                        "id": "4528"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "D52446B4-C2AD-336D-4435-495E9E73959D"
                        },
                        {
                            "type": "NOTICE",
                            "url": "98D06DA2-63ED-71C9-5C02-C77A81FFE31F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "F561E8A7-071C-511F-0511-6E1836DA22DF"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 350,
                    "updated_at": "2020-12-03T13:09:28Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "64f91c91-f19b-4469-931e-49312fabcde3",
                        "jury_id": "3c4cb318-37fd-4f1d-99bc-0ea3f7943358",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "2db85153-c19d-47ed-ae73-2faaaa65c63b",
                        "specialty_id": "9b34a94d-754d-4510-8bad-60f649fa825b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-12-03T13:10:16Z",
                    "degree_proof": false,
                    "id": "4000002116",
                    "location": {
                        "id": "4528"
                    },
                    "number": 1,
                    "open_spaces": 3,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "D52446B4-C2AD-336D-4435-495E9E73959D"
                        },
                        {
                            "type": "NOTICE",
                            "url": "98D06DA2-63ED-71C9-5C02-C77A81FFE31F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "F561E8A7-071C-511F-0511-6E1836DA22DF"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 350,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "64f91c91-f19b-4469-931e-49312fabcde3",
                        "jury_id": "3c4cb318-37fd-4f1d-99bc-0ea3f7943358",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "2db85153-c19d-47ed-ae73-2faaaa65c63b",
                        "specialty_id": "eca7ae7c-654b-407e-9b37-ad41ad2834b1",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-12-03T13:10:50Z",
                    "degree_proof": false,
                    "id": "4000002117",
                    "location": {
                        "id": "4528"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "D52446B4-C2AD-336D-4435-495E9E73959D"
                        },
                        {
                            "type": "NOTICE",
                            "url": "98D06DA2-63ED-71C9-5C02-C77A81FFE31F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "F561E8A7-071C-511F-0511-6E1836DA22DF"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 350,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "64f91c91-f19b-4469-931e-49312fabcde3",
                        "jury_id": "3c4cb318-37fd-4f1d-99bc-0ea3f7943358",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "2db85153-c19d-47ed-ae73-2faaaa65c63b",
                        "specialty_id": "0609ccdb-db5c-4c47-a306-31a0a655e95c",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-12-03T13:11:23Z",
                    "degree_proof": false,
                    "id": "4000002118",
                    "location": {
                        "id": "4528"
                    },
                    "number": 1,
                    "open_spaces": 4,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "D52446B4-C2AD-336D-4435-495E9E73959D"
                        },
                        {
                            "type": "NOTICE",
                            "url": "98D06DA2-63ED-71C9-5C02-C77A81FFE31F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "F561E8A7-071C-511F-0511-6E1836DA22DF"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 350,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "64f91c91-f19b-4469-931e-49312fabcde3",
                        "jury_id": "3c4cb318-37fd-4f1d-99bc-0ea3f7943358",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "2db85153-c19d-47ed-ae73-2faaaa65c63b",
                        "specialty_id": "8d4e50ad-d41e-40c9-9f4d-842251c2d2d9",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-12-03T13:11:46Z",
                    "degree_proof": false,
                    "id": "4000002119",
                    "location": {
                        "id": "4528"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "D52446B4-C2AD-336D-4435-495E9E73959D"
                        },
                        {
                            "type": "NOTICE",
                            "url": "98D06DA2-63ED-71C9-5C02-C77A81FFE31F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "F561E8A7-071C-511F-0511-6E1836DA22DF"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 350,
                    "updated_at": "2020-12-03T13:12:27Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "64f91c91-f19b-4469-931e-49312fabcde3",
                        "jury_id": "3c4cb318-37fd-4f1d-99bc-0ea3f7943358",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "2db85153-c19d-47ed-ae73-2faaaa65c63b",
                        "specialty_id": "25b55daa-bd57-453d-9099-8c9dfe6d622a",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-12-03T13:13:04Z",
                    "degree_proof": false,
                    "id": "4000002120",
                    "location": {
                        "id": "4528"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "D52446B4-C2AD-336D-4435-495E9E73959D"
                        },
                        {
                            "type": "NOTICE",
                            "url": "98D06DA2-63ED-71C9-5C02-C77A81FFE31F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "F561E8A7-071C-511F-0511-6E1836DA22DF"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 350,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "64f91c91-f19b-4469-931e-49312fabcde3",
                        "jury_id": "3c4cb318-37fd-4f1d-99bc-0ea3f7943358",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "2db85153-c19d-47ed-ae73-2faaaa65c63b",
                        "specialty_id": "710b6098-b1cc-40fb-a6e9-1978c156b947",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-12-03T13:13:30Z",
                    "degree_proof": false,
                    "id": "4000002121",
                    "location": {
                        "id": "4528"
                    },
                    "number": 1,
                    "open_spaces": 4,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "D52446B4-C2AD-336D-4435-495E9E73959D"
                        },
                        {
                            "type": "NOTICE",
                            "url": "98D06DA2-63ED-71C9-5C02-C77A81FFE31F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "F561E8A7-071C-511F-0511-6E1836DA22DF"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 350,
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "64f91c91-f19b-4469-931e-49312fabcde3",
                        "jury_id": "3c4cb318-37fd-4f1d-99bc-0ea3f7943358",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "2db85153-c19d-47ed-ae73-2faaaa65c63b",
                        "specialty_id": "776b092f-eb41-4150-a252-b23a0f7914b3",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-12-03T13:14:13Z",
                    "degree_proof": false,
                    "id": "4000002122",
                    "location": {
                        "id": "4528"
                    },
                    "number": 1,
                    "open_spaces": 3,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "D52446B4-C2AD-336D-4435-495E9E73959D"
                        },
                        {
                            "type": "NOTICE",
                            "url": "98D06DA2-63ED-71C9-5C02-C77A81FFE31F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "F561E8A7-071C-511F-0511-6E1836DA22DF"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "subscription_fee": 350,
                    "year": 2021
                }
            ],
            "has_student_answer": false,
            "has_user_solution": false,
            "has_video_solution": true,
            "id": "4000129738",
            "labels": [
                "FINAL_ANSWER_SHEET"
            ],
            "public": true,
            "slug": "Identifique18399351a1e",
            "solution": {
                "alternative_solutions": null,
                "author_email": "camila.moma@estrategiamed.com.br",
                "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                "brief": "",
                "brief_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "complete": "<b>Gabarito: alternativa (B)- F-V-V-V-V</b><div wfd-id=\"95829\"><b>ComentÃ¡rios:</b></div><div wfd-id=\"95828\"><br></div><div wfd-id=\"95827\">Vamos analisar cada afirmativa separadamente:</div><div wfd-id=\"95826\"><br></div><div wfd-id=\"95825\"><b>A afirmativa </b>âO mecanismo pelo qual a obesidade induz resistÃªncia Ã  insulina Ã© mal compreendido, mas descarta-se o processo inflamatÃ³rio como mediador comum que liga a obesidade Ã  patogÃªnese do DM2â <b>Ã© falsa</b>. De forma simplificada, a obesidade se relaciona ao diabetes mellitus tipo 2 da seguinte maneira: quando a expansÃ£o do tecido adiposo ultrapassa a capacidade de oxigenaÃ§Ã£o local, ocorre hipÃ³xia e formaÃ§Ã£o de estresse oxidativo, com liberaÃ§Ã£o de citocinas. Estas, por sua vez, atraem macrÃ³fagos que exacerbam o processo de inflamaÃ§Ã£o, ocasionando resistÃªncia Ã  insulina. Contribuindo para isso, o excesso de Ã¡cidos graxos comeÃ§a a se depositar em Ã³rgÃ£os viscerais, visto que o tecido adiposo nÃ£o consegue recebÃª-los integralmente devido Ã  inflamaÃ§Ã£o. O aumento de gordura visceral leva Ã  lipotoxicidade, com consequente disfunÃ§Ã£o tecidual. Os Ã³rgÃ£os acometidos, em especial o fÃ­gado e mÃºsculos, amplificam a produÃ§Ã£o dessas citocinas inflamatÃ³rias atravÃ©s de macrÃ³fagos locais; como resultado, hÃ¡ diminuiÃ§Ã£o de cÃ©lulas T reguladoras e eosinÃ³filos, responsÃ¡veis pelo controle da inflamaÃ§Ã£o, perpetuando, assim, o quadro inflamatÃ³rio que ocasiona a resistÃªncia Ã  insulina.&nbsp;</div><div wfd-id=\"95824\">&nbsp;Adicionalmente, o excesso de Ã¡cidos graxos livres, combinado com a resistÃªncia Ã  insulina, estimula a gliconeogÃªnese hepÃ¡tica, contribuindo para o aparecimento de hiperglicemia.</div><div wfd-id=\"95823\"><br></div><div wfd-id=\"95822\"><b>A afirmativa</b> âO DM2 Ã© causado por uma combinaÃ§Ã£o de vÃ¡rios graus de resistÃªncia Ã  insulina e de deficiÃªncia relativa de insulina e sua ocorrÃªncia provavelmente representa uma interaÃ§Ã£o complexa entre muitos genes e fatores ambientaisâ <b>Ã© verdadeira</b>. O diabetes mellitus tipo 2 engloba diversos defeitos no controle da homeostase da glicose que culminam com a presenÃ§a de hiperglicemia. Ã claro que a principal caracterÃ­stica do DM tipo 2 Ã© a resistÃªncia Ã  aÃ§Ã£o da insulina, que leva a menor captaÃ§Ã£o perifÃ©rica de glicose, mas temos que lembrar que hÃ¡ outras alteraÃ§Ãµes associadas, como:</div><div wfd-id=\"95821\">â¢\tDiminuiÃ§Ã£o da produÃ§Ã£o de incretinas (hormÃ´nios intestinais secretados em resposta Ã  chegada dos alimentos e que estimula a secreÃ§Ã£o de insulina);</div><div wfd-id=\"95820\">â¢\tMaior expressÃ£o de transportadores de sÃ³dio e glicose nos tÃºbulos renais (aumentando a reabsorÃ§Ã£o de glicose tubular);</div><div wfd-id=\"95819\">â¢\tAlteraÃ§Ã£o de neurotransmissores cerebrais (ocasionando aumento de apetite e diminuiÃ§Ã£o de saciedade);</div><div wfd-id=\"95818\">â¢\tDisfunÃ§Ã£o progressiva das cÃ©lulas beta pancreÃ¡ticas, aumento da produÃ§Ã£o hepÃ¡tica de glicose (pela resistÃªncia Ã  insulina aliada ao aumento dos nÃ­veis de glucagon).</div><div wfd-id=\"95817\">O diabetes mellitus tipo 2 Ã© uma doenÃ§a poligÃªnica com alta penetrÃ¢ncia familiar, o que faz com que encontremos vÃ¡rios familiares afetados. Entretanto, apesar da predisposiÃ§Ã£o genÃ©tica, os fatores ambientais contribuem de forma significativa para o aparecimento da hiperglicemia, sendo os mais importantes a obesidade, o sedentarismo, o padrÃ£o dietÃ©tico nÃ£o saudÃ¡vel (rico em gorduras saturadas e aÃ§Ãºcares e pobre em fibras), a sÃ­ndrome metabÃ³lica, o tabagismo ativo, as doenÃ§as cardiovasculares, a sÃ­ndrome dos ovÃ¡rios policÃ­sticos e o avanÃ§ar da idade.</div><div wfd-id=\"95816\"><br></div><div wfd-id=\"95815\"><b>A afirmativa </b>âA busca por genes candidatos plausÃ­veis na fisiopatologia do DM2 envolve os que codificam proteÃ­nas que possam estar envolvidas no desenvolvimento pancreÃ¡tico e na sÃ­ntese, secreÃ§Ã£o ou aÃ§Ã£o da insulinaâ <b>Ã© verdadeira</b>. Os estudos mostram que hÃ¡ diferentes genes envolvidos na regulaÃ§Ã£o da secreÃ§Ã£o de insulina e na deposiÃ§Ã£o de gordura corporal e que determinadas alteraÃ§Ãµes levam ao maior risco de desenvolvimento do diabetes mellitus tipo 2. Por exemplo, hÃ¡ genes que ocasionam menor despolarizaÃ§Ã£o da membrana celular, com consequente reduÃ§Ã£o da secreÃ§Ã£o dos grÃ¢nulos de insulina. Outros levam Ã  dificuldade de deposiÃ§Ã£o do excesso de energia proveniente de dietas hipercalÃ³ricas, o que ocasiona deposiÃ§Ã£o visceral e maior resistÃªncia Ã  aÃ§Ã£o da insulina.</div><div wfd-id=\"95814\"><br></div><div wfd-id=\"95813\"><b>A afirmativa</b> âOs fatores de risco ambientais mais marcantes na maioria dos pacientes que desenvolvem DM2 sÃ£o o aumento de peso e a diminuiÃ§Ã£o da atividade fÃ­sicaâ <b>Ã© verdadeira</b>. O aumento da prevalÃªncia de diabetes mellitus tipo 2 na populaÃ§Ã£o em geral acompanha de forma paralela o aumento da obesidade, mostrando a importÃ¢ncia do ganho ponderal e da diminuiÃ§Ã£o de atividade fÃ­sica no desenvolvimento da resistÃªncia Ã  insulina e da hiperglicemia.</div><div wfd-id=\"95812\"><br></div><div wfd-id=\"95811\"><b>A afirmativa</b> âUm grande nÃºmero de medicamentos pode prejudicar a tolerÃ¢ncia Ã  glicose, atuando na diminuiÃ§Ã£o da secreÃ§Ã£o de insulina, no aumento da produÃ§Ã£o hepÃ¡tica de glicose ou na induÃ§Ã£o de resistÃªncia Ã  aÃ§Ã£o da insulinaâ <b>Ã© verdadeira</b>. Vamos relembrar as medicaÃ§Ãµes que podem induzir hiperglicemia:</div><div wfd-id=\"95810\"><!-- BEGIN:IMAGE_TO_REPLACE --><img src=\"https://estrategia-prod-questoes.s3.amazonaws.com/images/C3B597DA-CBCA-C169-EF4B-3DA18463B3AC/C3B597DA-CBCA-C169-EF4B-3DA18463B3AC-400.png\"><!-- END:IMAGE_TO_REPLACE --><br></div><div wfd-id=\"95809\"><br></div>",
                "complete_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "created_at": "2021-05-16 22:17:11.616559 +0000 UTC",
                "id": "6dd1a4d0-2493-461e-9f56-c4b4a5d86e0e",
                "is_default": false,
                "sanitized_brief": "",
                "sanitized_complete": "Gabarito: alternativa (B)- F-V-V-V-VComentÃ¡rios:Vamos analisar cada afirmativa separadamente:A afirmativa âO mecanismo pelo qual a obesidade induz resistÃªncia Ã  insulina Ã© mal compreendido, mas descarta-se o processo inflamatÃ³rio como mediador comum que liga a obesidade Ã  patogÃªnese do DM2â Ã© falsa. De forma simplificada, a obesidade se relaciona ao diabetes mellitus tipo 2 da seguinte maneira: quando a expansÃ£o do tecido adiposo ultrapassa a capacidade de oxigenaÃ§Ã£o local, ocorre hipÃ³xia e formaÃ§Ã£o de estresse oxidativo, com liberaÃ§Ã£o de citocinas. Estas, por sua vez, atraem macrÃ³fagos que exacerbam o processo de inflamaÃ§Ã£o, ocasionando resistÃªncia Ã  insulina. Contribuindo para isso, o excesso de Ã¡cidos graxos comeÃ§a a se depositar em Ã³rgÃ£os viscerais, visto que o tecido adiposo nÃ£o consegue recebÃª-los integralmente devido Ã  inflamaÃ§Ã£o. O aumento de gordura visceral leva Ã  lipotoxicidade, com consequente disfunÃ§Ã£o tecidual. Os Ã³rgÃ£os acometidos, em especial o fÃ­gado e mÃºsculos, amplificam a produÃ§Ã£o dessas citocinas inflamatÃ³rias atravÃ©s de macrÃ³fagos locais; como resultado, hÃ¡ diminuiÃ§Ã£o de cÃ©lulas T reguladoras e eosinÃ³filos, responsÃ¡veis pelo controle da inflamaÃ§Ã£o, perpetuando, assim, o quadro inflamatÃ³rio que ocasiona a resistÃªncia Ã  insulina.Â Â Adicionalmente, o excesso de Ã¡cidos graxos livres, combinado com a resistÃªncia Ã  insulina, estimula a gliconeogÃªnese hepÃ¡tica, contribuindo para o aparecimento de hiperglicemia.A afirmativa âO DM2 Ã© causado por uma combinaÃ§Ã£o de vÃ¡rios graus de resistÃªncia Ã  insulina e de deficiÃªncia relativa de insulina e sua ocorrÃªncia provavelmente representa uma interaÃ§Ã£o complexa entre muitos genes e fatores ambientaisâ Ã© verdadeira. O diabetes mellitus tipo 2 engloba diversos defeitos no controle da homeostase da glicose que culminam com a presenÃ§a de hiperglicemia. Ã claro que a principal caracterÃ­stica do DM tipo 2 Ã© a resistÃªncia Ã  aÃ§Ã£o da insulina, que leva a menor captaÃ§Ã£o perifÃ©rica de glicose, mas temos que lembrar que hÃ¡ outras alteraÃ§Ãµes associadas, como:â¢\tDiminuiÃ§Ã£o da produÃ§Ã£o de incretinas (hormÃ´nios intestinais secretados em resposta Ã  chegada dos alimentos e que estimula a secreÃ§Ã£o de insulina);â¢\tMaior expressÃ£o de transportadores de sÃ³dio e glicose nos tÃºbulos renais (aumentando a reabsorÃ§Ã£o de glicose tubular);â¢\tAlteraÃ§Ã£o de neurotransmissores cerebrais (ocasionando aumento de apetite e diminuiÃ§Ã£o de saciedade);â¢\tDisfunÃ§Ã£o progressiva das cÃ©lulas beta pancreÃ¡ticas, aumento da produÃ§Ã£o hepÃ¡tica de glicose (pela resistÃªncia Ã  insulina aliada ao aumento dos nÃ­veis de glucagon).O diabetes mellitus tipo 2 Ã© uma doenÃ§a poligÃªnica com alta penetrÃ¢ncia familiar, o que faz com que encontremos vÃ¡rios familiares afetados. Entretanto, apesar da predisposiÃ§Ã£o genÃ©tica, os fatores ambientais contribuem de forma significativa para o aparecimento da hiperglicemia, sendo os mais importantes a obesidade, o sedentarismo, o padrÃ£o dietÃ©tico nÃ£o saudÃ¡vel (rico em gorduras saturadas e aÃ§Ãºcares e pobre em fibras), a sÃ­ndrome metabÃ³lica, o tabagismo ativo, as doenÃ§as cardiovasculares, a sÃ­ndrome dos ovÃ¡rios policÃ­sticos e o avanÃ§ar da idade.A afirmativa âA busca por genes candidatos plausÃ­veis na fisiopatologia do DM2 envolve os que codificam proteÃ­nas que possam estar envolvidas no desenvolvimento pancreÃ¡tico e na sÃ­ntese, secreÃ§Ã£o ou aÃ§Ã£o da insulinaâ Ã© verdadeira. Os estudos mostram que hÃ¡ diferentes genes envolvidos na regulaÃ§Ã£o da secreÃ§Ã£o de insulina e na deposiÃ§Ã£o de gordura corporal e que determinadas alteraÃ§Ãµes levam ao maior risco de desenvolvimento do diabetes mellitus tipo 2. Por exemplo, hÃ¡ genes que ocasionam menor despolarizaÃ§Ã£o da membrana celular, com consequente reduÃ§Ã£o da secreÃ§Ã£o dos grÃ¢nulos de insulina. Outros levam Ã  dificuldade de deposiÃ§Ã£o do excesso de energia proveniente de dietas hipercalÃ³ricas, o que ocasiona deposiÃ§Ã£o visceral e maior resistÃªncia Ã  aÃ§Ã£o da insulina.A afirmativa âOs fatores de risco ambientais mais marcantes na maioria dos pacientes que desenvolvem DM2 sÃ£o o aumento de peso e a diminuiÃ§Ã£o da atividade fÃ­sicaâ Ã© verdadeira. O aumento da prevalÃªncia de diabetes mellitus tipo 2 na populaÃ§Ã£o em geral acompanha de forma paralela o aumento da obesidade, mostrando a importÃ¢ncia do ganho ponderal e da diminuiÃ§Ã£o de atividade fÃ­sica no desenvolvimento da resistÃªncia Ã  insulina e da hiperglicemia.A afirmativa âUm grande nÃºmero de medicamentos pode prejudicar a tolerÃ¢ncia Ã  glicose, atuando na diminuiÃ§Ã£o da secreÃ§Ã£o de insulina, no aumento da produÃ§Ã£o hepÃ¡tica de glicose ou na induÃ§Ã£o de resistÃªncia Ã  aÃ§Ã£o da insulinaâ Ã© verdadeira. Vamos relembrar as medicaÃ§Ãµes que podem induzir hiperglicemia:",
                "updated_at": "2021-05-16 22:17:15.786623 +0000 UTC",
                "video_solution_id": "34ceb65c-f210-4cdc-a548-fb5017dbf64a"
            },
            "statement": "Identifique abaixo as afirmativas verdadeiras ( V ) e as falsas ( F ).<div><br></div><div>(&nbsp; &nbsp;) O mecanismo pelo qual a obesidade induz resistÃªncia Ã  insulina Ã© mal compreendido, mas descarta-se o processo inflamatÃ³rio  como mediador comum que liga a obesidade Ã  patogÃªnese do DM2.</div><div><br></div><div>(&nbsp; &nbsp;) O DM2 Ã© causado por uma combinaÃ§Ã£o de vÃ¡rios graus de resistÃªncia Ã  insulina e de deficiÃªncia relativa de insulina e sua ocorrÃªncia provavelmente representa uma interaÃ§Ã£o complexa entre muitos genes e fatores ambientais.</div><div><br></div><div>(&nbsp; &nbsp;) A busca por genes candidatos plausÃ­veis na fisiopatologia do DM2 envolve os que codificam proteÃ­nas que possam estar envolvidas no desenvolvimento pancreÃ¡tico e na sÃ­ntese, secreÃ§Ã£o ou aÃ§Ã£o da insulina.</div><div><br></div><div>(&nbsp; &nbsp;) Os fatores de risco ambientais mais marcantes na maioria dos pacientes que desenvolvem DM2 sÃ£o o aumento de peso e a diminuiÃ§Ã£o da atividade fÃ­sica.</div><div><br></div><div>(&nbsp; &nbsp;) Um grande nÃºmero de medicamentos pode prejudicar a tolerÃ¢ncia Ã  glicose, atuando na diminuiÃ§Ã£o da secreÃ§Ã£o de insulina, no aumento da produÃ§Ã£o hepÃ¡tica de glicose ou na induÃ§Ã£o de resistÃªncia Ã  aÃ§Ã£o da insulina.</div><div><br></div><div>Assinale a alternativa que indica a sequÃªncia correta, de cima para baixo.</div>",
            "statement_text": "Identifique abaixo as afirmativas verdadeiras ( V ) e as falsas ( F ).(Â  Â ) O mecanismo pelo qual a obesidade induz resistÃªncia Ã  insulina Ã© mal compreendido, mas descarta-se o processo inflamatÃ³rio  como mediador comum que liga a obesidade Ã  patogÃªnese do DM2.(Â  Â ) O DM2 Ã© causado por uma combinaÃ§Ã£o de vÃ¡rios graus de resistÃªncia Ã  insulina e de deficiÃªncia relativa de insulina e sua ocorrÃªncia provavelmente representa uma interaÃ§Ã£o complexa entre muitos genes e fatores ambientais.(Â  Â ) A busca por genes candidatos plausÃ­veis na fisiopatologia do DM2 envolve os que codificam proteÃ­nas que possam estar envolvidas no desenvolvimento pancreÃ¡tico e na sÃ­ntese, secreÃ§Ã£o ou aÃ§Ã£o da insulina.(Â  Â ) Os fatores de risco ambientais mais marcantes na maioria dos pacientes que desenvolvem DM2 sÃ£o o aumento de peso e a diminuiÃ§Ã£o da atividade fÃ­sica.(Â  Â ) Um grande nÃºmero de medicamentos pode prejudicar a tolerÃ¢ncia Ã  glicose, atuando na diminuiÃ§Ã£o da secreÃ§Ã£o de insulina, no aumento da produÃ§Ã£o hepÃ¡tica de glicose ou na induÃ§Ã£o de resistÃªncia Ã  aÃ§Ã£o da insulina.Assinale a alternativa que indica a sequÃªncia correta, de cima para baixo.",
            "status": {
                "change_actor": "cnishiama@admin.admin",
                "created_at": "2021-05-18 04:03:50.110334 +0000 UTC",
                "owner": "camila.moma@estrategiamed.com.br",
                "value": "APPROVED"
            },
            "topics": [
                {
                    "has_children": false,
                    "id": "50e079720efe49ae9f538ce2c1b4cc8f",
                    "master_id": "e7750157ebd549b78392eee4b4b3154d",
                    "name": "Fatores de risco",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Fatores de risco"
                },
                {
                    "has_children": false,
                    "id": "ab6c6a1fb6604cf98243ac486f80dac8",
                    "master_id": "0a6abdce2fbc45aa8ba8f0e75875ec84",
                    "name": "Endocrinologia ",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia "
                },
                {
                    "has_children": false,
                    "id": "d12204087c1e4318883189319608ecbe",
                    "master_id": "e7750157ebd549b78392eee4b4b3154d",
                    "name": "PatogÃªnese e evoluÃ§Ã£o da doenÃ§a",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]PatogÃªnese e evoluÃ§Ã£o da doenÃ§a"
                }
            ],
            "unlisted": false,
            "video_solution": {
                "available_resolutions": [
                    {
                        "resolution": "720",
                        "url": "https://api.estrategia.com/questoes/sign/medicina/processadas/4000129738-720.mp4"
                    }
                ],
                "id": "34ceb65c-f210-4cdc-a548-fb5017dbf64a",
                "identifier": "",
                "question_id": "4000129738"
            },
            "video_solution_id": "34ceb65c-f210-4cdc-a548-fb5017dbf64a"
        },
        {
            "active": true,
            "alternatives": [
                {
                    "answer_percentage": 66,
                    "answers": 2507,
                    "body": "ReduÃ§Ã£o do risco de cetoacidose diabÃ©tica em pacientes diabÃ©ticos tipo 2",
                    "correct": true,
                    "created_at": "2021-02-13 18:42:57.435285 +0000 UTC",
                    "id": "9764210c-be34-4a68-a037-f625140aee90",
                    "position": "0",
                    "sanitized_body": "ReduÃ§Ã£o do risco de cetoacidose diabÃ©tica em pacientes diabÃ©ticos tipo 2",
                    "solution": {
                        "alternative_id": "9764210c-be34-4a68-a037-f625140aee90",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (A) Ã© correta. </b>Com o uso mais frequente de iSGLT-2, foram descritos casos de cetoacidose diabÃ©tica euglicÃªmica (isto Ã©, com glicemias &lt; 250 mg/dL) em pacientes utilizando tal classe medicamentosa. O mecanismo fisiopatolÃ³gico para a ocorrÃªncia da cetoacidose Ã© que, em indivÃ­duos insulinopÃªnicos, o iSGLT-2 diminui ainda mais a secreÃ§Ã£o de insulina, uma vez que causa glicosÃºria e reduÃ§Ã£o da glicemia (vocÃª lembra que a secreÃ§Ã£o de insulina pela cÃ©lula beta Ã© regulada pelos nÃ­veis glicÃªmicos?); assim, em situaÃ§Ãµes em que hÃ¡ aumento dos hormÃ´nios contrarreguladores (infecÃ§Ãµes, traumas, cirurgias) e diminuiÃ§Ã£o da ingesta de carboidratos, nÃ£o hÃ¡ secreÃ§Ã£o de insulina suficiente para bloquear a cetogÃªnese. Portanto, pacientes usuÃ¡rios de iSGLT-2 que se queixam de dor abdominal, nÃ¡useas e vÃ´mitos devem ser avaliados quanto Ã  presenÃ§a de acidose mesmo se glicemia normal.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-19 20:55:27.605321 +0000 UTC",
                        "id": "63e3db74-a807-4cfb-951c-771c727cb982",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (A) Ã© correta. Com o uso mais frequente de iSGLT-2, foram descritos casos de cetoacidose diabÃ©tica euglicÃªmica (isto Ã©, com glicemias &lt; 250 mg/dL) em pacientes utilizando tal classe medicamentosa. O mecanismo fisiopatolÃ³gico para a ocorrÃªncia da cetoacidose Ã© que, em indivÃ­duos insulinopÃªnicos, o iSGLT-2 diminui ainda mais a secreÃ§Ã£o de insulina, uma vez que causa glicosÃºria e reduÃ§Ã£o da glicemia (vocÃª lembra que a secreÃ§Ã£o de insulina pela cÃ©lula beta Ã© regulada pelos nÃ­veis glicÃªmicos?); assim, em situaÃ§Ãµes em que hÃ¡ aumento dos hormÃ´nios contrarreguladores (infecÃ§Ãµes, traumas, cirurgias) e diminuiÃ§Ã£o da ingesta de carboidratos, nÃ£o hÃ¡ secreÃ§Ã£o de insulina suficiente para bloquear a cetogÃªnese. Portanto, pacientes usuÃ¡rios de iSGLT-2 que se queixam de dor abdominal, nÃ¡useas e vÃ´mitos devem ser avaliados quanto Ã  presenÃ§a de acidose mesmo se glicemia normal.",
                        "updated_at": "2021-05-19 20:55:30.125464 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-19 20:21:16.745853 +0000 UTC"
                },
                {
                    "answer_percentage": 9,
                    "answers": 326,
                    "body": "ReduÃ§Ã£o da mortalidade por insuficiÃªncia cardÃ­aca em pacientes nÃ£o diabÃ©ticos",
                    "correct": false,
                    "created_at": "2021-02-13 18:42:57.435285 +0000 UTC",
                    "id": "716099de-9ab8-4be5-8b0e-6382d5b5e71f",
                    "position": "1",
                    "sanitized_body": "ReduÃ§Ã£o da mortalidade por insuficiÃªncia cardÃ­aca em pacientes nÃ£o diabÃ©ticos",
                    "solution": {
                        "alternative_id": "716099de-9ab8-4be5-8b0e-6382d5b5e71f",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (B) Ã© incorreta. </b>Os iSGLT-2, em especial a dapagliflozina, mostraram reduÃ§Ã£o de mortalidade cardiovascular e de hospitalizaÃ§Ãµes em pacientes com insuficiÃªncia cardÃ­aca com fraÃ§Ã£o de ejeÃ§Ã£o reduzida, mesmo nÃ£o sendo diabÃ©ticos!",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-19 20:55:27.563284 +0000 UTC",
                        "id": "916da90e-36e9-44c1-9562-cfcf62714190",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (B) Ã© incorreta. Os iSGLT-2, em especial a dapagliflozina, mostraram reduÃ§Ã£o de mortalidade cardiovascular e de hospitalizaÃ§Ãµes em pacientes com insuficiÃªncia cardÃ­aca com fraÃ§Ã£o de ejeÃ§Ã£o reduzida, mesmo nÃ£o sendo diabÃ©ticos!",
                        "updated_at": "2021-05-19 20:55:30.091178 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-19 20:21:16.817243 +0000 UTC"
                },
                {
                    "answer_percentage": 5,
                    "answers": 181,
                    "body": "ReduÃ§Ã£o da velocidade da progressÃ£o da disfunÃ§Ã£o renal em pacientes com nefropatia diabÃ©tica",
                    "correct": false,
                    "created_at": "2021-02-13 18:42:57.435285 +0000 UTC",
                    "id": "ff6d3572-ce91-4294-8fd0-b0c758a2a5ae",
                    "position": "2",
                    "sanitized_body": "ReduÃ§Ã£o da velocidade da progressÃ£o da disfunÃ§Ã£o renal em pacientes com nefropatia diabÃ©tica",
                    "solution": {
                        "alternative_id": "ff6d3572-ce91-4294-8fd0-b0c758a2a5ae",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (C) Ã© incorreta.</b> Os iSGLT-2, em especial a canagliflozina, mostraram 32% de reduÃ§Ã£o da progressÃ£o da doenÃ§a renal em indivÃ­duos diabÃ©ticos com taxa de filtraÃ§Ã£o glomerular &gt; 30 mL/minuto, mas com albuminÃºria &gt; 300 mg/g de creatinina.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-19 20:55:27.584422 +0000 UTC",
                        "id": "ff6b6421-5205-4111-9611-084e5b2d0569",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (C) Ã© incorreta. Os iSGLT-2, em especial a canagliflozina, mostraram 32% de reduÃ§Ã£o da progressÃ£o da doenÃ§a renal em indivÃ­duos diabÃ©ticos com taxa de filtraÃ§Ã£o glomerular &gt; 30 mL/minuto, mas com albuminÃºria &gt; 300 mg/g de creatinina.",
                        "updated_at": "2021-05-19 20:55:30.110834 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-19 20:21:16.895149 +0000 UTC"
                },
                {
                    "answer_percentage": 14,
                    "answers": 548,
                    "body": "ReduÃ§Ã£o da mortalidade em pacientes nÃ£o diabÃ©ticos com doenÃ§a renal crÃ´nica e proteinÃºria",
                    "correct": false,
                    "created_at": "2021-02-13 18:42:57.435285 +0000 UTC",
                    "id": "fee54f94-a1a8-4971-ab2e-19f51927b805",
                    "position": "3",
                    "sanitized_body": "ReduÃ§Ã£o da mortalidade em pacientes nÃ£o diabÃ©ticos com doenÃ§a renal crÃ´nica e proteinÃºria",
                    "solution": {
                        "alternative_id": "fee54f94-a1a8-4971-ab2e-19f51927b805",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (D) Ã© incorreta. </b>Segundo um estudo randomizado, controlado e duplo-cego publicado em outubro de 2020, a dapagliflozina reduziu a progressÃ£o da doenÃ§a renal crÃ´nica, a mortalidade por todas as causas e a hospitalizaÃ§Ã£o por insuficiÃªncia cardÃ­aca em indivÃ­duos com taxa de filtraÃ§Ã£o glomerular entre 25-75 mL/minuto associada a albuminÃºria (200-5000 mg/g de creatinina), independentemente da presenÃ§a de diabetes mellitus.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-19 20:55:27.622602 +0000 UTC",
                        "id": "d0997dd0-d703-4284-9fc1-1102165e8bcd",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (D) Ã© incorreta. Segundo um estudo randomizado, controlado e duplo-cego publicado em outubro de 2020, a dapagliflozina reduziu a progressÃ£o da doenÃ§a renal crÃ´nica, a mortalidade por todas as causas e a hospitalizaÃ§Ã£o por insuficiÃªncia cardÃ­aca em indivÃ­duos com taxa de filtraÃ§Ã£o glomerular entre 25-75 mL/minuto associada a albuminÃºria (200-5000 mg/g de creatinina), independentemente da presenÃ§a de diabetes mellitus.",
                        "updated_at": "2021-05-19 20:55:30.141116 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-19 20:21:17.012515 +0000 UTC"
                },
                {
                    "answer_percentage": 6,
                    "answers": 224,
                    "body": "ReduÃ§Ã£o da taxa de hospitalizaÃ§Ã£o em pacientes diabÃ©ticos com insuficiÃªncia cardÃ­aca de fraÃ§Ã£o de ejeÃ§Ã£o reduzida",
                    "correct": false,
                    "created_at": "2021-02-13 18:42:57.435285 +0000 UTC",
                    "id": "d3f1a0ad-3460-4177-a262-6223e6337f53",
                    "position": "4",
                    "sanitized_body": "ReduÃ§Ã£o da taxa de hospitalizaÃ§Ã£o em pacientes diabÃ©ticos com insuficiÃªncia cardÃ­aca de fraÃ§Ã£o de ejeÃ§Ã£o reduzida",
                    "solution": {
                        "alternative_id": "d3f1a0ad-3460-4177-a262-6223e6337f53",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (E) Ã© incorreta.</b> A dapagliflozina tambÃ©m foi testado em estudo randomizado, controlado e duplo-cego para avaliaÃ§Ã£o de desfecho em pacientes com insuficiÃªncia cardÃ­aca com fraÃ§Ã£o de ejeÃ§Ã£o reduzida, independentemente da presenÃ§a de diabetes mellitus; mostrou-se eficaz em reduzir a mortalidade e as hospitalizaÃ§Ãµes por descompensaÃ§Ã£o. Em pacientes diabÃ©ticos, tal benefÃ­cio tambÃ©m foi demonstrado pela empagliflozina.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-19 20:55:27.569117 +0000 UTC",
                        "id": "71c4731b-91c6-4f45-bb6c-c8739d4d50e4",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (E) Ã© incorreta. A dapagliflozina tambÃ©m foi testado em estudo randomizado, controlado e duplo-cego para avaliaÃ§Ã£o de desfecho em pacientes com insuficiÃªncia cardÃ­aca com fraÃ§Ã£o de ejeÃ§Ã£o reduzida, independentemente da presenÃ§a de diabetes mellitus; mostrou-se eficaz em reduzir a mortalidade e as hospitalizaÃ§Ãµes por descompensaÃ§Ã£o. Em pacientes diabÃ©ticos, tal benefÃ­cio tambÃ©m foi demonstrado pela empagliflozina.",
                        "updated_at": "2021-05-19 20:55:30.114472 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-19 20:21:17.146867 +0000 UTC"
                }
            ],
            "answer_type": "MULTIPLE_CHOICE",
            "author_id": "bruno-cesar110@hotmail.com",
            "correct_answer_percentage": 66,
            "created_at": "2021-02-13 18:42:57.435285 +0000 UTC",
            "difficulty_level": "MEDIUM",
            "exams": [
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "70968071-52b0-4d19-9499-9f15a7302f70",
                        "jury_id": "9c7a774a-ba17-4b9e-981b-6868ac81c480",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "9fbb6169-ce34-45e3-ac72-71bd7e965496",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-02-13T17:30:19Z",
                    "degree_proof": false,
                    "id": "4000003234",
                    "location": {
                        "id": "17"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "FF7B24F2-6CAF-8D66-7CD7-DF5EA7712FCF"
                        },
                        {
                            "type": "EXAM",
                            "url": "A694C028-B54D-5FD3-5F20-3C2D19B98D8F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "2B4B1040-52F4-9D8C-4DD9-0D840C51E885"
                        }
                    ],
                    "questions_number": 100,
                    "remuneration": 333043,
                    "scholarity": "placeholder",
                    "subscription_fee": 490,
                    "updated_at": "2021-07-16T12:47:50Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "70968071-52b0-4d19-9499-9f15a7302f70",
                        "jury_id": "9c7a774a-ba17-4b9e-981b-6868ac81c480",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "046f0505-90c9-4862-b318-388c0d1e8026",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-02-13T17:30:41Z",
                    "degree_proof": false,
                    "id": "4000003235",
                    "location": {
                        "id": "17"
                    },
                    "number": 1,
                    "open_spaces": 31,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "FF7B24F2-6CAF-8D66-7CD7-DF5EA7712FCF"
                        },
                        {
                            "type": "EXAM",
                            "url": "A694C028-B54D-5FD3-5F20-3C2D19B98D8F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "2B4B1040-52F4-9D8C-4DD9-0D840C51E885"
                        }
                    ],
                    "questions_number": 100,
                    "remuneration": 333043,
                    "scholarity": "placeholder",
                    "subscription_fee": 490,
                    "updated_at": "2021-07-16T12:48:05Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "70968071-52b0-4d19-9499-9f15a7302f70",
                        "jury_id": "9c7a774a-ba17-4b9e-981b-6868ac81c480",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "32bef8bd-8aac-4ede-aede-06b9458b026b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-02-13T17:30:55Z",
                    "degree_proof": false,
                    "id": "4000003236",
                    "location": {
                        "id": "17"
                    },
                    "number": 1,
                    "open_spaces": 15,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "FF7B24F2-6CAF-8D66-7CD7-DF5EA7712FCF"
                        },
                        {
                            "type": "EXAM",
                            "url": "A694C028-B54D-5FD3-5F20-3C2D19B98D8F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "2B4B1040-52F4-9D8C-4DD9-0D840C51E885"
                        }
                    ],
                    "questions_number": 100,
                    "remuneration": 333043,
                    "scholarity": "placeholder",
                    "subscription_fee": 490,
                    "updated_at": "2021-07-16T12:48:22Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "f30d24a0-2f2d-43be-9812-73746e91a61a",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "70968071-52b0-4d19-9499-9f15a7302f70",
                        "jury_id": "9c7a774a-ba17-4b9e-981b-6868ac81c480",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "ffd79a37-01ce-4d4e-8bda-950d51a56fe4",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-02-13T17:31:14Z",
                    "degree_proof": false,
                    "id": "4000003237",
                    "location": {
                        "id": "17"
                    },
                    "number": 1,
                    "open_spaces": 6,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "FF7B24F2-6CAF-8D66-7CD7-DF5EA7712FCF"
                        },
                        {
                            "type": "EXAM",
                            "url": "A694C028-B54D-5FD3-5F20-3C2D19B98D8F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "2B4B1040-52F4-9D8C-4DD9-0D840C51E885"
                        }
                    ],
                    "questions_number": 100,
                    "remuneration": 333043,
                    "scholarity": "placeholder",
                    "subscription_fee": 490,
                    "updated_at": "2021-07-16T12:48:34Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "70968071-52b0-4d19-9499-9f15a7302f70",
                        "jury_id": "9c7a774a-ba17-4b9e-981b-6868ac81c480",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "9b34a94d-754d-4510-8bad-60f649fa825b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-02-13T17:31:35Z",
                    "degree_proof": false,
                    "id": "4000003238",
                    "location": {
                        "id": "17"
                    },
                    "number": 1,
                    "open_spaces": 113,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "FF7B24F2-6CAF-8D66-7CD7-DF5EA7712FCF"
                        },
                        {
                            "type": "EXAM",
                            "url": "A694C028-B54D-5FD3-5F20-3C2D19B98D8F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "2B4B1040-52F4-9D8C-4DD9-0D840C51E885"
                        }
                    ],
                    "questions_number": 100,
                    "remuneration": 333043,
                    "scholarity": "placeholder",
                    "subscription_fee": 490,
                    "updated_at": "2021-07-16T12:48:50Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "70968071-52b0-4d19-9499-9f15a7302f70",
                        "jury_id": "9c7a774a-ba17-4b9e-981b-6868ac81c480",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "dfa90599-1ee1-4de3-8605-a75ecd3799bd",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-02-13T17:31:56Z",
                    "degree_proof": false,
                    "id": "4000003239",
                    "location": {
                        "id": "17"
                    },
                    "number": 1,
                    "open_spaces": 33,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "FF7B24F2-6CAF-8D66-7CD7-DF5EA7712FCF"
                        },
                        {
                            "type": "EXAM",
                            "url": "A694C028-B54D-5FD3-5F20-3C2D19B98D8F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "2B4B1040-52F4-9D8C-4DD9-0D840C51E885"
                        }
                    ],
                    "questions_number": 100,
                    "remuneration": 333043,
                    "scholarity": "placeholder",
                    "subscription_fee": 490,
                    "updated_at": "2021-07-16T12:49:09Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "70968071-52b0-4d19-9499-9f15a7302f70",
                        "jury_id": "9c7a774a-ba17-4b9e-981b-6868ac81c480",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "eca7ae7c-654b-407e-9b37-ad41ad2834b1",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-02-13T17:32:14Z",
                    "degree_proof": false,
                    "id": "4000003240",
                    "location": {
                        "id": "17"
                    },
                    "number": 1,
                    "open_spaces": 10,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "FF7B24F2-6CAF-8D66-7CD7-DF5EA7712FCF"
                        },
                        {
                            "type": "EXAM",
                            "url": "A694C028-B54D-5FD3-5F20-3C2D19B98D8F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "2B4B1040-52F4-9D8C-4DD9-0D840C51E885"
                        }
                    ],
                    "questions_number": 100,
                    "remuneration": 333043,
                    "scholarity": "placeholder",
                    "subscription_fee": 490,
                    "updated_at": "2021-07-16T12:49:25Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "70968071-52b0-4d19-9499-9f15a7302f70",
                        "jury_id": "9c7a774a-ba17-4b9e-981b-6868ac81c480",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "2ca62942-4eab-49e5-acaf-e395254eee99",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-02-13T17:32:37Z",
                    "degree_proof": false,
                    "id": "4000003241",
                    "location": {
                        "id": "17"
                    },
                    "number": 1,
                    "open_spaces": 9,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "FF7B24F2-6CAF-8D66-7CD7-DF5EA7712FCF"
                        },
                        {
                            "type": "EXAM",
                            "url": "A694C028-B54D-5FD3-5F20-3C2D19B98D8F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "2B4B1040-52F4-9D8C-4DD9-0D840C51E885"
                        }
                    ],
                    "questions_number": 100,
                    "remuneration": 333043,
                    "scholarity": "placeholder",
                    "subscription_fee": 490,
                    "updated_at": "2021-07-16T12:49:40Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "70968071-52b0-4d19-9499-9f15a7302f70",
                        "jury_id": "9c7a774a-ba17-4b9e-981b-6868ac81c480",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "dcb47678-bdba-4669-aa0e-01f71e32541b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-02-13T17:33:01Z",
                    "degree_proof": false,
                    "id": "4000003242",
                    "location": {
                        "id": "17"
                    },
                    "number": 1,
                    "open_spaces": 84,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "FF7B24F2-6CAF-8D66-7CD7-DF5EA7712FCF"
                        },
                        {
                            "type": "EXAM",
                            "url": "A694C028-B54D-5FD3-5F20-3C2D19B98D8F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "2B4B1040-52F4-9D8C-4DD9-0D840C51E885"
                        }
                    ],
                    "questions_number": 100,
                    "remuneration": 333043,
                    "scholarity": "placeholder",
                    "subscription_fee": 490,
                    "updated_at": "2021-07-16T12:50:09Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "f30d24a0-2f2d-43be-9812-73746e91a61a",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "70968071-52b0-4d19-9499-9f15a7302f70",
                        "jury_id": "9c7a774a-ba17-4b9e-981b-6868ac81c480",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "66678bdd-d9e1-4267-a4cf-f3beebfd7d0e",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-02-13T17:33:37Z",
                    "degree_proof": false,
                    "id": "4000003243",
                    "location": {
                        "id": "17"
                    },
                    "number": 1,
                    "open_spaces": 3,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "FF7B24F2-6CAF-8D66-7CD7-DF5EA7712FCF"
                        },
                        {
                            "type": "EXAM",
                            "url": "A694C028-B54D-5FD3-5F20-3C2D19B98D8F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "2B4B1040-52F4-9D8C-4DD9-0D840C51E885"
                        }
                    ],
                    "questions_number": 100,
                    "remuneration": 333043,
                    "scholarity": "placeholder",
                    "subscription_fee": 490,
                    "updated_at": "2021-07-16T12:50:30Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "70968071-52b0-4d19-9499-9f15a7302f70",
                        "jury_id": "9c7a774a-ba17-4b9e-981b-6868ac81c480",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "8d4e50ad-d41e-40c9-9f4d-842251c2d2d9",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-02-13T17:33:58Z",
                    "degree_proof": false,
                    "id": "4000003244",
                    "location": {
                        "id": "17"
                    },
                    "number": 1,
                    "open_spaces": 13,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "FF7B24F2-6CAF-8D66-7CD7-DF5EA7712FCF"
                        },
                        {
                            "type": "EXAM",
                            "url": "A694C028-B54D-5FD3-5F20-3C2D19B98D8F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "2B4B1040-52F4-9D8C-4DD9-0D840C51E885"
                        }
                    ],
                    "questions_number": 100,
                    "remuneration": 333043,
                    "scholarity": "placeholder",
                    "subscription_fee": 490,
                    "updated_at": "2021-07-16T12:50:45Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "70968071-52b0-4d19-9499-9f15a7302f70",
                        "jury_id": "9c7a774a-ba17-4b9e-981b-6868ac81c480",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "417a198f-03b2-417e-8505-8acf83f3059d",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-02-13T17:34:19Z",
                    "degree_proof": false,
                    "id": "4000003245",
                    "location": {
                        "id": "17"
                    },
                    "number": 1,
                    "open_spaces": 10,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "FF7B24F2-6CAF-8D66-7CD7-DF5EA7712FCF"
                        },
                        {
                            "type": "EXAM",
                            "url": "A694C028-B54D-5FD3-5F20-3C2D19B98D8F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "2B4B1040-52F4-9D8C-4DD9-0D840C51E885"
                        }
                    ],
                    "questions_number": 100,
                    "remuneration": 333043,
                    "scholarity": "placeholder",
                    "subscription_fee": 490,
                    "updated_at": "2021-07-16T12:50:59Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "70968071-52b0-4d19-9499-9f15a7302f70",
                        "jury_id": "9c7a774a-ba17-4b9e-981b-6868ac81c480",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "0609ccdb-db5c-4c47-a306-31a0a655e95c",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-02-13T17:34:50Z",
                    "degree_proof": false,
                    "id": "4000003246",
                    "location": {
                        "id": "17"
                    },
                    "number": 1,
                    "open_spaces": 66,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "FF7B24F2-6CAF-8D66-7CD7-DF5EA7712FCF"
                        },
                        {
                            "type": "EXAM",
                            "url": "A694C028-B54D-5FD3-5F20-3C2D19B98D8F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "2B4B1040-52F4-9D8C-4DD9-0D840C51E885"
                        }
                    ],
                    "questions_number": 100,
                    "remuneration": 333043,
                    "scholarity": "placeholder",
                    "subscription_fee": 490,
                    "updated_at": "2021-07-16T12:51:14Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "70968071-52b0-4d19-9499-9f15a7302f70",
                        "jury_id": "9c7a774a-ba17-4b9e-981b-6868ac81c480",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "f2f2f3c5-9759-4201-bca7-2487751bd626",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-02-13T17:35:04Z",
                    "degree_proof": false,
                    "id": "4000003247",
                    "location": {
                        "id": "17"
                    },
                    "number": 1,
                    "open_spaces": 41,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "FF7B24F2-6CAF-8D66-7CD7-DF5EA7712FCF"
                        },
                        {
                            "type": "EXAM",
                            "url": "A694C028-B54D-5FD3-5F20-3C2D19B98D8F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "2B4B1040-52F4-9D8C-4DD9-0D840C51E885"
                        }
                    ],
                    "questions_number": 100,
                    "remuneration": 333043,
                    "scholarity": "placeholder",
                    "subscription_fee": 490,
                    "updated_at": "2021-07-16T12:51:29Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "70968071-52b0-4d19-9499-9f15a7302f70",
                        "jury_id": "9c7a774a-ba17-4b9e-981b-6868ac81c480",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "4d4116be-190d-4321-94c8-66da6d1acb11",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-02-13T17:35:26Z",
                    "degree_proof": false,
                    "id": "4000003248",
                    "location": {
                        "id": "17"
                    },
                    "number": 1,
                    "open_spaces": 4,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "FF7B24F2-6CAF-8D66-7CD7-DF5EA7712FCF"
                        },
                        {
                            "type": "EXAM",
                            "url": "A694C028-B54D-5FD3-5F20-3C2D19B98D8F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "2B4B1040-52F4-9D8C-4DD9-0D840C51E885"
                        }
                    ],
                    "questions_number": 100,
                    "remuneration": 333043,
                    "scholarity": "placeholder",
                    "subscription_fee": 490,
                    "updated_at": "2021-07-16T12:51:42Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "70968071-52b0-4d19-9499-9f15a7302f70",
                        "jury_id": "9c7a774a-ba17-4b9e-981b-6868ac81c480",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "710b6098-b1cc-40fb-a6e9-1978c156b947",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-02-13T17:35:53Z",
                    "degree_proof": false,
                    "id": "4000003249",
                    "location": {
                        "id": "17"
                    },
                    "number": 1,
                    "open_spaces": 59,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "FF7B24F2-6CAF-8D66-7CD7-DF5EA7712FCF"
                        },
                        {
                            "type": "EXAM",
                            "url": "A694C028-B54D-5FD3-5F20-3C2D19B98D8F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "2B4B1040-52F4-9D8C-4DD9-0D840C51E885"
                        }
                    ],
                    "questions_number": 100,
                    "remuneration": 333043,
                    "scholarity": "placeholder",
                    "subscription_fee": 490,
                    "updated_at": "2021-07-16T12:51:57Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "70968071-52b0-4d19-9499-9f15a7302f70",
                        "jury_id": "9c7a774a-ba17-4b9e-981b-6868ac81c480",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "cccffc77-8a54-477d-b101-01edbb244b74",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-02-13T17:36:14Z",
                    "degree_proof": false,
                    "id": "4000003250",
                    "location": {
                        "id": "17"
                    },
                    "number": 1,
                    "open_spaces": 19,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "FF7B24F2-6CAF-8D66-7CD7-DF5EA7712FCF"
                        },
                        {
                            "type": "EXAM",
                            "url": "A694C028-B54D-5FD3-5F20-3C2D19B98D8F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "2B4B1040-52F4-9D8C-4DD9-0D840C51E885"
                        }
                    ],
                    "questions_number": 100,
                    "remuneration": 333043,
                    "scholarity": "placeholder",
                    "subscription_fee": 490,
                    "updated_at": "2021-07-16T12:52:12Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "70968071-52b0-4d19-9499-9f15a7302f70",
                        "jury_id": "9c7a774a-ba17-4b9e-981b-6868ac81c480",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "776b092f-eb41-4150-a252-b23a0f7914b3",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-02-13T17:36:33Z",
                    "degree_proof": false,
                    "id": "4000003251",
                    "location": {
                        "id": "17"
                    },
                    "number": 1,
                    "open_spaces": 25,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "FF7B24F2-6CAF-8D66-7CD7-DF5EA7712FCF"
                        },
                        {
                            "type": "EXAM",
                            "url": "A694C028-B54D-5FD3-5F20-3C2D19B98D8F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "2B4B1040-52F4-9D8C-4DD9-0D840C51E885"
                        }
                    ],
                    "questions_number": 100,
                    "remuneration": 333043,
                    "scholarity": "placeholder",
                    "subscription_fee": 490,
                    "updated_at": "2021-07-16T12:52:28Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "23112f36-223f-447c-a1b6-08bf6dad1276",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "70968071-52b0-4d19-9499-9f15a7302f70",
                        "jury_id": "9c7a774a-ba17-4b9e-981b-6868ac81c480",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "b39a29ec-d8c7-4592-b019-d0c7ee728856",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-02-13T17:38:41Z",
                    "degree_proof": false,
                    "id": "4000003252",
                    "location": {
                        "id": "17"
                    },
                    "number": 1,
                    "open_spaces": 1,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "FF7B24F2-6CAF-8D66-7CD7-DF5EA7712FCF"
                        },
                        {
                            "type": "EXAM",
                            "url": "A694C028-B54D-5FD3-5F20-3C2D19B98D8F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "2B4B1040-52F4-9D8C-4DD9-0D840C51E885"
                        }
                    ],
                    "questions_number": 100,
                    "remuneration": 333043,
                    "scholarity": "placeholder",
                    "subscription_fee": 490,
                    "updated_at": "2021-07-16T12:52:43Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "70968071-52b0-4d19-9499-9f15a7302f70",
                        "jury_id": "9c7a774a-ba17-4b9e-981b-6868ac81c480",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "25b55daa-bd57-453d-9099-8c9dfe6d622a",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-02-13T17:40:38Z",
                    "degree_proof": false,
                    "id": "4000003253",
                    "location": {
                        "id": "17"
                    },
                    "number": 1,
                    "open_spaces": 4,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "FF7B24F2-6CAF-8D66-7CD7-DF5EA7712FCF"
                        },
                        {
                            "type": "EXAM",
                            "url": "A694C028-B54D-5FD3-5F20-3C2D19B98D8F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "2B4B1040-52F4-9D8C-4DD9-0D840C51E885"
                        }
                    ],
                    "questions_number": 100,
                    "remuneration": 333043,
                    "scholarity": "placeholder",
                    "subscription_fee": 490,
                    "updated_at": "2021-07-16T12:53:02Z",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "70968071-52b0-4d19-9499-9f15a7302f70",
                        "jury_id": "9c7a774a-ba17-4b9e-981b-6868ac81c480",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "727c6216-9122-4b12-88d1-7f8462a8cce7",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2021-02-13T17:41:28Z",
                    "degree_proof": false,
                    "id": "4000003254",
                    "location": {
                        "id": "17"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "FF7B24F2-6CAF-8D66-7CD7-DF5EA7712FCF"
                        },
                        {
                            "type": "EXAM",
                            "url": "A694C028-B54D-5FD3-5F20-3C2D19B98D8F"
                        },
                        {
                            "type": "ANSWER",
                            "url": "2B4B1040-52F4-9D8C-4DD9-0D840C51E885"
                        }
                    ],
                    "questions_number": 100,
                    "remuneration": 333043,
                    "scholarity": "placeholder",
                    "subscription_fee": 490,
                    "updated_at": "2021-07-16T12:53:17Z",
                    "year": 2021
                }
            ],
            "forum_id": "167ba49f-bdec-45fa-a040-f43fa8fbd9cc",
            "has_student_answer": false,
            "has_user_solution": false,
            "has_video_solution": true,
            "id": "4000141772",
            "labels": [
                "FINAL_ANSWER_SHEET"
            ],
            "public": true,
            "slug": "inibidores-SGLT2-sa3249496a12",
            "solution": {
                "alternative_solutions": null,
                "author_email": "camila.moma@estrategiamed.com.br",
                "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                "brief": "",
                "brief_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "complete": "<b>Gabarito: alternativa (A).</b><div><b>ComentÃ¡rios:</b></div><div>Os inibidores do cotransportador de sÃ³dio e glicose tipo 2 (iSGLT-2) sÃ£o drogas que inibem a reabsorÃ§Ã£o de glicose e sÃ³dio no tÃºbulo renal proximal, promovendo glicosÃºria. Por nÃ£o aumentarem a secreÃ§Ã£o de insulina, nÃ£o estÃ£o relacionadas ao ganho ponderal nem Ã s hipoglicemias. Muito pelo contrÃ¡rio, sÃ£o drogas que, ao causarem glicosÃºria, levam ao balanÃ§o energÃ©tico negativo, com consequente perda de peso, sendo uma Ã³tima indicaÃ§Ã£o de tratamento para indivÃ­duos diabÃ©ticos com sobrepeso e obesidade e que jÃ¡ estejam em uso metformina (nÃ£o se esqueÃ§a de que esta Ã© a primeira escolha terapÃªutica!).</div><div>As drogas que fazem parte desta classe sÃ£o: empagliflozina, canagliflozina, dapagliflozina e ertagliflozina.</div><div>AtenÃ§Ã£o! A alternativa correta Ã© aquela que nÃ£o contÃ©m um efeito benÃ©fico dos inibidores de SGLT-2!</div><div><br></div>",
                "complete_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "created_at": "2021-05-19 20:55:27.674057 +0000 UTC",
                "id": "3b4533b7-41b4-4dbe-99ed-3c061ab42a13",
                "is_default": false,
                "sanitized_brief": "",
                "sanitized_complete": "Gabarito: alternativa (A).ComentÃ¡rios:Os inibidores do cotransportador de sÃ³dio e glicose tipo 2 (iSGLT-2) sÃ£o drogas que inibem a reabsorÃ§Ã£o de glicose e sÃ³dio no tÃºbulo renal proximal, promovendo glicosÃºria. Por nÃ£o aumentarem a secreÃ§Ã£o de insulina, nÃ£o estÃ£o relacionadas ao ganho ponderal nem Ã s hipoglicemias. Muito pelo contrÃ¡rio, sÃ£o drogas que, ao causarem glicosÃºria, levam ao balanÃ§o energÃ©tico negativo, com consequente perda de peso, sendo uma Ã³tima indicaÃ§Ã£o de tratamento para indivÃ­duos diabÃ©ticos com sobrepeso e obesidade e que jÃ¡ estejam em uso metformina (nÃ£o se esqueÃ§a de que esta Ã© a primeira escolha terapÃªutica!).As drogas que fazem parte desta classe sÃ£o: empagliflozina, canagliflozina, dapagliflozina e ertagliflozina.AtenÃ§Ã£o! A alternativa correta Ã© aquela que nÃ£o contÃ©m um efeito benÃ©fico dos inibidores de SGLT-2!",
                "updated_at": "2021-05-19 20:55:30.182567 +0000 UTC",
                "video_solution_id": "692f91ae-1651-4897-a6cf-f5dc03be358a"
            },
            "statement": "Os inibidores da SGLT2 sÃ£o uma classe de drogas hipoglicemiantes, que tÃªm determinado efeitos benÃ©ficos alÃ©m do controle glicÃªmico.<div><br></div><div>Qual, dentre os abaixo relacionados, nÃ£o Ã© um efeito benÃ©fico dos inibidores da SGLT2?</div>",
            "statement_text": "Os inibidores da SGLT2 sÃ£o uma classe de drogas hipoglicemiantes, que tÃªm determinado efeitos benÃ©ficos alÃ©m do controle glicÃªmico.Qual, dentre os abaixo relacionados, nÃ£o Ã© um efeito benÃ©fico dos inibidores da SGLT2?",
            "status": {
                "change_actor": "cnishiama@admin.admin",
                "created_at": "2021-05-20 17:21:46.319276 +0000 UTC",
                "owner": "camila.moma@estrategiamed.com.br",
                "value": "APPROVED"
            },
            "topics": [
                {
                    "has_children": false,
                    "id": "0cad8ea0fa0e47efa8d56f8a97b383e5",
                    "master_id": "3b9e1e9de9ba4ff3959ae83d455880f9",
                    "name": "MedicaÃ§Ãµes que provocam glicosÃºria (inibidores de SGLT-2)",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Tratamento[$$]Tratamento medicamentoso[$$]Drogas antidiabÃ©ticas nÃ£o insulina[$$]MedicaÃ§Ãµes que provocam glicosÃºria (inibidores de SGLT-2)"
                },
                {
                    "has_children": false,
                    "id": "ab6c6a1fb6604cf98243ac486f80dac8",
                    "master_id": "0a6abdce2fbc45aa8ba8f0e75875ec84",
                    "name": "Endocrinologia ",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia "
                }
            ],
            "unlisted": false,
            "video_solution": {
                "available_resolutions": [
                    {
                        "resolution": "720",
                        "url": "https://api.estrategia.com/questoes/sign/medicina/processadas/4000141772-720.mp4"
                    }
                ],
                "id": "692f91ae-1651-4897-a6cf-f5dc03be358a",
                "identifier": "",
                "question_id": "4000141772"
            },
            "video_solution_id": "692f91ae-1651-4897-a6cf-f5dc03be358a"
        },
        {
            "active": true,
            "alternatives": [
                {
                    "answer_percentage": 34,
                    "answers": 552,
                    "body": "AnÃ¡logo de GLP1 e metformina.<div>&nbsp;</div>",
                    "correct": false,
                    "created_at": "2020-11-26 10:37:19.619046 +0000 UTC",
                    "id": "891d6c4f-229e-4572-b4f5-45062a9d88cf",
                    "position": "0",
                    "sanitized_body": "AnÃ¡logo de GLP1 e metformina.Â ",
                    "solution": {
                        "alternative_id": "891d6c4f-229e-4572-b4f5-45062a9d88cf",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (A) Ã© incorreta. </b>A metformina pertence Ã  classe das biguanidas e atua na melhora da resistÃªncia Ã  insulina, principalmente no fÃ­gado, reduzindo a produÃ§Ã£o hepÃ¡tica de glicose. TambÃ©m promove maior utilizaÃ§Ã£o de glicose pelo prÃ³prio intestino, contribuindo para o controle glicÃªmico.<div>JÃ¡ o anÃ¡logo de GLP-1 Ã© uma droga que se assemelha ao GLP-1, promovendo maior secreÃ§Ã£o de insulina (que ocorre de forma dependente dos nÃ­veis glicÃªmicos, garantindo a seguranÃ§a em relaÃ§Ã£o a hipoglicemias) e reduz a produÃ§Ã£o de glucagon, diminuindo a produÃ§Ã£o hepÃ¡tica de glicose.</div><div><br></div>",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-16 20:33:31.488116 +0000 UTC",
                        "id": "a1963023-f4e6-4283-b216-dfdf6a0d7cd2",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (A) Ã© incorreta. A metformina pertence Ã  classe das biguanidas e atua na melhora da resistÃªncia Ã  insulina, principalmente no fÃ­gado, reduzindo a produÃ§Ã£o hepÃ¡tica de glicose. TambÃ©m promove maior utilizaÃ§Ã£o de glicose pelo prÃ³prio intestino, contribuindo para o controle glicÃªmico.JÃ¡ o anÃ¡logo de GLP-1 Ã© uma droga que se assemelha ao GLP-1, promovendo maior secreÃ§Ã£o de insulina (que ocorre de forma dependente dos nÃ­veis glicÃªmicos, garantindo a seguranÃ§a em relaÃ§Ã£o a hipoglicemias) e reduz a produÃ§Ã£o de glucagon, diminuindo a produÃ§Ã£o hepÃ¡tica de glicose.",
                        "updated_at": "2021-05-16 20:41:16.400432 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-16 20:41:03.240383 +0000 UTC"
                },
                {
                    "answer_percentage": 3,
                    "answers": 52,
                    "body": "Inibidor de SGLT2 e pioglitazona.<div>&nbsp;</div>",
                    "correct": false,
                    "created_at": "2020-11-26 10:37:19.619046 +0000 UTC",
                    "id": "f70ccc21-35df-414d-89d2-d2817e097b69",
                    "position": "1",
                    "sanitized_body": "Inibidor de SGLT2 e pioglitazona.Â ",
                    "solution": {
                        "alternative_id": "f70ccc21-35df-414d-89d2-d2817e097b69",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (B) Ã© incorreta.</b> Os inibidores de SGLT-2 sÃ£o uma classe medicamentosa cujo mecanismo de aÃ§Ã£o se baseia na inibiÃ§Ã£o dos transportadores de sÃ³dio e glicose tipo 2 (SGLT-2) presentes principalmente nos tÃºbulos proximais renais, o que resulta em nÃ£o reabsorÃ§Ã£o da glicose tubular. Portanto, tais drogas promovem glicosÃºria, contribuindo para o controle glicÃªmico sem ocasionar hipoglicemias e estÃ£o associadas Ã  perda ponderal (devido ao balanÃ§o energÃ©tico negativo pela perda de glicose). TambÃ©m sÃ£o medicaÃ§Ãµes que reduzem o risco cardiovascular em pacientes com doenÃ§a cardiovascular estabelecida, diminuem a mortalidade em indivÃ­duos com insuficiÃªncia cardÃ­aca com fraÃ§Ã£o de ejeÃ§Ã£o reduzida e levam a menor progressÃ£o da doenÃ§a renal naqueles com doenÃ§a renal crÃ´nica e albuminÃºria positiva (&gt; 300 mg/g de creatinina).<div>A pioglitazona reduz a resistÃªncia perifÃ©rica Ã  insulina, por meio de aÃ§Ã£o em receptores intranucleares, que levam a modificaÃ§Ãµes na expressÃ£o dos transportadores de glicose na membrana celular (GLUT). Assim, hÃ¡ maior captaÃ§Ã£o de glicose pelos mÃºsculos, tecido adiposo e fÃ­gado.</div><div><br></div>",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-16 20:33:31.453306 +0000 UTC",
                        "id": "cf4e7116-a1ed-4265-97d7-24cdeaf93822",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (B) Ã© incorreta. Os inibidores de SGLT-2 sÃ£o uma classe medicamentosa cujo mecanismo de aÃ§Ã£o se baseia na inibiÃ§Ã£o dos transportadores de sÃ³dio e glicose tipo 2 (SGLT-2) presentes principalmente nos tÃºbulos proximais renais, o que resulta em nÃ£o reabsorÃ§Ã£o da glicose tubular. Portanto, tais drogas promovem glicosÃºria, contribuindo para o controle glicÃªmico sem ocasionar hipoglicemias e estÃ£o associadas Ã  perda ponderal (devido ao balanÃ§o energÃ©tico negativo pela perda de glicose). TambÃ©m sÃ£o medicaÃ§Ãµes que reduzem o risco cardiovascular em pacientes com doenÃ§a cardiovascular estabelecida, diminuem a mortalidade em indivÃ­duos com insuficiÃªncia cardÃ­aca com fraÃ§Ã£o de ejeÃ§Ã£o reduzida e levam a menor progressÃ£o da doenÃ§a renal naqueles com doenÃ§a renal crÃ´nica e albuminÃºria positiva (&gt; 300 mg/g de creatinina).A pioglitazona reduz a resistÃªncia perifÃ©rica Ã  insulina, por meio de aÃ§Ã£o em receptores intranucleares, que levam a modificaÃ§Ãµes na expressÃ£o dos transportadores de glicose na membrana celular (GLUT). Assim, hÃ¡ maior captaÃ§Ã£o de glicose pelos mÃºsculos, tecido adiposo e fÃ­gado.",
                        "updated_at": "2021-05-16 20:41:16.38412 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-16 20:41:03.345583 +0000 UTC"
                },
                {
                    "answer_percentage": 19,
                    "answers": 300,
                    "body": "Inibidor de SGLT2 e anÃ¡logo de GLP1.<div>&nbsp;</div>",
                    "correct": false,
                    "created_at": "2020-11-26 10:37:19.619046 +0000 UTC",
                    "id": "0978f318-f010-40cf-9a09-c1612cb07595",
                    "position": "2",
                    "sanitized_body": "Inibidor de SGLT2 e anÃ¡logo de GLP1.Â ",
                    "solution": {
                        "alternative_id": "0978f318-f010-40cf-9a09-c1612cb07595",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (C) Ã© incorreta. </b>Como comentado nas alternativas (A) e (B), o inibidor de SGLT-2 promove glicosÃºria enquanto o anÃ¡logo de GLP-1 aumenta a secreÃ§Ã£o de insulina de forma dependente dos nÃ­veis glicÃªmicos. Assim, nÃ£o hÃ¡ aÃ§Ã£o na resistÃªncia perifÃ©rica Ã  insulina.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-16 20:33:31.502201 +0000 UTC",
                        "id": "07a8eb1a-7dfe-43b9-bada-f4aa7978f9b3",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (C) Ã© incorreta. Como comentado nas alternativas (A) e (B), o inibidor de SGLT-2 promove glicosÃºria enquanto o anÃ¡logo de GLP-1 aumenta a secreÃ§Ã£o de insulina de forma dependente dos nÃ­veis glicÃªmicos. Assim, nÃ£o hÃ¡ aÃ§Ã£o na resistÃªncia perifÃ©rica Ã  insulina.",
                        "updated_at": "2021-05-16 20:41:16.418561 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-16 20:41:03.572923 +0000 UTC"
                },
                {
                    "answer_percentage": 44,
                    "answers": 702,
                    "body": "Metformina e pioglitazona.",
                    "correct": true,
                    "created_at": "2020-11-26 10:37:19.619046 +0000 UTC",
                    "id": "9a52abb9-fd51-43bf-ac9a-940e6773b817",
                    "position": "3",
                    "sanitized_body": "Metformina e pioglitazona.",
                    "solution": {
                        "alternative_id": "9a52abb9-fd51-43bf-ac9a-940e6773b817",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (D) Ã© correta.</b> Como dito nas alternativas (A) e (B), a metformina melhora a resistÃªncia Ã  insulina, com aÃ§Ã£o predominantemente hepÃ¡tica, enquanto a pioglitazona possui aÃ§Ã£o perifÃ©rica, aumentando a captaÃ§Ã£o de glicose pelos tecidos por maior expressÃ£o dos GLUT.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-16 20:33:31.501827 +0000 UTC",
                        "id": "c1d68179-3121-4600-b14c-b3ded58e3a3e",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (D) Ã© correta. Como dito nas alternativas (A) e (B), a metformina melhora a resistÃªncia Ã  insulina, com aÃ§Ã£o predominantemente hepÃ¡tica, enquanto a pioglitazona possui aÃ§Ã£o perifÃ©rica, aumentando a captaÃ§Ã£o de glicose pelos tecidos por maior expressÃ£o dos GLUT.",
                        "updated_at": "2021-05-16 20:41:16.42519 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-16 20:41:03.707505 +0000 UTC"
                }
            ],
            "answer_type": "MULTIPLE_CHOICE",
            "author_id": "vitoria21ribeiro@gmail.com",
            "correct_answer_percentage": 44,
            "created_at": "2020-11-26 10:37:19.619046 +0000 UTC",
            "difficulty_level": "MEDIUM",
            "exams": [
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "6eea706a-42c1-4b98-aeae-dde61a733cae",
                        "jury_id": "58e86d32-df81-42c9-9810-2e519e457a6e",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "046f0505-90c9-4862-b318-388c0d1e8026",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-11-26T10:05:22Z",
                    "degree_proof": false,
                    "id": "4000002037",
                    "location": {
                        "id": "10"
                    },
                    "number": 1,
                    "open_spaces": 10,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "C61A46A9-56EF-DCC6-3BC4-55AE93E2C6C9"
                        },
                        {
                            "type": "NOTICE",
                            "url": "DF40F0BE-F829-9B26-94B6-1424424B11F7"
                        },
                        {
                            "type": "ANSWER",
                            "url": "20AB3477-B075-3CB7-09F8-89B8B98AA4C0"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "6eea706a-42c1-4b98-aeae-dde61a733cae",
                        "jury_id": "58e86d32-df81-42c9-9810-2e519e457a6e",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "dfa90599-1ee1-4de3-8605-a75ecd3799bd",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-11-26T10:05:56Z",
                    "degree_proof": false,
                    "id": "4000002038",
                    "location": {
                        "id": "10"
                    },
                    "number": 1,
                    "open_spaces": 11,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "C61A46A9-56EF-DCC6-3BC4-55AE93E2C6C9"
                        },
                        {
                            "type": "NOTICE",
                            "url": "DF40F0BE-F829-9B26-94B6-1424424B11F7"
                        },
                        {
                            "type": "ANSWER",
                            "url": "20AB3477-B075-3CB7-09F8-89B8B98AA4C0"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "6eea706a-42c1-4b98-aeae-dde61a733cae",
                        "jury_id": "58e86d32-df81-42c9-9810-2e519e457a6e",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "32bef8bd-8aac-4ede-aede-06b9458b026b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-11-26T10:06:19Z",
                    "degree_proof": false,
                    "id": "4000002039",
                    "location": {
                        "id": "10"
                    },
                    "number": 1,
                    "open_spaces": 4,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "C61A46A9-56EF-DCC6-3BC4-55AE93E2C6C9"
                        },
                        {
                            "type": "NOTICE",
                            "url": "DF40F0BE-F829-9B26-94B6-1424424B11F7"
                        },
                        {
                            "type": "ANSWER",
                            "url": "20AB3477-B075-3CB7-09F8-89B8B98AA4C0"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "b9d13d45-c27d-4634-985c-fe9924095039",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "6eea706a-42c1-4b98-aeae-dde61a733cae",
                        "jury_id": "58e86d32-df81-42c9-9810-2e519e457a6e",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "9b34a94d-754d-4510-8bad-60f649fa825b",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-11-26T10:06:41Z",
                    "degree_proof": false,
                    "id": "4000002040",
                    "location": {
                        "id": "10"
                    },
                    "number": 1,
                    "open_spaces": 29,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "C61A46A9-56EF-DCC6-3BC4-55AE93E2C6C9"
                        },
                        {
                            "type": "NOTICE",
                            "url": "DF40F0BE-F829-9B26-94B6-1424424B11F7"
                        },
                        {
                            "type": "ANSWER",
                            "url": "20AB3477-B075-3CB7-09F8-89B8B98AA4C0"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "6eea706a-42c1-4b98-aeae-dde61a733cae",
                        "jury_id": "58e86d32-df81-42c9-9810-2e519e457a6e",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "eca7ae7c-654b-407e-9b37-ad41ad2834b1",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-11-26T10:07:05Z",
                    "degree_proof": false,
                    "id": "4000002041",
                    "location": {
                        "id": "10"
                    },
                    "number": 1,
                    "open_spaces": 2,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "C61A46A9-56EF-DCC6-3BC4-55AE93E2C6C9"
                        },
                        {
                            "type": "NOTICE",
                            "url": "DF40F0BE-F829-9B26-94B6-1424424B11F7"
                        },
                        {
                            "type": "ANSWER",
                            "url": "20AB3477-B075-3CB7-09F8-89B8B98AA4C0"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "6eea706a-42c1-4b98-aeae-dde61a733cae",
                        "jury_id": "58e86d32-df81-42c9-9810-2e519e457a6e",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "0609ccdb-db5c-4c47-a306-31a0a655e95c",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-11-26T10:07:38Z",
                    "degree_proof": false,
                    "id": "4000002042",
                    "location": {
                        "id": "10"
                    },
                    "number": 1,
                    "open_spaces": 6,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "C61A46A9-56EF-DCC6-3BC4-55AE93E2C6C9"
                        },
                        {
                            "type": "NOTICE",
                            "url": "DF40F0BE-F829-9B26-94B6-1424424B11F7"
                        },
                        {
                            "type": "ANSWER",
                            "url": "20AB3477-B075-3CB7-09F8-89B8B98AA4C0"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "6eea706a-42c1-4b98-aeae-dde61a733cae",
                        "jury_id": "58e86d32-df81-42c9-9810-2e519e457a6e",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "2ca62942-4eab-49e5-acaf-e395254eee99",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-11-26T10:07:59Z",
                    "degree_proof": false,
                    "id": "4000002043",
                    "location": {
                        "id": "10"
                    },
                    "number": 1,
                    "open_spaces": 3,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "C61A46A9-56EF-DCC6-3BC4-55AE93E2C6C9"
                        },
                        {
                            "type": "NOTICE",
                            "url": "DF40F0BE-F829-9B26-94B6-1424424B11F7"
                        },
                        {
                            "type": "ANSWER",
                            "url": "20AB3477-B075-3CB7-09F8-89B8B98AA4C0"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "6eea706a-42c1-4b98-aeae-dde61a733cae",
                        "jury_id": "58e86d32-df81-42c9-9810-2e519e457a6e",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "c51ec097-d9c1-43e8-9cc7-af320ab894a1",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-11-26T10:08:28Z",
                    "degree_proof": false,
                    "id": "4000002044",
                    "location": {
                        "id": "10"
                    },
                    "number": 1,
                    "open_spaces": 5,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "C61A46A9-56EF-DCC6-3BC4-55AE93E2C6C9"
                        },
                        {
                            "type": "NOTICE",
                            "url": "DF40F0BE-F829-9B26-94B6-1424424B11F7"
                        },
                        {
                            "type": "ANSWER",
                            "url": "20AB3477-B075-3CB7-09F8-89B8B98AA4C0"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "f30d24a0-2f2d-43be-9812-73746e91a61a",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "6eea706a-42c1-4b98-aeae-dde61a733cae",
                        "jury_id": "58e86d32-df81-42c9-9810-2e519e457a6e",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "66678bdd-d9e1-4267-a4cf-f3beebfd7d0e",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-11-26T10:08:56Z",
                    "degree_proof": false,
                    "id": "4000002045",
                    "location": {
                        "id": "10"
                    },
                    "number": 1,
                    "open_spaces": 1,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "C61A46A9-56EF-DCC6-3BC4-55AE93E2C6C9"
                        },
                        {
                            "type": "NOTICE",
                            "url": "DF40F0BE-F829-9B26-94B6-1424424B11F7"
                        },
                        {
                            "type": "ANSWER",
                            "url": "20AB3477-B075-3CB7-09F8-89B8B98AA4C0"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "6eea706a-42c1-4b98-aeae-dde61a733cae",
                        "jury_id": "58e86d32-df81-42c9-9810-2e519e457a6e",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "8d4e50ad-d41e-40c9-9f4d-842251c2d2d9",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-11-26T10:09:18Z",
                    "degree_proof": false,
                    "id": "4000002046",
                    "location": {
                        "id": "10"
                    },
                    "number": 1,
                    "open_spaces": 4,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "C61A46A9-56EF-DCC6-3BC4-55AE93E2C6C9"
                        },
                        {
                            "type": "NOTICE",
                            "url": "DF40F0BE-F829-9B26-94B6-1424424B11F7"
                        },
                        {
                            "type": "ANSWER",
                            "url": "20AB3477-B075-3CB7-09F8-89B8B98AA4C0"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "6eea706a-42c1-4b98-aeae-dde61a733cae",
                        "jury_id": "58e86d32-df81-42c9-9810-2e519e457a6e",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "f2f2f3c5-9759-4201-bca7-2487751bd626",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-11-26T10:09:44Z",
                    "degree_proof": false,
                    "id": "4000002047",
                    "location": {
                        "id": "10"
                    },
                    "number": 1,
                    "open_spaces": 11,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "C61A46A9-56EF-DCC6-3BC4-55AE93E2C6C9"
                        },
                        {
                            "type": "NOTICE",
                            "url": "DF40F0BE-F829-9B26-94B6-1424424B11F7"
                        },
                        {
                            "type": "ANSWER",
                            "url": "20AB3477-B075-3CB7-09F8-89B8B98AA4C0"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "6eea706a-42c1-4b98-aeae-dde61a733cae",
                        "jury_id": "58e86d32-df81-42c9-9810-2e519e457a6e",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "4d4116be-190d-4321-94c8-66da6d1acb11",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-11-26T10:10:02Z",
                    "degree_proof": false,
                    "id": "4000002048",
                    "location": {
                        "id": "10"
                    },
                    "number": 1,
                    "open_spaces": 3,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "C61A46A9-56EF-DCC6-3BC4-55AE93E2C6C9"
                        },
                        {
                            "type": "NOTICE",
                            "url": "DF40F0BE-F829-9B26-94B6-1424424B11F7"
                        },
                        {
                            "type": "ANSWER",
                            "url": "20AB3477-B075-3CB7-09F8-89B8B98AA4C0"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "6eea706a-42c1-4b98-aeae-dde61a733cae",
                        "jury_id": "58e86d32-df81-42c9-9810-2e519e457a6e",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "710b6098-b1cc-40fb-a6e9-1978c156b947",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-11-26T10:10:26Z",
                    "degree_proof": false,
                    "id": "4000002049",
                    "location": {
                        "id": "10"
                    },
                    "number": 1,
                    "open_spaces": 10,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "C61A46A9-56EF-DCC6-3BC4-55AE93E2C6C9"
                        },
                        {
                            "type": "NOTICE",
                            "url": "DF40F0BE-F829-9B26-94B6-1424424B11F7"
                        },
                        {
                            "type": "ANSWER",
                            "url": "20AB3477-B075-3CB7-09F8-89B8B98AA4C0"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "6eea706a-42c1-4b98-aeae-dde61a733cae",
                        "jury_id": "58e86d32-df81-42c9-9810-2e519e457a6e",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "cccffc77-8a54-477d-b101-01edbb244b74",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-11-26T10:10:46Z",
                    "degree_proof": false,
                    "id": "4000002050",
                    "location": {
                        "id": "10"
                    },
                    "number": 1,
                    "open_spaces": 3,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "C61A46A9-56EF-DCC6-3BC4-55AE93E2C6C9"
                        },
                        {
                            "type": "NOTICE",
                            "url": "DF40F0BE-F829-9B26-94B6-1424424B11F7"
                        },
                        {
                            "type": "ANSWER",
                            "url": "20AB3477-B075-3CB7-09F8-89B8B98AA4C0"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "year": 2021
                },
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 0,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "6eea706a-42c1-4b98-aeae-dde61a733cae",
                        "jury_id": "58e86d32-df81-42c9-9810-2e519e457a6e",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "62f67deb-31ba-415e-aafd-fe626a6d53c0",
                        "specialty_id": "776b092f-eb41-4150-a252-b23a0f7914b3",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-11-26T10:11:05Z",
                    "degree_proof": false,
                    "id": "4000002051",
                    "location": {
                        "id": "10"
                    },
                    "number": 1,
                    "open_spaces": 5,
                    "pdfs": [
                        {
                            "type": "EXAM",
                            "url": "C61A46A9-56EF-DCC6-3BC4-55AE93E2C6C9"
                        },
                        {
                            "type": "NOTICE",
                            "url": "DF40F0BE-F829-9B26-94B6-1424424B11F7"
                        },
                        {
                            "type": "ANSWER",
                            "url": "20AB3477-B075-3CB7-09F8-89B8B98AA4C0"
                        }
                    ],
                    "questions_number": 100,
                    "scholarity": "placeholder",
                    "year": 2021
                }
            ],
            "forum_id": "108a851a-35e5-4715-a35d-b446433a2da5",
            "has_student_answer": false,
            "has_user_solution": false,
            "has_video_solution": true,
            "id": "4000129604",
            "labels": [
                "FINAL_ANSWER_SHEET"
            ],
            "public": true,
            "slug": "Leia-caso-clinico120ac8334b3",
            "solution": {
                "alternative_solutions": null,
                "author_email": "camila.moma@estrategiamed.com.br",
                "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                "brief": "",
                "brief_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "complete": "<b>Gabarito: alternativa (D).</b><div wfd-id=\"692\"><b>ComentÃ¡rios:</b></div><div wfd-id=\"691\">Estamos diante de um paciente com obesidade grau 1 (IMC 34,55 kg/m2), com circunferÃªncia abdominal aumentada (pelos critÃ©rios da NCEP/ATP III, o valor normal seria &lt; 102 cm), hipertensÃ£o arterial e diabetes mellitus. Com tais dados, Ã© possÃ­vel realizar o diagnÃ³stico de sÃ­ndrome metabÃ³lica (o paciente possui 3 critÃ©rios pela NCEP e pela IDF).</div><div wfd-id=\"690\"><!-- BEGIN:IMAGE_TO_REPLACE --><img src=\"https://estrategia-prod-questoes.s3.amazonaws.com/images/955BF47B-388F-2261-2DE2-969A90514CA1/955BF47B-388F-2261-2DE2-969A90514CA1-400.png\"><!-- END:IMAGE_TO_REPLACE --><br></div><div wfd-id=\"698\">A principal caracterÃ­stica da sÃ­ndrome metabÃ³lica Ã© a resistÃªncia Ã  aÃ§Ã£o da insulina, que podemos observar pela presenÃ§a de acantose nigricans e de acrocÃ³rdons. A acantose nigricans Ã© uma lesÃ£o aveludada, hipercrÃ´mica, presente em dobras cutÃ¢neas e que ocorre devido Ã  hiperestimulaÃ§Ã£o dos receptores de IGF presentes nos melanÃ³citos pela insulina (o IGF e a insulina possuem similaridade estrutural e podem estimular o receptor um do outro). Pelo mesmo mecanismo, mas por estimulaÃ§Ã£o de fibroblastos e queratinÃ³citos, hÃ¡ o aparecimento de acrocÃ³rdons, que sÃ£o lesÃµes verrucosas pedunculadas, principalmente em regiÃ£o cervical e axilar.</div><div wfd-id=\"697\"><!-- BEGIN:IMAGE_TO_REPLACE --><img src=\"https://estrategia-prod-questoes.s3.amazonaws.com/images/0B024740-9582-FC0D-2053-72DD0D42C019/0B024740-9582-FC0D-2053-72DD0D42C019-400.png\"><!-- END:IMAGE_TO_REPLACE --><br></div><div wfd-id=\"697\">Assim, devido Ã  presenÃ§a de sÃ­ndrome metabÃ³lica e de resistÃªncia Ã  aÃ§Ã£o da insulina, o diabetes mellitus em questÃ£o Ã© o tipo 2. O paciente faz uso de insulina e alogliptina para o controle glicÃªmico, que ainda se mantÃ©m inadequado. Vamos relembrar as metas terapÃªuticas:</div><div wfd-id=\"697\">â¢\tGlicemia em jejum: &lt; 130 mg/dL</div><div wfd-id=\"697\">â¢\tGlicemia 2 horas apÃ³s a refeiÃ§Ã£o: &lt; 180 mg/dL</div><div wfd-id=\"697\">â¢\tHemoglobina glicada fraÃ§Ã£o A1c: &lt; 7%</div><div wfd-id=\"697\"><br></div><div wfd-id=\"697\">Portanto, Ã© necessÃ¡ria a otimizaÃ§Ã£o do tratamento do paciente, a fim de se evitarem complicaÃ§Ãµes a longo prazo!&nbsp;</div><div wfd-id=\"697\">Como a questÃ£o deseja saber quais medicaÃ§Ãµes atuariam na resistÃªncia Ã  insulina, vamos ver as alternativas:</div><div wfd-id=\"697\"><br></div>",
                "complete_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "created_at": "2021-05-16 20:33:31.613496 +0000 UTC",
                "id": "185df230-1447-4490-8b87-e92842765f4f",
                "is_default": false,
                "sanitized_brief": "",
                "sanitized_complete": "Gabarito: alternativa (D).ComentÃ¡rios:Estamos diante de um paciente com obesidade grau 1 (IMC 34,55 kg/m2), com circunferÃªncia abdominal aumentada (pelos critÃ©rios da NCEP/ATP III, o valor normal seria &lt; 102 cm), hipertensÃ£o arterial e diabetes mellitus. Com tais dados, Ã© possÃ­vel realizar o diagnÃ³stico de sÃ­ndrome metabÃ³lica (o paciente possui 3 critÃ©rios pela NCEP e pela IDF).A principal caracterÃ­stica da sÃ­ndrome metabÃ³lica Ã© a resistÃªncia Ã  aÃ§Ã£o da insulina, que podemos observar pela presenÃ§a de acantose nigricans e de acrocÃ³rdons. A acantose nigricans Ã© uma lesÃ£o aveludada, hipercrÃ´mica, presente em dobras cutÃ¢neas e que ocorre devido Ã  hiperestimulaÃ§Ã£o dos receptores de IGF presentes nos melanÃ³citos pela insulina (o IGF e a insulina possuem similaridade estrutural e podem estimular o receptor um do outro). Pelo mesmo mecanismo, mas por estimulaÃ§Ã£o de fibroblastos e queratinÃ³citos, hÃ¡ o aparecimento de acrocÃ³rdons, que sÃ£o lesÃµes verrucosas pedunculadas, principalmente em regiÃ£o cervical e axilar.Assim, devido Ã  presenÃ§a de sÃ­ndrome metabÃ³lica e de resistÃªncia Ã  aÃ§Ã£o da insulina, o diabetes mellitus em questÃ£o Ã© o tipo 2. O paciente faz uso de insulina e alogliptina para o controle glicÃªmico, que ainda se mantÃ©m inadequado. Vamos relembrar as metas terapÃªuticas:â¢\tGlicemia em jejum: &lt; 130 mg/dLâ¢\tGlicemia 2 horas apÃ³s a refeiÃ§Ã£o: &lt; 180 mg/dLâ¢\tHemoglobina glicada fraÃ§Ã£o A1c: &lt; 7%Portanto, Ã© necessÃ¡ria a otimizaÃ§Ã£o do tratamento do paciente, a fim de se evitarem complicaÃ§Ãµes a longo prazo!Â Como a questÃ£o deseja saber quais medicaÃ§Ãµes atuariam na resistÃªncia Ã  insulina, vamos ver as alternativas:",
                "updated_at": "2021-05-16 20:41:16.495314 +0000 UTC",
                "video_solution_id": "b37f536b-220e-4dc2-bbc7-ba70180028ed"
            },
            "statement": "Leia o caso clÃ­nico a seguir.<div><br><div>Paciente do sexo masculino, de 43 anos, procurou endocrinologista devido a quadro de diabetes descompensado apesar do uso de insulina nph - 60 unidades, duas vezes ao dia, associado a alogliptina-25mg/dia. Tem diagnÃ³stico de HAS e apneia do sono, porÃ©m sem tratamento. Ao exame, altura: 1,69 m; peso: 98,7 kg; IMC: 34.55 kg/mÂ²; cintura abdominal: 111 cm. FC: 88 BPM. PA: 155/98 mmHg. PresenÃ§a de acantose nigricans axilar e acrocÃ³rdons na regiÃ£o cervical. Exames laboratoriais com glicemia de jejum: 185 mg/dL e glicemia pÃ³s-prandial: 205 mg/dL. Hemoglobina glicada de 9,7%. PeptÃ­deo C jejum:</div><div>3,5 ng/mL.</div><div><br></div><div>Com o objetivo de amenizar o quadro de resistÃªncia insulÃ­nica do paciente, quais drogas teriam efeito direto na melhora da sensibilidade insulÃ­nica?</div><div>&nbsp;</div></div>",
            "statement_text": "Leia o caso clÃ­nico a seguir.Paciente do sexo masculino, de 43 anos, procurou endocrinologista devido a quadro de diabetes descompensado apesar do uso de insulina nph - 60 unidades, duas vezes ao dia, associado a alogliptina-25mg/dia. Tem diagnÃ³stico de HAS e apneia do sono, porÃ©m sem tratamento. Ao exame, altura: 1,69 m; peso: 98,7 kg; IMC: 34.55 kg/mÂ²; cintura abdominal: 111 cm. FC: 88 BPM. PA: 155/98 mmHg. PresenÃ§a de acantose nigricans axilar e acrocÃ³rdons na regiÃ£o cervical. Exames laboratoriais com glicemia de jejum: 185 mg/dL e glicemia pÃ³s-prandial: 205 mg/dL. Hemoglobina glicada de 9,7%. PeptÃ­deo C jejum:3,5 ng/mL.Com o objetivo de amenizar o quadro de resistÃªncia insulÃ­nica do paciente, quais drogas teriam efeito direto na melhora da sensibilidade insulÃ­nica?Â ",
            "status": {
                "change_actor": "cnishiama@admin.admin",
                "created_at": "2021-05-18 04:04:04.210345 +0000 UTC",
                "owner": "camila.moma@estrategiamed.com.br",
                "value": "APPROVED"
            },
            "topics": [
                {
                    "has_children": false,
                    "id": "3b9e1e9de9ba4ff3959ae83d455880f9",
                    "master_id": "778ea293dac8426ab5447d56646b3e72",
                    "name": "Drogas antidiabÃ©ticas nÃ£o insulina",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Tratamento[$$]Tratamento medicamentoso[$$]Drogas antidiabÃ©ticas nÃ£o insulina"
                },
                {
                    "has_children": false,
                    "id": "778ea293dac8426ab5447d56646b3e72",
                    "master_id": "e39487f7326345f982716782efb6d872",
                    "name": "Tratamento medicamentoso",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Tratamento[$$]Tratamento medicamentoso"
                },
                {
                    "has_children": false,
                    "id": "8bdc1fbeb2e54046a2c3ba4ac4e63ead",
                    "master_id": "3b9e1e9de9ba4ff3959ae83d455880f9",
                    "name": "MedicaÃ§Ãµes com efeito sensibilizador de insulina",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Tratamento[$$]Tratamento medicamentoso[$$]Drogas antidiabÃ©ticas nÃ£o insulina[$$]MedicaÃ§Ãµes com efeito sensibilizador de insulina"
                },
                {
                    "has_children": false,
                    "id": "ab6c6a1fb6604cf98243ac486f80dac8",
                    "master_id": "0a6abdce2fbc45aa8ba8f0e75875ec84",
                    "name": "Endocrinologia ",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia "
                }
            ],
            "unlisted": false,
            "video_solution": {
                "available_resolutions": [
                    {
                        "resolution": "720",
                        "url": "https://api.estrategia.com/questoes/sign/medicina/processadas/4000129604-720.mp4"
                    }
                ],
                "id": "b37f536b-220e-4dc2-bbc7-ba70180028ed",
                "identifier": "",
                "question_id": "4000129604"
            },
            "video_solution_id": "b37f536b-220e-4dc2-bbc7-ba70180028ed"
        },
        {
            "active": true,
            "alternatives": [
                {
                    "answer_percentage": 9,
                    "answers": 160,
                    "body": "Saxagliptina",
                    "correct": false,
                    "created_at": "2020-12-08 04:00:12.913422 +0000 UTC",
                    "id": "b12e69bb-19a5-4704-9c7e-d1d5de473298",
                    "position": "0",
                    "sanitized_body": "Saxagliptina",
                    "solution": {
                        "alternative_id": "b12e69bb-19a5-4704-9c7e-d1d5de473298",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (A) Ã© incorreta. </b>A saxagliptina Ã© um inibidor de DPP-4, tambÃ©m chamado de gliptina. Atua inibindo a dipeptidil peptidase-4 (DPP-4), enzima responsÃ¡vel pela clivagem do GLP-1, permitindo, assim, o aumento dos nÃ­veis endÃ³genos desse hormÃ´nio. Apesar do aumento do GLP-1, nÃ£o hÃ¡ perda ponderal (essa classe de drogas Ã© neutra em relaÃ§Ã£o ao peso).",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-17 01:43:41.929759 +0000 UTC",
                        "id": "9510114e-5868-475d-91ac-5cf307cd9296",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (A) Ã© incorreta. A saxagliptina Ã© um inibidor de DPP-4, tambÃ©m chamado de gliptina. Atua inibindo a dipeptidil peptidase-4 (DPP-4), enzima responsÃ¡vel pela clivagem do GLP-1, permitindo, assim, o aumento dos nÃ­veis endÃ³genos desse hormÃ´nio. Apesar do aumento do GLP-1, nÃ£o hÃ¡ perda ponderal (essa classe de drogas Ã© neutra em relaÃ§Ã£o ao peso).",
                        "updated_at": "2021-05-17 01:43:44.275685 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-17 01:42:29.336611 +0000 UTC"
                },
                {
                    "answer_percentage": 8,
                    "answers": 136,
                    "body": "Gliclazida",
                    "correct": false,
                    "created_at": "2020-12-08 04:00:12.913422 +0000 UTC",
                    "id": "dc65e8e4-2eae-47d5-9807-94fd52c93e57",
                    "position": "1",
                    "sanitized_body": "Gliclazida",
                    "solution": {
                        "alternative_id": "dc65e8e4-2eae-47d5-9807-94fd52c93e57",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (B) Ã© incorreta.</b> A gliclazida pertence Ã  classe das sulfonilureias, medicaÃ§Ãµes que estimulam a secreÃ§Ã£o de insulina de forma independente dos nÃ­veis glicÃªmicos. Por conta disso, hÃ¡ aumento do risco de hipoglicemias e do ganho ponderal (a insulina Ã© um hormÃ´nio anabÃ³lico na periferia, levando Ã  maior captaÃ§Ã£o de glicose, estimulando a sÃ­ntese proteica e inibindo a lipÃ³lise).",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-17 01:43:41.901113 +0000 UTC",
                        "id": "17b9e919-4e1e-4a99-898a-088270f52fd8",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (B) Ã© incorreta. A gliclazida pertence Ã  classe das sulfonilureias, medicaÃ§Ãµes que estimulam a secreÃ§Ã£o de insulina de forma independente dos nÃ­veis glicÃªmicos. Por conta disso, hÃ¡ aumento do risco de hipoglicemias e do ganho ponderal (a insulina Ã© um hormÃ´nio anabÃ³lico na periferia, levando Ã  maior captaÃ§Ã£o de glicose, estimulando a sÃ­ntese proteica e inibindo a lipÃ³lise).",
                        "updated_at": "2021-05-17 01:43:44.291724 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-17 01:42:29.449478 +0000 UTC"
                },
                {
                    "answer_percentage": 5,
                    "answers": 82,
                    "body": "Rosiglitazona",
                    "correct": false,
                    "created_at": "2020-12-08 04:00:12.913422 +0000 UTC",
                    "id": "2df5a6a3-45f4-4224-a183-02d3badd4d47",
                    "position": "2",
                    "sanitized_body": "Rosiglitazona",
                    "solution": {
                        "alternative_id": "2df5a6a3-45f4-4224-a183-02d3badd4d47",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (C) Ã© incorreta. </b>A rosiglitazona Ã© um agonista do PPAR-áµ (receptor de ativaÃ§Ã£o da proliferaÃ§Ã£o de peroxissomos- gama), cuja funÃ§Ã£o Ã© melhorar a resistÃªncia perifÃ©rica Ã  insulina. Atua em receptores intranucleares, levando a modificaÃ§Ãµes que culminam com maior captaÃ§Ã£o de glicose pelas cÃ©lulas. Promove ganho de peso, uma vez que estimula centros hipotalÃ¢micos, com consequente aumento de apetite.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-17 01:43:41.877583 +0000 UTC",
                        "id": "3ca51caa-3abb-44ab-af4c-aa2004997a6f",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (C) Ã© incorreta. A rosiglitazona Ã© um agonista do PPAR-áµ (receptor de ativaÃ§Ã£o da proliferaÃ§Ã£o de peroxissomos- gama), cuja funÃ§Ã£o Ã© melhorar a resistÃªncia perifÃ©rica Ã  insulina. Atua em receptores intranucleares, levando a modificaÃ§Ãµes que culminam com maior captaÃ§Ã£o de glicose pelas cÃ©lulas. Promove ganho de peso, uma vez que estimula centros hipotalÃ¢micos, com consequente aumento de apetite.",
                        "updated_at": "2021-05-17 01:43:44.266752 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-17 01:42:29.57045 +0000 UTC"
                },
                {
                    "answer_percentage": 78,
                    "answers": 1371,
                    "body": "Semaglutida",
                    "correct": true,
                    "created_at": "2020-12-08 04:00:12.913422 +0000 UTC",
                    "id": "1afbbaba-fab9-422e-a63c-1407f05f701a",
                    "position": "3",
                    "sanitized_body": "Semaglutida",
                    "solution": {
                        "alternative_id": "1afbbaba-fab9-422e-a63c-1407f05f701a",
                        "author_email": "camila.moma@estrategiamed.com.br",
                        "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                        "brief": "",
                        "brief_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "complete": "<b>Alternativa (D) Ã© correta. </b>A semaglutida Ã© um anÃ¡logo de GLP-1 com apresentaÃ§Ã£o injetÃ¡vel (uso subcutÃ¢neo, 1 vez por semana) e em comprimidos (uso oral, diÃ¡rio). Promove maior secreÃ§Ã£o de insulina, que ocorre de forma dependente dos nÃ­veis glicÃªmicos, reduz a produÃ§Ã£o de glucagon, retarda o esvaziamento gÃ¡strico e diminui o apetite atravÃ©s de aÃ§Ã£o central. Ã relacionada Ã  perda ponderal e, portanto, seria uma excelente opÃ§Ã£o para pacientes com diabetes mellitus tipo 2 e obesidade.",
                        "complete_attachments": [
                            {
                                "type": "AUDIO"
                            }
                        ],
                        "created_at": "2021-05-17 01:43:41.874192 +0000 UTC",
                        "id": "0bc5ae27-763c-43ab-a904-b4c0317302f4",
                        "sanitized_brief": "",
                        "sanitized_complete": "Alternativa (D) Ã© correta. A semaglutida Ã© um anÃ¡logo de GLP-1 com apresentaÃ§Ã£o injetÃ¡vel (uso subcutÃ¢neo, 1 vez por semana) e em comprimidos (uso oral, diÃ¡rio). Promove maior secreÃ§Ã£o de insulina, que ocorre de forma dependente dos nÃ­veis glicÃªmicos, reduz a produÃ§Ã£o de glucagon, retarda o esvaziamento gÃ¡strico e diminui o apetite atravÃ©s de aÃ§Ã£o central. Ã relacionada Ã  perda ponderal e, portanto, seria uma excelente opÃ§Ã£o para pacientes com diabetes mellitus tipo 2 e obesidade.",
                        "updated_at": "2021-05-17 01:43:44.289896 +0000 UTC"
                    },
                    "topics": [],
                    "updated_at": "2021-05-17 01:42:29.661565 +0000 UTC"
                }
            ],
            "answer_type": "MULTIPLE_CHOICE",
            "author_id": "bruno-cesar110@hotmail.com",
            "correct_answer_percentage": 78,
            "created_at": "2020-12-08 04:00:12.913422 +0000 UTC",
            "difficulty_level": "MEDIUM",
            "exams": [
                {
                    "accepted_candidates_number": 0,
                    "active": true,
                    "answers_type": "MÃºltipla escolha",
                    "author_id": "placeholder",
                    "candidates_number": 173,
                    "catalogs": {
                        "duration_id": "27dbfbf8-939d-4abc-b3d8-ea268d974c45",
                        "goal_id": "42bcdb35-c6b9-4ff2-bac0-2d2fa575f042",
                        "institution_id": "1a4c6e1c-9e91-41cf-ad6c-09af827d1642",
                        "jury_id": "4bc36cd6-7d4c-4b2a-967e-78a854b504b9",
                        "residency_id": "af7e85c2-2c30-4a9a-ba79-8caf9d22e744",
                        "sector_id": "b35c6fce-73ec-4b54-aae8-ad664a219e03",
                        "specialty_id": "710b6098-b1cc-40fb-a6e9-1978c156b947",
                        "subspecialty_id": "c0fb2a79-d5f3-4686-8eb4-078b329da379"
                    },
                    "created_at": "2020-12-08T02:38:21Z",
                    "degree_proof": false,
                    "id": "4000002181",
                    "location": {
                        "id": "2906"
                    },
                    "number": 1,
                    "open_spaces": 16,
                    "pdfs": [
                        {
                            "type": "NOTICE",
                            "url": "E8292FF7-9B84-959A-9FFA-BD3245BF1E62"
                        },
                        {
                            "type": "ANSWER",
                            "url": "809BAD6E-6F00-52A4-B5E7-8477447CDCB8"
                        },
                        {
                            "type": "EXAM",
                            "url": "7194893E-38B8-CAE4-FF00-BD4E9E5532AA"
                        }
                    ],
                    "questions_number": 100,
                    "remuneration": 333043,
                    "scholarity": "placeholder",
                    "subscription_fee": 450,
                    "year": 2021
                }
            ],
            "has_student_answer": false,
            "has_user_solution": false,
            "has_video_solution": true,
            "id": "4000131048",
            "labels": [
                "TEMPORARY_ANSWER_SHEET"
            ],
            "public": true,
            "slug": "Duas-condicoes215d09afec",
            "solution": {
                "alternative_solutions": null,
                "author_email": "camila.moma@estrategiamed.com.br",
                "author_id": "0c6f57bb-669d-4b82-aa45-baaed91e6f6c",
                "brief": "",
                "brief_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "complete": "<b>Gabarito: alternativa (D).</b><div><b>ComentÃ¡rios:</b></div><div>Nas Ãºltimas dÃ©cadas, tem se observado um aumento paralelo na prevalÃªncia de diabetes mellitus tipo 2 e de obesidade; esta Ãºltima, por apresentar um processo inflamatÃ³rio crÃ´nico que predispÃµe Ã  formaÃ§Ã£o da resistÃªncia Ã  insulina, Ã© um dos principais fatores de risco para desenvolvimento da hiperglicemia.</div><div>Assim, a perda ponderal Ã© um ponto-chave na prevenÃ§Ã£o do diabetes mellitus e, nos indivÃ­duos jÃ¡ portadores da doenÃ§a, Ã© fundamental para a melhora do controle glicÃªmico, impactando no risco de desenvolvimento de complicaÃ§Ãµes a longo prazo.</div><div>Quando escolhemos o tratamento para diabetes mellitus tipo 2, temos a metformina como primeira opÃ§Ã£o terapÃªutica. Ã uma droga que melhora a resistÃªncia Ã  aÃ§Ã£o da insulina, com aÃ§Ã£o predominantemente hepÃ¡tica, reduzindo a produÃ§Ã£o hepÃ¡tica de glicose. NÃ£o causa ganho ponderal nem hipoglicemias, alÃ©m de ter baixo custo, o que a torna a preferÃªncia para o inÃ­cio do tratamento.</div><div>Entretanto, nos indivÃ­duos que ainda estÃ£o fora das metas terapÃªuticas (hemoglobina glicada &lt; 7%) ou apresentam valores de hemoglobina glicada ao diagnÃ³stico &gt; 7,5%, Ã© necessÃ¡ria a introduÃ§Ã£o de uma segunda droga associada Ã  metformina. Nos pacientes com sobrepeso e obesidade, sempre que possÃ­vel, devemos optar por medicaÃ§Ãµes que nÃ£o causem ganho ponderal ou que possibilitem a perda de peso, como os inibidores de SGLT-2 e os anÃ¡logos/agonistas de GLP-1.</div><div>Os inibidores de SGLT-2 sÃ£o drogas que inibem o transportador de sÃ³dio e glicose tipo 2 presentes no tÃºbulo proximal renal, levando Ã  glicosÃºria. A perda de glicose faz com que ocorra um balanÃ§o energÃ©tico negativo, reduzindo o peso.</div><div>JÃ¡ os anÃ¡logos/agonistas de GLP-1 sÃ£o drogas que se assemelham ao prÃ³prio GLP-1, porÃ©m, com meia-vida mais longa. Estimulam a secreÃ§Ã£o de insulina, que ocorre de forma dependente dos nÃ­veis glicÃªmicos (nÃ£o causando hipoglicemias), reduzem o glucagon e atuam no hipotÃ¡lamo, diminuindo o apetite. Por isto, estÃ£o associados Ã  perda ponderal.&nbsp;</div><div><br></div>",
                "complete_attachments": [
                    {
                        "type": "AUDIO"
                    }
                ],
                "created_at": "2021-05-17 01:43:41.989855 +0000 UTC",
                "id": "4db1d0dd-a9a8-45a7-b06f-305e756e43c6",
                "is_default": false,
                "sanitized_brief": "",
                "sanitized_complete": "Gabarito: alternativa (D).ComentÃ¡rios:Nas Ãºltimas dÃ©cadas, tem se observado um aumento paralelo na prevalÃªncia de diabetes mellitus tipo 2 e de obesidade; esta Ãºltima, por apresentar um processo inflamatÃ³rio crÃ´nico que predispÃµe Ã  formaÃ§Ã£o da resistÃªncia Ã  insulina, Ã© um dos principais fatores de risco para desenvolvimento da hiperglicemia.Assim, a perda ponderal Ã© um ponto-chave na prevenÃ§Ã£o do diabetes mellitus e, nos indivÃ­duos jÃ¡ portadores da doenÃ§a, Ã© fundamental para a melhora do controle glicÃªmico, impactando no risco de desenvolvimento de complicaÃ§Ãµes a longo prazo.Quando escolhemos o tratamento para diabetes mellitus tipo 2, temos a metformina como primeira opÃ§Ã£o terapÃªutica. Ã uma droga que melhora a resistÃªncia Ã  aÃ§Ã£o da insulina, com aÃ§Ã£o predominantemente hepÃ¡tica, reduzindo a produÃ§Ã£o hepÃ¡tica de glicose. NÃ£o causa ganho ponderal nem hipoglicemias, alÃ©m de ter baixo custo, o que a torna a preferÃªncia para o inÃ­cio do tratamento.Entretanto, nos indivÃ­duos que ainda estÃ£o fora das metas terapÃªuticas (hemoglobina glicada &lt; 7%) ou apresentam valores de hemoglobina glicada ao diagnÃ³stico &gt; 7,5%, Ã© necessÃ¡ria a introduÃ§Ã£o de uma segunda droga associada Ã  metformina. Nos pacientes com sobrepeso e obesidade, sempre que possÃ­vel, devemos optar por medicaÃ§Ãµes que nÃ£o causem ganho ponderal ou que possibilitem a perda de peso, como os inibidores de SGLT-2 e os anÃ¡logos/agonistas de GLP-1.Os inibidores de SGLT-2 sÃ£o drogas que inibem o transportador de sÃ³dio e glicose tipo 2 presentes no tÃºbulo proximal renal, levando Ã  glicosÃºria. A perda de glicose faz com que ocorra um balanÃ§o energÃ©tico negativo, reduzindo o peso.JÃ¡ os anÃ¡logos/agonistas de GLP-1 sÃ£o drogas que se assemelham ao prÃ³prio GLP-1, porÃ©m, com meia-vida mais longa. Estimulam a secreÃ§Ã£o de insulina, que ocorre de forma dependente dos nÃ­veis glicÃªmicos (nÃ£o causando hipoglicemias), reduzem o glucagon e atuam no hipotÃ¡lamo, diminuindo o apetite. Por isto, estÃ£o associados Ã  perda ponderal.Â ",
                "updated_at": "2021-05-17 01:43:44.40826 +0000 UTC",
                "video_solution_id": "23d5588a-d960-4950-a903-4d91b19463b3"
            },
            "statement": "Duas condiÃ§Ãµes clÃ­nicas comumente sobrepostas sÃ£o a obesidade e o diabetes.&nbsp;<div><br></div><div>Qual dos antiabÃ©ticos abaixo possui efeito tambÃ©m na reduÃ§Ã£o de peso?</div>",
            "statement_text": "Duas condiÃ§Ãµes clÃ­nicas comumente sobrepostas sÃ£o a obesidade e o diabetes.Â Qual dos antiabÃ©ticos abaixo possui efeito tambÃ©m na reduÃ§Ã£o de peso?",
            "status": {
                "change_actor": "cnishiama@admin.admin",
                "created_at": "2021-05-18 04:01:22.05202 +0000 UTC",
                "owner": "camila.moma@estrategiamed.com.br",
                "value": "APPROVED"
            },
            "topics": [
                {
                    "has_children": false,
                    "id": "3b9e1e9de9ba4ff3959ae83d455880f9",
                    "master_id": "778ea293dac8426ab5447d56646b3e72",
                    "name": "Drogas antidiabÃ©ticas nÃ£o insulina",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Tratamento[$$]Tratamento medicamentoso[$$]Drogas antidiabÃ©ticas nÃ£o insulina"
                },
                {
                    "has_children": false,
                    "id": "778ea293dac8426ab5447d56646b3e72",
                    "master_id": "e39487f7326345f982716782efb6d872",
                    "name": "Tratamento medicamentoso",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Diabetes [$$]Diabetes Mellitus tipo 2 (DM 2)[$$]Tratamento[$$]Tratamento medicamentoso"
                },
                {
                    "has_children": false,
                    "id": "88b13354f06e4ec4b00661d442521c5e",
                    "master_id": "81ff3de13a7b48f09b3a721395b68db5",
                    "name": "Tratamento medicamentoso",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia [$$]Obesidade e sÃ­ndrome metabÃ³lica[$$]Tratamento nÃ£o medicamentoso[$$]Tratamento medicamentoso"
                },
                {
                    "has_children": false,
                    "id": "ab6c6a1fb6604cf98243ac486f80dac8",
                    "master_id": "0a6abdce2fbc45aa8ba8f0e75875ec84",
                    "name": "Endocrinologia ",
                    "order_index": 0,
                    "path": "ClÃ­nica MÃ©dica[$$]Endocrinologia "
                }
            ],
            "unlisted": false,
            "video_solution": {
                "available_resolutions": [
                    {
                        "resolution": "720",
                        "url": "https://api.estrategia.com/questoes/sign/medicina/processadas/4000131048-720.mp4"
                    }
                ],
                "id": "23d5588a-d960-4950-a903-4d91b19463b3",
                "identifier": "",
                "question_id": "4000131048"
            },
            "video_solution_id": "23d5588a-d960-4950-a903-4d91b19463b3"
        }
    ]
}